Table of Contents

 

 

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549


 

FORM 10-Q

 

x   Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended September 30, 2015

 

or

 

o   Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from              to             

 

Commission File Number 00 1-31901

 

PROTECTIVE LIFE INSURANCE COMPANY

(Exact name of registrant as specified in its charter)

 

TENNESSEE

 

63-0169720

(State or other jurisdiction of incorporation or organization)

 

(IRS Employer Identification Number)

 

2801 HIGHWAY 280 SOUTH

BIRMINGHAM, ALABAMA 35223

(Address of principal executive offices and zip code)

 

(205) 268-1000

(Registrant’s telephone number, including area code)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x   No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x   No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer, or a smaller reporting company. See definition of “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer o

 

Accelerated Filer o

 

 

 

Non-accelerated filer x

 

Smaller Reporting Company o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes o   No x

 

Number of shares of Common Stock, $1.00 Par Value, outstanding as of October 1, 2015:  5,000,000

 

 

 



Table of Contents

 

PROTECTIVE LIFE INSURANCE COMPANY

QUARTERLY REPORT ON FORM 10-Q

FOR QUARTERLY PERIOD ENDED SEPTEMBER 30, 2015

 

TABLE OF CONTENTS

 

 

 

Page

 

PART I

 

 

 

 

Item 1.

Financial Statements (unaudited):

 

 

Consolidated Condensed Statements of Income For The Three Months Ended September 30, 2015 (Successor Company), the Period of February 1, 2015 to September 30, 2015 (Successor Company), the Period of January 1, 2015 to January 31, 2015 (Predecessor Company) and For The Three and Nine Months Ended September 30, 2014 (Predecessor Company)

3

 

Consolidated Condensed Statements of Comprehensive Income (Loss) For The Three Months Ended September 30, 2015 (Successor Company), the Period of February 1, 2015 to September 30, 2015 (Successor Company), the Period of January 1, 2015 to January 31, 2015 (Predecessor Company) and For The Three and Nine Months Ended September 31, 2014 (Predecessor Company)

4

 

Consolidated Condensed Balance Sheets as of September 30, 2015 (Successor Company) and December 31, 2014 (Predecessor Company)

5

 

Consolidated Condensed Statements of Shareowner’s Equity for the Period of February 1, 2015 to September 30, 2015 (Successor Company) and for the Period of January 1, 2015 to January 31, 2015 (Predecessor Company)

7

 

Consolidated Condensed Statements of Cash Flows for the Period of February 1, 2015 to September 30, 2015 (Successor Company), the Period of January 1, 2015 to January 31, 2015 (Predecessor Company) and For The Nine Months Ended September 31, 2014 (Predecessor Company)

8

 

Notes to Consolidated Condensed Financial Statements

9

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

81

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

156

Item 4.

Controls and Procedures

156

 

 

 

 

PART II

 

 

 

 

Item 1A.

Risk Factors

 157

Item 6.

Exhibits

168

 

Signature

169

 

2



Table of Contents

 

PROTECTIVE LIFE INSURANCE COMPANY

CONSOLIDATED CONDENSED STATEMENTS OF INCOME

(Unaudited)

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Revenues

 

 

 

 

 

 

 

 

 

 

 

 

Premiums and policy fees

 

$

793,572

 

$

2,128,016

 

 

$

260,582

 

$

755,300

 

$

2,415,806

 

Reinsurance ceded

 

(312,256

)

(810,265

)

 

(91,632

)

(283,104

)

(964,865

)

Net of reinsurance ceded

 

481,316

 

1,317,751

 

 

168,950

 

472,196

 

1,450,941

 

Net investment income

 

413,544

 

1,093,902

 

 

164,605

 

532,861

 

1,572,474

 

Realized investment gains (losses):

 

 

 

 

 

 

 

 

 

 

 

 

Derivative financial instruments

 

41,895

 

47,513

 

 

22,031

 

41,769

 

(34,425

)

All other investments

 

5,309

 

(132,094

)

 

81,153

 

(116

)

152,496

 

Other-than-temporary impairment losses

 

(14,906

)

(28,301

)

 

(636

)

(1,142

)

(2,026

)

Portion recognized in other comprehensive income (before taxes)

 

4,842

 

12,503

 

 

155

 

(1,212

)

(3,379

)

Net impairment losses recognized in earnings

 

(10,064

)

(15,798

)

 

(481

)

(2,354

)

(5,405

)

Other income

 

74,671

 

199,311

 

 

23,388

 

72,404

 

209,214

 

Total revenues

 

1,006,671

 

2,510,585

 

 

459,646

 

1,116,760

 

3,345,295

 

Benefits and expenses

 

 

 

 

 

 

 

 

 

 

 

 

Benefits and settlement expenses, net of reinsurance ceded: (2015 Successor - $265,315 and $685,256); (2015 Predecessor - $87,830; 2014 Predecessor - three months: $217,179; nine months: $849,151)

 

674,815

 

1,853,631

 

 

266,575

 

628,527

 

2,102,596

 

Amortization of deferred policy acquisition costs and value of business acquired

 

8,979

 

77,363

 

 

4,817

 

140,517

 

266,572

 

Other operating expenses, net of reinsurance ceded: (2015 Successor - $51,174 and $138,013); (2015 Predecessor - $17,700; 2014 Predecessor - three months: $49,909; nine months: $141,502)

 

166,756

 

434,501

 

 

55,407

 

163,596

 

467,781

 

Total benefits and expenses

 

850,550

 

2,365,495

 

 

326,799

 

932,640

 

2,836,949

 

Income before income tax

 

156,121

 

145,090

 

 

132,847

 

184,120

 

508,346

 

Income tax expense

 

42,542

 

40,667

 

 

44,325

 

62,287

 

167,921

 

Net income

 

$

113,579

 

$

104,423

 

 

$

88,522

 

$

121,833

 

$

340,425

 

 

See Notes to Consolidated Condensed Financial Statements

 

3



Table of Contents

 

PROTECTIVE LIFE INSURANCE COMPANY

CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Net income

 

$

113,579

 

$

104,423

 

 

$

88,522

 

$

121,833

 

$

340,425

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

Change in net unrealized gains (losses) on investments, net of income tax: (2015 Successor - $(25,285) and $(506,797)); (2015 Predecessor - $259,616; 2014 Predecessor - three months: $(46,077); nine months: $429,653)

 

(46,958

)

(941,196

)

 

482,143

 

(85,574

)

797,925

 

Reclassification adjustment for investment amounts included in net income, net of income tax: (2015 Successor - $3,961 and $4,664); (2015 Predecessor - $(2,244); 2014 Predecessor - three months: $(6,962); nine months: $(15,543))

 

7,356

 

8,664

 

 

(4,166

)

(12,928

)

(28,864

)

Change in net unrealized gains (losses) relating to other-than-temporary impaired investments for which a portion has been recognized in earnings, net of income tax: (2015 Successor - $781 and $(1,677)); (2015 Predecessor - $(131); 2014 Predecessor - three months: $561; nine months: $2,419)

 

1,451

 

(3,115

)

 

(243

)

1,044

 

4,494

 

Change in accumulated (loss) gain - derivatives, net of income tax: (2015 Successor - $0 and $(45); (2015 Predecessor - $5; 2014 Predecessor - three months: $(22); nine months: $(31))

 

 

(86

)

 

9

 

(41

)

(58

)

Reclassification adjustment for derivative amounts included in net income, net of income tax: (2015 Successor - $0 and $45); (2015 Predecessor - $13; 2014 Predecessor - three months: $103; nine months: $552)

 

 

86

 

 

23

 

190

 

1,025

 

Total other comprehensive income (loss)

 

(38,151

)

(935,647

)

 

477,766

 

(97,309

)

774,522

 

Total comprehensive income (loss)

 

$

75,428

 

$

(831,224

)

 

$

566,288

 

$

24,524

 

$

1,114,947

 

 

See Notes to Consolidated Condensed Financial Statements

 

4



Table of Contents

 

PROTECTIVE LIFE INSURANCE COMPANY

CONSOLIDATED CONDENSED BALANCE SHEETS

(Unaudited)

 

 

 

Successor

 

Predecessor

 

 

 

Company

 

Company

 

 

 

As of

 

 

As of

 

 

 

September 30, 2015

 

 

December 31, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Assets

 

 

 

 

 

 

Fixed maturities, at fair value (amortized cost: 2015 Successor - $37,813,135; 2014 Predecessor - $33,716,848)

 

$

35,601,843

 

 

$

36,756,240

 

Fixed maturities, at amortized cost (fair value: 2015 Successor - $518,363; 2014 Predecessor - $485,422)

 

579,329

 

 

435,000

 

Equity securities, at fair value (cost: 2015 Successor - $692,622; 2014 Predecessor - $735,297)

 

684,696

 

 

756,790

 

Mortgage loans (related to securitizations: 2015 Successor - $382,738; 2014 Predecessor - $455,250)

 

5,728,237

 

 

5,133,780

 

Investment real estate, net of accumulated depreciation (2015 Successor - $86 2014 Predecessor - $246)

 

7,515

 

 

5,918

 

Policy loans

 

1,706,402

 

 

1,758,237

 

Other long-term investments

 

619,743

 

 

491,282

 

Short-term investments

 

233,337

 

 

246,717

 

Total investments

 

45,161,102

 

 

45,583,964

 

Cash

 

517,900

 

 

268,286

 

Accrued investment income

 

483,095

 

 

474,095

 

Accounts and premiums receivable

 

55,890

 

 

81,137

 

Reinsurance receivables

 

5,356,738

 

 

5,907,662

 

Deferred policy acquisition costs and value of business acquired

 

1,469,723

 

 

3,155,046

 

Goodwill

 

735,712

 

 

77,577

 

Other intangibles, net of accumulated amortization (2015 Successor - $27,541)

 

655,459

 

 

 

Property and equipment, net of accumulated depreciation (2015 Successor - $5,662; 2014 Predecessor - $116,688)

 

102,723

 

 

51,760

 

Other assets

 

249,821

 

 

398,574

 

Income tax receivable

 

 

 

1,648

 

Assets related to separate accounts

 

 

 

 

 

 

Variable annuity

 

12,646,751

 

 

13,157,429

 

Variable universal life

 

792,800

 

 

834,940

 

Total assets

 

$

68,227,714

 

 

$

69,992,118

 

 

See Notes to Consolidated Condensed Financial Statements

 

5



Table of Contents

 

PROTECTIVE LIFE INSURANCE COMPANY

CONSOLIDATED CONDENSED BALANCE SHEETS

(continued)

(Unaudited)

 

 

 

Successor

 

Predecessor

 

 

 

Company

 

Company

 

 

 

As of

 

 

As of

 

 

 

September 30, 2015

 

 

December 31, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Liabilities

 

 

 

 

 

 

Future policy benefits and claims

 

$

29,734,319

 

 

$

29,944,477

 

Unearned premiums

 

665,546

 

 

1,515,001

 

Total policy liabilities and accruals

 

30,399,865

 

 

31,459,478

 

Stable value product account balances

 

1,914,093

 

 

1,959,488

 

Annuity account balances

 

10,754,799

 

 

10,950,729

 

Other policyholders’ funds

 

1,128,486

 

 

1,430,325

 

Other liabilities

 

1,320,797

 

 

1,178,962

 

Income tax payable

 

65,010

 

 

 

Deferred income taxes

 

1,362,328

 

 

1,611,864

 

Non-recourse funding obligations

 

1,939,078

 

 

1,527,752

 

Repurchase program borrowings

 

455,718

 

 

50,000

 

Liabilities related to separate accounts

 

 

 

 

 

 

Variable annuity

 

12,646,751

 

 

13,157,429

 

Variable universal life

 

792,800

 

 

834,940

 

Total liabilities

 

62,779,725

 

 

64,160,967

 

Commitments and contingencies - Note 11

 

 

 

 

 

 

Shareowner’s equity

 

 

 

 

 

 

Preferred Stock; $1 par value, shares authorized: 2,000; Liquidation preference: $2,000

 

2

 

 

2

 

Common Stock, $1 par value, shares authorized and issued: 2015 and 2014 - 5,000,000

 

5,000

 

 

5,000

 

Additional paid-in-capital

 

6,274,211

 

 

1,437,787

 

Retained earnings

 

104,423

 

 

2,905,151

 

Accumulated other comprehensive income (loss):

 

 

 

 

 

 

Net unrealized gains (losses) on investments, net of income tax: (2015 Successor - $(502,133); 2014 Predecessor - $796,488)

 

(932,532

)

 

1,479,192

 

Net unrealized gains relating to other-than-temporary impaired investments for which a portion has been recognized in earnings, net of income tax: (2015 Successor - $(1,677); 2014 Predecessor - $2,208)

 

(3,115

)

 

4,101

 

Accumulated loss - derivatives, net of income tax: (2015 Successor - $0; 2014 Predecessor - $(45))

 

 

 

(82

)

Total shareowner’s equity

 

5,447,989

 

 

5,831,151

 

Total liabilities and shareowner’s equity

 

$

68,227,714

 

 

$

69,992,118

 

 

See Notes to Consolidated Condensed Financial Statements

 

6



Table of Contents

 

PROTECTIVE LIFE INSURANCE COMPANY

CONSOLIDATED CONDENSED STATEMENTS OF SHAREOWNER’S EQUITY

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

Additional

 

 

 

Other

 

Total

 

 

 

Preferred

 

Common

 

Paid-In-

 

Retained

 

Comprehensive

 

Shareowner’s

 

Predecessor Company

 

Stock

 

Stock

 

Capital

 

Earnings

 

Income (Loss)

 

Equity

 

 

 

(Dollars In Thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2014

 

$

2

 

$

5,000

 

$

1,437,787

 

$

2,905,151

 

$

1,483,211

 

$

5,831,151

 

Net income for the period of January 1, 2015 to January 31, 2015

 

 

 

 

 

 

 

88,522

 

 

 

88,522

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

477,766

 

477,766

 

Comprehensive income for the period of January 1, 2015 to January 31, 2015

 

 

 

 

 

 

 

 

 

 

 

566,288

 

Balance, January 31, 2015

 

$

2

 

$

5,000

 

$

1,437,787

 

$

2,993,673

 

$

1,960,977

 

$

6,397,439

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

Additional

 

 

 

Other

 

Total

 

 

 

Preferred

 

Common

 

Paid-In-

 

Retained

 

Comprehensive

 

Shareowner’s

 

Successor Company

 

Stock

 

Stock

 

Capital

 

Earnings

 

Income (Loss)

 

Equity

 

 

 

(Dollars In Thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, February 1, 2015

 

$

2

 

$

5,000

 

$

6,504,211

 

$

 

$

 

$

6,509,213

 

Net income for the period of February 1, 2015 to September 30, 2015

 

 

 

 

 

 

 

104,423

 

 

 

104,423

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

(935,647

)

(935,647

)

Comprehensive loss for the period of February 1, 2015 to September 30, 2015

 

 

 

 

 

 

 

 

 

 

 

(831,224

)

Return of capital

 

 

 

 

 

(230,000

)

 

 

 

 

(230,000

)

Balance, September 30, 2015

 

$

2

 

$

5,000

 

$

6,274,211

 

$

104,423

 

$

(935,647

)

$

5,447,989

 

 

See Notes to Consolidated Condensed Financial Statements

 

7



Table of Contents

 

PROTECTIVE LIFE INSURANCE COMPANY

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

Successor

 

Predecessor

 

 

 

Company

 

Company

 

 

 

February 1, 2015

 

 

January 1, 2015

 

For The Nine

 

 

 

to

 

 

to

 

Months Ended

 

 

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Cash flows from operating activities

 

 

 

 

 

 

 

 

Net income

 

$

104,423

 

 

$

88,522

 

$

340,425

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Realized investment losses (gains)

 

100,379

 

 

(102,703

)

(112,666

)

Amortization of deferred policy acquisition costs and value of business acquired

 

77,363

 

 

4,817

 

266,572

 

Capitalization of deferred policy acquisition costs

 

(210,162

)

 

(22,799

)

(219,157

)

Depreciation and amortization expense

 

33,254

 

 

796

 

5,461

 

Deferred income tax

 

4,555

 

 

91,709

 

29,556

 

Accrued income tax

 

115,127

 

 

(48,469

)

(16,247

)

Interest credited to universal life and investment products

 

521,760

 

 

79,088

 

663,117

 

Policy fees assessed on universal life and investment products

 

(756,276

)

 

(90,288

)

(729,929

)

Change in reinsurance receivables

 

181,899

 

 

(98,148

)

65,051

 

Change in accrued investment income and other receivables

 

16,984

 

 

(1,285

)

(28,075

)

Change in policy liabilities and other policyholders’ funds of traditional life and health products

 

(157,729

)

 

176,119

 

4,862

 

Trading securities:

 

 

 

 

 

 

 

 

Maturities and principal reductions of investments

 

90,548

 

 

17,946

 

71,646

 

Sale of investments

 

107,035

 

 

26,422

 

187,829

 

Cost of investments acquired

 

(174,455

)

 

(27,289

)

(160,134

)

Other net change in trading securities

 

66,189

 

 

(26,901

)

(43,699

)

Amortization of premiums and accretion of discounts on investments and mortgage loans

 

287,977

 

 

3,420

 

42,717

 

Change in other liabilities

 

23,500

 

 

211,031

 

256,769

 

Other income - gains on repurchase of non-recourse funding obligations

 

 

 

 

(1,500

)

Other, net

 

(39,211

)

 

(133,928

)

(84,508

)

Net cash provided by operating activities

 

393,160

 

 

148,060

 

538,090

 

Cash flows from investing activities

 

 

 

 

 

 

 

 

Maturities and principal reductions of investments, available-for-sale

 

756,207

 

 

59,028

 

941,989

 

Sale of investments, available-for-sale

 

1,152,725

 

 

200,716

 

1,485,538

 

Cost of investments acquired, available-for-sale

 

(2,316,843

)

 

(150,030

)

(3,055,927

)

Change in investments, held-to-maturity

 

(50,000

)

 

 

(50,000

)

Mortgage loans:

 

 

 

 

 

 

 

 

New lendings

 

(1,101,820

)

 

(100,530

)

(649,125

)

Repayments

 

894,164

 

 

45,741

 

908,364

 

Change in investment real estate, net

 

(59

)

 

7

 

4,840

 

Change in policy loans, net

 

45,470

 

 

6,365

 

48,516

 

Change in other long-term investments, net

 

(76,572

)

 

(25,372

)

(69,720

)

Change in short-term investments, net

 

22,703

 

 

(39,312

)

(22,401

)

Net unsettled security transactions

 

(30,877

)

 

37,510

 

8,243

 

Purchase of property and equipment

 

(5,700

)

 

(648

)

(6,160

)

Payments for business acquisitions

 

 

 

 

(906

)

Net cash (used in) provided by investing activities

 

(710,602

)

 

33,475

 

(456,749

)

Cash flows from financing activities

 

 

 

 

 

 

 

 

Issuance (repayment) of non-recourse funding obligations

 

50,000

 

 

 

44,000

 

Repurchase program borrowings

 

405,718

 

 

 

9,804

 

Dividends/Return of capital to parent company

 

(230,000

)

 

 

(225,000

)

Investment product deposits and change in universal life deposits

 

1,951,647

 

 

169,233

 

2,415,424

 

Investment product withdrawals

 

(1,720,926

)

 

(240,147

)

(2,461,200

)

Other financing activities, net

 

 

 

(4

)

(33

)

Net cash provided by (used in) financing activities

 

456,439

 

 

(70,918

)

(217,005

)

Change in cash

 

138,997

 

 

110,617

 

(135,664

)

Cash at beginning of period

 

378,903

 

 

268,286

 

345,579

 

Cash at end of period

 

$

517,900

 

 

$

378,903

 

$

209,915

 

 

See Notes to Consolidated Condensed Financial Statements

 

8



Table of Contents

 

PROTECTIVE LIFE INSURANCE COMPANY

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

1.                                       BASIS OF PRESENTATION

 

Basis of Presentation

 

Protective Life Insurance Company (the “Company”), a stock life insurance company, was founded in 1907. The Company is a wholly owned subsidiary of Protective Life Corporation (“PLC”), an insurance holding company. On February 1, 2015, PLC became a wholly owned subsidiary of The Dai-ichi Life Insurance Company, Limited, a kabushiki kaisha organized under the laws of Japan (“Dai-ichi Life”), when DL Investment (Delaware), Inc. a wholly owned subsidiary of Dai-ichi Life, merged with and into PLC (the “Merger”). Prior to February 1, 2015, and for the periods reported as “predecessor”, PLC’s stock was publicly traded on the New York Stock Exchange. Subsequent to the Merger date, PLC and the Company remain as SEC registrants within the United States. PLC is a holding company with subsidiaries that provide financial services through the production, distribution, and administration of insurance and investment products.

 

The Merger was accounted for by PLC under the acquisition method of accounting under ASC Topic 805 Business Combinations. In accordance with ASC Topic 805-20-30, all identifiable assets acquired and liabilities assumed were measured at fair value as of the acquisition date. PLC elected to apply “pushdown” accounting by applying the guidance allowed by ASC Topic 805, Business Combinations, including the initial recognition of most of PLC’s assets and liabilities at fair value as of the acquisition date, and similarly recognizing goodwill calculated based on the terms of the transaction and the fair value of the new basis of net assets of PLC. The new basis of accounting will be the basis of the accounting records in the preparation of future financial statements and related disclosures after the Merger date. Goodwill of $735.7 million was recorded as of the acquisition date which represents the cost in excess of the fair value of PLC’s net assets acquired (including identifiable intangibles) in the Merger, and reflects the Company’s assembled workforce, future growth potential and other sources of value not associated with identifiable assets.

 

The Merger was accounted for by the Company in a manner consistent with that utilized by PLC. In accordance with ASC Topic 805-20-30, all identifiable assets acquired and liabilities assumed were measured at fair value as of the acquisition date. In conjunction with PLC’s and the Company’s election to apply “pushdown” accounting to reflect the impact of the transaction and the new basis of net assets recorded as of February 1, 2015, the entire amount of goodwill and other identifiable intangible assets recognized by PLC were allocated to the Company. This was supported by the fact that the Company is the primary operating subsidiary of PLC and the workforce, distribution and sales organization, current and future policy and portfolio cash flows, and other items for which the transaction was primarily based are consistent between PLC and Company.  As such, the entire balance of goodwill of $735.7 million is included in the new basis of net assets of the Company. The new basis of accounting will be the basis of the accounting records in the preparation of future financial statements and related disclosures after the Merger date.

 

These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for the interim periods presented herein. Such accounting principles differ from statutory reporting practices used by insurance companies in reporting to state regulatory authorities. Accordingly, they do not include all of the disclosures required by GAAP for complete financial statements. In the opinion of management, the accompanying financial statements reflect all adjustments (consisting only of normal recurring items) necessary for a fair statement of the results for the interim periods presented. Operating results for the three months ended September 30, 2015 (Successor Company), the period of February 1, 2015 to September 30, 2015 (Successor Company) and the period of January 1, 2015 to January 31, 2015 (Predecessor Company) are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2015 (Successor Company). The year-end consolidated condensed financial data included herein was derived from audited financial statements but does not include all disclosures required by GAAP within this report. For further information, refer to the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 (Predecessor Company).

 

9



Table of Contents

 

The operating results of companies in the insurance industry have historically been subject to significant fluctuations due to changing competition, economic conditions, interest rates, investment performance, insurance ratings, claims, persistency, and other factors.

 

Reclassifications

 

Certain reclassifications have been made in the previously reported financial statements and accompanying notes to make the prior year amounts comparable to those of the current year. Such reclassifications had no effect on previously reported net income or shareowner’s equity.

 

Entities Included

 

The consolidated condensed financial statements for the predecessor and successor periods presented in this report include the accounts of Protective Life Insurance Company and its affiliate companies in which the Company holds a majority voting or economic interest. Intercompany balances and transactions have been eliminated.

 

2.                                       SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Significant Accounting Policies

 

For a full description of significant accounting policies, see Note 2 to Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 (Predecessor Company). Other than the accounting matters resulting from the application of pushdown accounting in connection with ASC Topic 805, the Company did not make significant changes to accounting policies during the period of February 1, 2015 to September 30, 2015 (Successor Company) except as noted below.

 

Intangible Assets

 

Intangible assets with definite lives are amortized over the estimated useful life of the asset and reviewed for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Amortizable intangible assets primarily consist of distribution relationships, trade names, and technology. Intangible assets with indefinite lives, primarily insurance licenses, are not amortized, but are reviewed for impairment on an annual basis or whenever events or changes in circumstances indicate that their carrying amount may not be recoverable.

 

Value of Business Acquired

 

In conjunction with the Merger, a portion of the purchase price was allocated to the right to receive future gross profits from cash flows and earnings of the Company’s insurance policies and investment contracts as of the date of the Merger. This intangible asset, called value of business acquired (“VOBA”), is based on the actuarially estimated present value of future cash flows from the Company’s insurance policies and investment contracts in-force on the date of the Merger. The estimated present value of future cash flows used in the calculation of the VOBA is based on certain assumptions, including mortality, persistency, expenses, and interest rates that the Company expects to experience in future years. The Company amortizes VOBA in proportion to gross premiums for traditional life products, or estimated gross margins (“EGMs”) for participating traditional life products within the MONY block. For interest sensitive products, the Company uses various amortization bases including expected gross profits (“EGPs”), revenues, or insurance in-force.

 

Goodwill

 

Goodwill of $735.7 million was recognized in conjunction with the Merger as the excess of the purchase considerations over the fair value of PLC’s identifiable assets acquired and liabilities assumed. The balance recognized as goodwill is not amortized, but is reviewed for impairment on an annual basis, or more frequently as events or

 

10



Table of Contents

 

circumstances may warrant, including those circumstances which would more likely than not reduce the fair value of the Company’s reporting units below its carrying amount.

 

Property and Equipment

 

In conjunction with the Merger, property and equipment was recorded at fair value and will be depreciated from this basis in future periods based on the respective estimated useful lives. Real estate assets were recorded at appraised values as of the acquisition date. The Company has estimated the remaining useful life of the home office building to be 25 years. Land is not depreciated.

 

The carrying amounts of the Company’s fixed assets are as follows:

 

 

 

Successor

 

Predecessor

 

 

 

Company

 

Company

 

 

 

As of

 

 

As of

 

 

 

September 30, 2015

 

 

December 31, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Home office building

 

$

65,342

 

 

$

75,109

 

Land

 

24,920

 

 

 

Data processing equipment

 

14,212

 

 

40,568

 

Other, principally furniture and equipment

 

3,911

 

 

52,771

 

Total property and equipment

 

108,385

 

 

168,448

 

Less: accumulated depreciation

 

5,662

 

 

116,688

 

Net property and equipment

 

$

102,723

 

 

$

51,760

 

 

Guaranteed Minimum Withdrawal Benefits

 

The Company also establishes reserves for guaranteed minimum withdrawal benefits (“GMWB”) on its variable annuity (“VA”) products. The GMWB is valued in accordance with FASB guidance under the ASC Derivatives and Hedging Topic which utilizes the valuation technique prescribed by the ASC Fair Value Measurements and Disclosures Topic, which requires the embedded derivative to be recorded at fair value using current implied volatilities for the equity indices. The fair value of the GMWB is impacted by equity market conditions and can result in the GMWB embedded derivative being in an overall net asset or net liability position.  In times of favorable equity market conditions the likelihood and severity of claims is reduced and expected fee income increases.  Since claims are generally expected later than fees, these favorable equity market conditions can result in the present value of fees being greater than the present value of claims, which results in a net GMWB embedded derivative asset.  In times of unfavorable equity market conditions the likelihood and severity of claims is increased and expected fee income decreases and can result in the present value of claims exceeding the present value of fees resulting in a net GMWB embedded derivative liability. The methods used to estimate the embedded derivatives employ assumptions about mortality, lapses, policyholder behavior, equity market returns, interest rates, and market volatility. The Company assumes age-based mortality from the National Association of Insurance Commissioners 1994 Variable Annuity MGDB Mortality Table for company experience. Differences between the actual experience and the assumptions used result in variances in profit and could result in losses. In conjunction with the Merger, the Company updated the fair value of the GMWB reserves to reflect current assumptions as of February 1, 2015 (Successor Company). As a result of the application of ASC Topic 805, the Company reset the hedge premium rates utilized in the valuation for all policies to be equal to the present value of future claims with the reset hedge premium rates being capped at the actual charges to the policyholder. This update resulted in a decrease in the net liability of approximately $69.4 million on the Merger date. The Company reinsures certain risks associated with the GMWB to Shades Creek Captive Insurance Company (“Shades Creek”), a direct wholly owned subsidiary of PLC. As of September 30, 2015 (Successor Company), the net GMWB liability held, including the impact of reinsurance was approximately $14.5 million.

 

11



Table of Contents

 

Policyholder Liabilities

 

Insurance Liabilities and Reserves

 

In conjunction with the Merger and in accordance with ASC 805, insurance liabilities and reserves were recorded at fair value and the underlying contracts were considered to be new contracts, for measurement and reporting purposes as of the acquisition date.  Estimating liabilities for future policy benefits on life and health insurance products requires the use of assumptions relative to future investment yields, mortality, morbidity, persistency, and other assumptions based on the Company’s historical experience, modified as necessary to reflect anticipated trends and to include provisions for possible adverse deviation. Determining liabilities for the Company’s property and casualty insurance products also requires the use of assumptions, including the projected levels of used vehicle prices, the frequency and severity of claims, and the effectiveness of internal processes designed to reduce the level of claims. The Company’s results depend significantly upon the extent to which its actual claims experience is consistent with the assumptions the Company used in determining its reserves and pricing its products. The Company’s reserve assumptions and estimates require significant judgment and, therefore, are inherently uncertain. The Company cannot determine with precision the ultimate amounts that it will pay for actual claims or the timing of those payments. As such, at the acquisition date, the Company updated the assumptions described above to reflect current best estimates and reserves were calculated in accordance with the methodology described below. VOBA was recorded to reflect the difference between the fair value of the contractual insurance liability and the reserve established.

 

Traditional Life, Health, and Credit Insurance Products

 

Traditional life insurance products consist principally of those products with fixed and guaranteed premiums and benefits, and they include whole life insurance policies, term and term-like life insurance policies, limited payment life insurance policies, and certain annuities with life contingencies. In accordance with ASC 805, the liabilities for future policy benefits on traditional life insurance products, when combined with the associated VOBA, were recorded at fair value. These values were computed using assumptions that include interest rates, mortality, lapse rates, expenses estimates, and other assumptions based on the Company’s experience, modified as necessary to reflect anticipated trends and to include provisions for possible adverse deviation. The liability for future policy benefits and claims on traditional life, health, and credit insurance products includes estimated unpaid claims that have been reported to us and claims incurred but not yet reported.

 

Universal Life and Investment Products

 

Universal life and investment products include universal life insurance, guaranteed investment contracts, guaranteed funding agreements, deferred annuities, and annuities without life contingencies. Benefit reserves for universal life and investment products represent policy account balances before applicable surrender charges plus certain deferred policy initiation fees that are recognized in income over the term of the policies. Policy benefits and claims that are charged to expense include benefit claims incurred in the period in excess of related policy account balances and interest credited to policy account balances.

 

The Company establishes liabilities for fixed indexed annuity (“FIA”) products. These products are deferred fixed annuities with a guaranteed minimum interest rate plus a contingent return based on equity market performance. The FIA product is considered a hybrid financial instrument under the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC” or “Codification”) Topic 815— Derivatives and Hedging which allows the Company to make the election to value the liabilities of these FIA products at fair value. This election was made for the FIA products issued prior to 2010 as the policies were issued. These products are no longer being marketed. The future changes in the fair value of the liability for these FIA products will be recorded in Benefit and settlement expenses with the liability being recorded in Annuity account balances . For more information regarding the determination of fair value of annuity account balances please refer to Note 15, Fair Value of Financial Instruments . Premiums and policy fees for these FIA products consist of fees that have been assessed against the policy account balances for surrenders. Such fees are recognized when assessed and earned.

 

The Company currently markets a deferred fixed annuity with a guaranteed minimum interest rate plus a contingent return based on equity market performance and the products are considered hybrid financial instruments under the FASB’s ASC Topic 815— Derivatives and Hedging . The Company did not elect to value these FIA products

 

12



Table of Contents

 

at fair value prior to the Merger date.  As a result the Company accounts for the provision that provides for a contingent return based on equity market performance as an embedded derivative. The embedded derivative is bifurcated from the host contract and recorded at fair value in Other liabilities . The host contract is accounted for as a debt instrument in accordance with ASC Topic 944— Financial Services—Insurance and is recorded in Annuity account balances with any discount to the minimum account value being accreted using the effective yield method. Benefits and settlement expenses include accreted interest and benefit claims incurred during the period.

 

The Company markets universal life products with a guaranteed minimum interest rate plus a contingent return based on equity market performance and are considered hybrid financial instruments under the FASB’s ASC Topic 815— Derivatives and Hedging . The Company did not elect to value these IUL products at fair value prior to the Merger date. As a result the Company accounts for the provision that provides for a contingent return based on equity market performance as an embedded derivative. The embedded derivative is bifurcated from the host contract and recorded at fair value in Other liabilities . Changes in the fair value of the embedded derivative are recorded in Realized investment gains (losses)—Derivative financial instruments . For more information regarding the determination of fair value of the IUL embedded derivative refer to Note 15, Fair Value of Financial Instruments . The host contract is accounted for as a debt instrument in accordance with ASC Topic 944— Financial Services—Insurance and is recorded in Future policy benefits and claims with any discount to the minimum account value being accreted using the effective yield method. Benefits and settlement expenses include accreted interest and benefit claims incurred during the period.

 

The Company’s accounting policies with respect to variable universal life (“VUL”) and VA are identical except that policy account balances (excluding account balances that earn a fixed rate) are valued at fair value and reported as components of assets and liabilities related to separate accounts.

 

The Company establishes liabilities for guaranteed minimum death benefits (“GMDB”) on its VA products. The methods used to estimate the liabilities employ assumptions about mortality and the performance of equity markets. The Company assumes age-based mortality from the National Association of Insurance Commissioners 1994 Variable Annuity MGDB Mortality Table for company experience. Future declines in the equity market would increase the Company’s GMDB liability. Differences between the actual experience and the assumptions used result in variances in profit and could result in losses. Our GMDB, as of September 30, 2015 (Successor Company), are subject to a dollar-for-dollar reduction upon withdrawal of related annuity deposits on contracts issued prior to January 1, 2003. The Company reinsures certain risks associated with the GMDB to Shades Creek. As of September 30, 2015 (Successor Company), the GMDB reserve, including the impact of reinsurance was $29.2 million.

 

Property and Casualty Insurance Products

 

Property and casualty insurance products include service contract business, surety bonds, and guaranteed asset protection (“GAP”). Unearned premium reserves are maintained for the portion of the premiums that is related to the unexpired period of the policy. Benefit reserves are recorded when insured events occur. Benefit reserves include case basis reserves for known but unpaid claims as of the balance sheet date as well as incurred but not reported (“IBNR”) reserves for claims where the insured event has occurred but has not been reported to the Company as of the balance sheet date. The case basis reserves and IBNR are calculated based on historical experience and on assumptions relating to claim severity and frequency, the level of used vehicle prices, and other factors. These assumptions are modified as necessary to reflect anticipated trends.

 

Reinsurance

 

The Company uses reinsurance extensively in certain of its segments and accounts for reinsurance and the recognition of the impact of reinsurance costs in accordance with the ASC Financial Services — Insurance Topic. The following summarizes some of the key aspects of the Company’s accounting policies for reinsurance.

 

Reinsurance Assets and Liabilities —Claim liabilities and policy benefits are calculated consistently for all policies, regardless of whether or not the policy is reinsured. Once the claim liabilities and policy benefits for the underlying policies are estimated, the amounts recoverable from the reinsurers are estimated based on a number of factors including the terms of the reinsurance contracts, historical payment patterns of reinsurance partners, and the financial strength and credit worthiness of reinsurance partners and recorded as Reinsurance receivables on the balance sheet. The reinsurance receivables were recorded in the balance sheet using current accounting policies and the most

 

13



Table of Contents

 

current assumptions as of the merger date. As of the merger date, the Company also calculated the ceded VOBA associated with the reinsured policies. The reinsurance receivables combined with the associated ceded VOBA represent the fair value of the reinsurance assets. Liabilities for unpaid reinsurance claims are produced from claims and reinsurance system records, which contain the relevant terms of the individual reinsurance contracts. The Company monitors claims due from reinsurers to ensure that balances are settled on a timely basis. Incurred but not reported claims are reviewed by the Company’s actuarial staff to ensure that appropriate amounts are ceded.

 

The Company analyzes and monitors the credit worthiness of each of its reinsurance partners to minimize collection issues. For newly executed reinsurance contracts with reinsurance companies that do not meet predetermined standards, the Company requires collateral such as assets held in trusts or letters of credit.

 

Accounting Pronouncements Recently Adopted

 

Accounting Standards Update (“ASU”) No. 2014-08—Reporting Discontinued Operations and Disclosure of Disposals of Components of an Entity. This Update changes the requirements for reporting discontinued operations and related disclosures. The Update limits the definition of a discontinued operation to disposals that represent “strategic shifts” that will have a major effect on an entity’s operation and financial results. Additionally, the Update requires enhanced disclosures about the components of discontinued operations and the financial effects of the disposal. The amendments in this Update are effective for annual and interim periods beginning after December 15, 2014. The Company has reviewed the additional disclosures required by the Update, and will apply the revised guidance to any disposals occurring after the effective date.

 

ASU No. 2014-11—Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures.   This Update changes the requirements for classification of certain repurchase agreements, and will expand the use of secured borrowing accounting for repurchase-to-maturity transactions. In addition, the Update requires additional disclosures for repurchase agreements accounted for both as sales and as secured borrowings. The amendments in this Update are effective for annual and interim periods beginning after December 15, 2014. The Update did not impact the Company’s financial position or results of operations. The Company has updated its policies and processes to ensure compliance with the additional disclosure requirements in this Update.

 

ASU No. 2014-17—Business Combinations (Topic 805).   This Update relates to “pushdown accounting”, which refers to pushing down the acquirer’s accounting and reporting basis (which is recognized in conjunction with its accounting for a business combination) to the acquiree’s standalone financial statements. The new guidance makes pushdown accounting optional for an acquiree that is a business or nonprofit activity when there is a change-in- control event (e.g., the acquirer in a business combination obtains control over the acquiree). In addition, the staff of the SEC released Staff Accounting Bulletin (“SAB”) No. 115, which rescinds SAB Topic 5J, “New Basis of Accounting Required in Certain Circumstances” (the SEC staff’s pre-existing guidance on pushdown accounting) and conforms SEC guidance on pushdown accounting to the FASB’s new guidance. Revised SEC guidance was codified in ASU No. 2015-08, issued in May 2015. The new pushdown accounting guidance became effective upon its issuance on November 18, 2014. Although now optional, the Company has applied pushdown accounting to its standalone financial statements effective with the Company becoming a wholly owned subsidiary of Dai-ichi Life on February 1, 2015. The presentation within this report for predecessor and successor periods is consistent with this Update.

 

Accounting Pronouncements Not Yet Adopted

 

ASU No. 2014-09—Revenue from Contracts with Customers (Topic 606). This Update provides for significant revisions to the recognition of revenue from contracts with customers across various industries. Under the new guidance, entities are required to apply a prescribed 5-step process to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The accounting for revenues associated with insurance products is not within the scope of this Update. The Update was originally effective for annual and interim periods beginning after December 15, 2016.  However, in August 2015, the FASB issued ASU No. 2015-14 — Revenues from Contracts with Customers: Deferral of the Effective Date , to defer the effective date of ASU No. 2014-09 by one year to annual and interim periods beginning after December 15, 2017. Early adoption will be allowed, but not before the original effective date. The Company is reviewing its policies and processes to ensure compliance with the requirements in this Update, upon adoption. The Company is currently assessing the impact this standard will have on its non-insurance operations.

 

14



Table of Contents

 

ASU No. 2014-15—Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. This Update will require management to assess an entity’s ability to continue as a going concern, and will require footnote disclosures in certain circumstances. Under the updated guidance, management should consider relevant conditions and evaluate whether it is probable that the entity will be unable to meet its obligations within one year after the issuance date of the financial statements. The Update is effective for annual periods ending December 31, 2016 and for annual and interim periods thereafter, with early adoption permitted. The amendments in this Update will not impact the Company’s financial position or results of operations. However, the new guidance will require a formal assessment of going concern by management based on criteria prescribed in the new guidance. The Company is reviewing its policies and processes to ensure compliance with the new guidance.

 

ASU No. 2015-02—Consolidation—Amendments to the Consolidation Analysis.   This Update makes several targeted changes to generally accepted accounting principles, including a) eliminating the presumption that a general partner should consolidate a limited partnership and b) eliminating the consolidation model specific to limited partnerships. The amendments also clarify when fees and related party relationships should be considered in the consolidation of variable interest entities. The amendments in this Update are effective for annual and interim periods beginning after December 15, 2015. The Company is reviewing its policies and processes to ensure compliance with the requirements in this Update, upon adoption.

 

ASU No. 2015-03—Interest—Imputation of Interest . The objective of this Update is to eliminate diversity in practice related to the presentation of debt issuance costs. The amendments in this Update require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this Update. The Update is effective for fiscal years beginning after December 15, 2015, and requires revised presentation of debt issuance costs in all periods presented in the financial statements. The Company is prepared to comply with the revised guidance.

 

ASU No. 2015-05 — Intangibles — Goodwill and Other — Internal-Use Software. The amendments in this Update provide guidance to customers about whether a cloud computing arrangement includes a software license. If a cloud computing arrangement includes a software license, then the customer should account for the software license element of the arrangement consistent with the acquisition of other software licenses. If a cloud computing arrangement does not include a software license, the customer should account for the arrangement as a service contract. The guidance will not change GAAP for a customer’s accounting for service contracts. The Update is effective for annual and interim periods beginning after December 15, 2015. The Company is prepared to comply with the revised guidance and does not believe it will materially impact the presentation of the Company’s financial position.

 

ASU No. 2015-09 — Financial Services—Insurance (Topic 944): Disclosures about Short-Duration Contracts. The amendments in this Update require additional disclosures for short-duration contracts issued by insurance entities. The additional disclosures focus on the liability for unpaid claims and claim adjustment expenses and include incurred and paid claims development information by accident year in tabular form, along with a reconciliation of this information to the statement of financial position. For accident years included in the development tables, the amendments also require disclosure of the total incurred-but-not-reported liabilities and expected development on reported claims, along with claims frequency information unless impracticable. Finally, the amendments require disclosure of the historical average annual percentage payout of incurred claims. With the exception of the current reporting period, claims development information may be presented as supplementary information. The Update is effective for annual periods beginning after December 15, 2015 and interim periods beginning after December 15, 2016. The Company is reviewing its products to determine the applicability and potential impact of the new disclosures.

 

ASU No. 2015-12 - Plan Accounting - (Topics 960, 962 and 965). This Update is a three-part standard that provides guidance on certain aspects of the accounting related to employee benefit plans. Part I requires an employee benefit plan to use contract value as the only measurement amount for fully-benefit responsive investment contracts. Part II simplifies and increases the effectiveness of plan investment disclosure requirements for employee benefit plans by eliminating certain disclosures related to individual investments over 5 percent and by eliminating the need to disaggregate investments in multiple ways. Part III provides a measurement-date practical expedient for plan investments when the fiscal year-end of a plan does not coincide with a month-end. The guidance is effective for fiscal years beginning after December 15, 2015 for all three parts and early adoption is permitted. For parts I and II,

 

15



Table of Contents

 

amendments should be applied retrospectively to all financial statements presented, while part III should be applied prospectively. The Company is reviewing its policies and procedures to ensure compliance with the revised guidance.

 

ASU No. 2015-15 — Interest - Imputation of Interest - Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements. The objective of this Update is to clarify the SEC Staff’s position on presenting and measuring debt issuance costs incurred in connection with line-of-credit arrangements given the lack of guidance on the topic in ASU No. 2015-03. This Update reflects the SEC Staff’s decision to not object when an entity defers and presents debt issuance costs as an asset and subsequently amortize the deferred debt issuance costs ratably over the term of the line-of-credit arrangement. The Company is prepared to comply with the revised guidance.

 

ASU No. 2015-16 - Business Combinations (Topic 805) - Simplifying the Accounting for Measurement-Period Adjustments. This Update provides that an acquirer must recognize adjustments to provisional amounts that are identified during the measurement period following a business combination in the reporting period in which the adjustment amounts are determined. This Update is effective for fiscal years beginning after December 15, 2015, including interim periods within those fiscal years. The amendments in the Update are to be applied prospectively for adjustments that occur after the effective date, with early adoption permitted for financial statements that have not been issued. The Company is prepared to comply with the revised guidance.

 

3.                                       RECENTLY ANNOUNCED REINSURANCE TRANSACTION

 

On September 30, 2015, the Company entered into a Master Agreement (the “Master Agreement”) with Genworth Life and Annuity Insurance Company (“GLAIC”). Pursuant to the Master Agreement, the Company agreed to enter into a reinsurance agreement (the “Reinsurance Agreement”) pursuant to which the Company will coinsure certain term life insurance business of GLAIC. In connection with the reinsurance transaction, the Company intends to enter into a financing transaction with a term of up to 20 years involving, among other parties, its indirect wholly owned subsidiary, Golden Gate Captive Insurance Company (“Golden Gate”), and a syndicate of third-party risk takers, to finance up to $2.2 billion of “XXX” reserves related to the GLAIC business to be reinsured and the other term life insurance business currently reinsured by Golden Gate. Although the Company intends to execute the financing transaction concurrently with its entry into the Reinsurance Agreement, the closing of the transactions contemplated by the Master Agreement is not conditioned upon the consummation of the financing transaction.

 

4.                                       DAI-ICHI MERGER

 

On February 1, 2015 PLC, subsequent to required approvals from PLC’s shareholders and relevant regulatory authorities, became a wholly owned subsidiary of Dai-ichi Life as contemplated by the Agreement and Plan of Merger (the “Merger Agreement”) with Dai-ichi Life and DL Investment (Delaware), Inc., a Delaware corporation and wholly owned subsidiary of Dai-ichi Life, which provided for the Merger of DL Investment (Delaware), Inc. with and into PLC, with PLC surviving the Merger as a wholly owned subsidiary of Dai-ichi Life. On February 1, 2015 each share of PLC’s common stock outstanding was converted into the right to receive $70 per share, without interest (the “Per Share Merger Consideration”). The aggregate cash consideration paid in connection with the Merger for the outstanding shares of common stock was approximately $5.6 billion and paid directly to the shareowners of record by Dai-ichi Life.  According to public statements by both companies, the Merger will provide Dai-ichi Life with a platform for growth in the United States, where it did not previously have a significant presence. In connection with the completion of the Merger, PLC’s previously publicly traded equity was delisted from the NYSE, although PLC and the Company remain SEC registrants for financial reporting purposes in the United States.

 

The Merger was accounted for under the acquisition method of accounting under ASC Topic 805. In accordance with ASC Topic 805-20-30, all identifiable assets acquired and liabilities assumed were measured at fair value as of the acquisition date. Goodwill of $735.7 million represents the cost in excess of the fair value of PLC’s net assets acquired (including identifiable intangibles) in the Merger, and reflects the Company’s assembled workforce, future growth potential and other sources of value not associated with identifiable assets. None of the goodwill is tax deductible.

 

16



Table of Contents

 

The following table summarizes the fair value of assets acquired and liabilities assumed at the acquisition date:

 

 

 

Fair Value

 

 

 

As of

 

 

 

February 1, 2015

 

 

 

(Dollars In Thousands)

 

Assets

 

 

 

Fixed maturities

 

$

38,342,948

 

Equity securities

 

699,081

 

Mortgage loans

 

5,580,229

 

Investment real estate

 

7,456

 

Policy loans

 

1,751,872

 

Other long-term investments

 

657,346

 

Short-term investments

 

311,236

 

Total investments

 

47,350,168

 

Cash

 

378,903

 

Accrued investment income

 

483,691

 

Accounts and premiums receivable

 

104,260

 

Reinsurance receivables

 

5,538,637

 

Value of business acquired

 

1,278,064

 

Goodwill

 

735,712

 

Other intangibles

 

683,000

 

Property and equipment

 

102,736

 

Other assets

 

224,555

 

Income tax receivable

 

50,117

 

Assets related to separate accounts

 

 

 

Variable annuity

 

12,970,587

 

Variable universal life

 

819,188

 

Total assets

 

$

70,719,618

 

Liabilities

 

 

 

Future policy and benefit claims

 

$

30,195,397

 

Unearned premiums

 

622,278

 

Total policy liabilities and accruals

 

30,817,675

 

Stable value product account balances

 

1,932,277

 

Annuity account balances

 

10,941,661

 

Other policyholders’ funds

 

1,388,083

 

Other liabilities

 

1,533,666

 

Deferred income taxes

 

1,861,632

 

Non-recourse funding obligations

 

1,895,636

 

Repurchase program borrowings

 

50,000

 

Liabilities related to separate accounts

 

 

 

Variable annuity

 

12,970,587

 

Variable universal life

 

819,188

 

Total liabilities

 

64,210,405

 

Net assets acquired

 

$

6,509,213

 

 

As of the acquisition date, all contractual cash flows related to the Company’s historical and acquired receivables (as presented within this consolidated balance sheet) are expected to be collected.

 

17



Table of Contents

 

Intangible assets recognized by the Company included the following (excluding goodwill):

 

 

 

Estimated

 

 

 

 

 

Fair Value on

 

Estimated

 

 

 

Acquisition Date

 

Useful Life

 

 

 

(Dollars In Thousands)

 

(In Years)

 

Distribution relationships

 

$

405,000

 

14-22

 

Trade names

 

103,000

 

13-17

 

Technology

 

143,000

 

7-14

 

Total intangible assets subject to amortization

 

651,000

 

 

 

 

 

 

 

 

 

Insurance licenses

 

32,000

 

Indefinite

 

Total intangible assets

 

$

683,000

 

 

 

 

Identified intangible assets were valued using the excess earnings method, relief from royalty method or cost approach, as appropriate.

 

Amortizable intangible assets will be amortized straight line over their assigned useful lives.  The following is a schedule of future estimated aggregate amortization expense:

 

Year

 

Amount

 

 

 

(Dollars In Thousands)

 

2015

 

$

10,328

 

2016

 

41,313

 

2017

 

41,313

 

2018

 

41,313

 

2019

 

41,313

 

 

All tangible and intangible assets of the Company were allocated to applicable operating segments in connection with the recording of pushdown accounting.  The purchase price was also allocated to each operating segment in accordance with the determined fair value of the operating segments, such that the total reconciled with the total consideration paid in the merger.  Subtraction of the fair value of the tangible and intangible assets for each operating segment from the allocated purchase price of that operating segment resulted in the goodwill allocated to each operating segment. The amount of goodwill allocated to each operating segment is reflected in Note 18, Operating Segments .

 

Treatment of Benefit Plans

 

At or immediately prior to the Merger, each stock appreciation right with respect to shares of PLC’s Common Stock granted under any Stock Plan (each, a “SAR”) that were outstanding and unexercised immediately prior to the Merger and that had a base price per share of Common Stock underlying such SAR (the “Base Price”) that was less than the Per Share Merger Consideration (each such SAR, an “In-the-Money SAR”), whether or not exercisable or vested, was cancelled and converted into the right to receive an amount in cash less any applicable withholding taxes, determined by multiplying (i) the excess of the Per Share Merger Consideration over the Base Price of such In-the-Money SAR by (ii) the number of shares of Common Stock subject to such In-the-Money SAR (such amount, the “SAR Consideration”).

 

At or immediately prior to the effective time of the Merger, each restricted stock unit with respect to a share of PLC Common Stock granted under any Stock Plan (each, a “RSU”) that was outstanding immediately prior to the Merger, whether or not vested, was cancelled and converted into the right to receive an amount in cash, without interest, less any applicable withholding taxes, determined by multiplying (i) the Per Share Merger Consideration by (ii) the number of RSUs.

 

18



Table of Contents

 

The number of performance shares earned for each award of performance shares granted under any Stock Plan was calculated by determining the number of performance shares that would have been paid if the subject award period had ended on the December 31 immediately preceding the Merger (based on the conditions set for payment of performance share awards for the subject award period), provided that the number of performance shares earned for each award were not less than the aggregate number of performance shares at the target performance level. Each performance share earned that was outstanding immediately prior to the Merger, whether or not vested, was cancelled and converted into the right to receive an amount in cash, without interest, less any applicable withholding taxes, determined by multiplying (i) the Per Share Merger Consideration by (ii) the number of Performance Shares.

 

5.                                       MONY CLOSED BLOCK OF BUSINESS

 

In 1998, MONY Life Insurance Company (“MONY”) converted from a mutual insurance company to a stock corporation (“demutualization”). In connection with its demutualization, an accounting mechanism known as a closed block (the “Closed Block”) was established for certain individuals’ participating policies in force as of the date of demutualization. Assets, liabilities, and earnings of the Closed Block are specifically identified to support its participating policyholders. The Company acquired the Closed Block in conjunction with the acquisition of MONY in 2013.

 

Assets allocated to the Closed Block inure solely to the benefit of each Closed Block’s policyholders and will not revert to the benefit of MONY or the Company. No reallocation, transfer, borrowing or lending of assets can be made between the Closed Block and other portions of MONY’s general account, any of MONY’s separate accounts or any affiliate of MONY without the approval of the Superintendent of The New York State Insurance Department (the “Superintendent”). Closed Block assets and liabilities are carried on the same basis as similar assets and liabilities held in the general account.

 

The excess of Closed Block liabilities over Closed Block assets (adjusted to exclude the impact of related amounts in accumulated other comprehensive income (loss) (“AOCI”)) at the merger date represented the estimated maximum future post-tax earnings from the Closed Block that would be recognized in income from continuing operations over the period the policies and contracts in the Closed Block remain in force. In connection with the acquisition of MONY, the Company developed an actuarial calculation of the expected timing of MONY’s Closed Block’s earnings as of October 1, 2013. Pursuant to the acquisition of PLC by Dai-ichi Life, this actuarial calculation of the expected timing of MONY’s Closed Block earnings was recalculated and reset as of February 1, 2015, along with the establishment of a policyholder dividend obligation as of such date.

 

If the actual cumulative earnings from the Closed Block are greater than the expected cumulative earnings, only the expected earnings will be recognized in the Company’s net income. Actual cumulative earnings in excess of expected cumulative earnings at any point in time are recorded as a policyholder dividend obligation because they will ultimately be paid to Closed Block policyholders as an additional policyholder dividend unless offset by future performance that is less favorable than originally expected. If a policyholder dividend obligation has been previously established and the actual Closed Block earnings in a subsequent period are less than the expected earnings for that period, the policyholder dividend obligation would be reduced (but not below zero). If, over the period the policies and contracts in the Closed Block remain in force, the actual cumulative earnings of the Closed Block are less than the expected cumulative earnings, only actual earnings would be recognized in income from continuing operations. If the Closed Block has insufficient funds to make guaranteed policy benefit payments, such payments will be made from assets outside the Closed Block.

 

Many expenses related to Closed Block operations, including amortization of VOBA, are charged to operations outside of the Closed Block; accordingly, net revenues of the Closed Block do not represent the actual profitability of the Closed Block operations. Operating costs and expenses outside of the Closed Block are, therefore, disproportionate to the business outside of the Closed Block.

 

19



Table of Contents

 

Summarized financial information for the Closed Block as of September 30, 2015 (Successor Company) and December 31, 2014 (Predecessor Company) is as follows :

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

As of

 

 

As of

 

 

 

September 30, 2015

 

 

December 31, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Closed block liabilities

 

 

 

 

 

 

Future policy benefits, policyholders’ account balances and other policyholder liabilities

 

$

6,036,312

 

 

$

6,138,505

 

Policyholder dividend obligation

 

58,435

 

 

366,745

 

Other liabilities

 

33,706

 

 

53,838

 

Total closed block liabilities

 

6,128,453

 

 

6,559,088

 

Closed block assets

 

 

 

 

 

 

Fixed maturities, available-for-sale, at fair value

 

$

4,426,194

 

 

$

4,524,037

 

Equity securities, available-for-sale, at fair value

 

 

 

5,387

 

Mortgage loans on real estate

 

247,797

 

 

448,855

 

Policy loans

 

749,908

 

 

771,120

 

Cash and other invested assets

 

131,183

 

 

30,984

 

Other assets

 

161,407

 

 

221,270

 

Total closed block assets

 

5,716,489

 

 

6,001,653

 

Excess of reported closed block liabilities over closed block assets

 

411,964

 

 

557,435

 

Portion of above representing accumulated other comprehensive income:

 

 

 

 

 

 

Net unrealized investment gains (losses) net of policyholder dividend obligation of $(154,143) (Successor) and $106,886 (Predecessor)

 

 

 

 

Future earnings to be recognized from closed block assets and closed block liabilities

 

$

411,964

 

 

$

557,435

 

 

Reconciliation of the policyholder dividend obligation is as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

February 1, 2015

 

 

January 1, 2015

 

For The Nine

 

 

 

to

 

 

to

 

Months Ended

 

 

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Policyholder dividend obligation, beginning of period

 

$

323,432

 

 

$

366,745

 

$

190,494

 

Applicable to net revenue (losses)

 

(27,854

)

 

(1,369

)

(8,781

)

Change in net unrealized investment gains (losses) allocated to the policyholder dividend obligation; includes deferred tax benefits of $(83,000) (Successor); $47,277 (2015 - Predecessor); $38,448 (2014 - Predecessor)

 

(237,143

)

 

135,077

 

119,502

 

Policyholder dividend obligation, end of period

 

$

58,435

 

 

$

500,453

 

$

301,215

 

 

20



Table of Contents

 

Closed Block revenues and expenses were as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Revenues

 

 

 

 

 

 

 

 

 

 

 

 

Premiums and other income

 

$

46,610

 

$

128,279

 

 

$

15,065

 

$

48,596

 

$

151,442

 

Net investment income (loss)

 

54,593

 

142,274

 

 

19,107

 

63,847

 

176,470

 

Net investment gains (losses)

 

167

 

3,017

 

 

568

 

223

 

6,328

 

Total revenues

 

101,370

 

273,570

 

 

34,740

 

112,666

 

334,240

 

Benefits and other deductions

 

 

 

 

 

 

 

 

 

 

 

 

Benefits and settlement expenses

 

90,966

 

245,711

 

 

31,152

 

101,200

 

300,735

 

Other operating expenses

 

258

 

733

 

 

 

286

 

376

 

Total benefits and other deductions

 

91,224

 

246,444

 

 

31,152

 

101,486

 

301,111

 

Net revenues before income taxes

 

10,146

 

27,126

 

 

3,588

 

11,180

 

33,129

 

Income tax expense

 

3,551

 

9,494

 

 

1,256

 

3,913

 

11,595

 

Net revenues

 

$

6,595

 

$

17,632

 

 

$

2,332

 

$

7,267

 

$

21,534

 

 

6.                                       INVESTMENT OPERATIONS

 

Net realized gains (losses) for all other investments are summarized as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Fixed maturities

 

$

(1,304

)

$

2,398

 

 

$

6,891

 

$

22,244

 

$

49,812

 

Equity securities

 

51

 

72

 

 

 

 

 

Impairments on fixed maturity securities

 

(10,064

)

(15,798

)

 

(481

)

(2,354

)

(5,405

)

Impairments on equity securities

 

 

 

 

 

 

 

Modco trading portfolio

 

8,377

 

(133,524

)

 

73,062

 

(17,225

)

110,067

 

Other investments

 

(1,815

)

(1,040

)

 

1,200

 

(5,135

)

(7,383

)

Total realized gains (losses) - investments

 

$

(4,755

)

$

(147,892

)

 

$

80,672

 

$

(2,470

)

$

147,091

 

 

For the three months ended September 30, 2015 (Successor Company) and for the period of February 1, 2015 to September 30, 2015 (Successor Company), gross realized gains on investments available-for-sale (fixed maturities, equity securities, and short-term investments) were $0.7 million and $7.6 million and gross realized losses were $12.0 million and $21.0 million, respectively, including $10.1 million and $15.8 million of impairment losses, respectively.

 

For the period of January 1, 2015 to January 31, 2015 (Predecessor Company), gross realized gains on investments available-for-sale (fixed maturities, equity securities, and short-term investments) were $6.9 million and gross realized losses were $0.5 million, including $0.4 million of impairment losses.

 

For the three and nine months ended September 30, 2014 (Predecessor Company), gross realized gains on investments available-for-sale (fixed maturities, equity securities, and short-term investments) were $22.5 million and $50.6 million and gross realized losses were $2.5 million and $5.9 million, including $2.3 million and $5.1 million of impairment losses, respectively.

 

21



Table of Contents

 

For the three months ended September 30, 2015 (Successor Company) and for the period of February 1, 2015 to September 30, 2015 (Successor Company), the Company sold securities in an unrealized gain position with a fair value (proceeds) of $94.8 million and $807.8 million, respectively. The gains realized on the sale of these securities was $0.7 million and $7.6 million, respectively. For the period of January 1, 2015 to January 31, 2015 (Predecessor Company), the Company sold securities in an unrealized gain position with a fair value (proceeds) of $172.6 million. The gain realized on the sale of these securities was $6.9 million.

 

For the three and nine months ended September 30, 2014 (Predecessor Company), the Company sold securities in an unrealized gain position with a fair value (proceeds) of $494.0 million and $1.1 billion, respectively. The gains realized on the sale of these securities was $22.5 million and $50.6 million, respectively.

 

For the three months ended September 30, 2015 (Successor Company) and for the period of February 1, 2015 to September 30, 2015 (Successor Company), the Company sold securities in an unrealized loss position with a fair value (proceeds) of $34.6 million and $83.9 million, respectively. The loss realized on the sale of these securities was $2.0 million and $5.2 million, respectively. The Company made the decision to exit these holdings in conjunction with our overall asset liability management process.

 

For the period of January 1, 2015 to January 31, 2015 (Predecessor Company), the Company sold securities in an unrealized loss position with a fair value (proceeds) of $0.4 million. The loss realized on the sale of these securities were immaterial to the Company. The Company made the decision to exit these holdings in conjunction with our overall asset liability management process.

 

For the three and nine months ended September 30, 2014 (Predecessor Company), the Company sold securities in an unrealized loss position with a fair value (proceeds) of $2.3 million and $6.7 million, respectively. The losses realized on the sale of these securities were $0.3 million and $0.8 million, respectively. The Company made the decision to exit these holdings in conjunction with our overall asset liability management process.

 

22



Table of Contents

 

The amortized cost and fair value of the Company’s investments classified as available-for-sale as of September 30, 2015 (Successor Company) and December 31, 2014 (Predecessor Company), are as follows:

 

 

 

 

 

Gross

 

Gross

 

 

 

Total OTTI

 

Successor Company

 

Amortized

 

Unrealized

 

Unrealized

 

Fair

 

Recognized

 

As of September 30, 2015

 

Cost

 

Gains

 

Losses

 

Value

 

in OCI (1)

 

 

 

(Dollars In Thousands)

 

 

 

Fixed maturities:

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage-backed securities

 

$

1,617,048

 

$

13,339

 

$

(14,565

)

$

1,615,822

 

$

 

Commercial mortgage-backed securities

 

1,293,603

 

1,982

 

(18,970

)

1,276,615

 

 

Other asset-backed securities

 

815,437

 

1,320

 

(23,743

)

793,014

 

 

U.S. government-related securities

 

1,631,826

 

1,189

 

(15,543

)

1,617,472

 

 

Other government-related securities

 

19,360

 

 

(476

)

18,884

 

 

States, municipals, and political subdivisions

 

1,732,549

 

759

 

(119,823

)

1,613,485

 

50

 

Corporate securities

 

27,928,309

 

29,838

 

(2,064,349

)

25,893,798

 

(4,842

)

Preferred stock

 

64,362

 

 

(2,250

)

62,112

 

 

 

 

35,102,494

 

48,427

 

(2,259,719

)

32,891,202

 

(4,792

)

Equity securities

 

685,969

 

2,835

 

(10,761

)

678,043

 

 

Short-term investments

 

168,163

 

 

 

168,163

 

 

 

 

$

35,956,626

 

$

51,262

 

$

(2,270,480

)

$

33,737,408

 

$

(4,792

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Predecessor Company

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2014

 

 

 

 

 

 

 

 

 

 

 

Fixed maturities:

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage-backed securities

 

$

1,374,141

 

$

56,381

 

$

(12,264

)

$

1,418,258

 

$

6,404

 

Commercial mortgage-backed securities

 

1,119,979

 

59,637

 

(2,364

)

1,177,252

 

 

Other asset-backed securities

 

857,365

 

17,961

 

(35,950

)

839,376

 

(95

)

U.S. government-related securities

 

1,394,028

 

44,149

 

(9,282

)

1,428,895

 

 

Other government-related securities

 

16,939

 

3,233

 

 

20,172

 

 

States, municipals, and political subdivisions

 

1,391,526

 

296,594

 

(431

)

1,687,689

 

 

Corporate securities

 

24,744,050

 

2,760,703

 

(138,975

)

27,365,778

 

 

 

 

30,898,028

 

3,238,658

 

(199,266

)

33,937,420

 

6,309

 

Equity securities

 

713,813

 

35,646

 

(14,153

)

735,306

 

 

Short-term investments

 

151,572

 

 

 

151,572

 

 

 

 

$

31,763,413

 

$

3,274,304

 

$

(213,419

)

$

34,824,298

 

$

6,309

 

 


(1) These amounts are included in the gross unrealized gains and gross unrealized losses columns above.

 

The preferred stock shown above as of September 30, 2015 (Successor Company) is included in the equity securities total as of December 31, 2014 (Predecessor Company).

 

23



Table of Contents

 

The amortized cost and fair value of the Company’s investments classified as held-to-maturity as of September 30, 2015 (Successor Company) and December 31, 2014 (Predecessor Company), are as follows:

 

 

 

 

 

Gross

 

Gross

 

 

 

Total OTTI

 

Successor Company

 

Amortized

 

Unrealized

 

Unrealized

 

Fair

 

Recognized

 

As of September 30, 2015

 

Cost

 

Gains

 

Losses

 

Value

 

in OCI

 

 

 

(Dollars In Thousands)

 

Fixed maturities:

 

 

 

 

 

 

 

 

 

 

 

Other

 

$

579,329

 

$

 

$

(60,966

)

$

518,363

 

$

 

 

 

$

579,329

 

$

 

$

(60,966

)

$

518,363

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Predecessor Company

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2014

 

 

 

 

 

 

 

 

 

 

 

Fixed maturities:

 

 

 

 

 

 

 

 

 

 

 

Other

 

$

435,000

 

$

50,422

 

$

 

$

485,422

 

$

 

 

 

$

435,000

 

$

50,422

 

$

 

$

485,422

 

$

 

 

During the period of February 1, 2015 to September 30, 2015 (Successor Company), the period of January 1, 2015 to January 31, 2015 (Predecessor Company), and for the nine months ended September 30, 2014 (Predecessor Company), the Company did not record any other-than-temporary impairments on held-to-maturity securities. The Company’s held-to-maturity securities had $61.0 million of gross unrecognized holding losses as of September 30, 2015 (Successor Company).  The Company does not consider these unrecognized holding losses to be other-than-temporary based on certain positive factors associated with the securities which include credit ratings, financial health of the issuer, continued access of the issuer to capital markets and other pertinent information.

 

The Company’s held-to-maturity securities had no gross unrecognized holding losses as of December 31, 2014 (Predecessor Company).

 

As of September 30, 2015 (Successor Company) and December 31, 2014 (Predecessor Company), the Company had an additional $2.7 billion and $2.8 billion of fixed maturities, $6.7 million and $21.5 million of equity securities, and $65.2 million and $95.1 million of short-term investments classified as trading securities, respectively.

 

The amortized cost and fair value of available-for-sale and held-to-maturity fixed maturities as of September 30, 2015 (Successor Company), by expected maturity, are shown below. Expected maturities of securities without a single maturity date are allocated based on estimated rates of prepayment that may differ from actual rates of prepayment.

 

 

 

Successor Company

 

 

 

Available-for-sale

 

Held-to-maturity

 

 

 

Amortized

 

Fair

 

Amortized

 

Fair

 

 

 

Cost

 

Value

 

Cost

 

Value

 

 

 

(Dollars In Thousands)

 

(Dollars In Thousands)

 

Due in one year or less

 

$

830,760

 

$

830,346

 

$

 

$

 

Due after one year through five years

 

5,907,186

 

5,863,235

 

 

 

Due after five years through ten years

 

7,683,133

 

7,495,785

 

 

 

Due after ten years

 

20,681,415

 

18,701,836

 

579,329

 

518,363

 

 

 

$

35,102,494

 

$

32,891,202

 

$

579,329

 

$

518,363

 

 

During the three months ended September 30, 2015 (Successor Company) and the period of February 1, 2015 to September 30, 2015 (Successor Company), the Company recorded pre-tax other-than-temporary impairments of investments of $14.9 million and $28.3 million, respectively. Of the $14.9 million of impairments for the three months ended September 30, 2015 (Successor Company), $10.1 million was recorded in earnings and $4.8 million was recorded in other comprehensive income (loss). Of the $28.3 million of impairments for the period of February 1, 2015

 

24



Table of Contents

 

to September 30, 2015 (Successor Company), $15.8 million was recorded in earnings and $12.5 million was recorded in other comprehensive income (loss).

 

There were no other-than-temporary impairments related to fixed maturities or equity securities that the Company intended to sell or expected to be required to sell for the three months ended September 30, 2015 (Successor Company) and for the period of February 1, 2015 to September 30, 2015 (Successor Company).

 

During the period of January 1, 2015 to January 31, 2015 (Predecessor Company), the Company recorded pre-tax other-than-temporary impairments of investments of $0.6 million, all of which related to fixed maturities. Credit impairments recorded in earnings during the period were $0.5 million. During the period of January 1, 2015 to January 31, 2015 (Predecessor Company), $0.1 million of non-credit losses previously recorded in other comprehensive income (loss) were recorded in earnings as credit losses. There were no other-than-temporary impairments related to fixed maturities or equity securities that the Company intended to sell or expected to be required to sell for the period of January 1, 2015 to January 31, 2015 (Predecessor Company).

 

During the three and nine months ended September 30, 2014 (Predecessor Company), the Company recorded pre-tax other-than-temporary impairments of investments of $1.1 million and $2.0 million, respectively, all of which related to fixed maturities. Credit impairments recorded in earnings during the three and nine months ended September 30, 2014 (Predecessor Company) were $2.3 million and $5.4 million, respectively. During the three and nine months ended September 30, 2014 (Predecessor Company), $1.2 million and $3.4 million, respectively, of non-credit losses previously recorded in other comprehensive income (loss) were recorded in earnings as credit losses. There were no other-than-temporary impairments related to fixed maturities or equity securities that the Company intended to sell or expected to be required to sell for the three and nine months ended September 30, 2014 (Predecessor Company).

 

The following chart is a rollforward of available-for-sale credit losses on fixed maturities held by the Company for which a portion of an other-than-temporary impairment was recognized in other comprehensive income (loss):

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Beginning balance

 

$

4,472

 

$

 

 

$

15,463

 

$

17,938

 

$

41,674

 

Additions for newly impaired securities

 

 

4,472

 

 

 

 

 

Additions for previously impaired securities

 

9,479

 

9,479

 

 

221

 

626

 

1,653

 

Reductions for previously impaired securities due to a change in expected cash flows

 

 

 

 

 

(3,640

)

(28,403

)

Reductions for previously impaired securities that were sold in the current period

 

(687

)

(687

)

 

 

 

 

Ending balance

 

$

13,264

 

$

13,264

 

 

$

15,684

 

$

14,924

 

$

14,924

 

 

25



Table of Contents

 

The following table includes the gross unrealized losses and fair value of the Company’s investments that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position as of September 30, 2015 (Successor Company):

 

 

 

Less Than 12 Months

 

12 Months or More

 

Total

 

 

 

Fair

 

Unrealized

 

Fair

 

Unrealized

 

Fair

 

Unrealized

 

 

 

Value

 

Loss

 

Value

 

Loss

 

Value

 

Loss

 

 

 

(Dollars In Thousands)

 

Residential mortgage-backed securities

 

$

884,032

 

$

(14,565

)

$

 

$

 

$

884,032

 

$

(14,565

)

Commercial mortgage-backed securities

 

1,104,282

 

(18,970

)

 

 

1,104,282

 

(18,970

)

Other asset-backed securities

 

704,678

 

(23,743

)

 

 

704,678

 

(23,743

)

U.S. government-related securities

 

1,359,161

 

(15,543

)

 

 

1,359,161

 

(15,543

)

Other government-related securities

 

18,884

 

(476

)

 

 

18,884

 

(476

)

States, municipalities, and political subdivisions

 

1,567,309

 

(119,823

)

 

 

1,567,309

 

(119,823

)

Corporate securities

 

23,902,127

 

(2,064,349

)

 

 

23,902,127

 

(2,064,349

)

Preferred stock

 

62,112

 

(2,250

)

 

 

62,112

 

(2,250

)

Equities

 

448,372

 

(10,761

)

 

 

448,372

 

(10,761

)

 

 

$

30,050,957

 

$

(2,270,480

)

$

 

$

 

$

30,050,957

 

$

(2,270,480

)

 

The preferred stock shown above as of September 30, 2015 (Successor Company) is included in the equity securities total as of December 31, 2014 (Predecessor Company).

 

The book value of the Company’s investment portfolio was marked to fair value as of February 1, 2015 (Successor Company), in conjunction with the Dai-ichi Merger which resulted in the elimination of previously unrealized gains and losses from accumulated other comprehensive income. The level of interest rates as of February 1, 2015 (Successor Company) resulted in an increase in the carrying value of the Company’s investments. Since February 1, 2015 (Successor Company), interest rates have increased resulting in net unrealized losses in the Company’s investment portfolio.

 

As of September 30, 2015 (Successor Company), the Company had a total of 2,433 positions that were in an unrealized loss position, but the Company does not consider these unrealized loss positions to be other-than-temporary. This is based on the aggregate factors discussed previously and because the Company has the ability and intent to hold these investments until the fair values recover, and the Company does not intend to sell or expect to be required to sell the securities before recovering the Company’s amortized cost of the securities.

 

The Company does not consider these unrealized loss positions to be other-than-temporary, based on the aggregate factors discussed previously and because the Company has the ability and intent to hold these investments until the fair values recover, and does not intend to sell or expect to be required to sell the securities before recovering the Company’s amortized cost of the securities.

 

26



Table of Contents

 

The following table includes the gross unrealized losses and fair value of the Company’s investments that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position as of December 31, 2014 (Predecessor Company):

 

 

 

Less Than 12 Months

 

12 Months or More

 

Total

 

 

 

Fair

 

Unrealized

 

Fair

 

Unrealized

 

Fair

 

Unrealized

 

 

 

Value

 

Loss

 

Value

 

Loss

 

Value

 

Loss

 

 

 

(Dollars In Thousands)

 

Residential mortgage-backed securities

 

$

165,877

 

$

(9,547

)

$

67,301

 

$

(2,717

)

$

233,178

 

$

(12,264

)

Commercial mortgage-backed securities

 

49,908

 

(334

)

102,529

 

(2,030

)

152,437

 

(2,364

)

Other asset-backed securities

 

108,665

 

(6,473

)

537,488

 

(29,477

)

646,153

 

(35,950

)

U.S. government-related securities

 

231,917

 

(3,868

)

280,803

 

(5,414

)

512,720

 

(9,282

)

Other government-related securities

 

 

 

 

 

 

 

States, municipalities, and political subdivisions

 

1,905

 

(134

)

10,481

 

(297

)

12,386

 

(431

)

Corporate securities

 

1,657,103

 

(76,285

)

776,863

 

(62,690

)

2,433,966

 

(138,975

)

Equities

 

17,430

 

(218

)

129,509

 

(13,935

)

146,939

 

(14,153

)

 

 

$

2,232,805

 

$

(96,859

)

$

1,904,974

 

$

(116,560

)

$

4,137,779

 

$

(213,419

)

 

RMBS had a gross unrealized loss greater than twelve months of $2.7 million as of December 31, 2014 (Predecessor Company). Factors such as the credit enhancement within the deal structure, the average life of the securities, and the performance of the underlying collateral support the recoverability of these investments.

 

CMBS had a gross unrealized loss greater than twelve months of $2.0 million as of December 31, 2014 (Predecessor Company). Factors such as the credit enhancement within the deal structure, the average life of the securities, and the performance of the underlying collateral support the recoverability of these investments.

 

The other asset-backed securities had a gross unrealized loss greater than twelve months of $29.5 million as of December 31, 2014 (Predecessor Company). This category predominately includes student-loan backed auction rate securities, the underlying collateral, of which is at least 97% guaranteed by the Federal Family Education Loan Program (“FFELP”). These unrealized losses have occurred within the Company’s auction rate securities (“ARS”) portfolio since the market collapse during 2008. At this time, the Company has no reason to believe that the U.S. Department of Education would not honor the FFELP guarantee, if it were necessary.

 

The U.S. government-related category had gross unrealized losses greater than twelve months of $5.4 million as of December 31, 2014 (Predecessor Company). These declines were entirely related to changes in interest rates.

 

The corporate securities category had gross unrealized losses greater than twelve months of $62.7 million as of December 31, 2014 (Predecessor Company). The aggregate decline in market value of these securities was deemed temporary due to positive factors supporting the recoverability of the respective investments. Positive factors considered include credit ratings, the financial health of the issuer, the continued access of the issuer to capital markets, and other pertinent information.

 

The equities category had a gross unrealized loss greater than twelve months of $14.0 million as of December 31, 2014 (Predecessor Company). The aggregate decline in market value of these securities was deemed temporary due to factors supporting the recoverability of the respective investments. Positive factors include credit ratings, the financial health of the issuer, the continued access of the issuer to the capital markets, and other pertinent information.

 

As of September 30, 2015 (Successor Company), the Company had securities in its available-for-sale portfolio which were rated below investment grade of $1.5 billion and had an amortized cost of $1.6 billion. In addition, included in the Company’s trading portfolio, the Company held $302.1 million of securities which were rated below investment grade. Approximately $973.4 million of the below investment grade securities were not publicly traded.

 

27



Table of Contents

 

The change in unrealized gains (losses), net of income tax, on fixed maturity and equity securities, classified as available-for-sale is summarized as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Fixed maturities

 

$

(54,274

)

$

(1,437,340

)

 

$

669,160

 

$

(143,278

)

$

1,004,483

 

Equity securities

 

2,385

 

(5,152

)

 

12,172

 

(3,784

)

29,220

 

 

Variable Interest Entities

 

The Company holds certain investments in entities in which its ownership interests could possibly be considered variable interests under Topic 810 of the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC” or “Codification”) (excluding debt and equity securities held as trading, available for sale, or held to maturity). The Company reviews the characteristics of each of these applicable entities and compares those characteristics to applicable criteria to determine whether the entity is a Variable Interest Entity (“VIE”). If the entity is determined to be a VIE, the Company then performs a detailed review to determine whether the interest would be considered a variable interest under the guidance. The Company then performs a qualitative review of all variable interests with the entity and determines whether the Company is the primary beneficiary. ASC 810 provides that an entity is the primary beneficiary of a VIE if the entity has 1) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance, and 2) the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the entity that could potentially be significant to the VIE.

 

Based on this analysis, the Company had an interest in one wholly owned subsidiary, Red Mountain, LLC (“Red Mountain”), that was determined to be a VIE as of September 30, 2015 (Successor Company) and December 31, 2014 (Predecessor Company). The activity most significant to Red Mountain is the issuance of a note in connection with a financing transaction involving Golden Gate V Vermont Captive Insurance Company (“Golden Gate V”) and the Company in which Golden Gate V issued non-recourse funding obligations to Red Mountain and Red Mountain issued the note to Golden Gate V. Credit enhancement on the Red Mountain Note is provided by an unrelated third party. For details of this transaction, see Note 10, Debt and Other Obligations . The Company had the power, via its 100% ownership through an affiliate, to direct the activities of the VIE, but did not have the obligation to absorb losses related to the primary risks or sources of variability to the VIE. The variability of loss would be borne primarily by the third party in its function as provider of credit enhancement on the Red Mountain Note. Accordingly, it was determined that the Company is not the primary beneficiary of the VIE. The Company’s risk of loss related to the VIE is limited to its investment of $10,000. Additionally, the Company has guaranteed the VIE’s payment obligation for the credit enhancement fee to the unrelated third party provider. As of September 30, 2015 (Successor Company), no payments have been made or required related to this guarantee.

 

7.                                       MORTGAGE LOANS

 

Mortgage Loans

 

The Company invests a portion of its investment portfolio in commercial mortgage loans. As of September 30, 2015 (Successor Company), the Company’s mortgage loan holdings were approximately $5.7 billion. The Company has specialized in making loans on either credit-oriented commercial properties or credit-anchored strip shopping centers and apartments. The Company’s underwriting procedures relative to its commercial loan portfolio are based, in the Company’s view, on a conservative and disciplined approach. The Company concentrates on a small number of commercial real estate asset types associated with the necessities of life (retail, multi-family, senior living, professional office buildings, and warehouses). The Company believes that these asset types tend to weather economic downturns better than other commercial asset classes in which it has chosen not to participate. The Company believes this disciplined approach has helped to maintain a relatively low delinquency and foreclosure rate throughout its history.

 

28



Table of Contents

 

The majority of the Company’s mortgage loans portfolio was underwritten and funded by the Company. From time to time, the Company may acquire loans in conjunction with an acquisition.

 

The Company’s commercial mortgage loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, and net of valuation allowances. Interest income is accrued on the principal amount of the loan based on the loan’s contractual interest rate. Amortization of premiums and discounts is recorded using the effective yield method. Interest income, amortization of premiums and discounts, and prepayment fees are reported in net investment income.

 

As of February 1, 2015, all mortgage loans were measured at fair value. Each mortgage loan was individually analyzed to determine the fair value. Each loan was either analyzed and assigned a discount rate or given an impairment, based on whether facts and circumstances which, as of the acquisition date, indicated less than full projected collections of contractual principal and interest payments. Various market factors were considered in determining the net present value of the expected cash flow stream or underlying real estate collateral, including the characteristics of the borrower, the underlying collateral, underlying credit worthiness of the tenants, and tenant payment history. Known events and risks, such as refinancing risks, were also considered in the fair value determination. In certain cases, fair value was based on the NPV of the expected cash flow stream or the underlying value of the real estate collateral.

 

Certain of the mortgage loans have call options between 3 and 10 years. However, if interest rates were to significantly increase, we may be unable to exercise the call options on our existing mortgage loans commensurate with the significantly increased market rates. As of September 30, 2015, assuming the loans are called at their next call dates, approximately $27.3 million would become due for the remainder of 2015, $944.4 million in 2016 through 2020, $365.3 million in 2021 through 2025, and $114.5  million thereafter.

 

The Company offers a type of commercial mortgage loan under which the Company will permit a loan-to-value ratio of up to 85% in exchange for a participating interest in the cash flows from the underlying real estate. As of September 30, 2015 (Successor Company) and December 31, 2014 (Predecessor Company), approximately $562.6 million and $553.6 million, respectively, of the Company’s mortgage loans have this participation feature. Cash flows received as a result of this participation feature are recorded as interest income. During the three months ended September 30, 2015 (Successor Company), the period of February 1, 2015 to September 30, 2015 (Successor Company), January 1, 2015 to January 31, 2015 (Predecessor Company), and for the three and nine months ended September 30, 2014 (Predecessor Company), the Company recognized $3.3 million, $8.4 million, $0.1 million, $8.0 million, and $13.8 million, respectively, of participating mortgage loan income.

 

As of September 30, 2015 (Successor Company), approximately $7.3 million, or 0.02%, of invested assets consisted of nonperforming mortgage loans and/or restructured mortgage loans since February 1, 2015 (Successor Company). The Company does not expect these investments to adversely affect its liquidity or ability to maintain proper matching of assets and liabilities. During the period of February 1, 2015 to September 30, 2015 (Successor Company) and the period of January 1, 2015 to January 31, 2015 (Predecessor Company), the Company entered into certain mortgage loan transactions that were accounted for as troubled debt restructurings under Topic 310 of the FASB ASC. For all mortgage loans, the impact of troubled debt restructurings is generally reflected in the Company’s investment balance and in the allowance for mortgage loan credit losses. Transactions accounted for as troubled debt restructurings during the period of February 1, 2015 to September 30, 2015 (Successor Company) and the period of January 1, 2015 to January 31, 2015 (Predecessor Company) included either the acceptance of assets in satisfaction of principal during the respective periods or at a future date, and were the result of agreements between the creditor and the debtor. During the period of February 1, 2015 to September 30, 2015 (Successor Company), the Company accepted or agreed to accept assets of $12.1 million in satisfaction of $15.2 million of principal and for the period of January 1, 2015 to January 31, 2015 (Predecessor Company), the Company accepted or agreed to accept assets of $11.3 million in satisfaction of $13.8 million of principal. These transactions resulted in no material realized losses in the Company’s investment in mortgage loans net of existing discounts recorded for mortgage loans losses for the period of February 1, 2015 to September 30, 2015 (Successor Company).

 

The Company’s mortgage loan portfolio consists of two categories of loans: 1) those not subject to a pooling and servicing agreement and 2) those subject to a contractual pooling and servicing agreement. As of September 30, 2015 (Successor Company), $7.3 million of mortgage loans not subject to a pooling and servicing agreement were

 

29



Table of Contents

 

nonperforming mortgage loans and/or restructured mortgage loans since February 1, 2015 (Successor Company). None of the restructured loans were nonperforming during the periods of February 1, 2015 to September 30, 2015 (Successor Company) and January 1, 2015 to January 31, 2015 (Predecessor Company). The Company did not foreclose on any nonperforming loans not subject to a pooling and servicing agreement during the periods of February 1, 2015 to September 30, 2015 (Successor Company) and January 1, 2015 to January 31, 2015 (Predecessor Company).

 

As of September 30, 2015 (Successor Company), none of the loans subject to a pooling and servicing agreement were nonperforming or restructured. The Company did not foreclose on any nonperforming loans subject to pooling and servicing agreement during the periods of February 1, 2015 to September 30, 2015 (Successor Company) and January 1, 2015 to January 31, 2015 (Predecessor Company).

 

As of September 30, 2015 (Successor Company) and December 31, 2014 (Predecessor Company), the Company had an allowance for mortgage loan credit losses of $2.0 million and $5.7 million, respectively. Due to the Company’s loss experience and nature of the loan portfolio, the Company believes that a collectively evaluated allowance would be inappropriate. The Company believes an allowance calculated through an analysis of specific loans that are believed to have a higher risk of credit impairment provides a more accurate presentation of expected losses in the portfolio and is consistent with the applicable guidance for loan impairments in ASC Subtopic 310. Since the Company uses the specific identification method for calculating the allowance, it is necessary to review the economic situation of each borrower to determine those that have higher risk of credit impairment. The Company has a team of professionals that monitors borrower conditions such as payment practices, borrower credit, operating performance, and property conditions, as well as ensuring the timely payment of property taxes and insurance. Through this monitoring process, the Company assesses the risk of each loan. When issues are identified, the severity of the issues are assessed and reviewed for possible credit impairment. If a loss is probable, an expected loss calculation is performed and an allowance is established for that loan based on the expected loss. The expected loss is calculated as the excess carrying value of a loan over either the present value of expected future cash flows discounted at the loan’s original effective interest rate, or the current estimated fair value of the loan’s underlying collateral. A loan may be subsequently charged off at such point that the Company no longer expects to receive cash payments, the present value of future expected payments of the renegotiated loan is less than the current principal balance, or at such time that the Company is party to foreclosure or bankruptcy proceedings associated with the borrower and does not expect to recover the principal balance of the loan.

 

A charge off is recorded by eliminating the allowance against the mortgage loan and recording the renegotiated loan or the collateral property related to the loan as investment real estate on the balance sheet, which is carried at the lower of the appraised fair value of the property or the unpaid principal balance of the loan, less estimated selling costs associated with the property.

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

February 1, 2015

 

 

January 1, 2015

 

 

 

 

 

to

 

 

to

 

As of

 

 

 

September 30, 2015

 

 

January 31, 2015

 

December 31, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Beginning balance

 

$

 

 

$

  5,720

 

$

  3,130

 

Charge offs

 

(535

)

 

(861

)

(675

)

Recoveries

 

(639

)

 

(2,359

)

(2,600

)

Provision

 

3,199

 

 

 

5,865

 

Ending balance

 

$

2,025

 

 

$

  2,500

 

$

  5,720

 

 

30



Table of Contents

 

It is the Company’s policy to cease to carry accrued interest on loans that are over 90 days delinquent. For loans less than 90 days delinquent, interest is accrued unless it is determined that the accrued interest is not collectible. If a loan becomes over 90 days delinquent, it is the Company’s general policy to initiate foreclosure proceedings unless a workout arrangement to bring the loan current is in place. For loans subject to a pooling and servicing agreement, there are certain additional restrictions and/or requirements related to workout proceedings, and as such, these loans may have different attributes and/or circumstances affecting the status of delinquency or categorization of those in nonperforming status. An analysis of the delinquent loans is shown in the following chart .

 

 

 

 

 

 

 

Greater

 

 

 

Successor Company

 

30-59 Days

 

60-89 Days

 

than 90 Days

 

Total

 

As of September 30, 2015

 

Delinquent

 

Delinquent

 

Delinquent

 

Delinquent

 

 

 

(Dollars In Thousands)

 

Commercial mortgage loans

 

$

6,386

 

$

6,087

 

$

1,190

 

$

13,663

 

Number of delinquent commercial mortgage loans

 

4

 

3

 

1

 

8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Predecessor Company

 

 

 

 

 

 

 

 

 

As of December 31, 2014

 

 

 

 

 

 

 

 

 

Commercial mortgage loans

 

$

8,972

 

$

 

$

1,484

 

$

10,456

 

Number of delinquent commercial mortgage loans

 

4

 

 

1

 

5

 

 

The Company’s commercial mortgage loan portfolio consists of mortgage loans that are collateralized by real estate. Due to the collateralized nature of the loans, any assessment of impairment and ultimate loss given a default on the loans is based upon a consideration of the estimated fair value of the real estate. The Company limits accrued interest income on impaired loans to 90 days of interest. Once accrued interest on the impaired loan is received, interest income is recognized on a cash basis. For information regarding impaired loans, please refer to the following chart :

 

 

 

 

 

Unpaid

 

 

 

Average

 

Interest

 

Cash Basis

 

Successor Company

 

Recorded

 

Principal

 

Related

 

Recorded

 

Income

 

Interest

 

As of September 30, 2015

 

Investment

 

Balance

 

Allowance

 

Investment

 

Recognized

 

Income

 

 

 

(Dollars In Thousands)

 

Commercial mortgage loans:

 

 

 

 

 

 

 

 

 

 

 

 

 

With no related allowance recorded

 

$

4,532

 

$

5,288

 

$

 

$

1,511

 

$

72

 

$

45

 

With an allowance recorded

 

5,676

 

5,828

 

2,025

 

2,838

 

 

48

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Predecessor Company

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2014

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial mortgage loans:

 

 

 

 

 

 

 

 

 

 

 

 

 

With no related allowance recorded

 

$

 

$

 

$

 

$

 

$

 

$

 

With an allowance recorded

 

19,632

 

20,603

 

5,720

 

3,272

 

1,224

 

1,280

 

 

31



Table of Contents

 

As of September 30, 2015 (Successor Company), the Company did not carry any mortgage loans that have been modified in a troubled debt restructuring. Mortgage loans that were modified in a troubled debt restructuring:

 

 

 

 

 

Pre-Modification

 

Post-Modification

 

 

 

 

 

Outstanding

 

Outstanding

 

Predecessor Company

 

Number of

 

Recorded

 

Recorded

 

As of December 31, 2014

 

Contracts

 

Investment

 

Investment

 

 

 

(Dollars In Thousands)

 

Troubled debt restructuring:

 

 

 

 

 

 

 

Commercial mortgage loans

 

6

 

$

28,648

 

$

19,593

 

 

8.                                       DEFERRED POLICY ACQUISITION COSTS AND VALUE OF BUSINESS ACQUIRED

 

Deferred policy acquisition costs

 

The balances and changes in DAC are as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

February 1, 2015

 

 

January 1, 2015

 

 

 

 

 

to

 

 

to

 

As of

 

 

 

September 30, 2015

 

 

January 31, 2015

 

December 31, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Balance, beginning of period

 

$

 

 

$

2,653,065

 

$

2,720,604

 

Capitalization of commissions, sales, and issue expenses

 

216,209

 

 

22,820

 

293,672

 

Amortization

 

(14,994

)

 

1,080

 

(194,517

)

Change in unrealized investment gains and losses

 

6,560

 

 

(96,830

)

(166,694

)

Balance, end of period

 

$

207,775

 

 

$

2,580,135

 

$

2,653,065

 

 

Value of business acquired

 

The balances and changes in VOBA are as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

February 1, 2015

 

 

January 1, 2015

 

 

 

 

 

to

 

 

to

 

As of

 

 

 

September 30, 2015

 

 

January 31, 2015

 

December 31, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Balance, beginning of period

 

$

1,278,063

 

 

$

501,981

 

$

756,018

 

Amortization

 

(62,370

)

 

(5,895

)

(113,803

)

Change in unrealized gains and losses

 

52,301

 

 

(79,417

)

(140,234

)

Other

 

(6,046

)

 

 

 

Balance, end of period

 

$

1,261,948

 

 

$

416,669

 

$

501,981

 

 

As of February 1, 2015, the existing deferred acquisition costs (“DAC”) and VOBA balance was written off in conjunction with the merger previously disclosed in Note 3, Dai-ichi Merger and in accordance with ASC Topic 805 — Business Combinations.

 

Concurrently, a VOBA asset was created representing the actuarial estimated present value of future cash flows from the Company’s insurance policies and investment contracts in-force on the date of the Merger.

 

32



Table of Contents

 

The expected amortization of VOBA for the next five years is as follows:

 

 

 

Expected

 

Years

 

Amortization

 

 

 

(Dollars In Thousands)

 

2015

 

$

39,662

 

2016

 

141,749

 

2017

 

129,671

 

2018

 

117,549

 

2019

 

99,536

 

 

9.                                       GOODWILL

 

During the period of January 1, 2015 to January 31, 2015 (Predecessor Company), the Company decreased its goodwill balance by approximately $0.3 million. The decrease for the period of the Predecessor Company was due to an adjustment in the Acquisitions segment related to tax benefits realized during the period on the portion of tax goodwill in excess of GAAP basis goodwill. The goodwill balances associated with the Predecessor Company were replaced with newly established goodwill balances in conjunction with the Dai-ichi Merger, in accordance with ASC Topic 805, as described below.

 

As permitted by ASC Topic 805, Business Combinations , the Company measured its assets and liabilities at fair value on the date of the merger, February 1, 2015. The purchase price in excess of the fair value of PLC’s assets and liabilities resulted in the establishment of goodwill as of the date of the merger. As of February 1, 2015 (Successor Company), the Company was allocated an aggregate goodwill balance of $735.7 million. Refer to Note 4, Dai-ichi Merger , for more information related to the Successor Company goodwill. There has been no change in the goodwill during the period of February 1, 2015 to September 30, 2015 (Successor Company).

 

Accounting for goodwill requires an estimate of the future profitability of the associated lines of business to assess the recoverability of the capitalized acquisition goodwill. The Company evaluates the carrying value of goodwill at the segment (or reporting unit) level at least annually and between annual evaluations if events occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Such circumstances could include, but are not limited to: 1) a significant adverse change in legal factors or in business climate, 2) unanticipated competition, or 3) an adverse action or assessment by a regulator. When evaluating whether goodwill is impaired, the Company first determines through qualitative analysis whether relevant events and circumstances indicate that it is more likely than not that segment goodwill balances are impaired as of the measurement date. If it is determined that it is more likely than not that impairment exists, the Company compares its estimate of the fair value of the reporting unit to which the goodwill is assigned to the reporting unit’s carrying amount, including goodwill. The Company utilizes a fair value measurement (which includes a discounted cash flows analysis) to assess the carrying value of the reporting units in consideration of the recoverability of the goodwill balance assigned to each reporting unit as of the measurement date. The Company’s material goodwill balances are attributable to certain of its operating segments (which are each considered to be reporting units). The cash flows used to determine the fair value of the Company’s reporting units are dependent on a number of significant assumptions. The Company’s estimates, which consider a market participant view of fair value, are subject to change given the inherent uncertainty in predicting future results and cash flows, which are impacted by such things as policyholder behavior, competitor pricing, capital limitations, new product introductions, and specific industry and market conditions. Additionally, the discount rate used is based on the Company’s judgment of the appropriate rate for each reporting unit based on the relative risk associated with the projected cash flows. As of September 30, 2015 (Successor Company) and for the period of February 1, 2015 through September 30, 2015 (Successor Company), the Company did not identify any events or circumstances which would indicate that the fair value of its operating segments would have declined below their book value, either individually or in the aggregate. Accordingly, no impairment to the Company’s goodwill balance has been recorded.

 

33



Table of Contents

 

10.                                DEBT AND OTHER OBLIGATIONS

 

In conjunction with the Merger and in accordance with ASC Topic 805, the Company adjusted the carrying value of its non-recourse funding obligations to fair value as of the date of the Merger, February 1, 2015. This resulted in the Company establishing premiums and discounts on its non-recourse funding obligations. The fair value of the Company’s non-recourse funding obligations associated with Golden Gate, Golden Gate II, and MONY Life Insurance Company, were determined using market prices as of February 1, 2015. The fair value of the Golden Gate V non-recourse funding obligation was determined using a discounted cash flow model with inputs derived from comparable financial instruments. The premiums and discounts established as of February 1, 2015 are amortized over the expected life of the instruments using the effective interest method. The amortization of premiums and discounts are recorded as a component of interest expense and are recorded in “Other operating expenses” on the Company’s Consolidated Condensed Statements of Income (Loss).

 

Under a revolving line of credit arrangement that was in effect until February 2, 2015 (the “Credit Facility”), the Company and PLC had the ability to borrow on an unsecured basis up to an aggregate principal amount of $750 million. The Company had the right in certain circumstances to request that the commitment under the Credit Facility be increased up to a maximum principal amount of $1.0 billion. Balances outstanding under the Credit Facility accrued interest at a rate equal to, at the option of the Borrowers, (i) LIBOR plus a spread based on the ratings of the Company’s senior unsecured long-term debt (“Senior Debt”), or (ii) the sum of (A) a rate equal to the highest of (x) the Administrative Agent’s prime rate, (y) 0.50% above the Federal Funds rate, or (z) the one-month LIBOR plus 1.00% and (B) a spread based on the ratings of our Senior Debt. The Credit Facility also provided for a facility fee at a rate, 0.175%, that could vary with the ratings of the Company’s Senior Debt and that was calculated on the aggregate amount of commitments under the Credit Facility, whether used or unused. The Credit Facility provided that PLC was liable for the full amount of any obligations for borrowings or letters of credit, including those of the Company, under the Credit Facility. The maturity date of the Credit Facility was July 17, 2017. The Company was not aware of any non-compliance with the financial debt covenants of the Credit Facility as of December 31, 2014 (Predecessor Company). PLC had an outstanding balance of $450.0 million bearing interest at a rate of LIBOR plus 1.20% under the Credit Facility as of December 31, 2014 (Predecessor Company). As of December 31, 2014 (Predecessor Company), the Company had used $55.0 million of borrowing capacity by executing a Letter of Credit under the Credit Facility for the benefit of an affiliated captive reinsurance subsidiary of the Company. This Letter of Credit had not been drawn upon as of December 31, 2014 (Predecessor Company).

 

On February 2, 2015, the Company and PLC amended and restated the Credit Facility (the “2015 Credit Facility”). Under the 2015 Credit Facility, the Company has the ability to borrow on an unsecured basis up to an aggregate principal amount of $1.0 billion. The Company has the right in certain circumstances to request that the commitment under the 2015 Credit Facility be increased up to a maximum principal amount of $1.25 billion. Balances outstanding under the 2015 Credit Facility accrue interest at a rate equal to, at the option of the Borrowers, (i) LIBOR plus a spread based on the ratings of PLC’s Senior Debt, or (ii) the sum of (A) a rate equal to the highest of (x) the Administrative Agent’s prime rate, (y) 0.50% above the Federal Funds rate, or (z) the one-month LIBOR plus 1.00% and (B) a spread based on the ratings of PLC’s Senior Debt. The 2015 Credit Facility also provided for a facility fee at a rate that varies with the ratings of PLC’s Senior Debt and that is calculated on the aggregate amount of commitments under the 2015 Credit Facility, whether used or unused. The initial facility fee rate was 0.15% on February 2, 2015, and was adjusted to 0.125% upon PLC’s subsequent ratings upgrade on February 2, 2015. The 2015 Credit Facility provides that PLC is liable for the full amount of any obligations for borrowings or letters of credit, including those of the Company, under the 2015 Credit Facility. The maturity date of the 2015 Credit Facility is February 2, 2020. The Company is not aware of any non-compliance with the financial debt covenants of the Credit Facility as of February 2, 2015 or the 2015 Credit Facility as of September 30, 2015 (Successor Company). PLC had an outstanding balance of $495.0 million bearing interest at a rate of LIBOR plus 1.00% as September 30, 2015 (Successor Company). As of September 30, 2015 (Successor Company), the $55.0 million Letter of Credit executed by the Company was no longer issued and outstanding.

 

34



Table of Contents

 

Non- Recourse Funding Obligations

 

Golden Gate Captive Insurance Company

 

Golden Gate Captive Insurance Company (“Golden Gate”), a South Carolina special purpose financial captive insurance company and wholly owned subsidiary, had three series of non-recourse funding obligations with a total outstanding balance of $800 million as of September 30, 2015 (Successor Company). PLC holds the entire outstanding balance of non-recourse funding obligations. The Series A1 non-recourse funding obligations have a balance of $400 million and accrue interest at 7.375%, the Series A2 non-recourse funding obligations have a balance of $100 million and accrue interest at 8.00%, and the Series A3 non-recourse funding obligations have a balance of $300 million and accrue interest at 8.45%.

 

Golden Gate II Captive Insurance Company

 

Golden Gate II Captive Insurance Company (“Golden Gate II”), a South Carolina special purpose financial captive insurance company and wholly owned subsidiary, had $575 million of outstanding non-recourse funding obligations as of September 30, 2015 (Successor Company). These outstanding non-recourse funding obligations were issued to special purpose trusts, which in turn issued securities to third parties. Certain of our affiliates own a portion of these securities. As of September 30, 2015 (Successor Company), securities related to $144.9 million of the outstanding balance of the non-recourse funding obligations were held by external parties, securities related to $145.3 million of the non-recourse funding obligations were held by nonconsolidated affiliates, and $284.8 million were held by consolidated subsidiaries of the Company. PLC has entered into certain support agreements with Golden Gate II obligating it to make capital contributions or provide support related to certain of Golden Gate II’s expenses and in certain circumstances, to collateralize certain of PLC’s obligations to Golden Gate II. These support agreements provide that amounts would become payable by PLC to Golden Gate II if its annual general corporate expenses were higher than modeled amounts or if Golden Gate II’s investment income on certain investments or premium income was below certain actuarially determined amounts. As of September 30, 2015 (Successor Company), no payments have been made under these agreements; however, certain support agreement obligations to Golden Gate II of approximately $1.9 million have been collateralized by PLC. Re-evaluation and, if necessary, adjustments of any support agreement collateralization amounts occur annually during the first quarter pursuant to the terms of the support agreements.  There are no support agreements between the Company and Golden Gate II.

 

Golden Gate V Vermont Captive Insurance Company

 

On October 10, 2012, Golden Gate V Vermont Captive Insurance Company (“Golden Gate V”), a Vermont special purpose financial insurance company and Red Mountain, LLC (“Red Mountain”), both wholly owned subsidiaries, entered into a 20-year transaction to finance up to $945 million of “AXXX” reserves related to a block of universal life insurance policies with secondary guarantees issued by the Company and its subsidiary, West Coast Life Insurance Company (“WCL”). Golden Gate V issued non-recourse funding obligations to Red Mountain, and Red Mountain issued a note with an initial principal amount of $275 million, increasing to a maximum of $945 million in 2027, to Golden Gate V for deposit to a reinsurance trust supporting Golden Gate V’s obligations under a reinsurance agreement with WCL, pursuant to which WCL cedes liabilities relating to the policies of WCL and retrocedes liabilities relating to the policies of the Company. Through the structure, Hannover Life Reassurance Company of America (“Hannover Re”), the ultimate risk taker in the transaction, provides credit enhancement to the Red Mountain note for the 20-year term in exchange for a fee. The transaction is “non-recourse” to Golden Gate V, Red Mountain, WCL, PLC, and the Company, meaning that none of these companies are liable for the reimbursement of any credit enhancement payments required to be made. As of September 30, 2015 (Successor Company), the principal balance of the Red Mountain note was $485 million. Future scheduled capital contributions to prefund credit enhancement fees amount to approximately $139.6 million and will be paid in annual installments through 2031. In connection with the transaction, PLC has entered into certain support agreements under which PLC guarantees or otherwise supports certain obligations of Golden Gate V or Red Mountain. The support agreements provide that amounts would become payable by PLC if Golden Gate V’s annual general corporate expenses were higher than modeled amounts or in the event write-downs due to other-than-temporary impairments on assets held in certain accounts exceed defined threshold levels. Additionally, PLC has entered into separate agreements to indemnify Golden Gate V with respect to material adverse changes in non-guaranteed elements of insurance policies reinsured by Golden Gate V, and to guarantee payment of certain fee

 

35



Table of Contents

 

amounts in connection with the credit enhancement of the Red Mountain note. As of September 30, 2015 (Successor Company), no payments have been made under these agreements.

 

In connection with the transaction outlined above, Golden Gate V had a $485 million outstanding non-recourse funding obligation as of September 30, 2015 (Successor Company). This non-recourse funding obligation matures in 2037, has scheduled increases in principal to a maximum of $945 million, and accrues interest at a fixed annual rate of 6.25%.

 

Non-recourse funding obligations outstanding as of September 30, 2015 (Successor Company), on a consolidated basis, are shown in the following table:

 

 

 

 

 

 

 

Year-to-Date

 

 

 

 

 

Maturity

 

Weighted-Avg

 

Issuer

 

Carrying Value (1)

 

Year

 

Interest Rate

 

 

 

(Dollars In Thousands)

 

 

 

 

 

Golden Gate Captive Insurance Company (2)

 

$

1,150,551

 

2037

 

4.66

%

Golden Gate II Captive Insurance Company

 

235,910

 

2052

 

1.19

%

Golden Gate V Vermont Captive Insurance Company (2)

 

550,079

 

2037

 

5.12

%

MONY Life Insurance Company (2)

 

2,538

 

2024

 

6.19

%

Total

 

$

1,939,078

 

 

 

 

 

 


(1)   Carrying values include premiums and discounts and do not represent unpaid principal balances.

(2)   Fixed rate obligations

 

During the period of February 1, 2015 to September 30, 2015 (Successor Company) and the period of January 1, 2015 to January 31, 2015 (Predecessor Company), the Company did not repurchase any of its outstanding non-recourse funding obligations. For the nine months ended September 30, 2014 (Predecessor Company), the Company repurchased $6.0 million of its outstanding non-recourse funding obligations, at a discount. The repurchase resulted in a $1.5 million pre-tax gain for the Company. These gains are recorded in other income in the consolidated condensed statements of income.

 

Letters of Credit

 

Golden Gate III Vermont Captive Insurance Company (“Golden Gate III”), a Vermont special purpose financial insurance company and wholly owned subsidiary, is party to a Reimbursement Agreement (the “Reimbursement Agreement”) with UBS AG, Stamford Branch (“UBS”), as issuing lender. Under the original Reimbursement Agreement, dated April 23, 2010, UBS issued a letter of credit (the “LOC”) in the initial amount of $505 million to a trust for the benefit of WCL. The Reimbursement Agreement was subsequently amended and restated effective November 21, 2011 (the “First Amended and Restated Reimbursement Agreement”), to replace the existing LOC with one or more letters of credit from UBS, and to extend the maturity date from April 1, 2018, to April 1, 2022. On August 7, 2013, Golden Gate III entered into a Second Amended and Restated Reimbursement Agreement with UBS (the “Second Amended and Restated Reimbursement Agreement”), which amended and restated the First Amended and Restated Reimbursement Agreement. Under the Second and Amended and Restated Reimbursement Agreement a new LOC in an initial amount of $710 million was issued by UBS in replacement of the existing LOC issued under the First Amended and Restated Reimbursement Agreement. The term of the LOC was extended from April 1, 2022 to October 1, 2023, subject to certain conditions being satisfied including scheduled capital contributions being made to Golden Gate III by one of its affiliates. The maximum stated amount of the LOC was increased from $610 million to $720 million in 2015 if certain conditions had been met. On June 25, 2014, Golden Gate III entered into a Third Amended and Restated Reimbursement Agreement with UBS (the “Third Amended and Restated Reimbursement Agreement”), which amended and restated the Second Amended and Restated Reimbursement Agreement. Under the Third Amended and Restated Reimbursement Agreement, a new LOC in an initial amount of $915 million was issued by UBS in replacement of the existing LOC issued under the Second Amended and Restated Reimbursement Agreement. The term of the LOC was extended from October 1, 2023 to April 1, 2025, subject to certain conditions being satisfied including scheduled capital contributions being made to Golden Gate III by one of its affiliates. The maximum stated amount of the LOC was increased from $720 million to $935 million in 2015 if certain conditions are met. The LOC is held in trust for the benefit of WCL, and supports certain obligations of Golden Gate III to WCL under an indemnity reinsurance agreement originally effective April 1, 2010, as amended and restated on November 21, 2011, and as further amended and restated on August 7, 2013 and on June 25, 2014 to include additional

 

36



Table of Contents

 

blocks of policies, and pursuant to which WCL cedes liabilities relating to the policies of WCL and retrocedes liabilities relating to the policies of the Company. The LOC balance was $935 million as of September 30, 2015 (Successor Company). The term of the LOC is expected to be approximately 15 years from the original issuance date. This transaction is “non-recourse” to WCL, PLC, and the Company, meaning that none of these companies other than Golden Gate III are liable for reimbursement on a draw of the LOC. PLC has entered into certain support agreements with Golden Gate III obligating PLC to make capital contributions or provide support related to certain of Golden Gate III’s expenses and in certain circumstances, to collateralize certain of PLC’s obligations to Golden Gate III. Future scheduled capital contributions amount to approximately $122.5 million and will be paid in three installments with the last payment occurring in 2021, and these contributions may be subject to potential offset against dividend payments as permitted under the terms of the Third Amended and Restated Reimbursement Agreement. The support agreements provide that amounts would become payable by PLC to Golden Gate III if Golden Gate III’s annual general corporate expenses were higher than modeled amounts or if specified catastrophic losses occur during defined time periods with respect to the policies reinsured by Golden Gate III. Pursuant to the terms of an amended and restated letter agreement with UBS, PLC has continued to guarantee the payment of fees to UBS as specified in the Third Amended and Restated Reimbursement Agreement. As of September 30, 2015 (Successor Company), no payments have been made under these agreements.

 

Golden Gate IV Vermont Captive Insurance Company (“Golden Gate IV”), a Vermont special purpose financial insurance company and wholly owned subsidiary, is party to a Reimbursement Agreement with UBS AG, Stamford Branch, as issuing lender. Under the Reimbursement Agreement, dated December 10, 2010, UBS issued an LOC in the initial amount of $270 million to a trust for the benefit of WCL. The LOC balance has increased, in accordance with the terms of the Reimbursement Agreement, during each quarter of 2015 and was $770 million as of September 30, 2015 (Successor Company). Subject to certain conditions, the amount of the LOC will be periodically increased up to a maximum of $790 million in 2016. The term of the LOC is expected to be 12 years from the original issuance date (stated maturity of December 30, 2022). The LOC was issued to support certain obligations of Golden Gate IV to WCL under an indemnity reinsurance agreement, pursuant to which WCL cedes liabilities relating to the policies of WCL and retrocedes liabilities relating to the policies of the Company. This transaction is “non-recourse” to WCL, PLC, and the Company, meaning that none of these companies other than Golden Gate IV are liable for reimbursement on a draw of the LOC. PLC has entered into certain support agreements with Golden Gate IV obligating PLC to make capital contributions or provide support related to certain of Golden Gate IV’s expenses and in certain circumstances, to collateralize certain of PLC’s obligations to Golden Gate IV. The support agreements provide that amounts would become payable by PLC to Golden Gate IV if Golden Gate IV’s annual general corporate expenses were higher than modeled amounts or if specified catastrophic losses occur during defined time periods with respect to the policies reinsured by Golden Gate IV. PLC has also entered into a separate agreement to guarantee the payments of LOC fees under the terms of the Reimbursement Agreement. As of September 30, 2015 (Successor Company), no payments have been made under these agreements.

 

Repurchase Program Borrowings

 

While the Company anticipates that the cash flows of its operating subsidiaries will be sufficient to meet its investment commitments and operating cash needs in a normal credit market environment, the Company recognizes that investment commitments scheduled to be funded may, from time to time, exceed the funds then available. Therefore, the Company has established repurchase agreement programs for certain of its insurance subsidiaries to provide liquidity when needed. The Company expects that the rate received on its investments will equal or exceed its borrowing rate. Under this program, the Company may, from time to time, sell an investment security at a specific price and agree to repurchase that security at another specified price at a later date. These borrowings are typically for a term less than 90 days. The market value of securities to be repurchased is monitored and collateral levels are adjusted where appropriate to protect the counterparty against credit exposure. Cash received is invested in fixed maturity securities, and the agreements provided for net settlement in the event of default or on termination of the agreements. As of September 30, 2015 (Successor Company), the fair value of securities pledged under the repurchase program was $500.5 million and the repurchase obligation of $455.7 million was included in the Company’s consolidated condensed balance sheets (at an average borrowing rate of 22 basis points). During the period of February 1, 2015 to September 30, 2015 (Successor Company) and the period of January 1, 2015 to January 31, 2015 (Predecessor Company), the maximum balance outstanding at any one point in time related to these programs was $652.2 million and $175.0 million, respectively. The average daily balance was $530.5 million and $77.4 million (at an average borrowing rate of 18 and 16 basis points, respectively) during the period of February 1, 2015 to September 30, 2015 (Successor

 

37



Table of Contents

 

Company) and the period of January 1, 2015 to January 31, 2015 (Predecessor Company), respectively. As of December 31, 2014 (Predecessor Company), the Company had a $50.0 million outstanding balance related to such borrowings. During 2014, the maximum balance outstanding at any one point in time related to these programs was $633.7 million. The average daily balance was $470.4 million (at an average borrowing rate of 11 basis points) during the year ended December 31, 2014 (Predecessor Company).

 

The following table provides the amount of collateral pledged for repurchase agreements, grouped by asset class, as of September 30, 2015 (Successor Company):

 

Repurchase Agreements, Securities Lending Transactions, and Repurchase-to-Maturity Transactions

Accounted for as Secured Borrowings

 

 

 

Remaining Contractual Maturity of the Agreements

 

 

As of September 30, 2015 (Successor Company)

 

 

(Dollars In Thousands)

 

 

 

Overnight and

 

 

 

 

 

Greater Than

 

 

 

 

 

Continuous

 

Up to 30 days

 

30-90 days

 

90 days

 

Total

 

Repurchase agreements and repurchase-to-maturity transactions

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury and agency securities

 

$

124,489

 

$

20,257

 

$

15,029

 

$

 

$

159,775

 

State and municipal securities

 

 

 

 

 

 

Other asset-backed securities

 

 

 

 

 

 

Corporate securities

 

 

 

 

 

 

Equity securities

 

 

 

 

 

 

Non-U.S. sovereign debt

 

 

 

 

 

 

Mortgage loans

 

340,767

 

 

 

 

340,767

 

Other asset-backed securities

 

 

 

 

 

 

Total borrowings

 

$

465,256

 

$

20,257

 

$

15,029

 

$

 

$

500,542

 

 

11.                                COMMITMENTS AND CONTINGENCIES

 

Under insurance guaranty fund laws, in most states insurance companies doing business therein can be assessed up to prescribed limits for policyholder losses incurred by insolvent companies. In addition, from time to time, companies may be asked to contribute amounts beyond prescribed limits. Most insurance guaranty fund laws provide that an assessment may be excused or deferred if it would threaten an insurer’s own financial strength. The Company does not believe its insurance guaranty fund assessments will be materially different from amounts already provided for in the financial statements.

 

A number of civil jury verdicts have been returned against insurers, broker dealers and other providers of financial services involving sales, refund or claims practices, alleged agent misconduct, failure to properly supervise representatives, relationships with agents or persons with whom the insurer does business, and other matters. Often these lawsuits have resulted in the award of substantial judgments that are disproportionate to the actual damages, including material amounts of punitive and non-economic compensatory damages. In some states, juries, judges, and arbitrators have substantial discretion in awarding punitive non-economic compensatory damages which creates the potential for unpredictable material adverse judgments or awards in any given lawsuit or arbitration. Arbitration awards are subject to very limited appellate review. In addition, in some class action and other lawsuits, companies have made material settlement payments. Publicly held companies in general and the financial services and insurance industries in particular are also sometimes the target of law enforcement and regulatory investigations relating to the numerous laws and regulations that govern such companies. Some companies have been the subject of law enforcement or regulatory actions or other actions resulting from such investigations. The Company, in the ordinary course of business, is involved in such matters.

 

The Company establishes liabilities for litigation and regulatory actions when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. For matters where a loss is believed to be reasonably possible, but not probable, no liability is established. For such matters, the Company may provide an

 

38



Table of Contents

 

estimate of the possible loss or range of loss or a statement that such an estimate cannot be made. The Company reviews relevant information with respect to litigation and regulatory matters on a quarterly and annual basis and updates its established liabilities, disclosures and estimates of reasonably possible losses or range of loss based on such reviews.

 

Although the Company cannot predict the outcome of any litigation or regulatory action, the Company does not believe that any such outcome will have an impact, either individually or in the aggregate, on its financial condition or results of operations that differs materially from the Company’s established liabilities. Given the inherent difficulty in predicting the outcome of such matters, however, it is possible that an adverse outcome in certain such matters could be material to the Company’s financial condition or results of operations for any particular reporting period.

 

In 2012, the IRS proposed favorable and unfavorable adjustments to the Company’s 2003 through 2007 reported taxable income. The Company protested certain unfavorable adjustments and was seeking resolution at the IRS’ Appeals Division. The case followed normal procedure and was under review at Congress’ Joint Committee on Taxation. Subsequent to September 30, 2015, Appeals accepted the Company’s proposed settlement offer that related to its earlier protest. As a result, PLC, the parent of the consolidated income tax return group of which the Company is a part, expects to pay approximately $13.0 million in tax. A portion of this payment would be made by the Company. This payment will not materially impact the Company nor its effective tax rate.

 

In the three months ended September 30, 2015, the IRS proposed favorable and unfavorable adjustments to the Company’s 2008 through 2011 reported taxable income. The Company agreed to these adjustments. As a result, PLC, the parent of the consolidated income tax return group of which the Company is a part, expects to receive approximately $9.8 million in tax refunds. However, due to the activity in the previous exam cycle per the preceding paragraph, these tax computations are in the process of being recomputed. Some portion of these refunds will be due to the Company. Regardless of these recalculations, these refunds will not materially affect the Company’s effective tax rate.

 

Through the acquisition of MONY by the Company certain income tax credit carryforwards, which arose in MONY’s pre-acquisition tax years, transferred to the Company. This transfer was in accordance with the applicable rules of the Internal Revenue Code and the related Regulations. In spite of this transfer, AXA, the former parent of the consolidated income tax return group in which MONY was a member, retains the right to utilize these credits in the future to offset future increases in its 2010 through 2013 tax liabilities. The Company had determined that, based on all information known as of the acquisition date and through the March 31, 2014 reporting date, it was probable that a loss of the utilization of these carryforwards had been incurred. Due to indemnification received from AXA during the quarter ending June 30, 2014, the probability of loss of these carryforwards has been eliminated. Accordingly, in the table summarizing the fair value of net assets acquired from the Acquisition, the amount of the deferred tax asset from the credit carryforwards is no longer offset by a liability.

 

Certain of the Company’s insurance subsidiaries, as well as certain other insurance companies for which the Company has coinsured blocks of life insurance and annuity policies, are under audit for compliance with the unclaimed property laws of a number of states. The audits are being conducted on behalf of the treasury departments or unclaimed property administrators in such states. The focus of the audits is on whether there have been unreported deaths, maturities, or policies that have exceeded limiting age with respect to which death benefits or other payments under life insurance or annuity policies should be treated as unclaimed property that should be escheated to the state. The Company is presently unable to estimate the reasonably possible loss or range of loss that may result from the audits due to a number of factors, including uncertainty as to the legal theory or theories that may give rise to liability, the early stages of the audits being conducted, and, with respect to one block of life insurance policies that is co-insured by a subsidiary of the Company, uncertainty as to whether the Company or other companies are responsible for the liabilities, if any, arising in connection with such policies. The Company will continue to monitor the matter for any developments that would make the loss contingency associated with the audits probable or reasonably estimable.

 

Certain of the Company’s subsidiaries are under a targeted multi-state examination with respect to their claims paying practices and their use of the U.S. Social Security Administration’s Death Master File or similar databases (a “Death Database”) to identify unreported deaths in their life insurance policies, annuity contracts and retained asset accounts. There is no clear basis in previously existing law for requiring a life insurer to search for unreported deaths in order to determine whether a benefit is owed, and substantial legal authority exists to support the position that the

 

39



Table of Contents

 

prevailing industry practice was lawful. A number of life insurers, however, have entered into settlement or consent agreements with state insurance regulators under which the life insurers agreed to implement procedures for periodically comparing their life insurance and annuity contracts and retained asset accounts against a Death Database, treating confirmed deaths as giving rise to a death benefit under their policies, locating beneficiaries and paying them the benefits and interest, and escheating the benefits and interest as well as penalties to the state if the beneficiary could not be found. It has been publicly reported that the life insurers have paid administrative and/or examination fees to the insurance regulators in connection with the settlement or consent agreements. The Company believes it is reasonably possible that insurance regulators could demand from the Company administrative and/or examination fees relating to the targeted multi-state examination. Based on publicly reported payments by other life insurers, the Company estimates the range of such fees to be from $0 to $3.5 million.

 

12.                                EMPLOYEE BENEFIT PLANS

 

Due to the Dai-ichi Life transaction, PLC re-measured all materially impacted benefit plans as of January 31, 2015 (Predecessor Company). Financial re-measurement was performed for the defined benefit pension plan, the unfunded excess benefit plan, and the postretirement life insurance plan as of January 31, 2015 (Predecessor Company). The January 2015 results for the retiree life plan were not material, and therefore, re-measurement was not deemed necessary for this plan. The Company has disclosed relevant financial information related to the applicable January 31, 2015 (Predecessor Company) re-measurements, as follows.

 

40



Table of Contents

 

The following table presents the benefit obligation, fair value of plan assets, and the funded status of the PLC’s defined benefit pension plan and unfunded excess benefit plan as of January 31, 2015 (Predecessor Company) and December 31, 2014 (Predecessor Company). This table also includes the amounts not yet recognized as components of net periodic pension costs as of January 31, 2015 (Predecessor Company) and December 31, 2014 (Predecessor Company).

 

 

 

Predecessor Company

 

 

 

Defined Benefit

 

Unfunded Excess

 

 

 

Pension Plan

 

Benefits Plan

 

 

 

As of

 

As of

 

As of

 

As of

 

 

 

January 31, 2015

 

December 31, 2014

 

January 31, 2015

 

December 31, 2014

 

 

 

(Dollars In Thousands)

 

Accumulated benefit obligation, end of period

 

$

262,290

 

$

249,453

 

$

49,251

 

$

47,368

 

Change in projected benefit obligation:

 

 

 

 

 

 

 

 

 

Projected benefit obligation at beginning of period

 

$

267,331

 

$

219,152

 

$

49,575

 

$

39,679

 

Service cost

 

974

 

9,411

 

95

 

954

 

Interest cost

 

1,002

 

10,493

 

140

 

1,696

 

Amendments

 

 

 

 

 

Actuarial (gain) or loss

 

12,384

 

38,110

 

1,555

 

9,153

 

Benefits paid

 

(592

)

(9,835

)

(122

)

(1,907

)

Projected benefit obligation at end of period

 

281,099

 

267,331

 

51,243

 

49,575

 

 

 

 

 

 

 

 

 

 

 

Change in plan assets:

 

 

 

 

 

 

 

 

 

Fair value of plan assets at beginning of period

 

203,772

 

180,173

 

 

 

Actual return on plan assets

 

(3,525

)

17,921

 

 

 

Employer contributions (1)

 

2,165

 

15,513

 

122

 

1,907

 

Benefits paid

 

(592

)

(9,835

)

(122

)

(1,907

)

Fair value of plan assets at end of period

 

201,820

 

203,772

 

 

 

After reflecting FASB guidance

 

 

 

 

 

 

 

 

 

Funded status

 

(79,279

)

(63,559

)

(51,243

)

(49,575

)

Amounts recognized in the balance sheet:

 

 

 

 

 

 

 

 

 

Other liabilities

 

(79,279

)

(63,559

)

(51,243

)

(49,575

)

 

 

 

 

 

 

 

 

 

 

Amounts recognized in accumulated other comprehensive income:

 

 

 

 

 

 

 

 

 

Net actuarial loss

 

96,965

 

80,430

 

22,401

 

20,983

 

Prior service cost/(credit)

 

(1,001

)

(1,033

)

23

 

24

 

Total amounts recognized in AOCI

 

$

95,964

 

$

79,397

 

$

22,424

 

$

21,007

 

 


(1)  Employer contributions disclosed are based on the Company’s fiscal filing year.

 

As of January 31, 2015 (Predecessor Company) and December 31, 2014 (Predecessor Company), the projected benefit obligation associated with the postretirement life insurance plan was $9.8 million and $9.3 million, respectively.

 

As a result of the Merger on February 1, 2015, all unrecognized prior service costs or credits, actuarial gains or losses, and any remaining transition assets or obligations were not carried forward on the acquisition date. Therefore, the amounts presented in the “Amounts recognized in accumulated other comprehensive income” in the chart above were set to zero on the Merger date.

 

41



Table of Contents

 

The benefit obligations as of January 31, 2015 (Predecessor Company) were determined based on the assumptions used in the 2014 year-end disclosures with the following exception:

 

 

 

Defined Benefit

 

Unfunded Excess

 

Postretirement

 

 

 

Pension Plan

 

Benefit Plan

 

Life Insurance Plan

 

Discount rate

 

3.55

%

3.26

%

3.79

%

 

Components of the net periodic benefit cost for the three months ended September 30, 2015 (Successor Company), the period of February 1, 2015 to September 30, 2015 (Successor Company), the period of January 1, 2015 to January 31, 2015 (Predecessor Company), and for the three and nine months ended September 30, 2014 (Predecessor Company) are as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

Defined

 

Unfunded

 

Defined

 

Unfunded

 

 

Defined

 

Unfunded

 

Defined

 

Unfunded

 

Defined

 

Unfunded

 

 

 

Benefit

 

Excess

 

Benefit

 

Excess

 

 

Benefit

 

Excess

 

Benefit

 

Excess

 

Benefit

 

Excess

 

 

 

Pension

 

Benefit

 

Pension

 

Benefit

 

 

Pension

 

Benefit

 

Pension

 

Benefit

 

Pension

 

Benefit

 

 

 

Plan

 

Plan

 

Plan

 

Plan

 

 

Plan

 

Plan

 

Plan

 

Plan

 

Plan

 

Plan

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Service cost — benefits earned during the period

 

$

2,973

 

$

333

 

$

7,928

 

$

888

 

 

$

974

 

$

95

 

$

2,227

 

$

226

 

$

6,680

 

$

678

 

Interest cost on projected benefit obligation

 

2,433

 

408

 

6,488

 

1,088

 

 

1,002

 

140

 

2,587

 

406

 

7,761

 

1,219

 

Expected return on plan assets

 

(3,642

)

 

(9,712

)

 

 

(1,293

)

 

(3,065

)

 

(9,194

)

 

Amortization of prior service cost

 

 

 

 

 

 

(33

)

1

 

(98

)

3

 

(294

)

9

 

Amortization of actuarial losses

 

 

 

 

 

 

668

 

138

 

1,576

 

321

 

4,727

 

962

 

Total net periodic benefit costs

 

$

1,764

 

$

741

 

$

4,704

 

$

1,976

 

 

$

1,318

 

$

374

 

$

3,227

 

$

956

 

$

9,680

 

$

2,868

 

 

During the period of January 1, 2015 to January 31, 2015 (Predecessor Company), PLC contributed $2.2 million to its defined benefit pension plan for the 2014 plan year. During the period of February 1, 2015 to September 30, 2015 (Successor Company), PLC contributed $1.4 million to its defined benefit pension plan for the 2014 plan year. PLC will continue to make contributions in future periods as necessary to at least satisfy minimum funding requirements. PLC may also make additional contributions in future periods to maintain an adjusted funding target attainment percentage (“AFTAP”) of at least 80% and to avoid certain Pension Benefit Guaranty Corporation (“PBGC”) reporting triggers.

 

42



Table of Contents

 

13.                                ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

 

The following tables summarize the changes in the accumulated balances for each component of accumulated other comprehensive income (loss) (“AOCI”) as of September 30, 2015 (Successor Company), January 31, 2015 (Predecessor Company), and December 31, 2014 (Predecessor Company).

 

Changes in Accumulated Other Comprehensive Income (Loss) by Component

 

 

 

 

 

 

 

Total

 

 

 

 

 

 

 

Accumulated

 

 

 

Unrealized

 

Accumulated

 

Other

 

 

 

Gains and Losses

 

Gain and Loss

 

Comprehensive

 

 

 

on Investments (2)

 

Derivatives

 

Income (Loss)

 

 

 

(Dollars In Thousands, Net of Tax)

 

Successor Company

 

 

 

 

 

 

 

Beginning Balance, February 1, 2015

 

$

 

$

 

$

 

Other comprehensive income (loss) before reclassifications

 

(941,196

)

(86

)

(941,282

)

Other comprehensive income relating to other-than-temporary impaired investments for which a portion has been recognized in earnings

 

(3,115

)

 

(3,115

)

Amounts reclassified from accumulated other comprehensive income (loss) (1)

 

8,664

 

86

 

8,750

 

Net current-period other comprehensive income (loss)

 

(935,647

)

 

(935,647

)

Ending Balance, September 30, 2015

 

$

(935,647

)

$

 

$

(935,647

)

 


(1)  See Reclassification table below for details.

(2)  As of September 30, 2015 net unrealized losses reported in AOCI were offset by $506.9 million due to the impact those net unrealized losses would have had on certain of the Company’s insurance assets and liabilities if the net unrealized losses had been recognized in net income.

 

 

Changes in Accumulated Other Comprehensive Income (Loss) by Component

 

 

 

 

 

 

 

Total

 

 

 

 

 

 

 

Accumulated

 

 

 

Unrealized

 

Accumulated

 

Other

 

 

 

Gains and Losses

 

Gain and Loss

 

Comprehensive

 

 

 

on Investments (2)

 

Derivatives

 

Income (Loss)

 

 

 

(Dollars In Thousands, Net of Tax)

 

Predecessor Company

 

 

 

 

 

 

 

Beginning Balance, December 31, 2014

 

$

1,483,293

 

$

(82

)

$

1,483,211

 

Other comprehensive income (loss) before reclassifications

 

482,143

 

9

 

482,152

 

Other comprehensive income relating to other-than-temporary impaired investments for which a portion has been recognized in earnings

 

(243

)

 

(243

)

Amounts reclassified from accumulated other comprehensive income (loss) (1)

 

(4,166

)

23

 

(4,143

)

Net current-period other comprehensive income (loss)

 

477,734

 

32

 

477,766

 

Ending Balance, January 31, 2015

 

$

1,961,027

 

$

(50

)

$

1,960,977

 

 


(1)  See Reclassification table below for details.

(2)  As of January 31, 2015 and December 31, 2014 net unrealized losses reported in AOCI were offset by $(492.6) million and

$(504.4) million due to the impact those net unrealized losses would have had on certain of the Company’s insurance assets and liabilities if the net unrealized losses had been recognized in net income.

 

43



Table of Contents

 

Changes in Accumulated Other Comprehensive Income (Loss) by Component

 

 

 

 

 

 

 

Total

 

 

 

 

 

 

 

Accumulated

 

 

 

Unrealized

 

Accumulated

 

Other

 

 

 

Gains and Losses

 

Gain and Loss

 

Comprehensive

 

 

 

on Investments (2)

 

Derivatives

 

Income (Loss)

 

 

 

(Dollars In Thousands, Net of Tax)

 

Predecessor Company

 

 

 

 

 

 

 

Beginning Balance, December 31, 2013

 

$

540,201

 

$

(1,235

)

$

538,966

 

Other comprehensive income (loss) before reclassifications

 

983,985

 

(2

)

983,983

 

Other comprehensive income relating to other-than-temporary impaired investments for which a portion has been recognized in earnings

 

3,498

 

 

3,498

 

Amounts reclassified from accumulated other comprehensive income (loss) (1)

 

(44,391

)

1,155

 

(43,236

)

Net current-period other comprehensive income (loss)

 

943,092

 

1,153

 

944,245

 

Ending Balance, December 31, 2014

 

$

1,483,293

 

$

(82

)

$

1,483,211

 

 


(1)  See Reclassification table below for details.

(2)  As of December 31, 2014 and 2013 net unrealized losses reported in AOCI were offset by $(504.4) million and $(189.8) million due to the impact those net unrealized losses would have had on certain of the Company’s insurance assets and liabilities if the net unrealized losses had been recognized in net income.

 

The following tables summarize the reclassifications amounts out of AOCI for the three months ended September 30, 2015 (Successor Company), the period of February 1, 2015 to September 30, 2015 (Successor Company), the period of January 1, 2015 to January 31, 2015 (Predecessor Company), and for the three and nine months ended September 30, 2014 (Predecessor Company).

 

Reclassifications Out of Accumulated Other Comprehensive Income (Loss)

 

 

 

Amount

 

 

 

 

 

Reclassified

 

 

 

 

 

from Accumulated

 

 

 

 

 

Other Comprehensive

 

Affected Line Item in the

 

 

 

Income (Loss)

 

Consolidated Condensed Statements of Income

 

 

 

(Dollars In Thousands)

 

 

 

 

 

 

 

 

 

Successor Company

 

 

 

 

 

For The Three Months Ended September 30, 2015

 

 

 

 

 

Unrealized gains and losses on available-for-sale securities

 

 

 

 

 

Net investment gains (losses)

 

$

(1,253

)

Realized investment gains (losses): All other investments

 

Impairments recognized in earnings

 

(10,064

)

Net impairment losses recognized in earnings

 

 

 

(11,317

)

Total before tax

 

 

 

3,961

 

Tax (expense) or benefit

 

 

 

$

(7,356

)

Net of tax

 

 


(1)  See Note 16, Derivative Financial Instruments for additional information.

 

44



Table of Contents

 

Reclassifications Out of Accumulated Other Comprehensive Income (Loss)

 

 

 

Amount

 

 

 

 

 

Reclassified

 

 

 

 

 

from Accumulated

 

 

 

 

 

Other Comprehensive

 

Affected Line Item in the

 

 

 

Income (Loss)

 

Consolidated Condensed Statements of Income

 

 

 

(Dollars In Thousands)

 

 

 

 

 

 

 

 

 

Successor Company

 

 

 

 

 

February 1, 2015 to September 30, 2015

 

 

 

 

 

Gains and losses on derivative instruments

 

 

 

 

 

Net settlement (expense)/benefit (1)

 

$

(131

)

Benefits and settlement expenses, net of reinsurance ceded

 

 

 

(131

)

Total before tax

 

 

 

45

 

Tax (expense) or benefit

 

 

 

$

(86

)

Net of tax

 

 

 

 

 

 

 

Unrealized gains and losses on available-for-sale securities

 

 

 

 

 

Net investment gains (losses)

 

$

2,470

 

Realized investment gains (losses): All other investments

 

Impairments recognized in earnings

 

(15,798

)

Net impairment losses recognized in earnings

 

 

 

(13,328

)

Total before tax

 

 

 

4,664

 

Tax (expense) or benefit

 

 

 

$

(8,664

)

Net of tax

 

 


(1)  See Note 16, Derivative Financial Instruments for additional information.

 

 

Reclassifications Out of Accumulated Other Comprehensive Income (Loss)

 

 

 

Amount

 

 

 

 

 

Reclassified

 

 

 

 

 

from Accumulated

 

 

 

 

 

Other Comprehensive

 

Affected Line Item in the

 

 

 

Income (Loss)

 

Consolidated Condensed Statements of Income

 

 

 

(Dollars In Thousands)

 

 

 

 

 

 

 

 

 

Predecessor Company

 

 

 

 

 

January 1, 2015 to January 31, 2015

 

 

 

 

 

Gains and losses on derivative instruments

 

 

 

 

 

Net settlement (expense)/benefit (1)

 

$

(36

)

Benefits and settlement expenses, net of reinsurance ceded

 

 

 

(36

)

Total before tax

 

 

 

13

 

Tax (expense) or benefit

 

 

 

$

(23

)

Net of tax

 

 

 

 

 

 

 

Unrealized gains and losses on available-for-sale securities

 

 

 

 

 

Net investment gains (losses)

 

$

6,891

 

Realized investment gains (losses): All other investments

 

Impairments recognized in earnings

 

(481

)

Net impairment losses recognized in earnings

 

 

 

6,410

 

Total before tax

 

 

 

(2,244

)

Tax (expense) or benefit

 

 

 

$

4,166

 

Net of tax

 

 


(1)  See Note 16, Derivative Financial Instruments for additional information.

 

45



Table of Contents

 

Reclassifications Out of Accumulated Other Comprehensive Income (Loss)

 

 

 

Amount

 

 

 

 

 

Reclassified

 

 

 

 

 

from Accumulated

 

 

 

 

 

Other Comprehensive

 

Affected Line Item in the

 

 

 

Income (Loss)

 

Consolidated Condensed Statements of Income

 

 

 

(Dollars In Thousands)

 

 

 

 

 

 

 

 

 

Predecessor Company

 

 

 

 

 

For The Three Months Ended September 30, 2014

 

 

 

 

 

Gains and losses on derivative instruments

 

 

 

 

 

Net settlement (expense)/benefit (1)

 

$

(293

)

Benefits and settlement expenses, net of reinsurance ceded

 

 

 

(293

)

Total before tax

 

 

 

103

 

Tax (expense) or benefit

 

 

 

$

(190

)

Net of tax

 

 

 

 

 

 

 

Unrealized gains and losses on available-for-sale securities

 

 

 

 

 

Net investment gains (losses)

 

$

22,244

 

Realized investment gains (losses): All other investments

 

Impairments recognized in earnings

 

(2,354

)

Net impairment losses recognized in earnings

 

 

 

19,890

 

Total before tax

 

 

 

(6,962

)

Tax (expense) or benefit

 

 

 

$

12,928

 

Net of tax

 

 


(1)  See Note 16, Derivative Financial Instruments for additional information.

 

Reclassifications Out of Accumulated Other Comprehensive Income (Loss)

 

 

 

Amount

 

 

 

 

 

Reclassified

 

 

 

 

 

from Accumulated

 

 

 

 

 

Other Comprehensive

 

Affected Line Item in the

 

 

 

Income (Loss)

 

Consolidated Condensed Statements of Income

 

 

 

(Dollars In Thousands)

 

 

 

 

 

 

 

 

 

Predecessor Company

 

 

 

 

 

For The Nine Months Ended September 30, 2014

 

 

 

 

 

Gains and losses on derivative instruments

 

 

 

 

 

Net settlement (expense)/benefit (1)

 

$

(1,577

)

Benefits and settlement expenses, net of reinsurance ceded

 

 

 

(1,577

)

Total before tax

 

 

 

552

 

Tax (expense) or benefit

 

 

 

$

(1,025

)

Net of tax

 

 

 

 

 

 

 

Unrealized gains and losses on available-for-sale securities

 

 

 

 

 

Net investment gains (losses)

 

$

49,812

 

Realized investment gains (losses): All other investments

 

Impairments recognized in earnings

 

(5,405

)

Net impairment losses recognized in earnings

 

 

 

44,407

 

Total before tax

 

 

 

(15,543

)

Tax (expense) or benefit

 

 

 

$

28,864

 

Net of tax

 

 


(1)  See Note 16, Derivative Financial Instruments for additional information.

 

46



Table of Contents

 

14.                                INCOME TAXES

 

The Company used its respective estimates of its annual 2015 and 2014 incomes in computing its effective income tax rates for the three months ended September 30, 2015 (Successor Company), the period of February 1, 2015 to September 30, 2015 (Successor Company), the period of January 1, 2015 to January 31, 2015 (Predecessor Company), and for the three and nine months ended September 30, 2014 (Predecessor Company). The effective tax rates for the three months ended September 30, 2015 (Successor Company), the period of February 1, 2015 to September 30, 2015 (Successor Company), the period of January 1, 2015 to January 31, 2015 (Predecessor Company), and for the three and nine months ended September 30, 2014 (Predecessor Company) were 27.3%, 28.0%, 32.8%, 33.8%, and 33.0%, respectively.

 

In conjunction with the Merger and as a result of the adjustments to the Company’s assets and liabilities which were discussed in Note 2, Summary of Significant Accounting Policies , the Company’s deferred tax assets and liabilities were re-measured as of the date of the Merger.

 

The components of the Company’s net deferred income tax liability are as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

As of

 

 

As of

 

 

 

September 30, 2015

 

 

December 31, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Deferred income tax assets:

 

 

 

 

 

 

Loss and credit carryforwards

 

$

75,781

 

 

$

35,642

 

Premium receivables and policy liabilities

 

 

 

154,720

 

Deferred compensation

 

103,788

 

 

104,117

 

Invested assets (other than unrealized gains)

 

 

 

2,960

 

Deferred policy acquisition costs

 

346,439

 

 

 

Net unrealized loss on investments

 

503,859

 

 

 

Valuation allowance

 

(796

)

 

(791

)

 

 

1,029,071

 

 

296,648

 

Deferred income tax liabilities:

 

 

 

 

 

 

VOBA and other intangibles

 

666,660

 

 

 

Premium receivables and policy liabilities

 

103,036

 

 

 

DAC and VOBA

 

 

 

1,073,499

 

Invested assets (other than unrealized gains)

 

1,619,114

 

 

 

Net unrealized gains on investments

 

 

 

798,529

 

Other

 

2,589

 

 

36,484

 

 

 

2,391,399

 

 

1,908,512

 

Net deferred income tax liability

 

$

(1,362,328

)

 

$

(1,611,864

)

 

47



Table of Contents

 

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

February 1, 2015

 

 

January 1, 2015

 

 

 

 

 

to

 

 

to

 

As of

 

 

 

September 30, 2015

 

 

January 31, 2015

 

December 31, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Balance, beginning of period

 

$

105,850

 

 

$

168,076

 

$

85,846

 

Additions for tax positions of the current year

 

8,217

 

 

(5,010

)

57,392

 

Additions for tax positions of prior years

 

1,602

 

 

1,149

 

34,371

 

Reductions of tax positions of prior years:

 

 

 

 

 

 

 

 

Changes in judgment

 

(899

)

 

(58,365

)

(9,533

)

Settlements during the period

 

(90,872

)

 

 

 

Lapses of applicable statute of limitations

 

 

 

 

 

Balance, end of period

 

$

23,898

 

 

$

105,850

 

$

168,076

 

 

The revisions to the Company’s unrecognized tax benefits for the period of February 1, 2015 to September 30, 2015 (Successor Company) are shown in the chart above. These revisions included increasing prior determinations of amounts accrued for earlier years as well as reducing some previously accrued amounts. These revisions were primarily related to timing issues. However, revisions were made to certain issues that constituted permanent differences between GAAP income and taxable income. The tax on these permanent differences, excluding interest, caused income tax expense to increase by approximately $4.1 million, $0.2 million, and $3.3 million for the period of February 1, 2015 to September 30, 2015 (Successor Company), the one month ended January 31, 2015 (Predecessor Company), and the year ended December 31, 2014 (Predecessor Company), respectively.

 

In the IRS audit that concluded in 2012, the IRS proposed favorable and unfavorable adjustments to the Company’s 2003 through 2007 reported taxable incomes. The Company protested certain unfavorable adjustments and was seeking resolution at the IRS’ Appeals Division. Subsequent to September 30, 2015, Appeals accepted the Company’s proposed settlement offer that related to its earlier protest. In the IRS audit that concluded during the three months ended September 30, 2015, the IRS proposed favorable and unfavorable adjustments to the Company’s 2008 through 2011 reported taxable income. The Company agreed to these adjustments. The resulting net adjustment to the Company’s income taxes for the year 2003 through 2011 will not materially affect the Company nor its effective tax rate.

 

The Company is currently under audit by the IRS for the years 2012 and 2013. As of September 30, 2015, no materially adverse adjustments to reported taxable income have been proposed.

 

The Company believes that in the next 12 months approximately $14.3 million of these unrecognized tax benefits will be reduced. Based upon technical guidance and ongoing discussions with the IRS, the Company anticipates that within the next 12 months it will reach final settlement with the IRS regarding its material uncertain tax positions for the years 2003 through 2013.

 

In general, the Company is no longer subject to U.S. federal, state, and local income tax examinations by taxing authorities for tax years that began before 2003.

 

Based on the Company’s current assessment of future taxable income, including available tax planning opportunities, the Company anticipates that it is more likely than not that it will generate sufficient taxable income to realize all of its material deferred tax assets. The Company did not record a valuation allowance against its material deferred tax assets as of September 30, 2015.

 

48



Table of Contents

 

15.                                FAIR VALUE OF FINANCIAL INSTRUMENTS

 

The Company determined the fair value of its financial instruments based on the fair value hierarchy established in FASB guidance referenced in the Fair Value Measurements and Disclosures Topic which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company has adopted the provisions from the FASB guidance that is referenced in the Fair Value Measurements and Disclosures Topic for non-financial assets and liabilities (such as property and equipment, goodwill, and other intangible assets) that are required to be measured at fair value on a periodic basis. The effect on the Company’s periodic fair value measurements for non-financial assets and liabilities was not material.

 

The Company has categorized its financial instruments, based on the priority of the inputs to the valuation technique, into a three level hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure fair value fall within different levels of the hierarchy, the category level is based on the lowest priority level input that is significant to the fair value measurement of the instrument.

 

Financial assets and liabilities recorded at fair value on the consolidated balance sheets are categorized as follows:

 

·                   Level 1: Unadjusted quoted prices for identical assets or liabilities in an active market.

 

·                   Level 2: Quoted prices in markets that are not active or significant inputs that are observable either directly or indirectly. Level 2 inputs include the following:

 

a)                                      Quoted prices for similar assets or liabilities in active markets

b)                                      Quoted prices for identical or similar assets or liabilities in non-active markets

c)                                       Inputs other than quoted market prices that are observable

d)                                      Inputs that are derived principally from or corroborated by observable market data through correlation or other means.

 

·                   Level 3: Prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. They reflect management’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.

 

49



Table of Contents

 

The following table presents the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of September 30, 2015 (Successor Company):

 

 

 

Level 1

 

Level 2

 

Level 3

 

Total

 

 

 

(Dollars In Thousands)

 

Assets:

 

 

 

 

 

 

 

 

 

Fixed maturity securities - available-for-sale

 

 

 

 

 

 

 

 

 

Residential mortgage-backed securities

 

$

 

$

1,615,819

 

$

3

 

$

1,615,822

 

Commercial mortgage-backed securities

 

 

1,276,615

 

 

1,276,615

 

Other asset-backed securities

 

 

207,263

 

585,751

 

793,014

 

U.S. government-related securities

 

1,102,371

 

515,101

 

 

1,617,472

 

State, municipalities, and political subdivisions

 

 

1,613,485

 

 

1,613,485

 

Other government-related securities

 

 

18,884

 

 

18,884

 

Corporate securities

 

83

 

24,844,977

 

1,048,738

 

25,893,798

 

Preferred stock

 

62,112

 

 

 

62,112

 

Total fixed maturity securities - available-for-sale

 

1,164,566

 

30,092,144

 

1,634,492

 

32,891,202

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities - trading

 

 

 

 

 

 

 

 

 

Residential mortgage-backed securities

 

 

288,280

 

 

288,280

 

Commercial mortgage-backed securities

 

 

148,640

 

 

148,640

 

Other asset-backed securities

 

 

121,937

 

155,153

 

277,090

 

U.S. government-related securities

 

236,425

 

4,880

 

 

241,305

 

State, municipalities, and political subdivisions

 

 

310,973

 

 

310,973

 

Other government-related securities

 

 

59,527

 

 

59,527

 

Corporate securities

 

 

1,359,582

 

18,319

 

1,377,901

 

Preferred stock

 

6,925

 

 

 

6,925

 

Total fixed maturity securities - trading

 

243,350

 

2,293,819

 

173,472

 

2,710,641

 

Total fixed maturity securities

 

1,407,916

 

32,385,963

 

1,807,964

 

35,601,843

 

Equity securities

 

606,400

 

11,792

 

66,504

 

684,696

 

Other long-term investments (1)

 

122,120

 

172,937

 

55,750

 

350,807

 

Short-term investments

 

228,621

 

4,716

 

 

233,337

 

Total investments

 

2,365,057

 

32,575,408

 

1,930,218

 

36,870,683

 

Cash

 

517,900

 

 

 

517,900

 

Assets related to separate accounts

 

 

 

 

 

 

 

 

 

Variable annuity

 

12,646,751

 

 

 

12,646,751

 

Variable universal life

 

792,800

 

 

 

792,800

 

Total assets measured at fair value on a recurring basis

 

$

16,322,508

 

$

32,575,408

 

$

1,930,218

 

$

50,828,134

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

Annuity account balances (2)

 

$

 

$

 

$

95,198

 

$

95,198

 

Other liabilities (1)

 

22,085

 

138,496

 

383,809

 

544,390

 

Total liabilities measured at fair value on a recurring basis

 

$

22,085

 

$

138,496

 

$

479,007

 

$

639,588

 

 


(1) Includes certain freestanding and embedded derivatives.

(2) Represents liabilities related to fixed indexed annuities.

 

50



Table of Contents

 

The following table presents the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2014 (Predecessor Company):

 

 

 

Level 1

 

Level 2

 

Level 3

 

Total

 

 

 

(Dollars In Thousands)

 

Assets:

 

 

 

 

 

 

 

 

 

Fixed maturity securities - available-for-sale

 

 

 

 

 

 

 

 

 

Residential mortgage-backed securities

 

$

 

$

1,418,255

 

$

3

 

$

1,418,258

 

Commercial mortgage-backed securities

 

 

1,177,252

 

 

1,177,252

 

Other asset-backed securities

 

 

275,415

 

563,961

 

839,376

 

U.S. government-related securities

 

1,165,188

 

263,707

 

 

1,428,895

 

State, municipalities, and political subdivisions

 

 

1,684,014

 

3,675

 

1,687,689

 

Other government-related securities

 

 

20,172

 

 

20,172

 

Corporate securities

 

132

 

26,039,963

 

1,325,683

 

27,365,778

 

Total fixed maturity securities - available-for-sale

 

1,165,320

 

30,878,778

 

1,893,322

 

33,937,420

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities - trading

 

 

 

 

 

 

 

 

 

Residential mortgage-backed securities

 

 

288,114

 

 

288,114

 

Commercial mortgage-backed securities

 

 

151,111

 

 

151,111

 

Other asset-backed securities

 

 

105,118

 

169,461

 

274,579

 

U.S. government-related securities

 

245,563

 

4,898

 

 

250,461

 

State, municipalities, and political subdivisions

 

 

325,446

 

 

325,446

 

Other government-related securities

 

 

57,032

 

 

57,032

 

Corporate securities

 

 

1,447,333

 

24,744

 

1,472,077

 

Total fixed maturity securities - trading

 

245,563

 

2,379,052

 

194,205

 

2,818,820

 

Total fixed maturity securities

 

1,410,883

 

33,257,830

 

2,087,527

 

36,756,240

 

Equity securities

 

590,832

 

99,267

 

66,691

 

756,790

 

Other long-term investments (1)

 

119,997

 

106,079

 

44,625

 

270,701

 

Short-term investments

 

243,436

 

3,281

 

 

246,717

 

Total investments

 

2,365,148

 

33,466,457

 

2,198,843

 

38,030,448

 

Cash

 

268,286

 

 

 

268,286

 

Other assets

 

 

 

 

 

Assets related to separate accounts

 

 

 

 

 

 

 

 

 

Variable annuity

 

13,157,429

 

 

 

13,157,429

 

Variable universal life

 

834,940

 

 

 

834,940

 

Total assets measured at fair value on a recurring basis

 

$

16,625,803

 

$

33,466,457

 

$

2,198,843

 

$

52,291,103

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

Annuity account balances (2)

 

$

 

$

 

$

97,825

 

$

97,825

 

Other liabilities (1)

 

62,146

 

61,046

 

506,343

 

629,535

 

Total liabilities measured at fair value on a recurring basis

 

$

62,146

 

$

61,046

 

$

604,168

 

$

727,360

 

 


(1) Includes certain freestanding and embedded derivatives.

(2) Represents liabilities related to fixed indexed annuities.

 

Determination of fair values

 

The valuation methodologies used to determine the fair values of assets and liabilities reflect market participant assumptions and are based on the application of the fair value hierarchy that prioritizes observable market inputs over unobservable inputs. The Company determines the fair values of certain financial assets and financial liabilities based on quoted market prices, where available. The Company also determines certain fair values based on future cash flows discounted at the appropriate current market rate. Fair values reflect adjustments for counterparty credit quality, the Company’s credit standing, liquidity, and where appropriate, risk margins on unobservable parameters. The following is a discussion of the methodologies used to determine fair values for the financial instruments as listed in the above table.

 

The fair value of fixed maturity, short-term, and equity securities is determined by management after considering one of three primary sources of information: third party pricing services, non-binding independent broker quotations, or pricing matrices. Security pricing is applied using a “waterfall” approach whereby publicly available

 

51



Table of Contents

 

prices are first sought from third party pricing services, the remaining unpriced securities are submitted to independent brokers for non-binding prices, or lastly, securities are priced using a pricing matrix. Typical inputs used by these three pricing methods include, but are not limited to: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data including market research publications. Third party pricing services price approximately 90% of the Company’s available-for-sale and trading fixed maturity securities. Based on the typical trading volumes and the lack of quoted market prices for available-for-sale and trading fixed maturities, third party pricing services derive the majority of security prices from observable market inputs such as recent reported trades for identical or similar securities making adjustments through the reporting date based upon available market observable information outlined above. If there are no recent reported trades, the third party pricing services and brokers may use matrix or model processes to develop a security price where future cash flow expectations are developed based upon collateral performance and discounted at an estimated market rate. Certain securities are priced via independent non-binding broker quotations, which are considered to have no significant unobservable inputs. When using non- binding independent broker quotations, the Company obtains one quote per security, typically from the broker from which we purchased the security. A pricing matrix is used to price securities for which the Company is unable to obtain or effectively rely on either a price from a third party pricing service or an independent broker quotation.

 

The pricing matrix used by the Company begins with current spread levels to determine the market price for the security. The credit spreads, assigned by brokers, incorporate the issuer’s credit rating, liquidity discounts, weighted- average of contracted cash flows, risk premium, if warranted, due to the issuer’s industry, and the security’s time to maturity. The Company uses credit ratings provided by nationally recognized rating agencies.

 

For securities that are priced via non-binding independent broker quotations, the Company assesses whether prices received from independent brokers represent a reasonable estimate of fair value through an analysis using internal and external cash flow models developed based on spreads and, when available, market indices. The Company uses a market-based cash flow analysis to validate the reasonableness of prices received from independent brokers. These analytics, which are updated daily, incorporate various metrics (yield curves, credit spreads, prepayment rates, etc.) to determine the valuation of such holdings. As a result of this analysis, if the Company determines there is a more appropriate fair value based upon the analytics, the price received from the independent broker is adjusted accordingly. The Company did not adjust any quotes or prices received from brokers during the period of February 1, 2015 to September 30, 2015 (Successor Company) and the period of January 1, 2015 to January 31, 2015 (Predecessor Company).

 

The Company has analyzed the third party pricing services’ valuation methodologies and related inputs and has also evaluated the various types of securities in its investment portfolio to determine an appropriate fair value hierarchy level based upon trading activity and the observability of market inputs that is in accordance with the Fair Value Measurements and Disclosures Topic of the ASC. Based on this evaluation and investment class analysis, each price was classified into Level 1, 2, or 3. Most prices provided by third party pricing services are classified into Level 2 because the significant inputs used in pricing the securities are market observable and the observable inputs are corroborated by the Company. Since the matrix pricing of certain debt securities includes significant non-observable inputs, they are classified as Level 3.

 

Asset-Backed Securities

 

This category mainly consists of residential mortgage-backed securities, commercial mortgage-backed securities, and other asset-backed securities (collectively referred to as asset-backed securities or “ABS”). As of September 30, 2015 (Successor Company), the Company held $3.7 billion of ABS classified as Level 2. These securities are priced from information provided by a third party pricing service and independent broker quotes. The third party pricing services and brokers mainly value securities using both a market and income approach to valuation. As part of this valuation process they consider the following characteristics of the item being measured to be relevant inputs: 1) weighted-average coupon rate, 2) weighted-average years to maturity, 3) types of underlying assets, 4) weighted-average coupon rate of the underlying assets, 5) weighted-average years to maturity of the underlying assets, 6) seniority level of the tranches owned, and 7) credit ratings of the securities.

 

After reviewing these characteristics of the ABS, the third party pricing service and brokers use certain inputs to determine the value of the security. For ABS classified as Level 2, the valuation would consist of predominantly market observable inputs such as, but not limited to: 1) monthly principal and interest payments on the underlying

 

52



Table of Contents

 

assets, 2) average life of the security, 3) prepayment speeds, 4) credit spreads, 5) treasury and swap yield curves, and 6) discount margin. The Company reviews the methodologies and valuation techniques (including the ability to observe inputs) in assessing the information received from external pricing services and in consideration of the fair value presentation.

 

As of September 30, 2015 (Successor Company), the Company held $740.9 million of Level 3 ABS, which included $585.8 million of other asset-backed securities classified as available-for-sale and $155.1 million of other asset-backed securities classified as trading. These securities are predominantly ARS whose underlying collateral is at least 97% guaranteed by the FFELP. As a result of the ARS market collapse during 2008, the Company prices its ARS using an income approach valuation model. As part of the valuation process the Company reviews the following characteristics of the ARS in determining the relevant inputs: 1) weighted-average coupon rate, 2) weighted-average years to maturity, 3) types of underlying assets, 4) weighted-average coupon rate of the underlying assets, 5) weighted-average years to maturity of the underlying assets, 6) seniority level of the tranches owned, 7) credit ratings of the securities, 8) liquidity premium, and 9) paydown rate.

 

Corporate Securities, U.S. Government-Related Securities, States, Municipals, and Political Subdivisions, and Other Government Related Securities

 

As of September 30, 2015 (Successor Company), the Company classified approximately $28.7 billion of corporate securities, U.S. government-related securities, states, municipals, and political subdivisions, and other government-related securities as Level 2. The fair value of the Level 2 securities is predominantly priced by broker quotes and a third party pricing service. The Company has reviewed the valuation techniques of the brokers and third party pricing service and has determined that such techniques used Level 2 market observable inputs. The following characteristics of the securities are considered to be the primary relevant inputs to the valuation: 1) weighted- average coupon rate, 2) weighted-average years to maturity, 3) seniority, and 4) credit ratings. The Company reviews the methodologies and valuation techniques (including the ability to observe inputs) in assessing the information received from external pricing services and in consideration of the fair value presentation.

 

The brokers and third party pricing service utilize valuation models that consist of a hybrid income and market approach to valuation. The pricing models utilize the following inputs: 1) principal and interest payments, 2) treasury yield curve, 3) credit spreads from new issue and secondary trading markets, 4) dealer quotes with adjustments for issues with early redemption features, 5) liquidity premiums present on private placements, and 6) discount margins from dealers in the new issue market.

 

As of September 30, 2015 (Successor Company), the Company classified approximately $1.1 billion of securities as Level 3 valuations. Level 3 securities primarily represent investments in illiquid bonds for which no price is readily available. To determine a price, the Company uses a discounted cash flow model with both observable and unobservable inputs. These inputs are entered into an industry standard pricing model to determine the final price of the security. These inputs include: 1) principal and interest payments, 2) coupon rate, 3) sector and issuer level spread over treasury, 4) underlying collateral, 5) credit ratings, 6) maturity, 7) embedded options, 8) recent new issuance, 9) comparative bond analysis, and 10) an illiquidity premium.

 

Equities

 

As of September 30, 2015 (Successor Company), the Company held approximately $78.3 million of equity securities classified as Level 2 and Level 3. Of this total, $65.7 million represents Federal Home Loan Bank (“FHLB”) stock. The Company believes that the cost of the FHLB stock approximates fair value. The remainder of these equity securities is primarily investments in preferred stock.

 

Other long-term investments and Other liabilities

 

Other long-term investments and other liabilities consist entirely of free-standing and embedded derivative financial instruments. Refer to Note 16, Derivative Financial Instruments for additional information related to derivatives. Derivative financial instruments are valued using exchange prices, independent broker quotations, or pricing valuation models, which utilize market data inputs. Excluding embedded derivatives, as of September 30, 2015 (Successor Company), 83.2% of derivatives based upon notional values were priced using exchange prices or independent broker quotations. The remaining derivatives were priced by pricing valuation models, which

 

53



Table of Contents

 

predominantly utilize observable market data inputs. Inputs used to value derivatives include, but are not limited to, interest swap rates, credit spreads, interest rate and equity market volatility indices, equity index levels, and treasury rates. The Company performs monthly analysis on derivative valuations that includes both quantitative and qualitative analyses.

 

Derivative instruments classified as Level 1 generally include futures and options, which are traded on active exchange markets.

 

Derivative instruments classified as Level 2 primarily include interest rate and inflation swaps, options, and swaptions. These derivative valuations are determined using independent broker quotations, which are corroborated with observable market inputs.

 

Derivative instruments classified as Level 3 are embedded derivatives and include at least one significant non-observable input. A derivative instrument containing Level 1 and Level 2 inputs will be classified as a Level 3 financial instrument in its entirety if it has at least one significant Level 3 input.

 

The Company utilizes derivative instruments to manage the risk associated with certain assets and liabilities. However, the derivative instruments may not be classified within the same fair value hierarchy level as the associated assets and liabilities. Therefore, the changes in fair value on derivatives reported in Level 3 may not reflect the offsetting impact of the changes in fair value of the associated assets and liabilities.

 

The embedded derivatives are carried at fair value in “other long-term investments” and “other liabilities” on the Company’s consolidated condensed balance sheet. The changes in fair value are recorded in earnings as “Realized investment gains (losses)—Derivative financial instruments”. Refer to Note 16, Derivative Financial Instruments for more information related to each embedded derivatives gains and losses.

 

The fair value of the GMWB embedded derivative is derived through the income method of valuation using a valuation model that projects future cash flows using multiple risk neutral stochastic equity scenarios and policyholder behavior assumptions. The risk neutral scenarios are generated using the current swap curve and projected equity volatilities and correlations. The projected equity volatilities are based on a blend of historical volatility and near- term equity market implied volatilities. The equity correlations are based on historical price observations. For policyholder behavior assumptions, expected lapse and utilization assumptions are used and updated for actual experience, as necessary. The Company assumes age-based mortality from the National Association of Insurance Commissioners 1994 Variable Annuity MGDB Mortality Table for company experience, with attained age factors varying from 44.5% - 100%. The present value of the cash flows is determined using the discount rate curve, which is based upon LIBOR plus a credit spread (to represent the Company’s non-performance risk). As a result of using significant unobservable inputs, the GMWB embedded derivative is categorized as Level 3. These assumptions are reviewed on a quarterly basis.

 

The balance of the FIA embedded derivative is impacted by policyholder cash flows associated with the FIA product that are allocated to the embedded derivative in addition to changes in the fair value of the embedded derivative during the reporting period. The fair value of the FIA embedded derivative is derived through the income method of valuation using a valuation model that projects future cash flows using current index values and volatility, the hedge budget used to price the product, and policyholder assumptions (both elective and non-elective). For policyholder behavior assumptions, expected lapse and withdrawal assumptions are used and updated for actual experience, as necessary. The Company assumes age-based mortality from the 1994 Variable Annuity MGDB mortality table modified for company experience, with attained age factors varying from 49% - 80%. The present value of the cash flows is determined using the discount rate curve, which is based upon LIBOR up to one year and constant maturity treasury rates plus a credit spread (to represent the Company’s non-performance risk) thereafter. Policyholder assumptions are reviewed on an annual basis. As a result of using significant unobservable inputs, the FIA embedded derivative is categorized as Level 3.

 

The balance of the indexed universal life (“IUL”) embedded derivative is impacted by policyholder cash flows associated with the IUL product that are allocated to the embedded derivative in addition to changes in the fair value of the embedded derivative during the reporting period. The fair value of the IUL embedded derivative is derived through the income method of valuation using a valuation model that projects future cash flows using current index values and

 

54



Table of Contents

 

volatility, the hedge budget used to price the product, and policyholder assumptions (both elective and non-elective). For policyholder behavior assumptions, expected lapse and withdrawal assumptions are used and updated for actual experience, as necessary. The Company assumes age-based mortality from the SOA 2015 VBT Primary Tables modified for company experience, with attained age factors varying from 38% - 153%. The present value of the cash flows is determined using the discount rate curve, which is based upon LIBOR up to one year and constant maturity treasury rates plus a credit spread (to represent the Company’s non-performance risk) thereafter. Policyholder assumptions are reviewed on an annual basis. As a result of using significant unobservable inputs, the IUL embedded derivative is categorized as Level 3.

 

The Company has assumed and ceded certain blocks of policies under modified coinsurance agreements in which the investment results of the underlying portfolios inure directly to the reinsurers. As a result, these agreements contain embedded derivatives that are reported at fair value. Changes in their fair value are reported in earnings. The investments supporting these agreements are designated as “trading securities”; therefore changes in their fair value are also reported in earnings. As of September 30, 2015 (Successor Company), the fair value of the embedded derivative is based upon the relationship between the statutory policy liabilities (net of policy loans) of $2.5 billion and the statutory unrealized gain (loss) of the securities of $227.9 million. As a result, changes in the fair value of the embedded derivatives are largely offset by the changes in fair value of the related investments and each are reported in earnings. The fair value of the embedded derivative is considered a Level 3 valuation due to the unobservable nature of the policy liabilities.

 

Certain of the Company’s subsidiaries have entered into interest support, yearly renewable term (“YRT”) premium support, and portfolio maintenance agreements with PLC. These agreements meet the definition of a derivative and are accounted for at fair value and are considered Level 3 valuations. The fair value of these derivatives as of September 30, 2015 (Successor Company) was $5.8 million and is included in Other long-term investments. For information regarding realized gains on these derivatives please refer to Note 16, Derivative Financial Instruments .

 

The Interest Support Agreement provides that PLC will make payments to Golden Gate II if actual investment income on certain of Golden Gate II’s asset portfolios falls below a calculated investment income amount as defined in the Interest Support Agreement. The calculated investment income amount is a level of investment income deemed to be sufficient to support certain of Golden Gate II’s obligations under a reinsurance agreement with the Company, dated July 1, 2007. The derivative is valued using an internal valuation model that assumes a conservative projection of investment income under an adverse interest rate scenario and the probability that the expectation falls below the calculated investment income amount. This derivative had a fair value of $3.7 million as of September 30, 2015 (Successor Company), however, interest support agreement obligations to Golden Gate II of approximately $1.9 million have been collateralized by PLC. Re-evaluation and, if necessary, adjustments of any support agreement collateralization amounts occur annually during the first quarter pursuant to the terms of the support agreement. As of September 30, 2015 (Successor Company), no payments have been triggered under this agreement.

 

55



Table of Contents

 

The YRT Premium support agreement provides that PLC will make payments to Golden Gate II in the event that YRT premium rates increase. The derivative is valued using an internal valuation model. The valuation model is a probability weighted discounted cash flow model. The value is primarily a function of the likelihood and severity of future YRT premium increases. The fair value of this derivative as of September 30, 2015 (Successor Company) was $2.2 million. As of September 30, 2015 (Successor Company), no payments have been made under this agreement.

 

The portfolio maintenance agreements provide that PLC will make payments to Golden Gate V and WCL in the event of other-than-temporary impairments on investments that exceed defined thresholds. The derivatives are valued using an internal discounted cash flow model. The significant unobservable inputs are the projected probability and severity of credit losses used to project future cash flows on the investment portfolios. The fair value of the portfolio maintenance agreements as of September 30, 2015 (Successor Company), was zero. As of September 30, 2015 (Successor Company), no payments have been made under this agreement.

 

The Funds Withheld derivative results from a reinsurance agreement with Shades Creek where the economic performance of certain hedging instruments held by the Company is ceded to Shades Creek. The value of the Funds Withheld derivative is directly tied to the value of the hedging instruments held in the funds withheld account. The hedging instruments predominantly consist of derivative instruments the fair values of which are classified as a Level 2 measurement; as such, the fair value of the Funds Withheld derivative has been classified as a Level 2 measurement.

 

The fair value of the Funds Withheld derivative as of September 30, 2015 (Successor Company) was a liability of $135.6 million.

 

Annuity account balances

 

The Company records certain of its FIA reserves at fair value. The fair value is considered a Level 3 valuation. The FIA valuation model calculates the present value of future benefit cash flows less the projected future profits to quantify the net liability that is held as a reserve. This calculation is done using multiple risk neutral stochastic equity scenarios. The cash flows are discounted using LIBOR plus a credit spread. Best estimate assumptions are used for partial withdrawals, lapses, expenses and asset earned rate with a risk margin applied to each. These assumptions are reviewed at least annually as a part of the formal unlocking process. If an event were to occur within a quarter that would make the assumptions unreasonable, the assumptions would be reviewed within the quarter.

 

The discount rate for the fixed indexed annuities is based on an upward sloping rate curve which is updated each quarter. The discount rates for September 30, 2015 (Successor Company), ranged from a one month rate of 0.40%, a 5 year rate of 2.19%, and a 30 year rate of 3.69%. A credit spread component is also included in the calculation to accommodate non-performance risk.

 

Separate Accounts

 

Separate account assets are invested in open-ended mutual funds and are included in Level 1.

 

56



Table of Contents

 

Valuation of Level 3 Financial Instruments

 

The following table presents the valuation method for material financial instruments included in Level 3, as well as the unobservable inputs used in the valuation of those financial instruments:

 

 

 

Successor

 

 

 

 

 

 

 

 

Company

 

 

 

 

 

 

 

 

Fair Value

 

 

 

 

 

 

 

 

As of

 

Valuation

 

Unobservable

 

Range

 

 

September 30, 2015

 

Technique

 

Input

 

(Weighted Average)

 

 

(Dollars In Thousands)

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other asset-backed securities

 

$

585,751

 

Discounted cash flow

 

Liquidity premium

 

0.43% - 1.49% (0.70%)

 

 

 

 

 

 

Paydown rate

 

9.85% - 15.41% (13.17%)

 

 

 

 

 

 

 

 

 

Corporate securities

 

1,022,464

 

Discounted cash flow

 

Spread over treasury

 

0.74% - 12.18% (2.45%)

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Embedded derivatives - GMWB (1)

 

$

14,454

 

Actuarial cash flow model

 

Mortality

 

1994 MGDB table with

 

 

 

 

 

 

 

 

company experience

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Lapse

 

0.3% - 15%, depending on

 

 

 

 

 

 

 

 

product/duration/funded

 

 

 

 

 

 

 

 

status of guarantee

 

 

 

 

 

 

Utilization

 

99%. 10% of policies have

 

 

 

 

 

 

 

 

a one-time over-utilization

 

 

 

 

 

 

 

 

of 400%

 

 

 

 

 

 

Nonperformance risk

 

0.21% - 1.17%

 

 

 

 

 

 

 

 

 

Annuity account balances (2)

 

 

95,198

 

Actuarial cash flow model

 

Asset earned rate

 

4.53% - 5.67%

 

 

 

 

 

 

Expenses

 

$81 per policy

 

 

 

 

 

 

Withdrawal rate

 

2.20%

 

 

 

 

 

 

Mortality

 

1994 MGDB table with

 

 

 

 

 

 

 

 

company experience

 

 

 

 

 

 

Lapse

 

2.2% - 33.0%, depending

 

 

 

 

 

 

 

 

on duration/surrender

 

 

 

 

 

 

 

 

charge period

 

 

 

 

 

 

Return on assets

 

1.50% - 1.85% depending on

 

 

 

 

 

 

 

 

surrender charge period

 

 

 

 

 

 

Nonperformance risk

 

0.21% - 1.17%

 

 

 

 

 

 

 

 

 

Embedded derivative - FIA

 

76,709

 

Actuarial cash flow model

 

Expenses

 

$81.5 per policy

 

 

 

 

 

 

Withdrawal rate

 

1.1% - 4.5% depending on

 

 

 

 

 

 

 

 

duration and tax qualification

 

 

 

 

 

 

Mortality

 

1994 MGDB table with

 

 

 

 

 

 

 

 

company experience

 

 

 

 

 

 

Lapse

 

2.5% - 40.0%, depending on

 

 

 

 

 

 

 

 

on duration/surrender

 

 

 

 

 

 

 

 

charge period

 

 

 

 

 

 

Nonperformance risk

 

0.21% - 1.17%

 

 

 

 

 

 

 

 

 

Embedded derivative - IUL

 

21,711

 

Actuarial cash flow model

 

Mortality

 

38% - 153% of 2015

 

 

 

 

 

 

 

 

VBT Primary Tables

 

 

 

 

 

 

Lapse

 

0.5% - 10.0%, depending on

 

 

 

 

 

 

 

 

duration/distribution channel

 

 

 

 

 

 

 

 

and smoking class

 

 

 

 

 

 

Nonperformance risk

 

0.21% - 1.17%

 


(1) The fair value for the GMWB embedded derivative is presented as a net liability for the purposes of this chart. Excludes modified coinsurance arrangements.

(2) Represents liabilities related to fixed indexed annuities.

 

The chart above excludes Level 3 financial instruments that are valued using broker quotes and those which book value approximates fair value.

 

57



Table of Contents

 

The Company has considered all reasonably available quantitative inputs as of September 30, 2015 (Successor Company), but the valuation techniques and inputs used by some brokers in pricing certain financial instruments are not shared with the Company. This resulted in $199.8 million of financial instruments being classified as Level 3 as of September 30, 2015 (Successor Company). Of the $199.8 million, $155.2 million are other asset-backed securities and $44.6 million are corporate securities.

 

In certain cases the Company has determined that book value materially approximates fair value. As of September 30, 2015 (Successor Company), the Company held $66.5 million of financial instruments where book value approximates fair value which were predominantly FHLB stock.

 

58



Table of Contents

 

The following table presents the valuation method for material financial instruments included in Level 3, as well as the unobservable inputs used in the valuation of those financial instruments:

 

 

 

Predecessor

 

 

 

 

 

 

 

 

Company

 

 

 

 

 

 

 

 

Fair Value

 

 

 

 

 

 

 

 

As of

 

Valuation

 

Unobservable

 

Range

 

 

December 31, 2014

 

Technique

 

Input

 

(Weighted Average)

 

 

(Dollars In Thousands)

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other asset-backed securities

 

$

563,752

 

Discounted cash flow

 

Liquidity premium

 

0.39% - 1.49% (0.69%)

 

 

 

 

 

 

Paydown rate

 

9.70% - 15.80% (12.08%)

 

 

 

 

 

 

 

 

 

Corporate securities

 

1,282,864

 

Discounted cash flow

 

Spread over

 

0.33% - 7.50% (2.19%)

 

 

 

 

 

 

treasury

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Embedded derivatives - GMWB (1)

 

$

25,927

 

Actuarial cash flow model

 

Mortality

 

44.5% to 100% of 1994

 

 

 

 

 

 

 

 

MGDB table

 

 

 

 

 

 

Lapse

 

0.25% - 17%, depending on

 

 

 

 

 

 

 

 

product/duration/funded

 

 

 

 

 

 

 

 

status of guarantee

 

 

 

 

 

 

Utilization

 

97% - 101%

 

 

 

 

 

 

Nonperformance risk

 

0.12% - 0.96%

 

 

 

 

 

 

 

 

 

Annuity account balances (2)

 

97,825

 

Actuarial cash flow model

 

Asset earned rate

 

3.86% - 5.92%

 

 

 

 

 

 

Expenses

 

$88 - $102 per policy

 

 

 

 

 

 

Withdrawal rate

 

2.20%

 

 

 

 

 

 

Mortality

 

49% to 80% of 1994

 

 

 

 

 

 

 

 

MGDB table

 

 

 

 

 

 

Lapse

 

2.2% - 33.0%, depending

 

 

 

 

 

 

 

 

on duration/surrender

 

 

 

 

 

 

 

 

charge period

 

 

 

 

 

 

Return on assets

 

1.50% - 1.85% depending on

 

 

 

 

 

 

 

 

surrender charge period

 

 

 

 

 

 

Nonperformance risk

 

0.12% - 0.96%

 

 

 

 

 

 

 

 

 

Embedded derivative - FIA

 

124,465

 

Actuarial cash flow model

 

Expenses

 

$83 - $97 per policy

 

 

 

 

 

 

Withdrawal rate

 

1.1% - 4.5% depending on

 

 

 

 

 

 

 

 

duration and tax qualification

 

 

 

 

 

 

Mortality

 

49% to 80% of 1994

 

 

 

 

 

 

 

 

MGDB table

 

 

 

 

 

 

Lapse

 

2.5% - 40.0%, depending

 

 

 

 

 

 

 

 

on duration/surrender

 

 

 

 

 

 

 

 

charge period

 

 

 

 

 

 

Nonperformance risk

 

0.12% - 0.96%

 

 

 

 

 

 

 

 

 

Embedded derivative - IUL

 

6,691

 

Actuarial cash flow model

 

Mortality

 

37% - 74% of 2008

 

 

 

 

 

 

 

 

VBT Primary Tables

 

 

 

 

 

 

Lapse

 

0.5% - 10.0%, depending

 

 

 

 

 

 

 

 

on duration/distribution

 

 

 

 

 

 

 

 

channel and smoking class

 

 

 

 

 

 

Nonperformance risk

 

0.12% - 0.96%

 


(1) The fair value for the GMWB embedded derivative is presented as a net liability, for the purposes of this chart.  Excludes modified coinsurance arrangements.

(2) Represents liabilities related to fixed indexed annuities.

 

59



Table of Contents

 

The chart above excludes Level 3 financial instruments that are valued using broker quotes and those which book value approximates fair value.

 

The Company has considered all reasonably available quantitative inputs as of December 31, 2014 (Predecessor Company), but the valuation techniques and inputs used by some brokers in pricing certain financial instruments are not shared with the Company. This resulted in $237.2 million of financial instruments being classified as Level 3 as of December 31, 2014 (Predecessor Company). Of the $237.2 million, $169.7 million are other asset backed securities and $67.5 million are corporate securities.

 

In certain cases the Company has determined that book value materially approximates fair value. As of December 31, 2014 (Predecessor Company), the Company held $70.4 million of financial instruments where book value approximates fair value. Of the $70.4 million, $66.7 million represents equity securities, which are predominantly FHLB stock, and $3.7 million of other fixed maturity securities.

 

The asset-backed securities classified as Level 3 are predominantly ARS. A change in the paydown rate (the projected annual rate of principal reduction) of the ARS can significantly impact the fair value of these securities. A decrease in the paydown rate would increase the projected weighted average life of the ARS and increase the sensitivity of the ARS’ fair value to changes in interest rates. An increase in the liquidity premium would result in a decrease in the fair value of the securities, while a decrease in the liquidity premium would increase the fair value of these securities.

 

The fair value of corporate bonds classified as Level 3 is sensitive to changes in the interest rate spread over the corresponding U.S. Treasury rate. This spread represents a risk premium that is impacted by company specific and market factors. An increase in the spread can be caused by a perceived increase in credit risk of a specific issuer and/or an increase in the overall market risk premium associated with similar securities. The fair values of corporate bonds are sensitive to changes in spread. When holding the treasury rate constant, the fair value of corporate bonds increases when spreads decrease, and decreases when spreads increase.

 

The fair value of the GMWB embedded derivative is sensitive to changes in the discount rate which includes the Company’s nonperformance risk, volatility, lapse, and mortality assumptions. The volatility assumption is an observable input as it is based on market inputs. The Company’s nonperformance risk, lapse, and mortality are unobservable. An increase in the three unobservable assumptions would result in a decrease in the fair value of the liability and conversely, if there is a decrease in the assumptions the fair value would increase. The fair value is also dependent on the assumed policyholder utilization of the GMWB where an increase in assumed utilization would result in an increase in the fair value of the liability and conversely, if there is a decrease in the assumption, the fair value would decrease.

 

The fair value of the FIA account balance liability is predominantly impacted by observable inputs such as discount rates and equity returns. However, the fair value of the FIA embedded derivative is sensitive to non-performance risk, which is unobservable. The value of the liability increases with decreases in discount rate and non-performance risk and decreases with increases in the discount rate and non-performance risk. The value of the liability increases with increases in equity returns and the liability decreases with a decrease in equity returns.

 

The fair value of the FIA embedded derivative is predominantly impacted by observable inputs such as discount rates and equity returns. However, the fair value of the FIA embedded derivative is sensitive to non-performance risk, which is unobservable. The value of the liability increases with decreases in the discount rate and non-performance risk and decreases with increases in the discount rate and nonperformance risk. The value of the liability increases with increases in equity returns and the liability decreases with a decrease in equity returns.

 

The fair value of the IUL embedded derivative is predominantly impacted by observable inputs such as discount rates and equity returns. However, the fair value of the IUL embedded derivative is sensitive to non-performance risk, which is unobservable. The value of the liability increases with decreases in the discount rate and non-performance risk and decreases with increases in the discount rate and non-performance risk. The value of the liability increases with increases in equity returns and the liability decreases with a decrease in equity returns.

 

60



Table of Contents

 

The following table presents a reconciliation of the beginning and ending balances for fair value measurements for the three months ended September 30, 2015 (Successor Company), for which the Company has used significant unobservable inputs (Level 3):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gains (losses)

 

 

 

 

 

Total

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

included in

 

 

 

 

 

Realized and Unrealized

 

Realized and Unrealized

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings

 

 

 

 

 

Gains

 

Losses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

related to

 

 

 

 

 

 

 

Included in

 

 

 

Included in

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Instruments

 

 

 

 

 

 

 

Other

 

 

 

Other

 

 

 

 

 

 

 

 

 

Transfers

 

 

 

 

 

still held at

 

 

 

Beginning

 

Included in

 

Comprehensive

 

Included in

 

Comprehensive

 

 

 

 

 

 

 

 

 

in/out of

 

 

 

Ending

 

the Reporting

 

 

 

Balance

 

Earnings

 

Income

 

Earnings

 

Income

 

Purchases

 

Sales

 

Issuances

 

Settlements

 

Level 3

 

Other

 

Balance

 

Date

 

 

 

(Dollars In Thousands)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities available-for-sale

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage-backed securities

 

$

3

 

$

 

$

 

$

 

$

 

$

 

$

 

$

 

$

 

$

 

$

 

$

3

 

$

 

Commercial mortgage-backed securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other asset-backed securities

 

590,885

 

 

 

 

(4,185

)

 

 

 

 

 

(949

)

585,751

 

 

U.S. government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

States, municipals, and political subdivisions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate securities

 

1,111,431

 

76

 

5,939

 

(164

)

(8,800

)

62,183

 

(101,161

)

 

 

(20,037

)

(729

)

1,048,738

 

 

Total fixed maturity securities - available-for-sale

 

1,702,319

 

76

 

5,939

 

(164

)

(12,985

)

62,183

 

(101,161

)

 

 

(20,037

)

(1,678

)

1,634,492

 

 

Fixed maturity securities - trading

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage-backed securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial mortgage-backed securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other asset-backed securities

 

160,594

 

83

 

 

(1,640

)

 

2,000

 

(6,001

)

 

 

 

117

 

155,153

 

(1,500

)

U.S. government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

States, municipals and political subdivisions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate securities

 

19,316

 

73

 

 

(970

)

 

 

(56

)

 

 

 

(44

)

18,319

 

(897

)

Total fixed maturity securities - trading

 

179,910

 

156

 

 

(2,610

)

 

2,000

 

(6,057

)

 

 

 

73

 

173,472

 

(2,397

)

Total fixed maturity securities

 

1,882,229

 

232

 

5,939

 

(2,774

)

(12,985

)

64,183

 

(107,218

)

 

 

(20,037

)

(1,605

)

1,807,964

 

(2,397

)

Equity securities

 

66,460

 

 

44

 

 

 

 

 

 

 

 

 

66,504

 

 

Other long-term investments (1)

 

100,519

 

 

 

(44,769

)

 

 

 

 

 

 

 

55,750

 

(44,769

)

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total investments

 

2,049,208

 

232

 

5,983

 

(47,543

)

(12,985

)

64,183

 

(107,218

)

 

 

(20,037

)

(1,605

)

1,930,218

 

(47,166

)

Total assets measured at fair value on a recurring basis

 

$

2,049,208

 

$

232

 

$

5,983

 

$

(47,543

)

$

(12,985

)

$

64,183

 

$

(107,218

)

$

 

$

 

$

(20,037

)

$

(1,605

)

$

1,930,218

 

$

(47,166

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Annuity account balances (2)

 

$

95,178

 

$

 

$

 

$

(3,173

)

$

 

$

 

$

 

$

93

 

$

3,246

 

 

$

 

$

95,198

 

$

 

Other liabilities (1)

 

342,945

 

17,329

 

 

(58,193

)

 

 

 

 

 

 

 

383,809

 

(40,864

)

Total liabilities measured at fair value on a recurring basis

 

$

438,123

 

$

17,329

 

$

 

$

(61,366

)

$

 

$

 

$

 

$

93

 

$

3,246

 

$

 

$

 

$

479,007

 

$

(40,864

)

 


(1) Represents certain freestanding and embedded derivatives.

(2) Represents liabilities related to fixed indexed annuities.

 

For the three months ended September 30, 2015 (Successor Company), there were no transfers of securities into Level 3.

 

For the three months ended September 30, 2015 (Successor Company), $20.0 million of securities were transferred into Level 2. This amount was transferred from Level 3. These transfers resulted from securities that were priced internally using significant unobservable inputs where market observable inputs were not available in previous periods but were priced by independent pricing services or brokers as of September 30, 2015 (Successor Company).

 

For the three months ended September 30, 2015 (Successor Company), there were no transfers of securities from Level 2 to Level 1.

 

For the three months ended September 30, 2015 (Successor Company), there were no transfers of securities from Level 1.

 

61



Table of Contents

 

The following table presents a reconciliation of the beginning and ending balances for fair value measurements for the period of February 1, 2015 to September 30, 2015 (Successor Company), for which the Company has used significant unobservable inputs (Level 3):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gains (losses)

 

 

 

 

 

Total

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

included in

 

 

 

 

 

Realized and Unrealized

 

Realized and Unrealized

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings

 

 

 

 

 

Gains

 

Losses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

related to

 

 

 

 

 

 

 

Included in

 

 

 

Included in

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Instruments

 

 

 

 

 

 

 

Other

 

 

 

Other

 

 

 

 

 

 

 

 

 

Transfers

 

 

 

 

 

still held at

 

 

 

Beginning

 

Included in

 

Comprehensive

 

Included in

 

Comprehensive

 

 

 

 

 

 

 

 

 

in/out of

 

 

 

Ending

 

the Reporting

 

 

 

Balance

 

Earnings

 

Income

 

Earnings

 

Income

 

Purchases

 

Sales

 

Issuances

 

Settlements

 

Level 3

 

Other

 

Balance

 

Date

 

 

 

(Dollars In Thousands)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities available-for-sale

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage-backed securities

 

$

3

 

$

 

$

 

$

 

$

 

$

 

$

 

$

 

$

 

$

 

$

 

$

3

 

$

 

Commercial mortgage-backed securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other asset-backed securities

 

603,646

 

 

165

 

(92

)

(17,076

)

 

(127

)

 

 

 

(765

)

585,751

 

 

U.S. government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

States, municipals, and political subdivisions

 

3,675

 

 

 

 

 

 

(3,675

)

 

 

 

 

 

 

Other government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate securities

 

1,307,259

 

4,367

 

21,558

 

(851

)

(33,047

)

174,112

 

(356,096

)

 

 

(61,890

)

(6,674

)

1,048,738

 

 

Total fixed maturity securities - available-for-sale

 

1,914,583

 

4,367

 

21,723

 

(943

)

(50,123

)

174,112

 

(359,898

)

 

 

(61,890

)

(7,439

)

1,634,492

 

 

Fixed maturity securities - trading

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage-backed securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial mortgage-backed securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other asset-backed securities

 

169,473

 

4,032

 

 

(6,813

)

 

2,000

 

(13,877

)

 

 

 

338

 

155,153

 

(6,896

)

U.S. government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

States, municipals and political subdivisions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate securities

 

25,130

 

247

 

 

(1,269

)

 

 

(5,640

)

 

 

 

(149

)

18,319

 

(1,546

)

Total fixed maturity securities - trading

 

194,603

 

4,279

 

 

(8,082

)

 

2,000

 

(19,517

)

 

 

 

189

 

173,472

 

(8,442

)

Total fixed maturity securities

 

2,109,186

 

8,646

 

21,723

 

(9,025

)

(50,123

)

176,112

 

(379,415

)

 

 

(61,890

)

(7,250

)

1,807,964

 

(8,442

)

Equity securities

 

66,691

 

 

44

 

 

 

 

(231

)

 

 

 

 

66,504

 

 

Other long-term investments (1)

 

64,200

 

40,032

 

 

(48,482

)

 

 

 

 

 

 

 

55,750

 

(8,450

)

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total investments

 

2,240,077

 

48,678

 

21,767

 

(57,507

)

(50,123

)

176,112

 

(379,646

)

 

 

(61,890

)

(7,250

)

1,930,218

 

(16,892

)

Total assets measured at fair value on a recurring basis

 

$

2,240,077

 

$

48,678

 

$

21,767

 

$

(57,507

)

$

(50,123

)

$

176,112

 

$

(379,646

)

$

 

$

 

$

(61,890

)

$

(7,250

)

$

1,930,218

 

$

(16,892

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Annuity account balances (2)

 

$

98,279

 

$

 

$

 

$

(4,716

)

$

 

$

 

$

 

$

179

 

$

7,976

 

$

 

$

 

$

95,198

 

$

 

Other liabilities (1)

 

530,118

 

230,183

 

 

(83,874

)

 

 

 

 

 

 

 

383,809

 

146,309

 

Total liabilities measured at fair value on a recurring basis

 

$

628,397

 

$

230,183

 

$

 

$

(88,590

)

$

 

$

 

$

 

$

179

 

$

7,976

 

$

 

$

 

$

479,007

 

$

146,309

 

 


(1) Represents certain freestanding and embedded derivatives.

(2) Represents liabilities related to fixed indexed annuities.

 

For the period of February 1, 2015 to September 30, 2015 (Successor Company), there were no transfers of securities into Level 3.

 

For the period of February 1, 2015 to September 30, 2015 (Successor Company), $61.9 million of securities were transferred into Level 2. This amount was transferred from Level 3. These transfers resulted from securities that were priced internally using significant unobservable inputs where market observable inputs were not available in previous periods but were priced by independent pricing services or brokers as of September 30, 2015 (Successor Company).

 

For the period of February 1, 2015 to September 30, 2015 (Successor Company), $90.4 million of securities were transferred from Level 2 to Level 1.

 

For the period of February 1, 2015 to September 30, 2015 (Successor Company), there were no transfers from Level 1.

 

62



Table of Contents

 

The following table presents a reconciliation of the beginning and ending balances for fair value measurements for period of January 1, 2015 to January 31, 2015 (Predecessor Company), for which the Company has used significant unobservable inputs (Level 3):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gains (losses)

 

 

 

 

 

Total

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

included in

 

 

 

 

 

Realized and Unrealized

 

Realized and Unrealized

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings

 

 

 

 

 

Gains

 

Losses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

related to

 

 

 

 

 

 

 

Included in

 

 

 

Included in

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Instruments

 

 

 

 

 

 

 

Other

 

 

 

Other

 

 

 

 

 

 

 

 

 

Transfers

 

 

 

 

 

still held at

 

 

 

Beginning

 

Included in

 

Comprehensive

 

Included in

 

Comprehensive

 

 

 

 

 

 

 

 

 

in/out of

 

 

 

Ending

 

the Reporting

 

 

 

Balance

 

Earnings

 

Income

 

Earnings

 

Income

 

Purchases

 

Sales

 

Issuances

 

Settlements

 

Level 3

 

Other

 

Balance

 

Date

 

 

 

(Dollars In Thousands)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities available-for-sale

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage-backed securities

 

$

3

 

$

 

$

 

$

 

$

 

$

 

$

 

$

 

$

 

$

 

$

 

$

3

 

$

 

Commercial mortgage-backed securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other asset-backed securities

 

563,961

 

 

 

 

(3,867

)

 

(32

)

 

 

43,205

 

379

 

603,646

 

 

U.S. government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

States, municipals, and political subdivisions

 

3,675

 

 

 

 

 

 

 

 

 

 

 

3,675

 

 

Other government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate securities

 

1,325,683

 

 

12,282

 

 

(23,029

)

 

(7,062

)

 

 

 

(615

)

1,307,259

 

 

Total fixed maturity securities - available-for-sale

 

1,893,322

 

 

12,282

 

 

(26,896

)

 

(7,094

)

 

 

43,205

 

(236

)

1,914,583

 

 

Fixed maturity securities - trading

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage-backed securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial mortgage-backed securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other asset-backed securities

 

169,461

 

586

 

 

(139

)

 

 

(472

)

 

 

 

37

 

169,473

 

447

 

U.S. government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

States, municipals and political subdivisions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate securities

 

24,744

 

602

 

 

(196

)

 

 

(20

)

 

 

 

 

25,130

 

406

 

Total fixed maturity securities - trading

 

194,205

 

1,188

 

 

(335

)

 

 

(492

)

 

 

 

37

 

194,603

 

853

 

Total fixed maturity securities

 

2,087,527

 

1,188

 

12,282

 

(335

)

(26,896

)

 

(7,586

)

 

 

43,205

 

(199

)

2,109,186

 

853

 

Equity securities

 

66,691

 

 

 

 

 

 

 

 

 

 

 

66,691

 

 

Other long-term investments (1)

 

44,625

 

16,617

 

 

(15,166

)

 

 

 

 

 

 

 

46,076

 

1,451

 

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total investments

 

2,198,843

 

17,805

 

12,282

 

(15,501

)

(26,896

)

 

(7,586

)

 

 

43,205

 

(199

)

2,221,953

 

2,304

 

Total assets measured at fair value on a recurring basis

 

$

2,198,843

 

$

17,805

 

$

12,282

 

$

(15,501

)

$

(26,896

)

$

 

$

(7,586

)

$

 

$

 

$

43,205

 

$

(199

)

$

2,221,953

 

$

2,304

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Annuity account balances (2)

 

$

97,825

 

$

 

$

 

$

(536

)

$

 

$

 

$

 

$

7

 

$

419

 

$

 

$

 

$

97,949

 

$

 

Other liabilities (1)

 

506,343

 

61

 

 

(125,995

)

 

 

 

 

 

 

 

632,277

 

(125,934

)

Total liabilities measured at fair value on a recurring basis

 

$

604,168

 

$

61

 

$

 

$

(126,531

)

$

 

$

 

$

 

$

7

 

$

419

 

$

 

$

 

$

730,226

 

$

(125,934

)

 


(1) Represents certain freestanding and embedded derivatives.

(2) Represents liabilities related to fixed indexed annuities.

 

For the period of January 1, 2015 to January 31, 2015 (Predecessor Company), $43.2 million of securities were transferred into Level 3. This amount was transferred from Level 2. These transfers resulted from securities that were priced by independent pricing services or brokers in previous periods, using no significant unobservable inputs, but were priced internally using significant unobservable inputs where market observable inputs were no longer available as of January 31, 2015 (Predecessor Company). All transfers are recognized as of the end of the period.

 

For the period of January 1, 2015 to January 31, 2015 (Predecessor Company), there were no transfers from Level 3 to Level 2.

 

For the period of January 1, 2015 to January 31, 2015 (Predecessor Company), there were no transfers from Level 2 to Level 1 and there were no transfers out of Level 1.

 

63



Table of Contents

 

The following table presents a reconciliation of the beginning and ending balances for fair value measurements for the three months ended September 30, 2014 (Predecessor Company), for which the Company has used significant unobservable inputs (Level 3):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gains (losses)

 

 

 

 

 

Total

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

included in

 

 

 

 

 

Realized and Unrealized

 

Realized and Unrealized

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings

 

 

 

 

 

Gains

 

Losses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

related to

 

 

 

 

 

 

 

Included in

 

 

 

Included in

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Instruments

 

 

 

 

 

 

 

Other

 

 

 

Other

 

 

 

 

 

 

 

 

 

Transfers

 

 

 

 

 

still held at

 

 

 

Beginning

 

Included in

 

Comprehensive

 

Included in

 

Comprehensive

 

 

 

 

 

 

 

 

 

in/out of

 

 

 

Ending

 

the Reporting

 

 

 

Balance

 

Earnings

 

Income

 

Earnings

 

Income

 

Purchases

 

Sales

 

Issuances

 

Settlements

 

Level 3

 

Other

 

Balance

 

Date

 

 

 

(Dollars In Thousands)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities available-for-sale

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage-backed securities

 

$

10

 

$

 

$

 

$

 

$

(1

)

$

 

$

(5

)

$

 

$

 

$

 

$

1

 

$

5

 

$

 

Commercial mortgage-backed securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other asset-backed securities

 

568,097

 

 

2,161

 

(71

)

(4,299

)

 

(140

)

 

 

 

(380

)

565,368

 

 

U.S. government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

States, municipals, and political subdivisions

 

3,675

 

 

 

 

 

 

 

 

 

 

 

3,675

 

 

Other government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate securities

 

1,524,297

 

201

 

8,435

 

 

(9,452

)

11,797

 

(59,352

)

 

 

(96,565

)

(1,555

)

1,377,806

 

 

Total fixed maturity securities - available-for-sale

 

2,096,079

 

201

 

10,596

 

(71

)

(13,752

)

11,797

 

(59,497

)

 

 

(96,565

)

(1,934

)

1,946,854

 

 

Fixed maturity securities - trading

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage-backed securities

 

842

 

11

 

 

 

 

 

 

 

 

(853

)

 

 

 

Commercial mortgage-backed securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other asset-backed securities

 

176,386

 

1,834

 

 

(837

)

 

 

(7,137

)

 

 

 

430

 

170,676

 

1,287

 

U.S. government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

States, municipals and political subdivisions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate securities

 

31,520

 

182

 

 

(676

)

 

 

(5,583

)

 

 

(2,518

)

252

 

23,177

 

234

 

Total fixed maturity securities - trading

 

208,748

 

2,027

 

 

(1,513

)

 

 

(12,720

)

 

 

(3,371

)

682

 

193,853

 

1,521

 

Total fixed maturity securities

 

2,304,827

 

2,228

 

10,596

 

(1,584

)

(13,752

)

11,797

 

(72,217

)

 

 

(99,936

)

(1,252

)

2,140,707

 

1,521

 

Equity securities

 

77,882

 

 

 

 

(91

)

 

(445

)

 

 

(10,651

)

 

66,695

 

 

Other long-term investments (1)

 

67,222

 

895

 

 

(6,843

)

 

 

 

 

 

 

 

61,274

 

(5,948

)

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total investments

 

2,449,931

 

3,123

 

10,596

 

(8,427

)

(13,843

)

11,797

 

(72,662

)

 

 

(110,587

)

(1,252

)

2,268,676

 

(4,427

)

Total assets measured at fair value on a recurring basis

 

$

2,449,931

 

$

3,123

 

$

10,596

 

$

(8,427

)

$

(13,843

)

$

11,797

 

$

(72,662

)

$

 

$

 

$

(110,587

)

$

(1,252

)

$

2,268,676

 

$

(4,427

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Annuity account balances (2)

 

$

102,456

 

$

862

 

$

 

$

 

$

 

$

 

$

 

$

125

 

$

3,590

 

$

 

$

 

$

98,129

 

$

 

Other liabilities (1)

 

399,669

 

22,317

 

 

(42,833

)

 

 

 

 

 

 

 

420,185

 

(20,516

)

Total liabilities measured at fair value on a recurring basis

 

$

502,125

 

$

23,179

 

$

 

$

(42,833

)

$

 

$

 

$

 

$

125

 

$

3,590

 

$

 

$

 

$

518,314

 

$

(20,516

)

 


(1) Represents certain freestanding and embedded derivatives.

(2) Represents liabilities related to fixed indexed annuities.

 

For the three months ended September 30, 2014 (Predecessor Company), there were no transfers into Level 3.

 

For the three months ended September 30, 2014 (Predecessor Company), there were $110.6 million of securities transferred out of Level 3. This amount was transferred to Level 2. These transfers resulted from securities that were previously priced internally using significant unobservable inputs, now being priced by independent pricing services or brokers.

 

For the three months ended September 30, 2014 (Predecessor Company), there were no transfers from Level 2 to Level 1.

 

For the three months ended September 30, 2014 (Predecessor Company), there were no transfers from Level 1.

 

64



Table of Contents

 

The following table presents a reconciliation of the beginning and ending balances for fair value measurements for the nine months ended September 30, 2014 (Predecessor Company), for which the Company has used significant unobservable inputs (Level 3):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gains (losses)

 

 

 

 

 

Total

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

included in

 

 

 

 

 

Realized and Unrealized

 

Realized and Unrealized

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings

 

 

 

 

 

Gains

 

Losses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

related to

 

 

 

 

 

 

 

Included in

 

 

 

Included in

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Instruments

 

 

 

 

 

 

 

Other

 

 

 

Other

 

 

 

 

 

 

 

 

 

Transfers

 

 

 

 

 

still held at

 

 

 

Beginning

 

Included in

 

Comprehensive

 

Included in

 

Comprehensive

 

 

 

 

 

 

 

 

 

in/out of

 

 

 

Ending

 

the Reporting

 

 

 

Balance

 

Earnings

 

Income

 

Earnings

 

Income

 

Purchases

 

Sales

 

Issuances

 

Settlements

 

Level 3

 

Other

 

Balance

 

Date

 

 

 

(Dollars In Thousands)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed maturity securities available-for-sale

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage-backed securities

 

$

28

 

$

 

$

 

$

 

$

(1

)

$

 

$

(23

)

$

 

$

 

$

 

$

1

 

$

5

 

$

 

Commercial mortgage-backed securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other asset-backed securities

 

545,808

 

 

36,227

 

(71

)

(5,532

)

 

(9,934

)

 

 

 

(1,130

)

565,368

 

 

U.S. government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

States, municipals, and political subdivisions

 

3,675

 

 

 

 

 

 

 

 

 

 

 

3,675

 

 

Other government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate securities

 

1,549,940

 

1,170

 

62,723

 

 

(16,717

)

102,029

 

(162,391

)

 

 

(151,858

)

(7,090

)

1,377,806

 

 

Total fixed maturity securities - available-for-sale

 

2,099,451

 

1,170

 

98,950

 

(71

)

(22,250

)

102,029

 

(172,348

)

 

 

(151,858

)

(8,219

)

1,946,854

 

 

Fixed maturity securities - trading

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Residential mortgage-backed securities

 

 

11

 

 

 

 

842

 

 

 

 

(853

)

 

 

 

Commercial mortgage-backed securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other asset-backed securities

 

194,977

 

8,685

 

 

(3,951

)

 

 

(29,832

)

 

 

 

797

 

170,676

 

1,959

 

U.S. government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

States, municipals and political subdivisions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other government-related securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate securities

 

29,199

 

1,060

 

 

(729

)

 

4,059

 

(10,693

)

 

 

4

 

277

 

23,177

 

(1

)

Total fixed maturity securities - trading

 

224,176

 

9,756

 

 

(4,680

)

 

4,901

 

(40,525

)

 

 

(849

)

1,074

 

193,853

 

1,958

 

Total fixed maturity securities

 

2,323,627

 

10,926

 

98,950

 

(4,751

)

(22,250

)

106,930

 

(212,873

)

 

 

(152,707

)

(7,145

)

2,140,707

 

1,958

 

Equity securities

 

67,979

 

 

1,192

 

 

(257

)

9,551

 

(1,119

)

 

 

(10,651

)

 

66,695

 

 

Other long-term investments (1)

 

98,886

 

1,320

 

 

(38,932

)

 

 

 

 

 

 

 

61,274

 

(37,612

)

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total investments

 

2,490,492

 

12,246

 

100,142

 

(43,683

)

(22,507

)

116,481

 

(213,992

)

 

 

(163,358

)

(7,145

)

2,268,676

 

(35,654

)

Total assets measured at fair value on a recurring basis

 

$

2,490,492

 

$

12,246

 

$

100,142

 

$

(43,683

)

$

(22,507

)

$

116,481

 

$

(213,992

)

$

 

$

 

$

(163,358

)

$

(7,145

)

$

2,268,676

 

$

(35,654

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Annuity account balances (2)

 

$

107,000

 

$

 

$

 

$

(2,261

)

$

 

$

 

$

 

$

300

 

$

11,432

 

$

 

$

 

$

98,129

 

$

 

Other liabilities (1)

 

233,738

 

22,342

 

 

(208,789

)

 

 

 

 

 

 

 

420,185

 

(186,447

)

Total liabilities measured at fair value on a recurring basis

 

$

340,738

 

$

22,342

 

$

 

$

(211,050

)

$

 

$

 

$

 

$

300

 

$

11,432

 

$

 

$

 

$

518,314

 

$

(186,447

)

 


(1) Represents certain freestanding and embedded derivatives.

(2) Represents liabilities related to fixed indexed annuities.

 

For the nine months ended September 30, 2014 (Predecessor Company), $31.0 million of securities were transferred into Level 3. This amount was transferred from Level 2. These transfers resulted from securities that were priced by independent pricing services or brokers in previous periods, using no significant unobservable inputs, but were priced internally using significant unobservable inputs where market observable inputs were no longer available as of September 30, 2014 (Predecessor Company). All transfers are recognized as of the end of the period.

 

For the nine months ended September 30, 2014 (Predecessor Company), $194.4 million of securities were transferred into Level 2. This amount was transferred from Level 3. These transfers resulted from securities that were previously priced internally using significant unobservable inputs, now being priced by independent pricing services or brokers.

 

For the nine months ended September 30, 2014 (Predecessor Company), there were no transfers from Level 2 to Level 1.

 

For the nine months ended September 30, 2014 (Predecessor Company), there were no transfers out of Level

 

65



Table of Contents

 

1.

 

Total realized and unrealized gains (losses) on Level 3 assets and liabilities are primarily reported in either realized investment gains (losses) within the consolidated condensed statements of income (loss) or other comprehensive income (loss) within shareowner’s equity based on the appropriate accounting treatment for the item.

 

Purchases, sales, issuances, and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period. Such activity primarily relates to purchases and sales of fixed maturity securities and issuances and settlements of fixed indexed annuities.

 

The Company reviews the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3 at the beginning fair value for the reporting period in which the changes occur. The asset transfers in the table(s) above primarily related to positions moved from Level 3 to Level 2 as the Company determined that certain inputs were observable.

 

The amount of total gains (losses) for assets and liabilities still held as of the reporting date primarily represents changes in fair value of trading securities and certain derivatives that exist as of the reporting date and the change in fair value of fixed indexed annuities.

 

Estimated Fair Value of Financial Instruments

 

The carrying amounts and estimated fair values of the Company’s financial instruments as of the periods shown below are as follows:

 

 

 

 

 

Successor

 

 

Predecessor

 

 

 

 

 

Company

 

 

Company

 

 

 

 

 

As of

 

 

As of

 

 

 

 

 

September 30, 2015

 

 

December 31, 2014

 

 

 

Fair Value

 

Carrying

 

 

 

 

Carrying

 

 

 

 

 

Level

 

Amounts

 

Fair Values

 

 

Amounts

 

Fair Values

 

 

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Mortgage loans on real estate

 

3

 

$

5,728,237

 

$

5,590,446

 

 

$

5,133,780

 

$

5,524,059

 

Policy loans

 

3

 

1,706,402

 

1,706,402

 

 

1,758,237

 

1,758,237

 

Fixed maturities, held-to-maturity (1)

 

3

 

579,329

 

518,363

 

 

435,000

 

458,422

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Stable value product account balances

 

3

 

$

1,914,093

 

$

1,903,615

 

 

$

1,959,488

 

$

1,973,624

 

Annuity account balances

 

3

 

10,754,799

 

10,321,313

 

 

10,950,729

 

10,491,775

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt:

 

 

 

 

 

 

 

 

 

 

 

 

Non-recourse funding obligations (2)

 

3

 

$

1,939,078

 

$

1,630,091

 

 

$

1,527,752

 

$

1,753,183

 

 


Except as noted below, fair values were estimated using quoted market prices.

 

(1)

Security purchased from unconsolidated subsidiary, Red Mountain LLC.

(2)

Of this carrying amount, $485.0 million, fair value of $496.7 million, as of September 30, 2015 (Successor Company), and $435.0 million, fair value of $461.4 million, as of December 31, 2014 (Predecessor Company), relates to non-recourse funding obligations issued by Golden Gate V.

 

66



Table of Contents

 

Fair Value Measurements

 

Mortgage loans on real estate

 

The Company estimates the fair value of mortgage loans using an internally developed model. This model includes inputs derived by the Company based on assumed discount rates relative to the Company’s current mortgage loan lending rate and an expected cash flow analysis based on a review of the mortgage loan terms. The model also contains the Company’s determined representative risk adjustment assumptions related to credit and liquidity risks.

 

Policy loans

 

The Company believes the fair value of policy loans approximates book value. Policy loans are funds provided to policy holders in return for a claim on the policy. The funds provided are limited to the cash surrender value of the underlying policy. The nature of policy loans is to have a negligible default risk as the loans are fully collateralized by the value of the policy. Policy loans do not have a stated maturity and the balances and accrued interest are repaid either by the policyholder or with proceeds from the policy. Due to the collateralized nature of policy loans and unpredictable timing of repayments, the Company believes the fair value of policy loans approximates carrying value.

 

Fixed maturities, held-to-maturity

 

The Company estimates the fair value of its fixed maturity, held-to-maturity securities using internal discounted cash flow models. The discount rates used in the model are based on a current market yield for similar financial instruments.

 

Stable Value Product and Annuity Account Balances

 

The Company estimates the fair value of stable value product account balances and annuity account balances using models based on discounted expected cash flows. The discount rates used in the models are based on a current market rate for similar financial instruments.

 

Non-recourse Funding Obligations

 

The Company estimates the fair value of its non-recourse funding obligations using internal discounted cash flow models. The discount rates used in the model are based on a current market yield for similar financial instruments.

 

16.                                DERIVATIVE FINANCIAL INSTRUMENTS

 

Types of Derivative Instruments and Derivative Strategies

 

The Company utilizes a risk management strategy that incorporates the use of derivative financial instruments to reduce exposure to certain risks, including but not limited to, interest rate risk, inflation risk, currency exchange risk, volatility risk, and equity market risk. These strategies are developed through the Company’s analysis of data from financial simulation models and other internal and industry sources, and are then incorporated into the Company’s risk management program.

 

Derivative instruments expose the Company to credit and market risk and could result in material changes from period to period. The Company attempts to minimize its credit risk by entering into transactions with highly rated counterparties. The Company manages the market risk by establishing and monitoring limits as to the types and degrees of risk that may be undertaken. The Company monitors its use of derivatives in connection with its overall asset/liability management programs and risk management strategies. In addition, all derivative programs are monitored by our risk management department.

 

Derivatives Related to Interest Rate Risk Management

 

Derivative instruments that are used as part of the Company’s interest rate risk management strategy include interest rate swaps, interest rate futures, interest rate caps, and interest rate swaptions. The Company’s inflation risk

 

67



Table of Contents

 

management strategy involves the use of swaps that requires the Company to pay a fixed rate and receive a floating rate that is based on changes in the Consumer Price Index (“CPI”).

 

Derivatives Related to Risk Mitigation of Certain Annuity Contracts

 

The Company may use the following types of derivative contracts to mitigate its exposure to certain guaranteed benefits related to VA, fixed indexed annuity, and indexed universal life contracts:

 

·                   Foreign Currency Futures

·                   Variance Swaps

·                   Interest Rate Futures

·                   Equity Options

·                   Equity Futures

·                   Credit Derivatives

·                   Interest Rate Swaps

·                   Interest Rate Swaptions

·                   Volatility Futures

·                   Volatility Options

·                   Funds Withheld Agreement

·                   Total Return Swaps

 

Other Derivatives

 

The Company and certain of its subsidiaries have derivatives with PLC. These derivatives consist of an interest support agreement, a YRT premium support agreement, and portfolio maintenance agreements with PLC.

 

The Company has a funds withheld account that consists of various derivative instruments held by us that is used to hedge the GMWB and GMDB riders. The economic performance of derivatives in the funds withheld account is ceded to Shades Creek. The funds withheld account is accounted for as a derivative financial instrument.

 

Accounting for Derivative Instruments

 

The Company records its derivative financial instruments in the consolidated condensed balance sheet in “other long-term investments” and “other liabilities” in accordance with GAAP, which requires that all derivative instruments be recognized in the balance sheet at fair value. The change in the fair value of derivative financial instruments is reported either in the statement of income or in other comprehensive income (loss), depending upon whether it qualified  for and also has been properly identified as being part of a hedging relationship, and also on the type of hedging relationship that exists.

 

For a derivative financial instrument to be accounted for as an accounting hedge, it must be identified and documented as such on the date of designation. For cash flow hedges, the effective portion of their realized gain or loss is reported as a component of other comprehensive income and reclassified into earnings in the same period during which the hedged item impacts earnings. Any remaining gain or loss, the ineffective portion, is recognized in current earnings. For fair value hedge derivatives, their gain or loss as well as the offsetting loss or gain attributable to the hedged risk of the hedged item is recognized in current earnings. Effectiveness of the Company’s hedge relationships is assessed on a quarterly basis.

 

The Company reports changes in fair values of derivatives that are not part of a qualifying hedge relationship through earnings in the period of change. Changes in the fair value of derivatives that are recognized in current earnings are reported in “Realized investment gains (losses) - Derivative financial instruments”.

 

68



Table of Contents

 

Derivative Instruments Designated and Qualifying as Hedging Instruments

 

Cash-Flow Hedges

 

·                   In connection with the issuance of inflation-adjusted funding agreements, the Company has entered into swaps to essentially convert the floating CPI-linked interest rate on these agreements to a fixed rate. The Company pays a fixed rate on the swap and receives a floating rate primarily determined by the period’s change in the CPI. The amounts that are received on the swaps are almost equal to the amounts that are paid on the agreements. None of these positions were held as of September 30, 2015 (Successor Company), as these funding agreements and correlating swaps matured in June of 2015.

 

Derivative Instruments Not Designated and Not Qualifying as Hedging Instruments

 

The Company uses various other derivative instruments for risk management purposes that do not qualify for hedge accounting treatment. Changes in the fair value of these derivatives are recognized in earnings during the period of change.

 

Derivatives Related to Variable Annuity Contracts

 

·                   The Company uses equity, interest rate, currency, and volatility futures to mitigate the risk related to certain guaranteed minimum benefits, including GMWB, within its VA products. In general, the cost of such benefits varies with the level of equity and interest rate markets, foreign currency levels, and overall volatility.

 

·                   The Company uses equity options, variance swaps, and volatility options to mitigate the risk related to certain guaranteed minimum benefits, including GMWB, within its VA products. In general, the cost of such benefits varies with the level of equity markets and overall volatility.

 

·                   The Company uses interest rate swaps and interest rate swaptions to mitigate the risk related to certain guaranteed minimum benefits, including GMWB, within its VA products.

 

·                   The Company markets certain VA products with a GMWB rider. The GMWB component is considered an embedded derivative, not considered to be clearly and closely related to the host contract.

 

·                   The Company has a funds withheld account that consists of various derivative instruments held by the Company that are used to hedge the GMWB and GMDB riders. The economic performance of derivatives in the funds withheld account is ceded to Shades Creek. The funds withheld account is accounted for as a derivative financial instrument.

 

Derivatives Related to Fixed Annuity Contracts

 

·                   The Company uses equity, futures, and options to mitigate the risk within its fixed indexed annuity products. In general, the cost of such benefits varies with the level of equity and overall volatility.

 

·                   The Company uses equity options to mitigate the risk within its fixed indexed annuity products. In general, the cost of such benefits varies with the level of equity markets.

 

·                   The Company markets certain fixed indexed annuity products. The FIA component is considered an embedded derivative, not considered to be clearly and closely related to the host contract.

 

Derivatives Related to Indexed Universal Life Contracts

 

·                   The Company uses equity, futures, and options to mitigate the risk within its indexed universal life products. In general, the cost of such benefits varies with the level of equity markets.

 

69



Table of Contents

 

·                   The Company markets certain IUL products. The IUL component is considered an embedded derivative, not considered to be clearly and closely related to the host contract.

 

Other Derivatives

 

·                   The Company uses certain interest rate swaps to mitigate the price volatility of fixed maturities.  None of these positions were held as of September 30, 2015 (Successor Company).

 

·                   The Company and certain of its subsidiaries have an interest support agreement, YRT premium support agreement, and two portfolio maintenance agreements with PLC. The Company entered into two separate portfolio maintenance agreements in October 2012.

 

·                   The Company uses various swaps and other types of derivatives to manage risk related to other exposures.

 

·                   The Company is involved in various modified coinsurance and funds withheld arrangements which contain embedded derivatives. Changes in their fair value are recorded in current period earnings. The investment portfolios that support the related modified coinsurance reserves and funds withheld arrangements had fair value changes which substantially offset the gains or losses on these embedded derivatives.

 

70



Table of Contents

 

The following table sets forth realized investments gains and losses for the periods shown:

 

Realized investment gains (losses) - derivative financial instruments

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

 

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

January 1, 2015

 

Months Ended

 

Months Ended

 

 

 

September 30,

 

September 30,

 

 

to

 

September 30,

 

September 30,

 

 

 

2015

 

2015

 

 

January 31, 2015

 

2014

 

2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Derivatives related to VA contracts:

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate futures - VA

 

$

12,140

 

$

(2,091

)

 

$

1,413

 

$

1,979

 

$

12,777

 

Equity futures - VA

 

40,951

 

3,215

 

 

9,221

 

861

 

(9,049

)

Currency futures - VA

 

4,000

 

1,428

 

 

7,778

 

10,185

 

6,020

 

Variance swaps - VA

 

 

 

 

 

1,570

 

(1,103

)

Equity options - VA

 

33,519

 

8,195

 

 

3,047

 

2,050

 

(31,240

)

Interest rate swaptions - VA

 

(3,618

)

(12,399

)

 

9,268

 

(2,812

)

(17,213

)

Interest rate swaps - VA

 

101,808

 

(74,150

)

 

122,710

 

22,011

 

124,548

 

Embedded derivative - GMWB

 

(71,296

)

10,543

 

 

(68,503

)

(11,407

)

(51,869

)

Funds withheld derivative

 

(52,872

)

(8,301

)

 

(9,073

)

(2,432

)

27,298

 

Total derivatives related to VA contracts

 

64,632

 

(73,560

)

 

75,861

 

22,005

 

60,169

 

Derivatives related to FIA contracts:

 

 

 

 

 

 

 

 

 

 

 

 

Embedded derivative - FIA

 

11,328

 

9,035

 

 

1,769

 

(2,462

)

(9,036

)

Equity futures - FIA

 

709

 

1,016

 

 

(184

)

117

 

1,067

 

Volatility futures - FIA

 

(24

)

6

 

 

 

(4

)

4

 

Equity options - FIA

 

(12,099

)

(6,499

)

 

(2,617

)

1,099

 

5,077

 

Total derivatives related to FIA contracts

 

(86

)

3,558

 

 

(1,032

)

(1,250

)

(2,888

)

Derivatives related to IUL contracts:

 

 

 

 

 

 

 

 

 

 

 

 

Embedded derivative - IUL

 

1,287

 

3,082

 

 

(486

)

347

 

62

 

Equity futures - IUL

 

17

 

39

 

 

3

 

16

 

16

 

Equity options - IUL

 

(1,110

)

(1,048

)

 

(115

)

(24

)

(24

)

Total derivatives related to IUL contracts

 

194

 

2,073

 

 

(598

)

339

 

54

 

Embedded derivative - Modco reinsurance treaties

 

(9,817

)

131,505

 

 

(68,026

)

20,426

 

(91,945

)

Derivatives with PLC (1)

 

(12,978

)

(16,096

)

 

15,863

 

398

 

536

 

Other derivatives

 

(50

)

33

 

 

(37

)

(149

)

(351

)

Total realized gains (losses) - derivatives

 

$

41,895

 

$

47,513

 

 

$

22,031

 

$

41,769

 

$

(34,425

)

 


(1)         These derivatives include the Interest, YRT premium support, and portfolio maintenance agreements between certain of the Company’s subsidiaries and PLC.

 

The following table sets forth realized investments gains and losses for the Modco trading portfolio that is included in realized investment gains (losses) — all other investments:

 

Realized investment gains (losses) - all other investments

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Modco trading portfolio (1)

 

$

8,377

 

$

(133,524

)

 

$

73,062

 

$

(17,225

)

$

110,067

 

 


(1) The Company elected to include the use of alternate disclosures for trading activities.

 

71



Table of Contents

 

The following table presents the components of the gain or loss on derivatives that qualify as a cash flow hedging relationship:

 

Gain (Loss) on Derivatives in Cash Flow Hedging Relationship

 

 

 

 

 

Amount and Location of

 

 

 

 

 

Amount of Gains (Losses)

 

Gains (Losses)

 

 

 

 

 

Deferred in

 

Reclassified from

 

Amount and Location of

 

 

 

Accumulated Other

 

Accumulated Other

 

(Losses) Recognized in

 

 

 

Comprehensive Income

 

Comprehensive Income

 

Income (Loss) on

 

 

 

(Loss) on Derivatives

 

(Loss) into Income (Loss)

 

Derivatives

 

 

 

(Effective Portion)

 

(Effective Portion)

 

(Ineffective Portion)

 

 

 

 

 

Benefits and settlement

 

Realized investment

 

 

 

 

 

expenses

 

gains (losses)

 

 

 

 

 

(Dollars In Thousands)

 

 

 

Successor Company

 

 

 

 

 

 

 

For The Three Months Ended September 30, 2015

 

 

 

 

 

 

 

Inflation

 

$

 

$

 

$

 

Total

 

$

 

$

 

$

 

 

 

 

 

 

 

 

 

Successor Company

 

 

 

 

 

 

 

February 1, 2015 to September 30, 2015

 

 

 

 

 

 

 

Inflation

 

$

(131

)

$

(131

)

$

73

 

Total

 

$

(131

)

$

(131

)

$

73

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Predecessor Company

 

 

 

 

 

 

 

January 1, 2015 to January 31, 2015

 

 

 

 

 

 

 

Inflation

 

$

13

 

$

(36

)

$

(7

)

Total

 

$

13

 

$

(36

)

$

(7

)

 

 

 

 

 

 

 

 

Predecessor Company

 

 

 

 

 

 

 

For The Three Months Ended September 30, 2014

 

 

 

 

 

 

 

Inflation

 

$

(64

)

$

(293

)

$

(79

)

Total

 

$

(64

)

$

(293

)

$

(79

)

 

 

 

 

 

 

 

 

Predecessor Company

 

 

 

 

 

 

 

For The Nine Months Ended September 30, 2014

 

 

 

 

 

 

 

Inflation

 

$

(90

)

$

(1,577

)

$

(205

)

Total

 

$

(90

)

$

(1,577

)

$

(205

)

 

72



Table of Contents

 

The table below present information about the nature and accounting treatment of the Company’s primary derivative financial instruments and the location in and effect on the consolidated condensed financial statements for the periods presented below:

 

 

 

Successor

 

Predecessor

 

 

 

Company

 

Company

 

 

 

As of September 30, 2015

 

 

As of December 31, 2014

 

 

 

Notional

 

Fair

 

 

Notional

 

Fair

 

 

 

Amount

 

Value

 

 

Amount

 

Value

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Other long-term investments

 

 

 

 

 

 

 

 

 

 

Derivatives not designated as hedging instruments:

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

$

1,325,000

 

$

82,642

 

 

$

1,550,000

 

$

50,743

 

Derivatives with PLC (1)

 

1,574,348

 

5,843

 

 

1,497,010

 

6,077

 

Embedded derivative - Modco reinsurance treaties

 

64,984

 

859

 

 

25,760

 

1,051

 

Embedded derivative — GMWB

 

1,688,779

 

49,048

 

 

1,302,895

 

37,497

 

Interest rate futures

 

946,551

 

2,547

 

 

27,977

 

938

 

Equity futures

 

297,690

 

9,806

 

 

26,483

 

427

 

Currency futures

 

239,526

 

2,608

 

 

197,648

 

2,384

 

Equity options

 

2,833,844

 

192,335

 

 

1,921,167

 

163,212

 

Interest rate swaptions

 

225,000

 

4,619

 

 

625,000

 

8,012

 

Other

 

1,336

 

500

 

 

242

 

360

 

 

 

$

9,197,058

 

$

350,807

 

 

$

7,174,182

 

$

270,701

 

Other liabilities

 

 

 

 

 

 

 

 

 

 

Cash flow hedges:

 

 

 

 

 

 

 

 

 

 

Inflation

 

$

 

$

 

 

$

40,469

 

$

142

 

Derivatives not designated as hedging instruments:

 

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

575,000

 

13,809

 

 

275,000

 

3,599

 

Embedded derivative - Modco reinsurance treaties

 

2,490,850

 

221,849

 

 

2,562,848

 

311,727

 

Funds withheld derivative

 

1,520,607

 

135,605

 

 

1,233,424

 

57,305

 

Embedded derivative - GMWB

 

1,715,488

 

63,540

 

 

1,702,899

 

63,460

 

Embedded derivative - FIA

 

962,123

 

76,709

 

 

749,933

 

124,465

 

Embedded derivative - IUL

 

44,581

 

21,711

 

 

12,019

 

6,691

 

Interest rate futures

 

7,727

 

140

 

 

 

 

Equity futures

 

81,421

 

1,835

 

 

385,256

 

15,069

 

Currency futures

 

37,137

 

93

 

 

 

 

Equity options

 

1,242,384

 

8,863

 

 

699,295

 

47,077

 

Other

 

1,091

 

236

 

 

 

 

 

 

$

8,678,409

 

$

544,390

 

 

$

7,661,143

 

$

629,535

 

 


(1)  These derivatives include the Interest, YRT premium support, and portfolio maintenance agreements between certain of the Company’s subsidiaries and PLC.

 

The Company reclassified the remaining balance of its cash flow hedge derivative financial instruments out of accumulated other comprehensive income (loss) into earnings during the period of February 1, 2015 to September 30, 2015 (Successor Company) as these derivative financial instruments matured in June of 2015.

 

17.           OFFSETTING OF ASSETS AND LIABILITIES

 

Certain of the Company’s derivative instruments are subject to enforceable master netting arrangements that provide for the net settlement of all derivative contracts between the Company and a counterparty in the event of default or upon the occurrence of certain termination events. Collateral support agreements associated with each master netting arrangement provide that the Company will receive or pledge financial collateral in the event either minimum thresholds, or in certain cases ratings levels, have been reached. Additionally, certain of the Company’s repurchase

 

73



Table of Contents

 

agreements provide for net settlement on termination of the agreement. Refer to Note 10, Debt and Other Obligations for details of the Company’s repurchase agreement programs.

 

The tables below present the derivative instruments by assets and liabilities for the Company as of September 30, 2015 (Successor Company).

 

 

 

 

 

 

 

Net Amounts

 

 

 

 

 

 

 

 

 

 

 

Gross

 

of Assets

 

Gross Amounts Not Offset

 

 

 

 

 

 

 

Amounts

 

Presented in

 

in the Statement of

 

 

 

 

 

Gross

 

Offset in the

 

the

 

Financial Position

 

 

 

 

 

Amounts of

 

Statement of

 

Statement of

 

 

 

Cash

 

 

 

 

 

Recognized

 

Financial

 

Financial

 

Financial

 

Collateral

 

 

 

 

 

Assets

 

Position

 

Position

 

Instruments

 

Received

 

Net Amount

 

 

 

(Dollars In Thousands)

 

Offsetting of Derivative Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives:

 

 

 

 

 

 

 

 

 

 

 

 

 

Free-Standing derivatives

 

$

294,769

 

$

 

$

294,769

 

$

24,953

 

$

148,469

 

$

121,347

 

Total derivatives, subject to a master netting arrangement or similar arrangement

 

294,769

 

 

294,769

 

24,953

 

148,469

 

121,347

 

Derivatives not subject to a master netting arrangement or similar arrangement

 

 

 

 

 

 

 

 

 

 

 

 

 

Embedded derivative - Modco reinsurance treaties

 

859

 

 

859

 

 

 

859

 

Embedded derivative - GMWB

 

49,048

 

 

49,048

 

 

 

49,048

 

Derivatives with PLC

 

5,843

 

 

5,843

 

 

 

5,843

 

Other

 

288

 

 

288

 

 

 

288

 

Total derivatives, not subject to a master netting arrangement or similar arrangement

 

56,038

 

 

56,038

 

 

 

56,038

 

Total derivatives

 

350,807

 

 

350,807

 

24,953

 

148,469

 

177,385

 

Total Assets

 

$

350,807

 

$

 

$

350,807

 

$

24,953

 

$

148,469

 

$

177,385

 

 

74



Table of Contents

 

 

 

 

 

 

 

Net Amounts

 

 

 

 

 

 

 

 

 

 

 

Gross

 

of Liabilities

 

Gross Amounts Not Offset

 

 

 

 

 

 

 

Amounts

 

Presented in

 

in the Statement of

 

 

 

 

 

Gross

 

Offset in the

 

the

 

Financial Position

 

 

 

 

 

Amounts of

 

Statement of

 

Statement of

 

 

 

Cash

 

 

 

 

 

Recognized

 

Financial

 

Financial

 

Financial

 

Collateral

 

 

 

 

 

Liabilities

 

Position

 

Position

 

Instruments

 

Paid

 

Net Amount

 

 

 

(Dollars In Thousands)

 

Offsetting of Derivative Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives:

 

 

 

 

 

 

 

 

 

 

 

 

 

Free-Standing derivatives

 

$

24,976

 

$

 

$

24,976

 

$

24,953

 

$

23

 

$

 

Total derivatives, subject to a master netting arrangement or similar arrangement

 

24,976

 

 

24,976

 

24,953

 

23

 

 

Derivatives, not subject to a master netting arrangement or similar arrangement

 

 

 

 

 

 

 

 

 

 

 

 

 

Embedded derivative - Modco reinsurance treaties

 

221,849

 

 

221,849

 

 

 

221,849

 

Funds withheld derivative

 

135,605

 

 

135,605

 

 

 

 

 

135,605

 

Embedded derivative - GMWB

 

63,540

 

 

63,540

 

 

 

63,540

 

Embedded derivative - FIA

 

76,709

 

 

76,709

 

 

 

76,709

 

Embedded derivative - IUL

 

21,711

 

 

21,711

 

 

 

21,711

 

Total derivatives, not subject to a master netting arrangement or similar arrangement

 

519,414

 

 

519,414

 

 

 

519,414

 

Total derivatives

 

544,390

 

 

544,390

 

24,953

 

23

 

519,414

 

Repurchase agreements (1)

 

455,718

 

 

455,718

 

 

 

455,718

 

Total Liabilities

 

$

1,000,108

 

$

 

$

1,000,108

 

$

24,953

 

$

23

 

$

975,132

 

 


(1)  Borrowings under repurchase agreements are for a term less than 90 days.

 

75



Table of Contents

 

The tables below present the derivative instruments by assets and liabilities for the Company as of December 31, 2014 (Predecessor Company).

 

 

 

 

 

 

 

Net Amounts

 

 

 

 

 

 

 

 

 

 

 

Gross

 

of Assets

 

Gross Amounts Not Offset

 

 

 

 

 

 

 

Amounts

 

Presented in

 

in the Statement of

 

 

 

 

 

Gross

 

Offset in the

 

the

 

Financial Position

 

 

 

 

 

Amounts of

 

Statement of

 

Statement of

 

 

 

Cash

 

 

 

 

 

Recognized

 

Financial

 

Financial

 

Financial

 

Collateral

 

 

 

 

 

Assets

 

Position

 

Position

 

Instruments

 

Received

 

Net Amount

 

 

 

(Dollars In Thousands)

 

Offsetting of Derivative Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives:

 

 

 

 

 

 

 

 

 

 

 

 

 

Free-Standing derivatives

 

$

225,716

 

$

 

$

225,716

 

$

53,612

 

$

73,935

 

$

98,169

 

Total derivatives, subject to a master netting arrangement or similar arrangement

 

225,716

 

 

225,716

 

53,612

 

73,935

 

98,169

 

Derivatives not subject to a master netting arrangement or similar arrangement

 

 

 

 

 

 

 

 

 

 

 

 

 

Embedded derivative - Modco reinsurance treaties

 

1,051

 

 

1,051

 

 

 

1,051

 

Embedded derivative - GMWB

 

37,497

 

 

37,497

 

 

 

37,497

 

Derivatives with PLC

 

6,077

 

 

6,077

 

 

 

6,077

 

Other

 

360

 

 

360

 

 

 

360

 

Total derivatives, not subject to a master netting arrangement or similar arrangement

 

44,985

 

 

44,985

 

 

 

44,985

 

Total derivatives

 

270,701

 

 

270,701

 

53,612

 

73,935

 

143,154

 

Total Assets

 

$

270,701

 

$

 

$

270,701

 

$

53,612

 

$

73,935

 

$

143,154

 

 

 

 

 

 

 

 

Net Amounts

 

 

 

 

 

 

 

 

 

 

 

Gross

 

of Liabilities

 

Gross Amounts Not Offset

 

 

 

 

 

 

 

Amounts

 

Presented in

 

in the Statement of

 

 

 

 

 

Gross

 

Offset in the

 

the

 

Financial Position

 

 

 

 

 

Amounts of

 

Statement of

 

Statement of

 

 

 

Cash

 

 

 

 

 

Recognized

 

Financial

 

Financial

 

Financial

 

Collateral

 

 

 

 

 

Liabilities

 

Position

 

Position

 

Instruments

 

Paid

 

Net Amount

 

 

 

(Dollars In Thousands)

 

Offsetting of Derivative Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives:

 

 

 

 

 

 

 

 

 

 

 

 

 

Free-Standing derivatives

 

$

65,887

 

$

 

$

65,887

 

$

53,612

 

$

12,258

 

$

17

 

Total derivatives, subject to a master netting arrangement or similar arrangement

 

65,887

 

 

65,887

 

53,612

 

12,258

 

17

 

Derivatives not subject to a master netting arrangement or similar arrangement

 

 

 

 

 

 

 

 

 

 

 

 

 

Embedded derivative - Modco reinsurance treaties

 

311,727

 

 

311,727

 

 

 

311,727

 

Funds withheld derivative

 

57,305

 

 

57,305

 

 

 

57,305

 

Embedded derivative - GMWB

 

63,460

 

 

63,460

 

 

 

63,460

 

Embedded derivative - FIA

 

124,465

 

 

124,465

 

 

 

124,465

 

Embedded derivative - IUL

 

6,691

 

 

6,691

 

 

 

6,691

 

Total derivatives, not subject to a master netting arrangement or similar arrangement

 

563,648

 

 

563,648

 

 

 

563,648

 

Total derivatives

 

629,535

 

 

629,535

 

53,612

 

12,258

 

563,665

 

Repurchase agreements (1)

 

50,000

 

 

50,000

 

 

 

50,000

 

Total Liabilities

 

$

679,535

 

$

 

$

679,535

 

$

53,612

 

$

12,258

 

$

613,665

 

 


(1)  Borrowings under repurchase agreements are for a term less than 90 days.

 

76



Table of Contents

 

18.                                OPERATING SEGMENTS

 

The Company has several operating segments each having a strategic focus. An operating segment is distinguished by products, channels of distribution, and/or other strategic distinctions. The Company periodically evaluates its operating segments, as prescribed in the ASC Segment Reporting Topic, and makes adjustments to its segment reporting as needed. There were no changes to the Company’s operating segments made or required to be made as a result of the Merger on February 1, 2015. A brief description of each segment follows.

 

·                                           The Life Marketing segment markets fixed universal life (“UL”), indexed universal life, variable universal life (“VUL”), bank-owned life insurance (“BOLI”), and level premium term insurance (“traditional”) products on a national basis primarily through networks of independent insurance agents and brokers, broker-dealers, financial institutions, and independent marketing organizations.

 

·                                           The Acquisitions segment focuses on acquiring, converting, and servicing policies acquired from other companies. The segment’s primary focus is on life insurance policies and annuity products that were sold to individuals. The level of the segment’s acquisition activity is predicated upon many factors, including available capital, operating capacity, potential return on capital, and market dynamics. Policies acquired through the Acquisitions segment are typically blocks of business where no new policies are being marketed. Therefore earnings and account values are expected to decline as the result of lapses, deaths, and other terminations of coverage unless new acquisitions are made.

 

·                                           The Annuities segment markets fixed and VA products. These products are primarily sold through broker-dealers, financial institutions, and independent agents and brokers.

 

·                                           The Stable Value Products segment sells fixed and floating rate funding agreements directly to the trustees of municipal bond proceeds, money market funds, bank trust departments, and other institutional investors. The segment also issues funding agreements to the FHLB, and markets guaranteed investment contracts (“GICs”) to 401(k) and other qualified retirement savings plans. The Company recently terminated its funding agreement-backed notes program registered with the United States Securities and Exchange Commission (the “SEC”) and, on October 2, 2015, established an unregistered funding agreement-backed notes program. No offers, sales or issuances under this program have been made to date.

 

·                                           The Asset Protection segment markets extended service contracts and credit life and disability insurance to protect consumers’ investments in automobiles and recreational vehicles. In addition, the segment markets a guaranteed asset protection (“GAP”) product. GAP coverage covers the difference between the loan pay-off amount and an asset’s actual cash value in the case of a total loss.

 

·                                           The Corporate and Other segment primarily consists of net investment income not assigned to the segments above (including the impact of carrying liquidity) and expenses not attributable to the segments above. This segment includes earnings from several non-strategic or runoff lines of business, various investment-related transactions, the operations of several small subsidiaries, and the repurchase of non-recourse funding obligations.

 

The Company uses the same accounting policies and procedures to measure segment operating income (loss) and assets as it uses to measure consolidated net income and assets. Segment operating income (loss) is income before income tax, excluding realized gains and losses on investments and derivatives net of the amortization related to DAC, VOBA, and benefits and settlement expenses. Operating earnings exclude changes in the GMWB embedded derivatives (excluding the portion attributed to economic cost), actual GMWB incurred claims and the related amortization of DAC/VOBA attributed to each of these items.

 

Segment operating income (loss) represents the basis on which the performance of the Company’s business is internally assessed by management. Premiums and policy fees, other income, benefits and settlement expenses, and amortization of DAC/VOBA are attributed directly to each operating segment. Net investment income is allocated based on directly related assets required for transacting the business of that segment. Realized investment gains (losses) and other operating expenses are allocated to the segments in a manner that most appropriately reflects the operations of

 

77



Table of Contents

 

that segment. Investments and other assets are allocated based on statutory policy liabilities net of associated statutory policy assets, while DAC/VOBA and goodwill are shown in the segments to which they are attributable. The goodwill as of September 30, 2015 (Successor Company) was the result of the Dai-ichi Merger. The purchase price was allocated to the segments in proportion to the segment’s respective fair value. The allocated purchase price in excess of the fair value of assets and liabilities of each segment resulted in the establishment of that segment’s goodwill as of the date of the Merger.

 

There were no significant intersegment transactions during the three months ended September 30, 2015 (Successor Company), the period of February 1, 2015 to September 30, 2015 (Successor Company), the period of January 1, 2015 to January 31, 2015 (Predecessor Company) and for the three and nine months ended September 30, 2014 (Predecessor Company).

 

78



Table of Contents

 

The following tables summarize financial information for the Company’s segments (Predecessor and Successor periods are not comparable):

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Revenues

 

 

 

 

 

 

 

 

 

 

 

 

Life Marketing

 

$

358,194

 

$

960,807

 

 

$

133,361

 

$

368,479

 

$

1,098,015

 

Acquisitions

 

352,141

 

974,915

 

 

139,761

 

408,522

 

1,273,714

 

Annuities

 

200,798

 

293,610

 

 

130,918

 

200,366

 

582,645

 

Stable Value Products

 

17,065

 

44,063

 

 

8,181

 

38,719

 

93,696

 

Asset Protection

 

77,476

 

204,397

 

 

24,566

 

77,277

 

227,244

 

Corporate and Other

 

997

 

32,793

 

 

22,859

 

23,397

 

69,981

 

Total revenues

 

$

1,006,671

 

$

2,510,585

 

 

$

459,646

 

$

1,116,760

 

$

3,345,295

 

Segment Operating Income (Loss)

 

 

 

 

 

 

 

 

 

 

 

 

Life Marketing

 

$

18,758

 

$

28,711

 

 

$

(2,271

)

$

31,571

 

$

79,471

 

Acquisitions

 

59,016

 

132,962

 

 

20,134

 

72,929

 

198,807

 

Annuities

 

37,090

 

108,976

 

 

11,363

 

42,659

 

136,590

 

Stable Value Products

 

12,785

 

28,249

 

 

4,529

 

19,506

 

54,190

 

Asset Protection

 

4,415

 

12,938

 

 

1,907

 

6,962

 

18,535

 

Corporate and Other

 

(34,557

)

(84,888

)

 

(16,662

)

(25,986

)

(76,363

)

Total segment operating income

 

97,507

 

226,948

 

 

19,000

 

147,641

 

411,230

 

Realized investment (losses) gains - investments (1)

 

8,586

 

(150,063

)

 

89,414

 

(11,903

)

112,769

 

Realized investment (losses) gains - derivatives

 

50,028

 

68,205

 

 

24,433

 

48,382

 

(15,653

)

Income tax expense

 

(42,542

)

(40,667

)

 

(44,325

)

(62,287

)

(167,921

)

Net income

 

$

113,579

 

$

104,423

 

 

$

88,522

 

$

121,833

 

$

340,425

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2) Investment gains (losses)

 

$

(4,755

)

$

(147,892

)

 

$

80,672

 

$

(2,470

)

$

147,091

 

Less: amortization related to DAC/VOBA and benefits and settlement expenses

 

(13,341

)

2,171

 

 

(8,742

)

9,433

 

34,322

 

Realized investment gains (losses) - investments

 

$

8,586

 

$

(150,063

)

 

$

89,414

 

$

(11,903

)

$

112,769

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3) Derivative gains (losses)

 

$

41,895

 

$

47,513

 

 

$

22,031

 

$

41,769

 

$

(34,425

)

Less: VA GMWB economic cost

 

(8,133

)

(20,692

)

 

(2,402

)

(6,613

)

(18,772

)

Realized investment gains (losses) - derivatives

 

$

50,028

 

$

68,205

 

 

$

24,433

 

$

48,382

 

$

(15,653

)

 


(1)  Includes credit related other-than-temporary impairments of $10.1 million and $15.8 million for the three months ended September 30, 2015 (Successor Company) and for the period of February 1, 2015 to September 30, 2015 (Successor Company), respectively. Includes credit related other-than-temporary impairments of $0.5 million, $2.3 million, and $5.4 million for the period of January 1, 2015 to January 31, 2015 (Predecessor Company) and for the three and nine months ended September 30, 2014 (Predecessor Company), respectively.

(2) Includes realized investment gains (losses) before related amortization.

(3) Includes realized gains (losses) on derivatives before the VA GMWB economic cost.

 

79



Table of Contents

 

 

 

Operating Segment Assets

 

 

 

As of September 30, 2015 (Successor Company)

 

 

 

(Dollars In Thousands)

 

 

 

Life

 

 

 

 

 

Stable Value

 

 

 

Marketing

 

Acquisitions

 

Annuities

 

Products

 

Investments and other assets

 

$

13,223,607

 

$

20,014,577

 

$

19,565,914

 

$

1,790,724

 

Deferred policy acquisition costs and value of business acquired

 

1,078,408

 

(182,038

)

531,735

 

 

Other intangibles

 

324,362

 

40,297

 

200,112

 

9,556

 

Goodwill

 

203,543

 

14,524

 

336,677

 

113,813

 

Total assets

 

$

14,829,920

 

$

19,887,360

 

$

20,634,438

 

$

1,914,093

 

 

 

 

Asset

 

Corporate

 

 

 

Total

 

 

 

Protection

 

and Other

 

Adjustments

 

Consolidated

 

Investments and other assets

 

$

788,749

 

$

9,972,530

 

$

10,719

 

$

65,366,820

 

Deferred policy acquisition costs and value of business acquired

 

41,618

 

 

 

1,469,723

 

Other intangibles

 

81,132

 

 

 

 

 

655,459

 

Goodwill

 

67,155

 

 

 

735,712

 

Total assets

 

$

978,654

 

$

9,972,530

 

$

10,719

 

$

68,227,714

 

 

 

 

 

Operating Segment Assets

 

 

 

As of December 31, 2014 (Predecessor Company)

 

 

 

(Dollars In Thousands)

 

 

 

Life

 

 

 

 

 

Stable Value

 

 

 

Marketing

 

Acquisitions

 

Annuities

 

Products

 

Investments and other assets

 

$

13,858,491

 

$

19,858,284

 

$

20,678,948

 

$

1,958,867

 

Deferred policy acquisition costs and value of business acquired

 

1,973,156

 

600,482

 

539,965

 

621

 

Goodwill

 

 

29,419

 

 

 

Total assets

 

$

15,831,647

 

$

20,488,185

 

$

21,218,913

 

$

1,959,488

 

 

 

 

Asset

 

Corporate

 

 

 

Total

 

 

 

Protection

 

and Other

 

Adjustments

 

Consolidated

 

Investments and other assets

 

$

832,887

 

$

9,557,226

 

$

14,792

 

$

66,759,495

 

Deferred policy acquisition costs and value of business acquired

 

40,503

 

319

 

 

3,155,046

 

Goodwill

 

48,158

 

 

 

77,577

 

Total assets

 

$

921,548

 

$

9,557,545

 

$

14,792

 

$

69,992,118

 

 

19.                                SUBSEQUENT EVENTS

 

The Company has evaluated the effects of events subsequent to September 30, 2015 (Successor Company), and through the date we filed our consolidated condensed financial statements with the United States Securities and Exchange Commission. All accounting and disclosure requirements related to subsequent events are included in our consolidated condensed financial statements.

 

80



Table of Contents

 

Item 2.          Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read in conjunction with our consolidated condensed financial statements included under Part I, Item 1, Financial Statements  ( Unaudited ), of this Quarterly Report on Form 10-Q and our audited consolidated financial statements for the year ended December 31, 2014 (Predecessor Company), included in our Annual Report on Form 10-K.

 

For a more complete understanding of our business and current period results, please read the following MD&A in conjunction with our latest Annual Report on Form 10-K and other filings with the United States Securities and Exchange Commission (the “SEC”).

 

Certain reclassifications have been made in the previously reported financial statements and accompanying notes to make the prior period amounts comparable to those of the current period. Such reclassifications had no effect on previously reported net income or shareowner’s equity.

 

FORWARD-LOOKING STATEMENTS — CAUTIONARY LANGUAGE

 

This report reviews our financial condition and results of operations, including our liquidity and capital resources. Historical information is presented and discussed, and where appropriate, factors that may affect future financial performance are also identified and discussed. Certain statements made in this report include “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include any statement that may predict, forecast, indicate, or imply future results, performance, or achievements instead of historical facts and may contain words like “believe,” “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “plan,” “will,” “shall,” “may,” and other words, phrases, or expressions with similar meaning. Forward-looking statements involve risks and uncertainties, which may cause actual results to differ materially from the results contained in the forward-looking statements, and we cannot give assurances that such statements will prove to be correct. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise. For more information about the risks, uncertainties, and other factors that could affect our future results, please refer to Part I, Item 2, Risks and Uncertainties and Part II, Item 1A, Risk Factors , of this report, as well as Part I, Item 1A, Risk Factors , of our Annual Report on Form 10-K for the fiscal year ended December 31, 2014 (Predecessor Company).

 

IMPORTANT INVESTOR INFORMATION

 

We file reports with the SEC, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other reports as required. The public may read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. We are an electronic filer and the SEC maintains an internet site at www.sec.gov that contains these reports and other information filed electronically by us. We make available through our website, www.protective.com, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports as soon as reasonably practicable after such materials are electronically filed with or furnished to the SEC. We will furnish such documents to anyone who requests such copies in writing. Requests for copies should be directed to: Financial Information, Protective Life Corporation, P. O. Box 2606, Birmingham, Alabama 35202, Telephone (205) 268-3912, Fax (205) 268-3642.

 

We also make available to the public current information, including financial information, regarding the Company and our affiliates on the Financial Information page of our website, www.protective.com. We encourage investors, the media and others interested in us and our affiliates to review the information we post on our website. The information found on our website is not part of this or any other report filed with or furnished to the SEC.

 

81



Table of Contents

 

OVERVIEW

 

Our business

 

We are a wholly owned subsidiary of Protective Life Corporation (“PLC”). Founded in 1907, we are the largest operating subsidiary of PLC. On February 1, 2015, PLC became a wholly owned subsidiary of The Dai-ichi Life Insurance Company, Limited, a kabushiki kaish a organized under the laws of Japan (“Dai-ichi Life”), when DL Investment (Delaware), Inc., a wholly owned subsidiary of Dai-ichi Life, merged with and into PLC (the “Merger”). Prior to February 1, 2015, PLC’s stock was publicly traded on the New York Stock Exchange. Subsequent to the Merger, PLC and the Company remains an SEC registrant for financial reporting purposes in the United States. We provide financial services through the production, distribution, and administration of insurance and investment products. Unless the context otherwise requires, the “Company,” “we,” “us,” or “our” refers to the consolidated group of Protective Life Insurance Company and our subsidiaries.

 

We have several operating segments, each having a strategic focus. An operating segment is distinguished by products, channels of distribution, and/or other strategic distinctions. We periodically evaluate our operating segments as prescribed in the Accounting Standards Codification (“ASC”) Segment Reporting Topic, and make adjustments to our segment reporting as needed. There were no changes to our operating segments made or required to be made as a result of the Merger on February 1, 2015.

 

Our operating segments are Life Marketing, Acquisitions, Annuities, Stable Value Products, Asset Protection, and Corporate and Other.

 

·                   Life Marketing - We market fixed universal life (“UL”), indexed universal life (“IUL”), variable universal life (“VUL”), bank-owned life insurance (“BOLI”), and level premium term insurance (“traditional”) products on a national basis primarily through networks of independent insurance agents and brokers, broker-dealers, financial institutions, and independent marketing organizations.

 

·                   Acquisitions - We focus on acquiring, converting, and servicing policies from other companies. This segment’s primary focus is on life insurance policies and annuity products that were sold to individuals. The level of the segment’s acquisition activity is predicated upon many factors, including available capital, operating capacity, potential return on capital, and market dynamics. Policies acquired through the Acquisitions segment are typically blocks of business where no new policies are being marketed. Therefore earnings and account values are expected to decline as the result of lapses, deaths, and other terminations of coverage unless new acquisitions are made.

 

·                   Annuities - We market fixed and variable annuity (“VA”) products. These products are primarily sold through broker-dealers, financial institutions, and independent agents and brokers.

 

·                   Stable Value Products - We sell fixed and floating rate funding agreements directly to the trustees of municipal bond proceeds, money market funds, bank trust departments, and other institutional investors. The segment also issues funding agreements to the Federal Home Loan Bank (“FHLB”), and markets guaranteed investment contracts (“GICs”) to 401(k) and other qualified retirement savings plans. We recently terminated our funding agreement-backed notes program registered with the SEC and, on October 2, 2015, established an unregistered funding agreement-backed notes program. No offers, sales or issuances under this program have been made to date.

 

·                   Asset Protection - We market extended service contracts and credit life and disability insurance to protect consumers’ investments in automobiles and recreational vehicles. In addition, the segment markets a guaranteed asset protection (“GAP”) product. GAP coverage covers the difference between the loan pay-off amount and an asset’s actual cash value in the case of a total loss.

 

·                   Corporate and Other - This segment primarily consists of net investment income not assigned to the segments above (including the impact of carrying liquidity) and expenses not attributable to the segments above. This segment includes earnings from several non-strategic or runoff lines of business, various

 

82



Table of Contents

 

investment-related transactions, the operations of several small subsidiaries, and the repurchase of non-recourse funding obligations.

 

RECENT DEVELOPMENTS

 

On September 30, 2015, we entered into a Master Agreement (the “Master Agreement”) with Genworth Life and Annuity Insurance Company (“GLAIC”). Pursuant to the Master Agreement, we agreed to enter into a reinsurance agreement (the “Reinsurance Agreement”) pursuant to which we will coinsure certain term life insurance business of GLAIC. In connection with the reinsurance transaction, we intend to enter into a financing transaction with a term of up to 20 years involving, among other parties, our indirect wholly owned subsidiary, Golden Gate Captive Insurance Company (“Golden Gate”), and a syndicate of third-party risk takers, to finance up to $2.2 billion of “XXX” reserves related to the GLAIC business to be reinsured and the other term life insurance business currently reinsured by Golden Gate. Although we intend to execute the financing transaction concurrently with its entry into the Reinsurance Agreement, the closing of the transactions contemplated by the Master Agreement is not conditioned upon the consummation of the financing transaction.

 

RISKS AND UNCERTAINTIES

 

The factors which could affect our future results include, but are not limited to, general economic conditions and the following risks and uncertainties:

 

Risks Related to the Dai-ichi Merger and our Status as an Indirect Subsidiary of Dai-ichi Life

 

·                   uncertainty following the Merger could adversely affect our business and operations;

·                   the debt ratings and the financial strength ratings of PLC and its insurance subsidiaries, including the Company may be adversely affected by it being a subsidiary of Dai-ichi Life;

 

General

 

·                   we may not be able to achieve the expected results from our recently announced reinsurance transaction or obtain financing on terms currently anticipated,

·                   exposure to the risks of natural and man-made catastrophes, diseases, epidemics, pandemics, malicious acts, terrorist acts and climate change could adversely affect our operations and results;

·                   a disruption affecting the electronic systems of the Company or those on whom the Company relies could adversely affect our business, financial condition and results of operations;

·                   confidential information maintained in the systems of the Company or other parities upon which the Company relies could be compromised or misappropriated, damaging our business and reputation and adversely affecting our financial condition and results of operations;

·                   our results and financial condition may be negatively affected should actual experience differ from management’s assumptions and estimates;

·                   we may not realize our anticipated financial results from our acquisitions strategy;

·                   assets allocated to the MONY Closed Block benefit only the holders of certain policies; adverse performance of Closed Block assets or adverse experience of Closed Block liabilities may negatively affect us;

·                   we are dependent on the performance of others;

·                   our risk management policies, practices, and procedures could leave us exposed to unidentified or unanticipated risks, which could negatively affect our business or result in losses;

·                   our strategies for mitigating risks arising from our day-to-day operations may prove ineffective resulting in a material adverse effect on our results of operations and financial condition;

 

Financial environment

 

·                   interest rate fluctuations and sustained periods of low interest rates could negatively affect our interest earnings and spread income, or otherwise impact our business;

·                   our investments are subject to market and credit risks, which could be heightened during periods of extreme volatility or disruption in financial and credit markets;

 

83



Table of Contents

 

·                   equity market volatility could negatively impact our business;

·                   our use of derivative financial instruments within our risk management strategy may not be effective or sufficient;

·                   credit market volatility or disruption could adversely impact our financial condition or results from operations;

·                   our ability to grow depends in large part upon the continued availability of capital;

·                   we could be adversely affected by a ratings downgrade or other negative action by a ratings organization;

·                   we could be forced to sell investments at a loss to cover policyholder withdrawals;

·                   disruption of the capital and credit markets could negatively affect our ability to meet our liquidity and financing needs;

·                   difficult general economic conditions could materially adversely affect our business and results of operations;

·                   we may be required to establish a valuation allowance against our deferred tax assets, which could materially adversely affect our results of operations, financial condition, and capital position;

·                   we could be adversely affected by an inability to access our credit facility;

·                   we could be adversely affected by an inability to access FHLB lending;

·                   our financial condition or results of operations could be adversely impacted if our assumptions regarding the fair value and future performance of our investments differ from actual experience;

·                   adverse actions of certain funds or their advisers could have a detrimental impact on our ability to sell our variable life and annuity products, or maintain current levels of assets in those products;

·                   the amount of statutory capital that we have and the amount of statutory capital that we must hold to maintain our financial strength and credit ratings and meet other requirements can vary significantly from time to time and is sensitive to a number of factors outside of our control;

 

Industry

 

·                   we are highly regulated and are subject to routine audits, examinations and actions by regulators, law enforcement agencies, and self-regulatory organizations;

·                   changes to tax law or interpretations of existing tax law could adversely affect our ability to compete with non-insurance products or reduce the demand for certain insurance products;

·                   financial services companies are frequently the targets of legal proceedings, including class action litigation, which could result in substantial judgments;

·                   the financial services and insurance industries are sometimes the target of law enforcement investigations and the focus of increased regulatory scrutiny;

·                   new accounting rules, changes to existing accounting rules, or the grant of permitted accounting practices to competitors could negatively impact us;

·                   use of reinsurance introduces variability in our statements of income;

·                   our reinsurers could fail to meet assumed obligations, increase rates, terminate agreements, or be subject to adverse developments that could affect us;

·                   our policy claims fluctuate from period to period resulting in earnings volatility;

 

Competition

 

·                   we operate in a mature, highly competitive industry, which could limit our ability to gain or maintain our position in the industry and negatively affect profitability;

·                   our ability to maintain competitive unit costs is dependent upon the level of new sales and persistency of existing business; and

·                   we may not be able to protect our intellectual property and may be subject to infringement claims.

 

For more information about the risks, uncertainties, and other factors that could affect our future results, please see Part II, Item 1A of this report and our Annual Report on Form 10-K.

 

84



Table of Contents

 

CRITICAL ACCOUNTING POLICIES

 

Our accounting policies require the use of judgments relating to a variety of assumptions and estimates, including, but not limited to expectations of current and future mortality, morbidity, persistency, expenses, and interest rates, as well as expectations around the valuations of securities. Because of the inherent uncertainty when using the assumptions and estimates, the effect of certain accounting policies under different conditions or assumptions could be materially different from those reported in the consolidated condensed financial statements. For a complete listing of our critical accounting policies, refer to our Annual Report on Form 10-K for the year ended December 31, 2014 (Predecessor Company). Certain of our accounting policies were amended in conjunction with the Dai-ichi Merger. Please refer to Note 2, Summary of Significant Accounting Policies , included in this Form 10-Q for more information.

 

RESULTS OF OPERATIONS

 

We use the same accounting policies and procedures to measure segment operating income (loss) and assets as we use to measure consolidated net income and assets. Segment operating income (loss) is income before income tax, excluding realized gains and losses on investments and derivatives, net of the amortization related to deferred acquisition costs (“DAC”), value of business acquired (“VOBA”), and benefits and settlement expenses. Segment operating income (loss) also excludes changes in the guaranteed minimum withdrawal benefits (“GMWB”) embedded derivatives (excluding the portion attributed to economic cost), actual GMWB incurred claims and the related amortization of DAC attributed to each of these items.

 

Segment operating income (loss) represents the basis on which the performance of our business is internally assessed by management. Premiums and policy fees, other income, benefits and settlement expenses, and amortization of DAC/VOBA are attributed directly to each operating segment. Net investment income is allocated based on directly related assets required for transacting the business of that segment. Realized investment gains (losses) and other operating expenses are allocated to the segments in a manner that most appropriately reflects the operations of that segment. Investments and other assets are allocated based on statutory policy liabilities net of associated statutory policy assets, while DAC/VOBA and goodwill are shown in the segments to which they are attributable.

 

However, segment operating income (loss) should not be viewed as a substitute for net income calculated in accordance with accounting principles generally accepted in the United States of America (“GAAP”). In addition, our segment operating income (loss) measures may not be comparable to similarly titled measures reported by other companies.

 

We periodically review and update as appropriate our key assumptions on products using the ASC Financial Services-Insurance Topic, including future mortality, expenses, lapses, premium persistency, benefit utilization, investment yields, interest spreads, and equity market returns. Changes to these assumptions result in adjustments which increase or decrease DAC/VOBA amortization and/or benefits and expenses. The periodic review and updating of assumptions is referred to as “unlocking”. When referring to DAC/VOBA amortization or unlocking on products covered under the ASC Financial Services-Insurance Topic, the reference is to changes in all balance sheet components amortized over estimated gross profits.

 

85



Table of Contents

 

The following table presents a summary of results and reconciles segment operating income (loss) to consolidated net income (Predecessor and Successor periods are not comparable):

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Segment Operating Income (Loss)

 

 

 

 

 

 

 

 

 

 

 

 

Life Marketing

 

$

18,758

 

$

28,711

 

 

$

(2,271

)

$

31,571

 

$

79,471

 

Acquisitions

 

59,016

 

132,962

 

 

20,134

 

72,929

 

198,807

 

Annuities

 

37,090

 

108,976

 

 

11,363

 

42,659

 

136,590

 

Stable Value Products

 

12,785

 

28,249

 

 

4,529

 

19,506

 

54,190

 

Asset Protection

 

4,415

 

12,938

 

 

1,907

 

6,962

 

18,535

 

Corporate and Other

 

(34,557

)

(84,888

)

 

(16,662

)

(25,986

)

(76,363

)

Total segment operating income

 

97,507

 

226,948

 

 

19,000

 

147,641

 

411,230

 

Realized investment gains (losses) - investments (1)

 

8,586

 

(150,063

)

 

89,414

 

(11,903

)

112,769

 

Realized investment gains (losses) - derivatives

 

50,028

 

68,205

 

 

24,433

 

48,382

 

(15,653

)

Income tax expense

 

(42,542

)

(40,667

)

 

(45,325

)

(62,287

)

(167,921

)

Net income

 

$

113,579

 

$

104,423

 

 

$

87,522

 

$

121,833

 

$

340,425

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment gains (losses) (2)

 

$

(4,755

)

$

(147,892

)

 

$

80,672

 

$

(2,470

)

$

147,091

 

Less: amortization related to DAC/VOBA and benefits and settlement expense

 

(13,341

)

2,171

 

 

(8,742

)

9,433

 

34,322

 

Realized investment gains (losses) - investments

 

$

8,586

 

$

(150,063

)

 

$

89,414

 

$

(11,903

)

$

112,769

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative gains (losses) (3)

 

$

41,895

 

$

47,513

 

 

$

22,031

 

$

41,769

 

$

(34,425

)

Less: VA GMWB economic cost

 

(8,133

)

(20,692

)

 

(2,402

)

(6,613

)

(18,772

)

Realized investment gains (losses) - derivatives

 

$

50,028

 

$

68,205

 

 

$

24,433

 

$

48,382

 

$

(15,653

)

 


(1)            Includes credit related other-than-temporary impairments of $10.1 million and $15.8 million for the three months ended September 30, 2015 (Successor Company) and for the period of February 1, 2015 to September 30, 2015 (Successor Company), respectively. Includes $0.5 million, $2.3 million, and $5.4 million of credit related other-than-temporary impairments for the period of January 1, 2015 to January 31, 2015 (Predecessor Company) and for the three and nine months ended September 30, 2014 (Predecessor Company), respectively.

(2)            Includes realized investment gains (losses) before related amortization.

(3)            Includes realized gains (losses) on derivatives before the VA GMWB economic cost.

 

For The Three Months Ended September 30, 2015 (Successor Company)

 

Net income was $113.6 million and operating income was $97.5 million for the three months ended September 30, 2015.

 

We experienced net realized gains of $37.1 million for the three months ended September 30, 2015. The gains realized were primarily related to net gains of $64.6 million of derivatives related to variable annuity contracts and net gains of $0.2 million related to IUL contracts. Partially offsetting these gains were $12.9 million of losses related to derivatives with PLC, $10.1 million of other-than-temporary impairments credit-related losses, net losses of $1.9 million related to other investment and derivative activity, $1.4 million of losses related to the net activity of the modified coinsurance portfolio, $1.3 million of losses related to investment securities sale activity, and net losses of $0.1 million of derivatives related to FIA contracts.

 

·                   Life Marketing segment operating income was $18.8 million which consisted of universal life operating income of $8.1 million, traditional life operating income of $11.3 million, and an operating loss of $0.6 million in other lines.

 

86



Table of Contents

 

·                   Acquisitions segment operating income was $59.0 million. This included expected runoff of the in-force blocks of business.

 

·                   Annuities segment operating income was $37.1 million which included $19.5 million of fixed annuity operating earnings, $21.8 million of variable annuity operating earnings, and a $4.2 million loss in other annuity earnings. The fixed annuity results were negatively impacted by $3.0 million of unfavorable single premium immediate annuities (“SPIA”) mortality. The segment recorded $0.9 million of favorable unlocking.

 

·                   Stable Value Products segment operating income of $12.8 million was primarily due to activity in average account values, operating spread, and participating mortgage income. Participating mortgage income was $1.8 million and the adjusted operating spread, which excludes participating income, was 227 basis points.

 

·                   Asset Protection segment operating income was $4.4 million which consisted of service contract earnings of $1.3 million, GAP product earnings of $2.2 million, and credit insurance earnings of $0.9 million.

 

·                   Corporate and Other segment’s $34.6 million operating loss was primarily due to $48.2 million of other operating expense which is primarily interest expense and corporate overhead expenses. These expenses were partially offset by $14.0 million of investment income which represents income on assets supporting our equity capital.

 

For The Period of February 1, 2015 to September 30, 2015 (Successor Company)

 

Net income was $104.4 million and operating income was $226.9 million for the period of February 1, 2015 to September 30, 2015.

 

We experienced net realized losses of $100.4 million for the period of February 1, 2015 to September 30, 2015. The losses realized were primarily related to net losses of $73.6 million of derivatives related to variable annuity contracts, $15.8 million of other-than-temporary impairment credit-related losses, $16.1 million of losses related to derivatives with PLC, $2.0 million of losses related to the net activity of the modified coinsurance portfolio, and net losses of $1.0 million related to other investment and derivative activity. The impact of derivatives related to VA contracts in addition to capital market impacts were affected by the lowering of assumed lapses used to value the GMWB embedded derivatives. Partially offsetting these losses were net gains of $3.6 million of derivatives related to FIA contracts, net gains of $2.1 million related to IUL contracts, and $2.4 million of gains related to investment securities sale activity.

 

·                   Life Marketing segment operating income was $28.7 million which consisted of universal life operating income of $23.4 million, traditional life operating income of $8.8 million, and an operating loss of $3.5 million in other lines.

 

·                   Acquisitions segment operating income was $133.0 million. This included expected runoff of the in force blocks of business.

 

·                   Annuities segment operating income was $109.0 million which included $63.9 million of fixed annuity operating earnings, $56.1 million of variable annuity operating earnings, and a $11.0 million loss in other annuity earnings. The fixed annuity results were positively impacted by $1.8 million of favorable SPIA mortality. The segment recorded $1.3 million of favorable unlocking.

 

·                   Stable Value Products segment operating income of $28.2 million was primarily due to activity in average account values, operating spread, and participating mortgage income. Participating mortgage income was $3.5 million and the adjusted operating spread, which excludes participating income, was 190 basis points.

 

·                   Asset Protection segment operating income was $12.9 million which consisted of service contract earnings of $6.1 million, GAP product earnings of $4.8 million, and credit insurance earnings of $2.0 million.

 

87



Table of Contents

 

·                   The Corporate and Other segment’s $84.9 million operating loss was primarily due to $126.0 million of other operating expense which is primarily interest expense and corporate overhead expenses. These expenses were partially offset by $40.8 million of investment income which represents income on assets supporting our equity capital.

 

For The Period of January 1, 2015 to January 31, 2015 (Predecessor Company)

 

Net income was $87.5 million and operating income was $19.0 million for the period of January 1, 2015 to January 31, 2015.

 

We experienced net realized gains of $102.7 million for the period of January 1, 2015 to January 31, 2015. The gains realized for the period of January 1, 2015 to January 31, 2015, were primarily related to net gains of $75.9 million of derivatives related to variable annuity contracts, $15.9 million of gains related to derivatives with PLC, $6.9 million of gains related to investment securities sale activity, $5.0 million of gains related to the net activity of the modified coinsurance portfolio, and net gains of $1.2 million related to other investment and derivative activity. Partially offsetting these gains were net losses of $1.0 million of derivatives related to FIA contracts, net losses of $0.6 million of derivatives related to IUL contracts, and $0.5 million for other-than-temporary impairment credit-related losses.

 

·                   Life Marketing segment operating loss was $2.3 million. Included in that amount was a traditional life operating loss of $3.4 million, universal life operating income of $1.2 million, and operating loss of $0.1 million in other lines.

 

·                   Acquisitions segment operating income was $20.1 million. This included expected runoff of the in force blocks of business.

 

·                   Annuities segment operating income was $11.4 million for the period of January 1, 2015 to January 31, 2015. Included in that amount was $2.8 million of favorable SPIA mortality results and $2.6 million of unfavorable unlocking.

 

·                   Stable Value Products segment operating income of $4.5 million was primarily due activity in average account values, operating spread, and participating mortgage income.  Participating mortgage income was $0.1 million and the adjusted operating spread, which excludes participating income, was 276 basis points.

 

·                   Asset Protection segment operating income was $1.9 million which consisted of $0.8 million in service contract earnings, $0.9 million in GAP product earnings, and credit insurance earnings of $0.2 million.

 

·                   The Corporate and Other segment’s $16.7 million operating loss was primarily due to $18.3 million of total benefits and expenses offset by $0.3 million of net investment income and $1.3 million of premiums and policy fees.

 

For The Three Months Ended September 30, 2014 (Predecessor Company)

 

Net income was $121.8 million and operating income was $147.6 million for the three months ended September 30, 2014.

 

We experienced net realized gains of $39.3 million for three months ended September 30, 2014. The gains realized were primarily related to $22.2 million of gains related to investment securities sale activity, net gains of $22.0 million of derivatives related to variable annuity contracts, $3.2 million of gains related to the net activity of the modified coinsurance portfolio, $0.4 million of gains related to derivatives with PLC, and net gains of $0.3 million related to IUL contracts. Partially offsetting these gains were net losses of $5.3 million related to other investment and derivative activity, $2.4 million of other-than-temporary impairment credit-related losses, and $1.3 million of derivatives related to FIA contracts.

 

·                   Life Marketing segment operating income was $31.6 million which consisted of a universal life operating loss of $5.7 million, traditional life operating income of $30.2 million, and operating income of $7.1 million in other lines.

 

88



Table of Contents

 

·                   Acquisitions segment operating income was $72.9 million. This included expected runoff of the in force blocks of business.

 

·                   Annuities segment operating income was $42.7 million. Included in that amount were $6.7 million of unfavorable SPIA mortality results and $3.6 million of unfavorable DAC unlocking.

 

·                   Stable Value Products segment operating income of $19.5 million was primarily due activity in average account values, operating spread, and participating mortgage income. Participating mortgage income was $3.9 million and the adjusted operating spread, which excludes participating income, was 264 basis points.

 

·                   Asset Protection segment operating income was $7.0 million which consisted of service contract earnings of $3.4 million, GAP product earnings of $3.0 million, and credit insurance earnings of $0.6 million.

 

·                   The Corporate and Other segment’s $26.0 million operating loss was primarily due to $48.4 million of other operating expense which is primarily interest expense and corporate overhead expenses. These expenses were partially offset by $22.7 million of investment income which represents income on assets supporting our equity capital.

 

For The Nine Months Ended September 30, 2014 (Predecessor Company)

 

Net income was $340.4 million and operating income was $411.2 million for the nine months ended September 30, 2014.

 

We experienced net realized gains of $112.7 million for nine months ended September 30, 2014. The gains realized were primarily related to net gains of $60.2 million of derivatives related to variable annuity contracts, $49.8 million of gains related to investment securities sale activity, and $18.1 million of gains related to the net activity of the modified coinsurance portfolio. Partially offsetting these gains were net losses of $7.7 million related to other investment and derivative activity, $5.4 million of other-than-temporary impairment credit-related losses, and net losses of $2.9 million of derivatives related to FIA contracts.

 

·                   Life Marketing segment operating income was $79.5 million which consisted of a universal life operating loss of $12.9 million, traditional life operating income of $63.4 million, and operating income of $29.0 million in other lines.

 

·                   Acquisitions segment operating income was $198.8 million. This included expected runoff of the in force blocks of business.

 

·                   Annuities segment operating income was $136.6 million. Included in that amount was $21.7 million of unfavorable SPIA mortality results and $1.0 million of unfavorable DAC unlocking.

 

·                   Stable Value Products segment operating income of $54.2 million was primarily due activity in average account values, operating spread, and participating mortgage income. Participating mortgage income was $4.9 million and the adjusted operating spread, which excludes participating income, was 265 basis points.

 

·                   Asset Protection segment operating income was $18.5 million which consisted of service contract earnings of $8.9 million, GAP product earnings of $8.2 million, and credit insurance earnings of $1.4 million.

 

·                   The Corporate and Other segment’s $76.4 million operating loss was primarily due to $132.4 million of other operating expense which is primarily interest expense and corporate overhead expenses. These expenses were partially offset by $56.3 million of investment income which represents income on assets supporting our equity capital.

 

89



Table of Contents

 

Life Marketing

 

Segment Results of Operations

 

Segment results were as follows:

 

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

REVENUES

 

 

 

 

 

 

 

 

 

 

 

 

Gross premiums and policy fees

 

$

415,673

 

$

1,099,068

 

 

$

136,068

 

$

377,014

 

$

1,226,218

 

Reinsurance ceded

 

(175,652

)

(455,331

)

 

(51,142

)

(150,586

)

(550,661

)

Net premiums and policy fees

 

240,021

 

643,737

 

 

84,926

 

226,428

 

675,557

 

Net investment income

 

122,344

 

320,603

 

 

47,622

 

139,710

 

410,233

 

Other income

 

397

 

1,337

 

 

414

 

614

 

1,663

 

Total operating revenues

 

362,762

 

965,677

 

 

132,962

 

366,752

 

1,087,453

 

Realized gains (losses) - investments

 

(4,762

)

(6,944

)

 

997

 

1,388

 

10,508

 

Realized gains (losses) - derivatives

 

194

 

2,074

 

 

(598

)

339

 

54

 

Total revenues

 

358,194

 

960,807

 

 

133,361

 

368,479

 

1,098,015

 

BENEFITS AND EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

Benefits and settlement expenses

 

298,981

 

813,330

 

 

123,525

 

215,949

 

819,615

 

Amortization of deferred policy acquisition costs and value of business acquired

 

27,060

 

80,635

 

 

4,584

 

106,737

 

148,179

 

Other operating expenses

 

17,963

 

43,001

 

 

7,124

 

12,495

 

40,188

 

Operating benefits and settlement expenses

 

344,004

 

936,966

 

 

135,233

 

335,181

 

1,007,982

 

Amortization related to benefits and settlement expenses

 

120

 

1,639

 

 

(346

)

29

 

1,740

 

Amortization of DAC/VOBA related to realized gains (losses)- investments

 

(264

)

(223

)

 

229

 

200

 

3,555

 

Total benefits and expenses

 

343,860

 

938,382

 

 

135,116

 

335,410

 

1,013,277

 

INCOME (LOSS) BEFORE INCOME TAX

 

14,334

 

22,425

 

 

(1,755

)

33,069

 

84,738

 

Less: realized gains (losses)

 

(4,568

)

(4,870

)

 

399

 

1,727

 

10,562

 

Less: amortization related to benefits and settlement expenses

 

(120

)

(1,639

)

 

346

 

(29

)

(1,740

)

Less: related amortization of DAC/VOBA

 

264

 

223

 

 

(229

)

(200

)

(3,555

)

OPERATING INCOME (LOSS)

 

$

18,758

 

$

28,711

 

 

$

(2,271

)

$

31,571

 

$

79,471

 

 

90



Table of Contents

 

The following table summarizes key data for the Life Marketing segment:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Sales By Product

 

 

 

 

 

 

 

 

 

 

 

 

Traditional life

 

$

226

 

$

437

 

 

$

42

 

$

183

 

$

433

 

Universal life

 

40,272

 

103,618

 

 

11,473

 

33,058

 

93,942

 

BOLI

 

 

15

 

 

 

 

22

 

 

 

$

40,498

 

$

104,070

 

 

$

11,515

 

$

33,241

 

$

94,397

 

Sales By Distribution Channel

 

 

 

 

 

 

 

 

 

 

 

 

Independent agents

 

$

30,758

 

$

78,358

 

 

$

9,027

 

$

24,587

 

$

70,945

 

Stockbrokers / banks

 

8,203

 

21,647

 

 

2,169

 

7,923

 

21,409

 

Other

 

1,537

 

4,065

 

 

319

 

731

 

2,043

 

 

 

$

40,498

 

$

104,070

 

 

$

11,515

 

$

33,241

 

$

94,397

 

Average Life Insurance In-force (1)

 

 

 

 

 

 

 

 

 

 

 

 

Traditional

 

$

380,319,124

 

$

384,496,436

 

 

$

391,411,413

 

$

399,961,084

 

$

405,583,949

 

Universal life

 

176,507,856

 

167,136,110

 

 

153,317,720

 

139,804,885

 

132,052,762

 

 

 

$

556,826,980

 

$

551,632,546

 

 

$

544,729,133

 

$

539,765,969

 

$

537,636,711

 

Average Account Values

 

 

 

 

 

 

 

 

 

 

 

 

Universal life

 

$

7,317,345

 

$

7,290,874

 

 

$

7,250,973

 

$

7,175,792

 

$

7,142,767

 

Variable universal life

 

581,420

 

582,183

 

 

574,257

 

561,709

 

545,762

 

 

 

$

7,898,765

 

$

7,873,057

 

 

$

7,825,230

 

$

7,737,501

 

$

7,688,529

 

 


(1)  Amounts are not adjusted for reinsurance ceded.

 

Operating expenses detail

 

Other operating expenses for the segment were as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Insurance companies

 

 

 

 

 

 

 

 

 

 

 

 

First year commissions

 

$

45,672

 

$

117,093

 

 

$

14,108

 

$

38,875

 

$

111,908

 

Renewal commissions

 

8,335

 

21,732

 

 

2,513

 

7,653

 

22,319

 

First year ceding allowances

 

(831

)

(2,267

)

 

(49

)

(663

)

(1,556

)

Renewal ceding allowances

 

(39,316

)

(107,457

)

 

(12,364

)

(37,755

)

(100,571

)

General & administrative

 

52,506

 

137,268

 

 

17,466

 

44,850

 

132,415

 

Taxes, licenses, and fees

 

7,675

 

20,585

 

 

2,509

 

7,236

 

20,401

 

Other operating expenses incurred

 

74,041

 

186,954

 

 

24,183

 

60,196

 

184,916

 

Less: commissions, allowances & expenses capitalized

 

(56,078

)

(143,953

)

 

(17,059

)

(47,701

)

(144,728

)

Other operating expenses

 

$

17,963

 

$

43,001

 

 

$

7,124

 

$

12,495

 

$

40,188

 

 

91



Table of Contents

 

For The Three Months Ended September 30, 2015 (Successor Company)

 

Net premiums and policy fees

 

Net premiums and policy fees were $240.0 million for the three months ended September 30, 2015.  Included in this amount are traditional life net premiums of $115.2 million and universal life policy fees of $124.6 million.

 

Net investment income

 

Net investment income was $122.3 million for the three months ended September 30, 2015. Included in this amount is traditional life net investment income of $16.6 million and universal life investment income of $102.7 million.

 

Other income

 

Other income was $0.4 million for the three months ended September 30, 2015, was primarily due to fees on variable universal life funds.

 

Benefits and settlement expenses

 

Benefit and settlement expenses were $299.0 million for the three months ended September 30, 2015. This amount includes traditional life benefit and settlement expenses of $85.7 million and universal life benefit and settlement expenses of $212.7 million, including $81.0 million of interest on funds for universal life policies. For the three months ended September 30, 2015, universal life and BOLI unlocking increased policy benefits and settlement expenses $1.2 million and was largely driven by assumption changes to lapses and yields.

 

Amortization of DAC and VOBA

 

DAC and VOBA amortization was $27.1 million for the three months ended September 30, 2015. For the three months ended September 30, 2015, universal life and BOLI unlocking decreased amortization $1.5 million.

 

Other operating expenses

 

Other operating expenses were $18.0 million for the three months ended September 30, 2015. Other operating expenses for the insurance companies reflect commissions of $54.0 million, general and administrative expenses of $52.5 million, and taxes, licenses, and fees of $7.7 million, partly offset by ceding allowances of $40.1 million and capitalization of $56.1 million.

 

Sales

 

Sales for the segment were $40.5 million for the three months ended September 30, 2015, comprised primarily of universal life sales.

 

For The Period of February 1, 2015 to September 30, 2015 (Successor Company)

 

Net premiums and policy fees

 

Net premiums and policy fees were $643.7 million for the period of February 1, 2015 to September 30, 2015.  Included in this amount are traditional life net premiums of $328.1 million and universal life policy fees of $315.2 million.

 

Net investment income

 

Net investment income was $320.6 million for the period of February 1, 2015 to September 30, 2015. Included in this amount is traditional life net investment income of $42.6 million and universal life investment income of $270.1 million.

 

92



Table of Contents

 

Other income

 

Other income was $1.3 million for the period of February 1, 2015 to September 30, 2015, primarily due to fees on variable universal life funds.

 

Benefits and settlement expenses

 

Benefit and settlement expenses were $813.3 million for the period of February 1, 2015 to September 30, 2015. This amount includes traditional life benefit and settlement expenses of $268.3 million and universal life benefit and settlement expenses of $544.1 million, including $212.7 million of interest on funds for universal life policies. For the period of February 1, 2015 to September 30, 2015, universal life and BOLI unlocking increased policy benefits and settlement expenses $1.3 million and was largely driven by assumption changes to lapses and yields.

 

Amortization of DAC and VOBA

 

DAC and VOBA amortization was $80.6 million for the period of February 1, 2015 to September 30, 2015. For the period of February 1, 2015 to September 30, 2015, universal life and BOLI unlocking decreased amortization $1.6 million.

 

Other operating expenses

 

Other operating expenses were $43.0 million for the period of February 1, 2015 to September 30, 2015. Other operating expenses for the insurance companies reflect commissions of $138.8 million, general and administrative expenses of $137.3 million, and taxes, licenses, and fees of $20.6 million, partly offset by ceding allowances of $109.7 million and capitalization of $144.0 million.

 

Sales

 

Sales for the segment were $104.1 million for the period of February 1, 2015 to September 30, 2015, comprised primarily of universal life sales .

 

For The Period of January 1, 2015 to January 31, 2015 (Predecessor Company)

 

Net premiums and policy fees

 

Net premiums and policy fees were $84.9 million for the period of January 1, 2015 to January 31, 2015. This amount is comprised of traditional life net premiums of $41.8 million and universal life policy fees of $43.1 million.

 

Net investment income

 

Net investment income was $47.6 million for the period of January 1, 2015 to January 31, 2015. Included in this amount is traditional net investment income of $6.3 million and universal life investment income of $40.1 million.

 

Other income

 

Other income was $0.4 million for the period of January 1, 2015 to January 31, 2015, primarily due to fees on variable universal life funds.

 

Benefits and settlement expenses

 

Benefit and settlement expenses were $123.5 million for the period of January 1, 2015 to January 31, 2015. This amount includes traditional life benefit and settlement expenses of $44.7 million, including an elevated level of claims and universal life benefit and settlement expenses of $77.7 million, partly comprised of $25.7 million of interest on funds for universal life policies.

 

93



Table of Contents

 

Amortization of DAC and VOBA

 

DAC and VOBA amortization was $4.6 million for the period of January 1, 2015 to January 31, 2015.

 

Other operating expenses

 

Other operating expenses were $7.1 million for the period of January 1, 2015 to January 31, 2015.  Other operating expenses for the insurance companies reflect commissions of $16.6 million, general and administrative expenses of $17.5 million, and taxes of $2.5 million, partly offset by ceding allowances of $12.4 million and capitalization of $17.1 million.

 

Sales

 

Sales for the segment were $11.5 million for the period of January 1, 2015 to January 31, 2015, almost entirely comprised of universal life sales.

 

For The Three Months Ended September 30, 2014 (Predecessor Company)

 

Net premiums and policy fees

 

Net premiums and policy fees were $226.4 million for the three months ended September 30, 2014. This amount is comprised of traditional net premiums of $125.7 million and universal life policy fees of $99.4 million.

 

Net investment income

 

Net investment income in the segment was $139.7 million for the three months ended September 30, 2014. Included in this amount is traditional net investment income of $19.3 million and universal life investment income of $116.6 million.

 

Other income

 

Other income was $0.6 million for the three months ended September 30, 2014, primarily due to fees on variable universal life funds.

 

Benefits and settlement expenses

 

Benefits and settlement expenses were $215.9 million for the three months ended September 30, 2014. This amount includes traditional benefit and settlement expenses of $95.0 million and universal life benefit and settlement expenses of $119.2 million, partly comprised of $77.6 million of interest on funds for universal life policies. For the three months ended September 30, 2014, universal life and BOLI unlocking decreased policy benefits and settlement expenses $78.7 million and was largely driven by assumption changes to mortality, reinsurance, and yields.

 

Amortization of DAC

 

DAC amortization was $106.7 million for the three months ended September 30, 2014. For the three months ended September 30, 2014, universal life and BOLI unlocking increased amortization $90.6 million.

 

Other operating expenses

 

Other operating expenses were $12.5 million for the three months ended September 30, 2014. Other operating expenses for the insurance companies reflect commissions of $46.5 million, general and administrative expenses of $44.8 million and taxes, licenses, and fees of $7.2 million, partly offset by ceding allowances of $38.4 million and capitalization of $47.7 million.

 

94



Table of Contents

 

Sales

 

Sales for the segment were $33.2 million for the three months ended September 30, 2014, almost entirely comprised of universal life sales.

 

For The Nine Months Ended September 30, 2014 (Predecessor Company)

 

Net premiums and policy fees

 

Net premiums and policy fees were $675.6 million for the nine months ended September 30, 2014. This amount is comprised of traditional net premiums of $353.9 million and universal life policy fees of $320.0 million.

 

Net investment income

 

Net investment income in the segment was $410.2 million for the nine months ended September 30, 2014. Included in this amount is traditional net investment income of $51.8 million and universal life investment income of $347.7 million.

 

Other income

 

Other income was $1.7 million for the nine months ended September 30, 2014, primarily due to fees on variable universal life funds.

 

Benefits and settlement expenses

 

Benefits and settlement expenses were $819.6 million for the nine months ended September 30, 2014. This amount includes traditional benefit and settlement expenses of $278.8 million and universal life benefit and settlement expenses of $539.9 million, partly comprised of $229.7 million of interest on funds for universal life policies. For the nine months ended September 30, 2014, universal life and BOLI unlocking decreased policy benefits and settlement expenses $57.5 million and was largely driven by assumption changes to mortality, reinsurance, and yields. Included in the impact due to unlocking is an increase of $23.5 million in policy benefits, which is offset within the decline in ceded premiums in the second quarter of 2014.

 

Amortization of DAC

 

DAC amortization was $148.2 million for the nine months ended September 30, 2014. For the nine months ended September 30, 2014, universal life and BOLI unlocking increased amortization $95.8 million.

 

Other operating expenses

 

Other operating expenses were $40.2 million for the nine months ended September 30, 2014. Other operating expenses for the insurance companies reflect commissions of $134.2 million, general and administrative expenses of $132.4 million and taxes, licenses, and fees of $20.4 million, partly offset by ceding allowances of $102.1 million and capitalization of $144.7 million.

 

Sales

 

Sales for the segment were $94.4 million for the nine months ended September 30, 2014, almost entirely comprised of universal life sales.

 

Reinsurance

 

Currently, the Life Marketing segment reinsures significant amounts of its life insurance in-force. Pursuant to the underlying reinsurance contracts, reinsurers pay allowances to the segment as a percentage of both first year and renewal premiums. Reinsurance allowances represent the amount the reinsurer is willing to pay for reimbursement of acquisition costs incurred by the direct writer of the business. A portion of reinsurance allowances received is deferred as part of DAC and a portion is recognized immediately as a reduction of other operating expenses. As the non-deferred

 

95



Table of Contents

 

portion of allowances reduces operating expenses in the period received, these amounts represent a net increase to operating income during that period.

 

Reinsurance allowances do not affect the methodology used to amortize DAC or the period over which such DAC is amortized. However, they do affect the amounts recognized as DAC amortization. DAC on universal life-type, limited-payment long duration, and investment contracts business is amortized based on the estimated gross profits of the policies in-force. Reinsurance allowances are considered in the determination of estimated gross profits, and therefore, impact DAC amortization on these lines of business. Deferred reinsurance allowances on level term business are recorded as ceded DAC, which is amortized over estimated ceded premiums of the policies in-force. Thus, deferred reinsurance allowances may impact DAC amortization. A more detailed discussion of the components of reinsurance can be found in the Reinsurance section of Note 2, Summary of Significant Accounting Policies to our consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014 (Predecessor Company).

 

Impact of reinsurance

 

Reinsurance impacted the Life Marketing segment line items as shown in the following table:

 

Life Marketing Segment

Line Item Impact of Reinsurance

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

REVENUES

 

 

 

 

 

 

 

 

 

 

 

 

Reinsurance ceded

 

$

(175,652

)

$

(455,331

)

 

$

(51,142

)

$

(150,586

)

$

(550,661

)

BENEFITS AND EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

Benefits and settlement expenses

 

(152,744

)

(403,470

)

 

(58,501

)

(131,579

)

(558,976

)

Amortization of DAC/VOBA

 

(1,662

)

(3,845

)

 

(3,766

)

(26,144

)

(45,333

)

Other operating expenses (1)

 

(37,953

)

(104,057

)

 

(11,728

)

(36,119

)

(101,763

)

Total benefits and expenses

 

(192,359

)

(511,372

)

 

(73,995

)

(193,842

)

(706,072

)

 

 

 

 

 

 

 

 

 

 

 

 

 

NET IMPACT OF REINSURANCE (2)

 

$

16,707

 

$

56,041

 

 

$

22,853

 

$

43,256

 

$

155,411

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowances received

 

$

(40,148

)

$

(109,724

)

 

$

(12,413

)

$

(38,418

)

$

(102,127

)

Less: Amount deferred

 

2,195

 

5,667

 

 

685

 

2,299

 

364

 

Allowances recognized
(ceded other operating expenses)
(1)

 

$

(37,953

)

$

(104,057

)

 

$

(11,728

)

$

(36,119

)

$

(101,763

)

 


(1)  Other operating expenses ceded per the income statement are equal to reinsurance allowances recognized after capitalization.

 

The table above does not reflect the impact of reinsurance on our net investment income. By ceding business to the assuming companies, we forgo investment income on the reserves ceded. Conversely, the assuming companies will receive investment income on the reserves assumed, which will increase the assuming companies’ profitability on the business that we cede. The net investment income impact to us and the assuming companies has not been quantified. The impact of including foregone investment income would be to substantially reduce the favorable net impact of reinsurance reflected above. We estimate that the impact of foregone investment income would be to reduce the net impact of reinsurance presented in the table above by 100% to 315%. The Life Marketing segment’s reinsurance programs do not materially impact the “other income” line of our income statement.

 

96



Table of Contents

 

As shown above, reinsurance had a favorable impact on the Life Marketing segment’s operating income for the periods presented above. The impact of reinsurance is largely due to our quota share coinsurance program in place prior to mid-2005. Under that program, generally 90% of the segment’s traditional new business was ceded to reinsurers. Since mid-2005, a much smaller percentage of overall term business has been ceded due to a change in reinsurance strategy on traditional business. In addition, since 2012, a much smaller percentage of the segment’s new universal life business has been ceded. As a result of that change, the relative impact of reinsurance on the Life Marketing segment’s overall results is expected to decrease over time. While the significance of reinsurance is expected to decline over time, the overall impact of reinsurance for a given period may fluctuate due to variations in mortality and unlocking of balances .

 

For The Three Months Ended September 30, 2015 (Successor Company)

 

The ceded premiums were primarily comprised of ceded traditional life premiums of $74.3 million and universal life premiums of $100.5 million.

 

Ceded benefits and settlement expenses were $152.7 million for the three months ended September 30, 2015. This amount is driven by ceded claims. Traditional life ceded benefits activity of $98.0 million was due to ceded death benefits, slightly offset by ceded reserves. Universal life ceded benefits of $54.9 million were largely comprised of $57.9 million in ceded universal life claims during the period.

 

Ceded amortization of DAC and VOBA activity was $1.7 million for the three months ended September 30, 2015.

 

Ceded other operating expenses reflect the impact of reinsurance allowances on net income.

 

For The Period of February 1, 2015 to September 30, 2015 (Successor Company)

 

The ceded premiums were primarily comprised of ceded traditional life premiums of $188.0 million and universal life premiums of $266.0 million.

 

Ceded benefits and settlement expenses were $403.5 million for the period of February 1, 2015 to September 30, 2015. This amount is driven by ceded claims, partly offset by change in ceded reserves. Traditional life ceded benefits activity of $203.4 million was due to ceded death benefits, partly offset by ceded reserves. Universal life ceded benefits of $200.5 million were largely comprised of $181.9 million in ceded universal life claims during the period.

 

Ceded amortization of DAC and VOBA activity was $3.8 million for the period of February 1, 2015 to September 30, 2015 .

 

For The Period of January 1, 2015 to January 31, 2015 (Predecessor Company)

 

The ceded premiums were primarily comprised of ceded traditional life premiums of $22.6 million and universal life premiums of $27.2 million. Traditional life ceded premiums for the period January 1, 2015 to January 31, 2015 were impacted by runoff and a number of policies with post level activity.

 

Ceded benefits and settlement expenses were $58.5 million for the period of January 1, 2015 to January 31, 2015.  This amount is driven by ceded claims, partly offset by change in ceded reserves. Traditional life ceded benefits activity of $29.3 million was due to ceded death benefits, partly offset by ceded reserves. Universal life ceded benefits of $30.0 million were mainly comprised of $30.4 million in ceded universal life claims during the period.

 

Ceded amortization of DAC and VOBA activity was $3.8 million for the period of January 1, 2015 to January 31, 2015.

 

Ceded other operating expenses reflect the impact of reinsurance allowances on net income.

 

97



Table of Contents

 

For The Three Months Ended September 30, 2014 (Predecessor Company)

 

The ceded premiums for the three months ended September 30, 2014 were primarily comprised of ceded traditional life premiums of $54.1 million and universal life premiums of $96.1 million.

 

Ceded benefits and settlement expenses were $131.6 million for the three months ended September 30, 2014.  This amount was primarily driven by the impact of ceded claims, with traditional ceded death benefits of $126.9 million and universal life ceded death benefits of $75.3 million, partly offset by ceded reserves.

 

Ceded amortization of deferred policy acquisitions costs was $26.1 million for the three months ended September 30, 2014.

 

Ceded other operating expenses reflect the impact of reinsurance allowances on net income.

 

For The Nine Months Ended September 30, 2014 (Predecessor Company)

 

The ceded premiums for the nine months ended September 30, 2014 were primarily comprised of ceded traditional life premiums of $292.0 million and universal life premiums of $257.3 million. Traditional ceded premiums for the nine months ended September 30, 2014 were impacted by runoff and a number of policies with post level activity. Universal life ceded premiums were reduced by $23.5 million due to a reinsurance settlement in the second quarter of 2014.

 

Ceded benefits and settlement expenses were $559.0 million for the nine months ended September 30, 2014. This amount was primarily driven by the impact of ceded claims, with traditional ceded death benefits of $396.3 million and universal life ceded death benefits of $241.2 million, partly offset by ceded reserves.

 

Ceded amortization of deferred policy acquisitions costs was $45.3 million for the nine months ended September 30, 2014.

 

Ceded other operating expenses reflect the impact of reinsurance allowances on net income.

 

98



Table of Contents

 

Acquisitions

 

Segment Results of Operations

 

Segment results were as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

REVENUES

 

 

 

 

 

 

 

 

 

 

 

 

Gross premiums and policy fees

 

$

269,715

 

$

742,187

 

 

$

88,855

 

$

270,959

 

$

872,356

 

Reinsurance ceded

 

(91,358

)

(236,076

)

 

(26,512

)

(90,744

)

(293,459

)

Net premiums and policy fees

 

178,357

 

506,111

 

 

62,343

 

180,215

 

578,897

 

Net investment income

 

175,928

 

465,435

 

 

71,088

 

219,453

 

656,113

 

Other income

 

2,218

 

7,582

 

 

1,240

 

3,036

 

10,386

 

Total operating revenues

 

356,503

 

979,128

 

 

134,671

 

402,704

 

1,245,396

 

Realized gains (losses) - investments

 

4,575

 

(136,049

)

 

73,601

 

(14,718

)

119,927

 

Realized gains (losses) - derivatives

 

(8,937

)

131,836

 

 

(68,511

)

20,536

 

(91,609

)

Total revenues

 

352,141

 

974,915

 

 

139,761

 

408,522

 

1,273,714

 

BENEFITS AND EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

Benefits and settlement expenses

 

274,470

 

780,653

 

 

100,693

 

295,252

 

919,849

 

Amortization of value of business acquired

 

(967

)

(129

)

 

4,803

 

2,703

 

37,106

 

Other operating expenses

 

23,984

 

65,642

 

 

9,041

 

31,820

 

89,634

 

Operating benefits and expenses

 

297,487

 

846,166

 

 

114,537

 

329,775

 

1,046,589

 

Amortization related to benefits and settlement expenses

 

2,752

 

10,020

 

 

1,233

 

2,564

 

13,595

 

Amortization of VOBA related to realized gains (losses) - investments

 

(2

)

(30

)

 

230

 

612

 

1,393

 

Total benefits and expenses

 

300,237

 

856,156

 

 

116,000

 

332,951

 

1,061,577

 

INCOME BEFORE INCOME TAX

 

51,904

 

118,759

 

 

23,761

 

75,571

 

212,137

 

Less: realized gains (losses)

 

(4,362

)

(4,213

)

 

5,090

 

5,818

 

28,318

 

Less: amortization related to benefits and settlement expenses

 

(2,752

)

(10,020

)

 

(1,233

)

(2,564

)

(13,595

)

Less: related amortization of VOBA

 

2

 

30

 

 

(230

)

(612

)

(1,393

)

OPERATING INCOME

 

$

59,016

 

$

132,962

 

 

$

20,134

 

$

72,929

 

$

198,807

 

 

99



Table of Contents

 

The following table summarizes key data for the Acquisitions segment:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Average Life Insurance In-Force (1)

 

 

 

 

 

 

 

 

 

 

 

 

Traditional

 

$

173,787,595

 

$

176,933,932

 

 

$

182,177,575

 

$

186,577,010

 

$

190,139,888

 

Universal life

 

31,683,397

 

32,356,826

 

 

33,413,557

 

34,619,902

 

35,366,654

 

 

 

$

205,470,992

 

$

209,290,758

 

 

$

215,591,132

 

$

221,196,912

 

$

225,506,542

 

Average Account Values

 

 

 

 

 

 

 

 

 

 

 

 

Universal life

 

$

4,392,446

 

$

4,446,460

 

 

$

4,486,843

 

$

4,540,271

 

$

4,573,397

 

Fixed annuity (2)

 

3,624,609

 

3,657,960

 

 

3,712,578

 

3,765,858

 

3,795,553

 

Variable annuity

 

1,289,074

 

1,360,950

 

 

1,396,587

 

1,462,919

 

1,492,537

 

 

 

$

9,306,129

 

$

9,465,370

 

 

$

9,596,008

 

$

9,769,048

 

$

9,861,487

 

Interest Spread - UL & Fixed Annuities

 

 

 

 

 

 

 

 

 

 

 

 

Net investment income yield (3)

 

4.37

%

4.34

%

 

5.73

%

5.66

%

5.67

%

Interest credited to policyholders

 

4.06

 

4.05

 

 

4.05

 

3.97

 

3.98

 

Interest spread

 

0.31

%

0.29

%

 

1.68

%

1.69

%

1.69

%

 


(1)  Amounts are not adjusted for reinsurance ceded.

(2)  Includes general account balances held within variable annuity products and is net of coinsurance ceded.

(3)  Earned rates exclude portfolios supporting modified coinsurance and crediting rates exclude 100% cessions.

 

For The Three Months Ended September 30, 2015 (Successor Company)

 

Operating revenues

 

Operating revenues for the segment were $356.5 million and included net premiums and policy fees of $178.4 million, net investment income of $175.9 million, and other income of $2.2 million. The segment experienced expected runoff in the current period.

 

Total benefits and expenses

 

Total benefits and expenses were $300.2 million, primarily due to operating benefits and expenses of $297.5 million. Operating benefits and expenses included benefits and settlement expenses of $274.5 million, amortization of VOBA of $(1.0) million, and other operating expenses of $24.0 million. The net impact of amortization related to benefits and settlement expenses and amortization of VOBA related to realized gains (losses) on investments contributed $2.8 million to total benefits and expenses.

 

For The Period of February 1, 2015 to September 30, 2015 (Successor Company)

 

Operating revenues

 

Operating revenues for the segment were $979.1 million and included net premiums and policy fees of $506.1 million, net investment income of $465.4 million, and other income of $7.6 million. The segment experienced expected runoff in the current period.

 

100



Table of Contents

 

Total benefits and expenses

 

Total benefits and expenses were $856.2 million, primarily due to operating benefits and expenses of $846.2 million. Operating benefits and expenses included benefits and settlement expenses of $780.7 million, amortization of VOBA of $(0.1) million, and other operating expenses of $65.6 million. The net impact of amortization related to benefits and settlement expenses and amortization of VOBA related to realized gains (losses) on investments contributed $10.0 million to total benefits and expenses.

 

For The Period of January 1, 2015 to January 31, 2015 (Predecessor Company)

 

Operating revenues

 

Operating revenues for the segment were $134.7 million and included net premiums and policy fees of $62.3 million, net investment income of $71.1 million, and other income of $1.2 million. The segment experienced expected runoff in the current period.

 

Total benefits and expenses

 

Total benefits and expenses were $116.0 million, primarily due to operating benefits and expenses of $114.5 million. Operating benefits and expenses included benefits and settlement expenses of $100.7 million, amortization of VOBA of $4.8 million, and other operating expenses of $9.0 million. The net impact of amortization related to benefits and settlement expenses and amortization of VOBA related to realized gains (losses) on investments contributed $1.5 million to total benefits and expenses.

 

For The Three Months Ended September 30, 2014 (Predecessor Company)

 

Operating revenues

 

Net premiums and policy fees were $180.2 million for the three months ended September 30, 2014. Net investment income was $219.5 million for the three months ended September 30, 2014. The segment experienced expected runoff.

 

Total benefits and expenses

 

Total benefits and expenses were $333.0 million for the three months ended September 30, 2014. The segment experienced expected runoff and favorable unlocking of $9.7 million for the three months ended September 30, 2014.

 

For The Nine Months Ended September 30, 2014 (Predecessor Company)

 

Operating revenues

 

Net premiums and policy fees were $578.9 million for the nine months ended September 30, 2014. Net investment income was $656.1 million for the nine months ended September 30, 2014. The segment experienced expected runoff.

 

Total benefits and expenses

 

Total benefits and expenses were $1.1 billion for the nine months ended September 30, 2014. The segment experienced expected runoff and favorable unlocking of $6.3 million for the nine months ended September 30, 2014.

 

Reinsurance

 

The Acquisitions segment currently reinsures portions of both its life and annuity in-force. The cost of reinsurance to the segment is reflected in the chart shown below. A more detailed discussion of the components of reinsurance can be found in the Reinsurance section of Note 2, Summary of Significant Accounting Policies   of our Annual Report on Form 10-K for the fiscal year ended December 31, 2014 (Predecessor Company) .

 

101



Table of Contents

 

Impact of reinsurance

 

Reinsurance impacted the Acquisitions segment line items as shown in the following table:

 

Acquisitions Segment

Line Item Impact of Reinsurance

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

REVENUES

 

 

 

 

 

 

 

 

 

 

 

 

Reinsurance ceded

 

$

(91,358

)

$

(236,076

)

 

$

(26,512

)

$

(90,744

)

$

(293,459

)

BENEFITS AND EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

Benefits and settlement expenses

 

(82,259

)

(204,324

)

 

(25,832

)

(69,300

)

(240,838

)

Amortization of value of business acquired

 

(84

)

(168

)

 

(233

)

(3,544

)

(9,703

)

Other operating expenses

 

(11,491

)

(31,088

)

 

(3,647

)

(12,027

)

(34,972

)

Total benefits and expenses

 

(93,834

)

(235,580

)

 

(29,712

)

(84,871

)

(285,513

)

 

 

 

 

 

 

 

 

 

 

 

 

 

NET IMPACT OF REINSURANCE (1)

 

$

2,476

 

$

(496

)

 

$

3,200

 

$

(5,873

)

$

(7,946

)

 


 (1)       Assumes no investment income on reinsurance. Foregone investment income would substantially reduce the favorable impact of reinsurance.

 

The segment’s reinsurance programs do not materially impact the other income line of the income statement. In addition, net investment income generally has no direct impact on reinsurance cost. However, by ceding business to the assuming companies, we forgo investment income on the reserves ceded to the assuming companies. Conversely, the assuming companies will receive investment income on the reserves assumed which will increase the assuming companies’ profitability on business assumed from the Company. For business ceded under modified coinsurance arrangements, the amount of investment income attributable to the assuming company is included as part of the overall change in policy reserves and, as such, is reflected in benefit and settlement expenses. The net investment income impact to us and the assuming companies has not been quantified as it is not fully reflected in our consolidated financial statements.

 

The net impact of reinsurance activity for the three months ended September 30, 2015 (Successor Company) was primarily due to ceded premiums in relation to ceded benefits and settlement expenses. Ceded benefits and settlement expenses were primarily driven by ceded claims.

 

The net impact of reinsurance activity for the period of February 1, 2015 to September 30, 2015 (Successor Company) was primarily due to ceded premiums in relation to ceded benefits and settlement expenses. Ceded benefits and settlement expenses were primarily driven by ceded claims.

 

The net impact of reinsurance activity for the period of January 1, 2015 to January 31, 2015 (Predecessor Company) was primarily due to ceded premiums in relation to ceded benefits and settlement expenses. Ceded benefits and settlement expenses were primarily driven by ceded claims.

 

The net impact of reinsurance activity for the three and nine months ended September 30, 2014 (Predecessor Company) was primarily due to ceded premiums in relation to ceded benefits and settlement expenses. Ceded benefits and settlement expenses were primarily driven by ceded claims .

 

102



Table of Contents

 

Annuities

 

Segment Results of Operations

 

Segment results were as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

REVENUES

 

 

 

 

 

 

 

 

 

 

 

 

Gross premiums and policy fees

 

$

37,836

 

$

101,055

 

 

$

12,473

 

$

38,614

 

$

112,445

 

Reinsurance ceded

 

(20,507

)

(55,091

)

 

(6,118

)

(18,640

)

(53,832

)

Net premiums and policy fees

 

17,329

 

45,964

 

 

6,355

 

19,974

 

58,613

 

Net investment income

 

80,395

 

214,180

 

 

37,189

 

117,646

 

351,946

 

Realized gains (losses) - derivatives

 

(8,133

)

(20,692

)

 

(2,402

)

(6,613

)

(18,772

)

Other income

 

40,222

 

107,194

 

 

12,690

 

37,204

 

107,071

 

Total operating revenues

 

129,813

 

346,646

 

 

53,832

 

168,211

 

498,858

 

Realized gains (losses) - investments

 

(1,694

)

(3,726

)

 

(145

)

4,787

 

7,734

 

Realized gains (losses) - derivatives, net of economic cost

 

72,679

 

(49,310

)

 

77,231

 

27,368

 

76,053

 

Total revenues

 

200,798

 

293,610

 

 

130,918

 

200,366

 

582,645

 

BENEFITS AND EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

Benefits and settlement expenses

 

66,459

 

161,838

 

 

26,919

 

77,165

 

231,239

 

Amortization of deferred policy acquisition costs and value of business acquired

 

(7,472

)

(13,196

)

 

6,217

 

18,428

 

45,417

 

Other operating expenses

 

33,736

 

89,028

 

 

9,333

 

29,959

 

85,612

 

Operating benefits and expenses

 

92,723

 

237,670

 

 

42,469

 

125,552

 

362,268

 

Amortization related to benefits and settlement expenses

 

(22

)

(1,371

)

 

3,128

 

290

 

2,297

 

Amortization of DAC/VOBA related to realized gains (losses) - investments

 

(15,925

)

(7,864

)

 

(13,216

)

5,738

 

11,742

 

Total benefits and expenses

 

76,776

 

228,435

 

 

32,381

 

131,580

 

376,307

 

INCOME BEFORE INCOME TAX

 

124,022

 

65,175

 

 

98,537

 

68,786

 

206,338

 

Less: realized gains (losses) - investments

 

(1,694

)

(3,726

)

 

(145

)

4,787

 

7,734

 

Less: realized gains (losses) - derivatives, net of economic cost

 

72,679

 

(49,310

)

 

77,231

 

27,368

 

76,053

 

Less: amortization related to benefits and settlement expenses

 

22

 

1,371

 

 

(3,128

)

(290

)

(2,297

)

Less: related amortization of DAC/VOBA

 

15,925

 

7,864

 

 

13,216

 

(5,738

)

(11,742

)

OPERATING INCOME

 

$

37,090

 

$

108,976

 

 

$

11,363

 

$

42,659

 

$

136,590

 

 

103



Table of Contents

 

The following tables summarize key data for the Annuities segment:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Sales

 

 

 

 

 

 

 

 

 

 

 

 

Fixed annuity

 

$

174,864

 

$

328,470

 

 

$

28,335

 

$

267,604

 

$

717,359

 

Variable annuity

 

311,336

 

857,042

 

 

59,115

 

279,458

 

686,966

 

 

 

$

486,200

 

$

1,185,512

 

 

$

87,450

 

$

547,062

 

$

1,404,325

 

Average Account Values

 

 

 

 

 

 

 

 

 

 

 

 

Fixed annuity (1)

 

$

8,263,278

 

$

8,239,829

 

 

$

8,171,438

 

$

8,243,541

 

$

8,212,895

 

Variable annuity

 

12,450,917

 

12,556,869

 

 

12,365,217

 

12,456,974

 

12,268,923

 

 

 

$

20,714,195

 

$

20,796,698

 

 

$

20,536,655

 

$

20,700,515

 

$

20,481,818

 

Interest Spread - Fixed Annuities (2)

 

 

 

 

 

 

 

 

 

 

 

 

Net investment income yield

 

3.68

%

3.68

%

 

5.22

%

5.47

%

5.48

%

Interest credited to policyholders

 

2.88

 

2.89

 

 

3.17

 

3.33

 

3.34

 

Interest spread

 

0.80

%

0.79

%

 

2.05

%

2.14

%

2.14

%

 


(1)  Includes general account balances held within variable annuity products.

(2) Interest spread on average general account values.

 

104



Table of Contents

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Derivatives related to VA contracts:

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate futures - VA

 

$

12,140

 

$

(2,091

)

 

$

1,413

 

$

1,979

 

$

12,777

 

Equity futures - VA

 

40,951

 

3,215

 

 

9,221

 

861

 

(9,049

)

Currency futures - VA

 

4,000

 

1,428

 

 

7,778

 

10,185

 

6,020

 

Variance swaps - VA

 

 

 

 

 

1,570

 

(1,103

)

Equity options - VA

 

33,519

 

8,195

 

 

3,047

 

2,050

 

(31,240

)

Interest rate swaptions - VA

 

(3,618

)

(12,399

)

 

9,268

 

(2,812

)

(17,213

)

Interest rate swaps - VA

 

101,808

 

(74,150

)

 

122,710

 

22,011

 

124,548

 

Embedded derivative - GMWB (1)

 

(71,296

)

10,543

 

 

(68,503

)

(11,407

)

(51,869

)

Funds withheld derivative

 

(52,872

)

(8,301

)

 

(9,073

)

(2,432

)

27,298

 

Total derivatives related to VA contracts

 

64,632

 

(73,560

)

 

75,861

 

22,005

 

60,169

 

Derivatives related to FIA contracts:

 

 

 

 

 

 

 

 

 

 

 

 

Embedded derivative- FIA

 

11,328

 

9,035

 

 

1,769

 

(2,462

)

(9,036

)

Equity futures- FIA

 

709

 

1,016

 

 

(184

)

117

 

1,067

 

Volatility futures - FIA

 

(24

)

6

 

 

 

(4

)

4

 

Equity options- FIA

 

(12,099

)

(6,499

)

 

(2,617

)

1,099

 

5,077

 

Total derivatives related to FIA contracts

 

(86

)

3,558

 

 

(1,032

)

(1,250

)

(2,888

)

VA GMWB economic cost (2)

 

8,133

 

20,692

 

 

2,402

 

6,613

 

18,772

 

Realized gains (losses) - derivatives, net of economic cost

 

$

72,679

 

$

(49,310

)

 

$

77,231

 

$

27,368

 

$

76,053

 

 


(1) Includes impact of nonperformance risk of $11.5 million and $10.1 million for the three months ended September 30, 2015 (Successor Company) and the period of February 1, 2015 to September 30, 2015 (Successor Company), $3.1 million for the period of January 1, 2015 to January 31, 2015 (Predecessor Company), and $2.6 million and a net zero impact million for the three and nine months ended September 30, 2014 (Predecessor Company), respectively.

(2) Economic cost is the long-term expected average cost of providing the product benefit over the life of the policy based on product pricing assumptions. These include assumptions about the economic/market environment, and elective and non-elective policy owner behavior (e.g. lapses, withdrawal timing, mortality, etc.).

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

As of

 

 

As of

 

 

 

September 30, 2015

 

 

December 31, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

GMDB - Net amount at risk (1)

 

$

185,218

 

 

$

82,346

 

GMDB Reserves

 

26,318

 

 

21,403

 

GMWB and GMAB Reserves

 

14,492

 

 

25,964

 

Account value subject to GMWB rider (2)

 

9,248,699

 

 

9,738,496

 

GMWB Benefit Base (2)

 

10,187,634

 

 

9,837,891

 

GMAB Benefit Base (2)

 

4,522

 

 

4,967

 

S&P 500® Index

 

1,920

 

 

2,059

 

 


(1) Guaranteed benefits in excess of contract holder account balance.

(2) These account balances are not impacted by the effect of reinsurance

 

105



Table of Contents

 

For The Three Months Ended September 30, 2015 (Successor Company)

 

Operating revenues

 

Segment operating revenues were $129.8 million for the three months ended September 30, 2015. Operating revenue consisted of $80.4 million of net investment income, $37.8 million of policy fees, $20.5 million of ceded premiums, $40.2 million in other income, and $8.1 million related to GMWB economic cost from the VA line of business.

 

Benefits and settlement expenses

 

Benefits and settlement expenses were $66.5 million for the three months ended September 30, 2015. Included in that amount was $3.0 million in unfavorable SPIA mortality results along with an increase of $1.8 million in guaranteed benefit reserves from the VA line of business, and $1.9 million of unfavorable unlocking.

 

Amortization of DAC and VOBA

 

DAC and VOBA amortization was $7.5 million favorable for the three months ended September 30, 2015 due to the allocation of negative VOBA to some of the products within the segment. There was $2.9 million of favorable unlocking recorded by the segment during the three months ended September 30, 2015.

 

Other operating expenses

 

Other operating expenses were $33.7 million for three months ended September 30, 2015. Operating expenses consisted of $8.7 million in acquisition expenses, $12.8 million in maintenance and overhead expenses, and $12.2 million in commission expenses.

 

Sales

 

Total sales were $486.2 million for the three months ended September 30, 2015. Fixed annuity sales were $174.9 million and variable annuity sales were $311.3 million.

 

For The Period of February 1, 2015 to September 30, 2015 (Successor Company)

 

Operating revenues

 

Segment operating revenues were $346.6 million for the period of February 1, 2015 to September 30, 2015. Operating revenue consisted of $214.2 million of net investment income, $101.1 million of policy fees, $55.1 million of ceded premiums, $107.2 million in other income, and $20.7 million related to GMWB economic cost from the VA line of business.

 

Benefits and settlement expenses

 

Benefits and settlement expenses were $161.8 million for the period of February 1, 2015 to September 30, 2015. Included in that amount was $1.8 million in favorable SPIA mortality results, an increase in guaranteed benefit reserves of $3.4 million from the VA line of business, and $1.9 million of unfavorable unlocking.

 

Amortization of DAC and VOBA

 

DAC and VOBA amortization was $13.2 million favorable for the period of February 1, 2015 to September 30, 2015 due to the allocation of negative VOBA to some of the products within the segment. There was $3.2 million of favorable unlocking recorded by the segment during the period of February 1, 2015 to September 30, 2015.

 

106



Table of Contents

 

Other operating expenses

 

Other operating expenses were $89.0 million for the period of February 1, 2015 to September 30, 2015. Operating expenses consisted of $22.8 million in acquisition expenses, $32.6 million in maintenance and overhead expenses, and $33.6 million in commission expenses.

 

Sales

 

Total sales were $1.2 billion for the period of February 1, 2015 to September 30, 2015. Fixed annuity sales were $328.5 million and variable annuity sales were $857.0 million .

 

For The Period of January 1, 2015 to January 31, 2015 (Predecessor Company)

 

Operating revenues

 

Segment operating revenues were $53.8 million for the period of January 1, 2015 to January 31, 2015. Operating revenue consisted of $37.2 million of net investment income, $12.5 million of policy fees, $6.1 million of ceded premiums, $12.7 million in other income and $2.4 million related to GMWB economic cost from the VA line of business.

 

Benefits and settlement expenses

 

Benefits and settlement expenses were $26.9 million for the period of January 1, 2015 to January 31, 2015. Included in that amount was $2.8 million of unfavorable SPIA mortality results and a $2.1 million increase in guaranteed benefit reserves from the VA line of business.

 

Amortization of DAC and VOBA

 

DAC and VOBA amortization was $6.2 million unfavorable for the period of January 1, 2015 to January 31, 2015. The segment recorded $2.6 million in unfavorable unlocking.

 

Other operating expenses

 

Other operating expenses were $9.3 million for the period of January 1, 2015 to January 31, 2015. Operating expenses consisted of $2.8 million in acquisition expenses, $2.8 million in maintenance and overhead expenses, and $3.7 million in commission expenses.

 

Sales

 

Total sales were $87.5 million for the period of January 1, 2015 to January 31, 2015. Fixed annuity sales were $28.3 million and variable annuity sales were $59.1 million.

 

For The Three Months Ended September 30, 2014 (Predecessor Company)

 

Operating revenues

 

Segment operating revenues were $168.2 million for the three months ended September 30, 2014. Operating revenue consisted of $117.6 million of investment income, $38.6 million of policy fees, $37.2 million in other income, $18.6 million in ceded premiums, and $6.6 million related to GMWB economic cost from the VA line of business.

 

Benefits and settlement expenses

 

Benefits and settlement expenses were $77.2 million for the three months ended September 30, 2014. Included in that amount is $6.7 million of unfavorable SPIA mortality results.

 

107



Table of Contents

 

Amortization of DAC and VOBA

 

DAC and VOBA amortization was $18.4 million for the three months ended September 30, 2014. The segment recorded unfavorable unlocking of $3.6 million.

 

Other operating expenses

 

Other operating expenses were $30.0 million for the three months ended September 30, 2014. Operating expenses consisted of $9.0 million in acquisition expense, $8.1 million in maintenance and overhead expenses, and $12.8 million in commission expenses.

 

Sales

 

Total sales were $547.1 million for the three months ended September 30, 2014. Fixed annuity sales were $267.6 million and variable annuity sales were $279.5 million.

 

For The Nine Months Ended September 30, 2014 (Predecessor Company)

 

Operating revenues

 

Segment operating revenues were $498.9 million for the nine months ended September 30, 2014. Operating revenue consisted of $351.9 million of investment income, $112.4 million of policy fees, $107.1 million in other income, $53.8 million in ceded premiums, and $18.8 million related to GMWB economic cost from the VA line of business.

 

Benefits and settlement expenses

 

Benefits and settlement expenses were $231.2 million for the nine months ended September 30, 2014. Included in that amount is $21.7 million of unfavorable SPIA mortality results.

 

Amortization of DAC and VOBA

 

DAC and VOBA amortization was $45.4 million for the nine months ended September 30, 2014.  The segment recorded unfavorable unlocking of $1.0 million.

 

Other operating expenses

 

Other operating expenses were $85.6 million for the nine months ended September 30, 2014. Operating expenses consisted of $24.9 million in acquisition expense, $24.4 million in maintenance and overhead expenses, and $36.3 million in commission expenses.

 

Sales

 

Total sales were $1.4 billion for the nine months ended September 30, 2014. Fixed annuity sales were $717.4 million and variable annuity sales were $687.0 million.

 

Reinsurance

 

During the year ended December 31, 2012 (Predecessor Company), the Annuity segment began reinsuring certain risks associated with the GMWB and GMDB riders to Shades Creek Captive Insurance Company (“Shades Creek”), a direct wholly subsidiary of PLC. The cost of reinsurance to the segment is reflected in the chart shown below. The impact of the Shades Creek reinsurance arrangement for the three month period ending March 31, 2013 was eliminated in consolidation.  Prior to April 1, 2013, we paid as a dividend all of Shades Creek’s outstanding common stock to its parent, PLC. A more detailed discussion of the components of reinsurance can be found in the Reinsurance section of Note 2, Summary of Significant Accounting Policies of our Annual Report on Form 10-K for the fiscal year ended December 31, 2014 (Predecessor Company).

 

108



Table of Contents

 

Impact of reinsurance

 

Reinsurance impacted the Annuities segment line items as shown in the following table:

 

Annuities Segment

Line Item Impact of Reinsurance

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

REVENUES

 

 

 

 

 

 

 

 

 

 

 

 

Reinsurance ceded

 

$

(20,507

)

$

(55,091

)

 

$

(6,118

)

$

(18,640

)

$

(53,832

)

Realized gains (losses) - derivatives

 

11,285

 

30,050

 

 

3,754

 

11,315

 

33,605

 

Total operating revenues

 

(9,222

)

(25,041

)

 

(2,364

)

(7,325

)

(20,227

)

Realized gains (losses) - derivatives, net of economic costs

 

118,177

 

(20,095

)

 

125,688

 

26,276

 

122,930

 

Total revenues

 

108,955

 

(45,136

)

 

123,324

 

18,951

 

102,703

 

BENEFITS AND EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

Benefits and settlement expenses

 

(574

)

(1,549

)

 

(567

)

(866

)

(1,626

)

Amortization of deferred policy acquisition

 

 

 

 

 

 

 

 

 

 

costs and value of business acquired

 

 

 

 

304

 

92

 

912

 

Other operating expenses

 

(505

)

(1,011

)

 

(523

)

(532

)

(1,623

)

Operating benefits and expenses

 

(1,079

)

(2,560

)

 

(786

)

(1,306

)

(2,337

)

Amortization of deferred policy acquisition acquisition costs related to realized gain (loss) investments

 

 

 

 

402

 

5,757

 

24,888

 

Total benefit and expenses

 

(1,079

)

(2,560

)

 

(384

)

4,451

 

22,551

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET IMPACT OF REINSURANCE (1)

 

$

110,034

 

$

(42,576

)

 

$

123,708

 

$

14,500

 

$

80,152

 

 

The table above does not reflect the impact of reinsurance on our net investment income. The net investment income impact to us and the assuming company has been quantified and is immaterial. The Annuities segment’s reinsurance programs do not materially impact the “other income” line of our income statement.

 

The net impact of reinsurance for the three months ended September 30, 2015 (Successor Company) and for the period of February 1, 2015 to September 30, 2015 (Successor Company), was favorable by $110.0 million and unfavorable by $42.6 million, respectively, primarily due to realized gains and losses on derivatives that were ceded. For the period of January 1, 2015 to January 31, 2015 (Successor Company) the net impact of reinsurance was favorable by $123.7 million. For the three and nine months ended September 30, 2014 (Predecessor Company), the net impact of reinsurance was favorable $14.5 million and $80.2 million, respectively, primarily due to realized losses on derivatives that were ceded.

 

109



Table of Contents

 

Stable Value Products

 

Segment Results of Operations

 

Segment results were as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

REVENUES

 

 

 

 

 

 

 

 

 

 

 

 

Net investment income

 

$

17,080

 

$

42,824

 

 

$

6,888

 

$

28,781

 

$

83,737

 

Other income

 

 

133

 

 

 

 

1

 

Total operating revenues

 

17,080

 

42,957

 

 

6,888

 

28,781

 

83,738

 

Realized gains (losses)

 

(15

)

1,106

 

 

1,293

 

9,938

 

9,958

 

Total revenues

 

17,065

 

44,063

 

 

8,181

 

38,719

 

93,696

 

BENEFITS AND EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

Benefits and settlement expenses

 

3,188

 

12,794

 

 

2,255

 

8,793

 

28,126

 

Amortization of deferred policy acquisition costs and value of business acquired

 

 

 

 

25

 

96

 

295

 

Other operating expenses

 

1,107

 

1,914

 

 

79

 

386

 

1,127

 

Total benefits and expenses

 

4,295

 

14,708

 

 

2,359

 

9,275

 

29,548

 

INCOME BEFORE INCOME TAX

 

12,770

 

29,355

 

 

5,822

 

29,444

 

64,148

 

Less: realized gains (losses)

 

(15

)

1,106

 

 

1,293

 

9,938

 

9,958

 

OPERATING INCOME

 

$

12,785

 

$

28,249

 

 

$

4,529

 

$

19,506

 

$

54,190

 

 

110



Table of Contents

 

The following table summarizes key data for the Stable Value Products segment:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Sales

 

 

 

 

 

 

 

 

 

 

 

 

GIC

 

$

6,800

 

$

112,700

 

 

$

 

$

15,000

 

$

40,850

 

GFA - Direct Institutional

 

150,000

 

300,000

 

 

 

 

50,000

 

 

 

$

156,800

 

$

412,700

 

 

$

 

$

15,000

 

$

90,850

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average Account Values

 

$

1,952,113

 

$

1,921,035

 

 

$

1,932,722

 

$

2,358,842

 

$

2,478,224

 

Ending Account Values

 

$

1,914,093

 

$

1,914,093

 

 

$

1,911,751

 

$

2,261,546

 

$

2,261,546

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Spread

 

 

 

 

 

 

 

 

 

 

 

 

Net investment income yield

 

3.53

%

3.38

%

 

4.28

%

4.88

%

4.51

%

Other income yield

 

 

0.01

 

 

 

 

 

Interest credited

 

0.66

 

1.04

 

 

1.40

 

1.49

 

1.51

 

Operating expenses

 

0.23

 

0.15

 

 

0.07

 

0.08

 

0.08

 

Operating spread

 

2.64

%

2.20

%

 

2.81

%

3.31

%

2.92

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted operating spread (1)

 

2.27

%

1.90

%

 

2.76

%

2.64

%

2.65

%

 


(1) Excludes participating mortgage loan income and other income.

 

For The Three Months Ended September 30, 2015 (Successor Company)

 

Segment operating income

 

Operating income of $12.8 million was primarily due to activity in average account values, operating spread, and participating mortgage income. Participating mortgage income was $1.8 million and the adjusted operating spread, which excludes participating income, was 227 basis points.

 

For The Period of February 1, 2015 to September 30, 2015 (Successor Company)

 

Segment operating income

 

Operating income of $28.2 million was primarily due to activity in average account values, operating spread, and participating mortgage income. Participating mortgage income was $3.5 million and the adjusted operating spread, which excludes participating income, was 190 basis points.

 

For The Period of January 1, 2015 to January 31, 2015 (Predecessor Company)

 

Segment operating income

 

Operating income of $4.5 million was primarily due to activity in average account values, operating spread, and participating mortgage income. Participating mortgage income was $0.1 million and the adjusted operating spread, which excludes participating income, was 276 basis points.

 

111



Table of Contents

 

For The Three Months Ended September 30, 2014 (Predecessor Company)

 

Segment operating income

 

Operating income of $19.5 million was primarily due to activity in average account values, operating spread, and participating mortgage income. Participating mortgage income was $3.9 million and the adjusted operating spread, which excludes participating income, was 264 basis points.

 

For The Nine Months Ended September 30, 2014 (Predecessor Company)

 

Segment operating income

 

Operating income of $54.2 million was primarily due to activity in average account values, operating spread, and participating mortgage income. Participating mortgage income was $4.9 million and the adjusted operating spread, which excludes participating income, was 265 basis points.

 

112



Table of Contents

 

Asset Protection

 

Segment Results of Operations

 

Segment results were as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

REVENUES

 

 

 

 

 

 

 

 

 

 

 

 

Gross premiums and policy fees

 

$

66,593

 

$

175,517

 

 

$

21,843

 

$

64,602

 

$

192,122

 

Reinsurance ceded

 

(24,619

)

(63,630

)

 

(7,860

)

(23,132

)

(66,905

)

Net premiums and policy fees

 

41,974

 

111,887

 

 

13,983

 

41,470

 

125,217

 

Net investment income

 

3,847

 

10,033

 

 

1,540

 

4,615

 

14,151

 

Other income

 

31,655

 

82,477

 

 

9,043

 

31,192

 

87,876

 

Total operating revenues

 

77,476

 

204,397

 

 

24,566

 

77,277

 

227,244

 

BENEFITS AND EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

Benefits and settlement expenses

 

24,785

 

64,381

 

 

7,447

 

23,853

 

71,414

 

Amortization of deferred policy acquisition costs and value of business acquired

 

6,549

 

18,144

 

 

1,858

 

5,883

 

18,522

 

Other operating expenses

 

41,727

 

108,934

 

 

13,354

 

40,579

 

118,773

 

Total benefits and expenses

 

73,061

 

191,459

 

 

22,659

 

70,315

 

208,709

 

INCOME BEFORE INCOME TAX

 

4,415

 

12,938

 

 

1,907

 

6,962

 

18,535

 

OPERATING INCOME

 

$

4,415

 

$

12,938

 

 

$

1,907

 

$

6,962

 

$

18,535

 

 

The following table summarizes key data for the Asset Protection segment:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Sales

 

 

 

 

 

 

 

 

 

 

 

 

Credit insurance

 

$

6,756

 

$

17,965

 

 

$

2,087

 

$

7,754

 

$

22,812

 

Service contracts

 

98,062

 

258,767

 

 

26,551

 

96,869

 

266,934

 

GAP

 

24,605

 

63,553

 

 

6,318

 

19,193

 

54,951

 

 

 

$

129,423

 

$

340,285

 

 

$

34,956

 

$

123,816

 

$

344,697 

 

Loss Ratios (1)

 

 

 

 

 

 

 

 

 

 

 

 

Credit insurance

 

18.2

%

28.6

%

 

27.9

%

30.5

%

29.2

%

Service contracts

 

56.6

 

54.6

 

 

54.4

 

60.3

 

58.9

 

GAP

 

85.6

 

82.6

 

 

61.5

 

59.6

 

64.0

 

 


(1)  Incurred claims as a percentage of earned premiums.

 

113



Table of Contents

 

For The Three Months Ended September 30, 2015 (Successor Company)

 

Net premiums and policy fees

 

Net premiums and policy fees were $42.0 million which consisted of service contract premiums of $30.6 million, GAP premiums of $8.0 million, and credit insurance premiums of $3.4 million.

 

Other income

 

Other income activity consisted of $26.6 million from the service contract line and $5.1 million from the GAP product line.

 

Benefits and settlement expenses

 

Benefits and settlement expenses activity was $17.3 million in service contract claims, $6.9 million in GAP claims and $0.6 million in credit insurance claims.

 

Amortization of DAC and VOBA and Other operating expenses

 

Amortization of DAC and VOBA consisted of $3.6 million in the credit insurance line, $2.6 million in the GAP line, and $0.4 million in the service contract line, primarily resulting from amortization of VOBA activity. Other operating expenses were $41.7 million including activity in all product lines.

 

Sales

 

Total segment sales consisted of $98.1 million in the service contract line, $24.6 million in the GAP product line, and credit insurance sales of $6.7 million.

 

For The Period of February 1, 2015 to September 30, 2015 (Successor Company)

 

Net premiums and policy fees

 

Net premiums and policy fees were $111.9 million which consisted of service contract premiums of $82.2 million, GAP premiums of $20.4 million, and credit insurance premiums of $9.3 million.

 

Other income

 

Other income activity consisted of $69.3 million from the service contract line and $13.2 million from the GAP product line.

 

Benefits and settlement expenses

 

Benefits and settlement expenses activity was $44.9 million in service contract claims, $16.8 million in GAP claims and $2.7 million in credit insurance claims.

 

Amortization of DAC and VOBA and Other operating expenses

 

Amortization of DAC and VOBA consisted of $9.7 million in the credit insurance line, $7.4 million in the GAP line, and $1.0 million in the service contract line, primarily resulting from amortization of VOBA activity. Other operating expenses were $108.9 million including activity in all product lines.

 

Sales

 

Total segment sales consisted of $258.8 million in the service contract line, $63.5 million in the GAP product line, and credit insurance sales of $18.0 million.

 

114



Table of Contents

 

For The Period of January 1, 2015 to January 31, 2015 (Predecessor Company)

 

Net premiums and policy fees

 

Net premiums and policy fees consisted of service contract premiums of $10.4 million, GAP premiums of $2.4 million, and $1.2 million of credit insurance premiums.

 

Other income

 

Other income consisted of $7.7 million from the service contract line and $1.4 million from the GAP product line.

 

Benefits and settlement expenses

 

Benefits and settlement expenses included service contract claims of $5.6 million, GAP claims of $1.5 million, and credit insurance claims of $0.3 million.

 

Amortization of DAC and VOBA and Other operating expenses

 

Amortization of DAC and VOBA consisted of $1.1 million in the credit insurance line, $0.5 million in the service contract line, and $0.2 million in the GAP line.  Other operating expenses were $13.4 million including activity in all product lines.

 

Sales

 

Total segment sales consisted of $26.6 million in the service contract line, $6.3 million in the GAP product line, and credit insurance sales of $2.1 million.

 

For The Three Months Ended September 30, 2014 (Predecessor Company)

 

Net premiums and policy fees

 

Net premiums and policy fees were $41.5 million which consisted of service contract premiums of $31.0 million, GAP premiums of $6.8 million, and credit insurance premiums of $3.7 million.

 

Other income

 

Other income activity consisted of $27.3 million from the service contract line and $3.9 million from the GAP product line.

 

Benefits and settlement expenses

 

Benefits and settlement expenses activity was $18.7 million in service contract claims, $4.1 million in GAP claims and $1.1 million in credit insurance claims.

 

Amortization of DAC and VOBA and Other operating expenses

 

Amortization of DAC and VOBA consisted of $3.2 million in the credit insurance line, $0.6 million in the GAP line, and $2.1 million in the service contract line primarily resulting from amortization of VOBA activity.  Other operating expenses were $40.6 million including activity in all product lines.

 

Sales

 

Total segment sales consisted of $96.9 million in the service contract line, $19.2  million in the GAP product line, and credit insurance sales of $7.7 million.

 

115



Table of Contents

 

For The Nine Months Ended September 30, 2014 (Predecessor Company)

 

Net premiums and policy fees

 

Net premiums and policy fees were $125.2 million which consisted of service contract premiums of $93.6 million, GAP premiums of $20.2 million, and credit insurance premiums of $11.4 million.

 

Other income

 

Other income activity consisted of $76.3 million from the service contract line, $11.5 million from the GAP product line, and $0.1 million from the credit insurance line.

 

Benefits and settlement expenses

 

Benefits and settlement expenses activity was $55.2 million in service contract claims, $12.9 million in GAP claims, and $3.3 million in credit insurance claims.

 

Amortization of DAC and VOBA and Other operating expenses

 

Amortization of DAC and VOBA consisted of $10.1 million in the credit insurance line, $1.9 million in the GAP line, and $6.5 million in the service contract line primarily resulting from amortization of VOBA activity.  Other operating expenses were $118.8 million including activity in all product lines.

 

Sales

 

Total segment sales consisted of $266.9 million in the service contract line, $55.0 million in the GAP product line, and credit insurance sales of $22.8 million.

 

Reinsurance

 

The majority of the Asset Protection segment’s reinsurance activity relates to the cession of single premium credit life and credit accident and health insurance, vehicle service contracts, and guaranteed asset protection insurance to producer affiliated reinsurance companies (“PARCs”). These arrangements are coinsurance contracts ceding the business on a first dollar quota share basis at 100% to limit our exposure and allow the PARCs to share in the underwriting income of the product. Reinsurance contracts do not relieve us from our obligations to our policyholders. A more detailed discussion of the components of reinsurance can be found in the Reinsurance section of Note 2, Summary of Significant Accounting Policies to our Annual Report on Form 10-K for the fiscal year ended December 31, 2014 (Predecessor Company).

 

116



Table of Contents

 

Reinsurance impacted the Asset Protection segment line items as shown in the following table:

 

Asset Protection Segment

Line Item Impact of Reinsurance

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

REVENUES

 

 

 

 

 

 

 

 

 

 

 

 

Reinsurance ceded

 

$

(24,619

)

$

(63,630

)

 

$

(7,860

)

$

(23,132

)

$

(66,905

)

BENEFITS AND EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

Benefits and settlement expenses

 

(16,646

)

(41,598

)

 

(4,249

)

(14,134

)

(42,719

)

Amortization of deferred policy acquisition costs and value of business acquired

 

4

 

78

 

 

(481

)

(1,843

)

(5,888

)

Other operating expenses

 

(2,077

)

(5,517

)

 

(653

)

(1,942

)

(5,806

)

Total benefits and expenses

 

(18,719

)

(47,037

)

 

(5,383

)

(17,919

)

(54,413

)

 

 

 

 

 

 

 

 

 

 

 

 

 

NET IMPACT OF REINSURANCE (1)

 

$

(5,900

)

$

(16,593

)

 

$

(2,477

)

$

(5,213

)

$

(12,492

)

 


(1)    Assumes no investment income on reinsurance. Foregone investment income would substantially change the impact of reinsurance.

 

For The Three Months Ended September 30, 2015 (Successor Company)

 

Reinsurance premiums ceded of $24.6 million consisted of ceded premiums in the service contract line of $15.4 million, ceded premiums in the GAP product line of $4.8 million, and ceded premiums in the credit insurance line of $4.4 million.

 

Benefits and settlement expenses consisted of $13.1 million in service contract ceded claims, $2.4 million in GAP ceded claims, and $1.1 million in credit insurance ceded claims.

 

Other operating expenses ceded of $2.1 million were mainly due to ceded activity in the credit insurance and GAP product lines.

 

Net investment income has no direct impact on reinsurance cost. However, by ceding business to the assuming companies, we forgo investment income on the reserves ceded. Conversely, the assuming companies will receive investment income on the reserves assumed which generally will increase the assuming companies’ profitability on business we cede. The net investment income impact to us and the assuming companies has not been quantified as it is not reflected in our consolidated condensed financial statements.

 

For The Period of February 1, 2015 to September 30, 2015 (Successor Company)

 

Reinsurance premiums ceded of $63.6 million consisted of ceded premiums in the service contract line of $39.3 million, ceded premiums in the GAP product line of $12.7 million, and ceded premiums in the credit insurance line of $11.6 million.

 

Benefits and settlement expenses consisted of $33.2 million in service contract ceded claims, $5.9 million in GAP ceded claims, and $2.5 million in credit insurance ceded claims.

 

117



Table of Contents

 

Other operating expenses ceded of $5.5 million were mainly due to ceded activity in the credit insurance and GAP product lines.

 

Net investment income has no direct impact on reinsurance cost. However, by ceding business to the assuming companies, we forgo investment income on the reserves ceded. Conversely, the assuming companies will receive investment income on the reserves assumed which generally will increase the assuming companies’ profitability on business we cede. The net investment income impact to us and the assuming companies has not been quantified as it is not reflected in our consolidated condensed financial statements.

 

For The Period of January 1, 2015 to January 31, 2015 (Predecessor Company)

 

Reinsurance premiums ceded of $7.9 million consisted of ceded premiums in the service contract line of $4.7 million, ceded premiums in the GAP product line of $1.7 million, and ceded premiums in the credit insurance line of $1.5 million.

 

Benefits and settlement expenses ceded consisted of $3.6 million in service contract ceded claims, $0.4 million in GAP ceded claims, and $0.2 million in credit insurance ceded claims.

 

Amortization of DAC and VOBA ceded of $0.5 million was primarily the result of ceded activity of $0.1 million in the service contract line, $0.2 million in the GAP line, and $0.2 million in the credit insurance line. Other operating expenses ceded consisted of $0.5 million of ceded activity in the credit insurance line and $0.2 million in the GAP product line.

 

Net investment income has no direct impact on reinsurance cost. However, by ceding business to the assuming companies, we forgo investment income on the reserves ceded. Conversely, the assuming companies will receive investment income on the reserves assumed which generally will increase the assuming companies’ profitability on business we cede. The net investment income impact to us and the assuming companies has not been quantified as it is not reflected in our consolidated condensed financial statements.

 

For The Three Months Ended September 30, 2014 (Predecessor Company)

 

Reinsurance premiums ceded of $23.1 million consisted of ceded premiums in the service contract line of $13.5 million, ceded premiums in the GAP product line of $5.0 million, and ceded premiums in the credit insurance line of $4.6 million.

 

Benefits and settlement expenses consisted of $11.9 million in service contract ceded claims, $1.4 million in GAP ceded claims, and $0.8 million in credit insurance ceded claims.

 

Amortization of DAC and VOBA ceded of $1.8 million was primarily the result of ceded activity of $0.9 million in the GAP line, $0.6 million in the credit insurance line, and $0.3 million in the service contract line. Other operating expenses ceded of $1.9 million were mainly due to ceded activity in the credit insurance and GAP product lines.

 

Net investment income has no direct impact on reinsurance cost. However, by ceding business to the assuming companies, we forgo investment income on the reserves ceded. Conversely, the assuming companies will receive investment income on the reserves assumed which generally will increase the assuming companies’ profitability on business we cede. The net investment income impact to us and the assuming companies has not been quantified as it is not reflected in our consolidated condensed financial statements.

 

For The Nine Months Ended September 30, 2014 (Predecessor Company)

 

Reinsurance premiums ceded of $66.9 million consisted of ceded premiums in the service contract line of $37.9 million, ceded premiums in the GAP product line of $14.9 million, and ceded premiums in the credit insurance line of $14.1 million.

 

118



Table of Contents

 

Benefits and settlement expenses consisted of $35.7 million in service contract ceded claims, $4.5 million in GAP ceded claims, and $2.5 million in credit insurance ceded claims.

 

Amortization of DAC and VOBA ceded of $5.9 million was primarily the result of ceded activity of $3.2 million in the GAP line, $1.7 million in the credit insurance line, and $1.0 million in the service contract line. Other operating expenses ceded of $5.8 million were mainly due to ceded activity in the credit insurance and GAP product lines.

 

Net investment income has no direct impact on reinsurance cost. However, by ceding business to the assuming companies, we forgo investment income on the reserves ceded. Conversely, the assuming companies will receive investment income on the reserves assumed which generally will increase the assuming companies’ profitability on business we cede. The net investment income impact to us and the assuming companies has not been quantified as it is not reflected in our consolidated condensed financial statements.

 

119



Table of Contents

 

Corporate and Other

 

Segment Results of Operations

 

Segment results were as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

REVENUES

 

 

 

 

 

 

 

 

 

 

 

 

Gross premiums and policy fees

 

$

3,755

 

$

10,189

 

 

$

1,343

 

$

4,111

 

$

12,665

 

Reinsurance ceded

 

(120

)

(137

)

 

 

(2

)

(8

)

Net premiums and policy fees

 

3,635

 

10,052

 

 

1,343

 

4,109

 

12,657

 

Net investment income

 

13,950

 

40,827

 

 

278

 

22,656

 

56,294

 

Other income

 

179

 

588

 

 

1

 

358

 

2,217

 

Total operating revenues

 

17,764

 

51,467

 

 

1,622

 

27,123

 

71,168

 

Realized gains (losses) - investments

 

(2,859

)

(2,206

)

 

4,919

 

(3,944

)

(1,241

)

Realized gains (losses) - derivatives

 

(13,908

)

(16,468

)

 

16,318

 

218

 

54

 

Total revenues

 

997

 

32,793

 

 

22,859

 

23,397

 

69,981

 

BENEFITS AND EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

Benefits and settlement expenses

 

4,082

 

10,347

 

 

1,721

 

4,632

 

14,721

 

Amortization of deferred policy acquisition costs and value of business acquired

 

 

26

 

 

87

 

120

 

363

 

Other operating expenses

 

48,239

 

125,982

 

 

16,476

 

48,357

 

132,447

 

Total benefits and expenses

 

52,321

 

136,355

 

 

18,284

 

53,109

 

147,531

 

INCOME (LOSS) BEFORE INCOME TAX

 

(51,324

)

(103,562

)

 

4,575

 

(29,712

)

(77,550

)

Less: realized gains (losses) - investments

 

(2,859

)

(2,206

)

 

4,919

 

(3,944

)

(1,241

)

Less: realized gains (losses) - derivatives

 

(13,908

)

(16,468

)

 

16,318

 

218

 

54

 

OPERATING INCOME (LOSS)

 

$

(34,557

)

$

(84,888

)

 

$

(16,662

)

$

(25,986

)

$

(76,363

)

 

For The Three Months Ended September 30, 2015 (Successor Company)

 

Operating revenues

 

Operating revenues of $17.8 million were primarily due to $14.0 million of investment income, which represents income on assets supporting our equity capital.

 

Total benefits and expenses

 

Total benefits and expenses of $52.3 million were primarily due to $48.2 million of other operating expenses which included corporate overhead expenses and $20.8 million of interest expense.

 

For The Period of February 1, 2015 to September 30, 2015 (Successor Company)

 

Operating revenues

 

Operating revenues of $51.5 million were primarily due to $40.8 million of investment income, which represents income on assets supporting our equity capital.

 

120



Table of Contents

 

Total benefits and expenses

 

Total benefits and expenses of $136.4 million were primarily due to $126.0 million of other operating expenses which included corporate overhead expenses and $54.8 million of interest expense.

 

For The Period of January 1, 2015 to January 31, 2015 (Predecessor Company)

 

Operating revenues

 

Operating revenues of $1.6 million were primarily due to $1.3 million of premium and policy fees and $0.3 million of net investment income.

 

Total benefits and expenses

 

Total benefits and expenses of $18.3 million was primarily due to $16.5 million of other operating expenses which included corporate overhead expenses and $7.2 million of interest expense.

 

For The Three Months Ended September 30, 2014 (Predecessor Company)

 

Operating revenues

 

Operating revenues of $27.1 million were primarily due to $22.7 million of investment income, which represents income on assets supporting our equity capital.

 

Total benefits and expenses

 

Total benefits and expenses of $53.1 million were primarily due to $48.4 million of other operating expenses which included corporate overhead expenses and $22.3 million of interest expense.

 

For The Nine Months Ended September 30, 2014 (Predecessor Company)

 

Operating revenues

 

Operating revenues of $71.2 million were primarily due to $56.3 million of investment income, which represents income on assets supporting our equity capital.

 

Total benefits and expenses

 

Total benefits and expenses of $147.5 million were primarily due to $132.4 million of other operating expenses which included corporate overhead expenses and $65.4 million of interest expense.

 

121



Table of Contents

 

CONSOLIDATED INVESTMENTS

 

As of September 30, 2015, (Successor Company), our investment portfolio was approximately $45.2 billion. The types of assets in which we may invest are influenced by various state insurance laws which prescribe qualified investment assets. Within the parameters of these laws, we invest in assets giving consideration to such factors as liquidity and capital needs, investment quality, investment return, matching of assets and liabilities, and the overall composition of the investment portfolio by asset type and credit exposure.

 

The following table presents the reported values of our invested assets:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

As of

 

 

As of

 

 

 

September 30, 2015

 

 

December 31, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Publicly issued bonds (amortized cost: 2015 Successor - $29,573,439; 2014 Predecessor - $26,358,248)

 

$

27,675,603

 

61.3

%

 

$

28,835,015

 

63.3

%

Privately issued bonds (amortized cost: 2015 Successor - $8,747,737; 2014 Predecessor - $7,793,600)

 

8,436,532

 

18.7

 

 

8,356,225

 

18.3

 

Preferred stock (amortized cost: 2015 Successor - $71,288)

 

69,037

 

0.2

 

 

 

 

Fixed maturities

 

36,181,172

 

80.2

 

 

37,191,240

 

81.6

 

Equity securities (cost: 2015 Successor - $692,622; 2014 Predecessor - $735,297)

 

684,696

 

1.5

 

 

756,790

 

1.7

 

Mortgage loans

 

5,728,237

 

12.7

 

 

5,133,780

 

11.3

 

Investment real estate

 

7,515

 

 

 

5,918

 

 

Policy loans

 

1,706,402

 

3.8

 

 

1,758,237

 

3.9

 

Other long-term investments

 

619,743

 

1.4

 

 

491,282

 

1.1

 

Short-term investments

 

233,337

 

0.4

 

 

246,717

 

0.4

 

Total investments

 

$

45,161,102

 

100.0

%

 

$

45,583,964

 

100.0

%

 

Included in the preceding table are $2.7 billion and $2.8 billion of fixed maturities and $65.2 million and $95.1 million of short-term investments classified as trading securities as of September 30, 2015 (Successor Company) and December 31, 2014 (Predecessor Company), respectively. The trading portfolio includes invested assets of $2.7 billion and $2.8 billion as of September 30, 2015 (Successor Company) and December 31, 2014 (Predecessor Company), respectively, held pursuant to modified coinsurance (“Modco”) arrangements under which the economic risks and benefits of the investments are passed to third party reinsurers. Also included above are $579.3 million and $435.0 million of securities classified as held-to-maturity as of September 30, 2015 (Successor Company) and December 31, 2014 (Predecessor Company), respectively. The preferred stock shown above as of September 30, 2015 (Successor Company) is included in the equity securities total as of December 31, 2014 (Predecessor Company).

 

122



Table of Contents

 

Fixed Maturity Investments

 

As of September 30, 2015 (Successor Company), our fixed maturity investment holdings were approximately $36.2 billion. The approximate percentage distribution of our fixed maturity investments by quality rating is as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

As of

 

 

As of

 

Rating

 

September 30, 2015

 

 

December 31, 2014

 

AAA

 

14.0

%

 

12.3

%

AA

 

7.7

 

 

7.4

 

A

 

31.8

 

 

33.1

 

BBB

 

39.8

 

 

40.9

 

Below investment grade

 

5.0

 

 

5.2

 

Not rated

 

1.7

 

 

1.1

 

 

 

100.0

%

 

100.0

%

 

We use various Nationally Recognized Statistical Rating Organizations’ (“NRSRO”) ratings when classifying securities by quality ratings. When the various NRSRO ratings are not consistent for a security, we use the second-highest convention in assigning the rating. When there are no such published ratings, we assign a rating based on the statutory accounting rating system if such ratings are available.

 

We do not have material exposure to financial guarantee insurance companies with respect to our investment portfolio.

 

Changes in fair value for our available-for-sale portfolio, net of tax and the related impact on certain insurance assets and liabilities are recorded directly to shareowner’s equity. Declines in fair value that are other-than-temporary are recorded as realized losses in the consolidated condensed statements of income, net of any applicable non-credit component of the loss, which is recorded as an adjustment to other comprehensive income (loss).

 

The distribution of our fixed maturity investments by type is as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

As of

 

 

As of

 

Type

 

September 30, 2015

 

 

December 31, 2014

 

 

 

(Dollars In Millions)

 

 

(Dollars In Millions)

 

Corporate securities

 

$

27,271.7

 

 

$

28,837.8

 

Residential mortgage-backed securities

 

1,904.1

 

 

1,706.4

 

Commercial mortgage-backed securities

 

1,425.3

 

 

1,328.4

 

Other asset-backed securities

 

1,070.1

 

 

1,114.0

 

U.S. government-related securities

 

1,858.8

 

 

1,679.3

 

Other government-related securities

 

78.4

 

 

77.2

 

States, municipals, and political subdivisions

 

1,924.5

 

 

2,013.1

 

Preferred stock

 

69.0

 

 

 

Other

 

579.3

 

 

435.0

 

Total fixed income portfolio

 

$

36,181.2

 

 

$

37,191.2

 

 

The preferred stock shown above as of September 30, 2015 (Successor Company) is included in the equity securities total as of December 31, 2014 (Predecessor Company).

 

Within our fixed maturity investments, we maintain portfolios classified as “available-for-sale”, “trading”, and “held-to-maturity”.  We purchase our available-for-sale investments with the intent to hold to maturity by purchasing investments that match future cash flow needs. However, we may sell any of our available-for-sale and trading

 

123



Table of Contents

 

investments to maintain proper matching of assets and liabilities. Accordingly, we classified $32.9 billion, or 90.9%, of our fixed maturities as “available-for-sale” as of September 30, 2015 (Successor Company). These securities are carried at fair value on our consolidated condensed balance sheets.

 

Fixed maturities with respect to which we have both the positive intent and ability to hold to maturity are classified as “held-to-maturity”. We classified $579.3 million, or 1.6%, of our fixed maturities as “held-to-maturity” as of September 30, 2015 (Successor Company). These securities are carried at amortized cost on our consolidated condensed balance sheets.

 

Trading securities are carried at fair value and changes in fair value are recorded on the income statement as they occur. Our trading portfolio accounted for $2.7 billion, or 7.5%, of our fixed maturities and $65.2 million of short-term investments as of September 30, 2015 (Successor Company). Changes in fair value on the Modco trading portfolio, including gains and losses from sales, are passed to the reinsurers through the contractual terms of the reinsurance arrangements. Partially offsetting these amounts are corresponding changes in the fair value of the embedded derivative associated with the underlying reinsurance arrangement. The total Modco trading portfolio fixed maturities by rating is as follows:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

As of

 

 

As of

 

Rating

 

September 30, 2015

 

 

December 31, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

AAA

 

$

533,032

 

 

$

478,632

 

AA

 

308,738

 

 

290,255

 

A

 

807,032

 

 

910,669

 

BBB

 

759,697

 

 

824,143

 

Below investment grade

 

302,142

 

 

312,594

 

Total Modco trading fixed maturities

 

$

2,710,641

 

 

$

2,816,293

 

 

A portion of our bond portfolio is invested in residential mortgage-backed securities (“RMBS”), commercial mortgage-backed securities (“CMBS”), and other asset-backed securities (collectively referred to as asset-backed securities or “ABS”). ABS are securities that are backed by a pool of assets. These holdings as of September 30, 2015 (Successor Company), were approximately $4.4 billion. Mortgage-backed securities (“MBS”) are constructed from pools of mortgages and may have cash flow volatility as a result of changes in the rate at which prepayments of principal occur with respect to the underlying loans. Excluding limitations on access to lending and other extraordinary economic conditions, prepayments of principal on the underlying loans can be expected to accelerate with decreases in market interest rates and diminish with increases in interest rates.

 

124



Table of Contents

 

Residential mortgage-backed securities - As of September 30, 2015 (Successor Company), our RMBS portfolio was approximately $1.9 billion. As of December 31, 2014 (Predecessor Company), our RMBS portfolio was approximately $1.7 billion. Sequential securities receive payments in order until each class is paid off. Planned amortization class securities (“PACs”) pay down according to a schedule. Pass through securities receive principal as principal of the underlying mortgages is received.

 

The tables below include a breakdown of these holdings by type and rating as of September 30, 2015 (Successor Company).

 

 

 

Percentage of

 

 

 

Residential

 

 

 

Mortgage-
Backed

 

Type

 

Securities

 

Sequential

 

36.8

%

PAC

 

32.3

 

Pass Through

 

8.1

 

Other

 

22.8

 

 

 

100.0

%

 

 

 

Percentage of

 

 

 

Residential

 

 

 

Mortgage-Backed

 

Rating

 

Securities

 

AAA

 

74.2

%

AA

 

0.1

 

A

 

0.2

 

BBB

 

0.2

 

Below investment grade

 

25.3

 

 

 

100.0

%

 

125



Table of Contents

 

Alt-A Collateralized Holdings

 

As of September 30, 2015 (Successor Company), we held securities with a fair value of $318.3 million, or 0.7%, of invested assets, supported by collateral classified as Alt-A. As of December 31, 2014 (Predecessor Company), we held securities with a fair value of $351.6 million supported by collateral classified as Alt-A. We included in this classification certain whole loan securities where such securities had underlying mortgages with a high level of limited loan documentation. As of September 30, 2015 (Successor Company), these securities had a fair value of $119.1 million and an unrealized gain of $0.1 million.

 

The following table includes the percentage of our collateral classified as Alt-A, grouped by rating category, as of September 30, 2015 (Successor Company):

 

 

 

Percentage of

 

 

 

Alt-A

 

Rating

 

Securities

 

A

 

%

BBB

 

0.3

 

Below investment grade

 

99.7

 

 

 

100.0

%

 

The following tables categorize the estimated fair value and unrealized gain/(loss) of our mortgage-backed securities collateralized by Alt-A mortgage loans by rating as of September 30, 2015 (Successor Company):

 

Alt-A Collateralized Holdings

 

 

 

Estimated Fair Value of Security by Year of Security Origination

 

 

 

2011 and

 

 

 

 

 

 

 

 

 

 

 

Rating

 

Prior

 

2012

 

2013

 

2014

 

2015

 

Total

 

 

 

(Dollars In Millions)

 

A

 

$

 

$

 

$

 

$

 

$

 

$

 

BBB

 

1.0

 

 

 

 

 

1.0

 

Below investment grade

 

317.3

 

 

 

 

 

317.3

 

Total mortgage-backed securities collateralized by Alt-A mortgage loans

 

$

318.3

 

$

 

$

 

$

 

$

 

$

318.3

 

 

 

 

Estimated Unrealized Gain (Loss) of Security by Year of Security Origination

 

 

 

2011 and

 

 

 

 

 

 

 

 

 

 

 

Rating

 

Prior

 

2012

 

2013

 

2014

 

2015

 

Total

 

 

 

(Dollars In Millions)

 

A

 

$

 

$

 

$

 

$

 

$

 

$

 

BBB

 

 

 

 

 

 

 

Below investment grade

 

(2.5

)

 

 

 

 

(2.5

)

Total mortgage-backed securities collateralized by Alt-A mortgage loans

 

$

(2.5

)

$

 

$

 

$

 

$

 

$

(2.5

)

 

126



Table of Contents

 

Sub-prime Collateralized Holdings

 

As of September 30, 2015 (Successor Company), we held securities with a total fair value of $1.5 million that were supported by collateral classified as sub-prime. As of December 31, 2014 (Predecessor Company), we held securities with a fair value of $1.7 million that were supported by collateral classified as sub-prime.

 

Prime Collateralized Holdings

 

As of September 30, 2015 (Successor Company), we had RMBS collateralized by prime mortgage loans (including agency mortgages) with a total fair value of $1.6 billion, or 3.5%, of total invested assets. As of December 31, 2014 (Predecessor Company), we held securities with a fair value of $1.4 billion of RMBS collateralized by prime mortgage loans (including agency mortgages).

 

The following table includes the percentage of our collateral classified as prime, grouped by rating category, as of September 30, 2015 (Successor Company):

 

 

 

Percentage of

 

 

 

Prime

 

Rating

 

Securities

 

AAA

 

89.2

%

AA

 

0.1

 

A

 

0.2

 

BBB

 

0.2

 

Below investment grade

 

10.3

 

 

 

100.0

%

 

The following tables categorize the estimated fair value and unrealized gain/(loss) of our mortgage-backed securities collateralized by prime mortgage loans (including agency mortgages) by rating as of September 30, 2015 (Successor Company):

 

Prime Collateralized Holdings

 

 

 

Estimated Fair Value of Security by Year of Security Origination

 

 

 

2011 and

 

 

 

 

 

 

 

 

 

 

 

Rating

 

Prior

 

2012

 

2013

 

2014

 

2015

 

Total

 

 

 

(Dollars In Millions)

 

AAA

 

$

762.1

 

$

26.3

 

$

159.9

 

$

158.2

 

$

307.0

 

$

1,413.5

 

AA

 

 

 

 

1.6

 

 

1.6

 

A

 

3.7

 

 

 

 

 

3.7

 

BBB

 

3.0

 

 

 

 

 

3.0

 

Below investment grade

 

162.5

 

 

 

 

 

162.5

 

Total mortgage-backed securities collateralized by prime mortgage loans

 

$

931.3

 

$

26.3

 

$

159.9

 

$

159.8

 

$

307.0

 

$

1,584.3

 

 

 

 

Estimated Unrealized Gain (Loss) of Security by Year of Security Origination

 

 

 

2011 and

 

 

 

 

 

 

 

 

 

 

 

Rating

 

Prior

 

2012

 

2013

 

2014

 

2015

 

Total

 

 

 

(Dollars In Millions)

 

AAA

 

$

7.0

 

$

(0.7

)

$

(3.3

)

$

(1.7

)

$

(0.6

)

$

0.7

 

AA

 

 

 

 

 

 

 

A

 

 

 

 

 

 

 

BBB

 

 

 

 

 

 

 

Below investment grade

 

0.3

 

 

 

 

 

0.3

 

Total mortgage-backed securities collateralized by prime mortgage loans

 

$

7.3

 

$

(0.7

)

$

(3.3

)

$

(1.7

)

$

(0.6

)

$

1.0

 

 

127



Table of Contents

 

Commercial mortgage-backed securities - Our CMBS portfolio consists of commercial mortgage-backed securities issued in securitization transactions. As of September 30, 2015 (Successor Company), the CMBS holdings were approximately $1.4 billion. As of December 31, 2014 (Predecessor Company), the CMBS holdings were approximately $1.3 billion.

 

The following table includes the percentages of our CMBS holdings, grouped by rating category, as of September 30, 2015 (Successor Company):

 

 

 

Percentage of

 

 

 

Commercial

 

 

 

Mortgage-Backed

 

Rating

 

Securities

 

AAA

 

67.3

%

AA

 

18.4

 

A

 

13.1

 

BBB

 

1.2

 

 

 

100.0

%

 

The following tables categorize the estimated fair value and unrealized gain/(loss) of our CMBS as of September 30, 2015 (Successor Company):

 

Commercial Mortgage-Backed Securities

 

 

 

Estimated Fair Value of Security by Year of Security Origination

 

 

 

2011 and

 

 

 

 

 

 

 

 

 

 

 

Rating

 

Prior

 

2012

 

2013

 

2014

 

2015

 

Total

 

 

 

(Dollars In Millions)

 

AAA

 

$

318.4

 

$

319.7

 

$

151.4

 

$

148.8

 

$

20.4

 

$

958.7

 

AA

 

63.8

 

43.8

 

30.2

 

60.1

 

64.2

 

262.1

 

A

 

102.9

 

14.6

 

20.5

 

 

48.2

 

186.2

 

BBB

 

18.3

 

 

 

 

 

18.3

 

Total commercial mortgage-backed securities

 

$

503.4

 

$

378.1

 

$

202.1

 

$

208.9

 

$

132.8

 

$

1,425.3

 

 

 

 

Estimated Unrealized Gain (Loss) of Security by Year of Security Origination

 

 

 

2011 and

 

 

 

 

 

 

 

 

 

 

 

Rating

 

Prior

 

2012

 

2013

 

2014

 

2015

 

Total

 

 

 

(Dollars In Millions)

 

AAA

 

$

(2.6

)

$

(4.1

)

$

(2.7

)

$

(4.2

)

$

0.1

 

$

(13.5

)

AA

 

(0.8

)

(0.4

)

(0.7

)

(2.8

)

1.1

 

(3.6

)

A

 

(0.4

)

(0.1

)

(0.4

)

 

(0.1

)

(1.0

)

BBB

 

(0.1

)

 

 

 

 

(0.1

)

Total commercial mortgage-backed securities

 

$

(3.9

)

$

(4.6

)

$

(3.8

)

$

(7.0

)

$

1.1

 

$

(18.2

)

 

128



Table of Contents

 

Other asset-backed securities — Other asset-backed securities pay down based on cash flow received from the underlying pool of assets, such as receivables on auto loans, student loans, credit cards, etc. As of September 30, 2015 (Successor Company), these holdings were approximately $1.1 billion. As of December 31, 2014 (Predecessor Company), these holdings were approximately $1.1 billion.

 

The following table includes the percentages of our other asset-backed holdings, grouped by rating category, as of September 30, 2015 (Successor Company):

 

 

 

Percentage of

 

 

 

Other Asset-
Backed

 

Rating

 

Securities

 

AAA

 

55.3

%

AA

 

18.1

 

A

 

14.8

 

BBB

 

0.7

 

Below investment grade

 

11.1

 

 

 

100.0

%

 

The following tables categorize the estimated fair value and unrealized gain/(loss) of our other asset-backed securities as of September 30, 2015 (Successor Company):

 

Other Asset-Backed Securities

 

 

 

Estimated Fair Value of Security by Year of Security Origination

 

 

 

2011 and

 

 

 

 

 

 

 

 

 

 

 

Rating

 

Prior

 

2012

 

2013

 

2014

 

2015

 

Total

 

 

 

(Dollars In Millions)

 

AAA

 

$

491.5

 

$

45.0

 

$

18.9

 

$

24.7

 

$

11.5

 

$

591.6

 

AA

 

145.4

 

48.1

 

 

 

 

193.5

 

A

 

67.8

 

47.9

 

30.1

 

10.3

 

2.0

 

158.1

 

BBB

 

7.6

 

 

 

 

 

7.6

 

Below investment grade

 

119.3

 

 

 

 

 

119.3

 

Total other asset-backed securities

 

$

831.6

 

$

141.0

 

$

49.0

 

$

35.0

 

$

13.5

 

$

1,070.1

 

 

 

 

Estimated Unrealized Gain (Loss) of Security by Year of Security Origination

 

 

 

2011 and

 

 

 

 

 

 

 

 

 

 

 

Rating

 

Prior

 

2012

 

2013

 

2014

 

2015

 

Total

 

 

 

(Dollars In Millions)

 

AAA

 

$

(16.0

)

$

(1.0

)

$

(0.6

)

$

(0.5

)

$

0.1

 

$

(18.0

)

AA

 

(1.4

)

(0.2

)

 

 

 

(1.6

)

A

 

(2.8

)

 

(2.6

)

(0.1

)

 

(5.5

)

BBB

 

0.1

 

 

 

 

 

0.1

 

Below investment grade

 

(1.2

)

 

 

 

 

(1.2

)

Total other asset-backed securities

 

$

(21.3

)

$

(1.2

)

$

(3.2

)

$

(0.6

)

$

0.1

 

$

(26.2

)

 

129



Table of Contents

 

We obtained ratings of our fixed maturities from Moody’s Investors Service, Inc. (“Moody’s”), Standard & Poor’s Corporation (“S&P”), and/or Fitch Ratings (“Fitch”). If a fixed maturity is not rated by Moody’s, S&P, or Fitch, we use ratings from the National Association of Insurance Commissioners (“NAIC”), or we rate the fixed maturity based upon a comparison of the unrated issue to rated issues of the same issuer or rated issues of other issuers with similar risk characteristics. As of September 30, 2015 (Successor Company), 98.3% of our fixed maturities were rated by Moody’s, S&P, Fitch, and/or the NAIC.

 

The industry segment composition of our fixed maturity securities is presented in the following table:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

As of

 

% Fair

 

 

As of

 

% Fair

 

 

 

September 30, 2015

 

Value

 

 

December 31, 2014

 

Value

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Banking

 

$

3,281,160

 

9.1

%

 

$

2,931,579

 

7.9

%

Other finance

 

430,489

 

1.2

 

 

665,866

 

1.8

 

Electric

 

3,778,300

 

10.4

 

 

4,062,991

 

10.9

 

Energy and natural gas

 

4,231,922

 

11.7

 

 

4,593,251

 

12.4

 

Insurance

 

2,904,681

 

8.0

 

 

2,969,648

 

8.0

 

Communications

 

1,380,846

 

3.8

 

 

1,504,581

 

4.0

 

Basic industrial

 

1,604,258

 

4.4

 

 

1,763,195

 

4.7

 

Consumer noncyclical

 

3,008,863

 

8.3

 

 

3,247,522

 

8.7

 

Consumer cyclical

 

1,671,939

 

4.6

 

 

1,986,710

 

5.3

 

Finance companies

 

173,335

 

0.5

 

 

240,976

 

0.6

 

Capital goods

 

1,392,929

 

3.8

 

 

1,369,912

 

3.7

 

Transportation

 

962,089

 

2.7

 

 

993,067

 

2.7

 

Other industrial

 

303,831

 

0.8

 

 

338,285

 

0.9

 

Brokerage

 

472,524

 

1.3

 

 

607,445

 

1.6

 

Technology

 

1,253,737

 

3.5

 

 

1,078,026

 

2.9

 

Real estate

 

190,127

 

0.5

 

 

246,712

 

0.7

 

Other utility

 

230,669

 

0.6

 

 

238,089

 

0.6

 

Commercial mortgage-backed securities

 

1,425,255

 

3.9

 

 

1,328,363

 

3.6

 

Other asset-backed securities

 

1,070,104

 

3.0

 

 

1,113,955

 

3.0

 

Residential mortgage-backed non-agency securities

 

960,223

 

2.7

 

 

779,612

 

2.1

 

Residential mortgage-backed agency securities

 

943,879

 

2.6

 

 

926,760

 

2.5

 

U.S. government-related securities

 

1,858,777

 

5.1

 

 

1,679,356

 

4.5

 

Other government-related securities

 

78,411

 

0.2

 

 

77,204

 

0.2

 

State, municipals, and political divisions

 

1,924,458

 

5.3

 

 

2,013,135

 

5.4

 

Preferred stock

 

69,037

 

0.2

 

 

 

 

Other

 

579,329

 

1.8

 

 

435,000

 

1.3

 

Total

 

$

36,181,172

 

100.0

%

 

$

37,191,240

 

100.0

%

 

The preferred stock shown above as of September 30, 2015 (Successor Company) is included in the equity securities total as of December 31, 2014 (Predecessor Company).

 

Our investments classified as available-for-sale and trading in debt and equity securities are reported at fair value. Our investments classified as held-to-maturity are reported at amortized cost. As of September 30, 2015 (Successor Company), our fixed maturity investments (bonds and redeemable preferred stocks) had a fair value of $36.2 billion, which was 6.0% below amortized cost of $38.5 billion. These assets are invested for terms approximately corresponding to anticipated future benefit payments. Thus, market fluctuations are not expected to adversely affect liquidity.

 

130



Table of Contents

 

Fair values for private, non-traded securities are determined as follows: 1) we obtain estimates from independent pricing services and 2) we estimate fair value based upon a comparison to quoted issues of the same issuer or issues of other issuers with similar terms and risk characteristics. We analyze the independent pricing services valuation methodologies and related inputs, including an assessment of the observability of market inputs. Upon obtaining this information related to fair value, management makes a determination as to the appropriate valuation amount.

 

Mortgage Loans

 

We invest a portion of our investment portfolio in commercial mortgage loans. As of September 30, 2015 (Successor Company), our mortgage loan holdings were approximately $5.7 billion. We have specialized in making loans on either credit-oriented commercial properties or credit-anchored strip shopping centers and apartments. Our underwriting procedures relative to our commercial loan portfolio are based, in our view, on a conservative and disciplined approach. We concentrate on a small number of commercial real estate asset types associated with the necessities of life (retail, multi-family, senior living, professional office buildings, and warehouses). We believe that these asset types tend to weather economic downturns better than other commercial asset classes in which we have chosen not to participate. We believe this disciplined approach has helped to maintain a relatively low delinquency and foreclosure rate throughout our history. The majority of our mortgage loans portfolio was underwritten and funded by us. From time to time, we may acquire loans in conjunction with an acquisition.

 

Our commercial mortgage loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, and net of valuation allowances. Interest income is accrued on the principal amount of the loan based on the loan’s contractual interest rate. Amortization of premiums and discounts is recorded using the effective yield method. Interest income, amortization of premiums and discounts, and prepayment fees are reported in net investment income.

 

Certain of the mortgage loans have call options between 3 and 10 years. However, if interest rates were to significantly increase, we may be unable to exercise the call options on our existing mortgage loans commensurate with the significantly increased market rates. As of September 30, 2015, assuming the loans are called at their next call dates, approximately $27.3 million would become due for the remainder of 2015, $944.4 million in 2016 through 2020, $365.3 million in 2021 through 2025, and $114.5 million thereafter .

 

We also offer a type of commercial mortgage loan under which we will permit a loan-to-value ratio of up to 85% in exchange for a participating interest in the cash flows from the underlying real estate. As of September 30, 2015 (Successor Company) and December 31, 2014 (Predecessor Company), approximately $562.6 million and $553.6 million, respectively, of our mortgage loans had this participation feature. Cash flows received as a result of this participation feature are recorded as interest income. During the three months ended September 30, 2015 (Successor Company), the period of February 1, 2015 to September 30, 2015 (Successor Company), the period of January 1, 2015 to January 31, 2015 (Predecessor Company), and for the three and nine months ended September 30, 2014 (Predecessor Company), we recognized $3.3 million, $8.4 million, $0.1 million, $8.0 million, and $13.8 million of participating mortgage loan income, respectively.

 

We record mortgage loans net of an allowance for credit losses. This allowance is calculated through analysis of specific loans that have indicators of potential impairment based on current information and events. As of September 30, 2015 (Successor Company) and December 31, 2014 (Predecessor Company), our allowance for mortgage loan credit losses was $2.0 million and $5.7 million, respectively. While our mortgage loans do not have quoted market values, as of September 30, 2015 (Successor Company), we estimated the fair value of our mortgage loans to be $5.6 billion (using discounted cash flows from the next call date), which was approximately 2.4% less than the amortized cost, less any related loan loss reserve.

 

At the time of origination, our mortgage lending criteria targets that the loan-to-value ratio on each mortgage is 75% or less. We target projected rental payments from credit anchors (i.e., excluding rental payments from smaller local tenants) of 70% of the property’s projected operating expenses and debt service.

 

As of September 30, 2015 (Successor Company), approximately $7.3 million, or 0.02%, of invested assets consisted of nonperforming mortgage loans and/or restructured loans since February 1, 2015 (Successor Company). We

 

131



Table of Contents

 

do not expect these investments to adversely affect our liquidity or ability to maintain proper matching of assets and liabilities. During the three months ended September 30, 2015 (Successor Company), the period of February 1, 2015 to September 30, 2015 (Successor Company) and the period of January 1, 2015 to January 31, 2015 (Predecessor Company), we entered into certain mortgage loan transactions that were accounted for as troubled debt restructurings under Topic 310 of the FASB ASC. For all mortgage loans, the impact of troubled debt restructurings is generally reflected in our investment balance and in the allowance for mortgage loan credit losses. Transactions accounted for as troubled debt restructurings during the period of February 1, 2015 to September 30, 2015 (Successor Company) and the period of January 1, 2015 to January 31, 2015 (Predecessor Company) included either the acceptance of assets in satisfaction of principal during the respective periods or at a future date, and were the result of agreements between the creditor and the debtor. During the period of February 1, 2015 to September 30, 2015 (Successor Company), we accepted or agreed to accept assets of $12.1 million in satisfaction of $15.2 million of principal and for the period of January 1, 2015 to January 31, 2015 (Predecessor Company), we accepted or agreed to accept assets of $11.3 million in satisfaction of $13.8 million of principal. These transactions resulted in no material realized losses in our investment in mortgage loans net of existing allowances for mortgage loans losses for the period of February 1, 2015 to September 30, 2015 (Successor Company). Of the mortgage loan transactions accounted for as troubled debt restructurings, none remain on our balance sheet as of September 30, 2015 (Successor Company).

 

Our mortgage loan portfolio consists of two categories of loans: 1) those not subject to a pooling and servicing agreement and 2) those subject to a contractual pooling and servicing agreement. As of September 30, 2015 (Successor Company), $7.3 million of mortgage loans not subject to a pooling and servicing agreement were nonperforming mortgage loans and/or restructured loans since February 1, 2015 (Successor Company). None of the restructured loans were nonperforming during the periods of February 1, 2015 to September 30, 2015 (Successor Company) and January 1, 2015 to January 31, 2015 (Predecessor Company). We did not foreclose on any nonperforming loans not subject to a pooling and servicing agreement during the periods of February 1, 2015 to September 30, 2015 (Successor Company) and January 1, 2015 to January 31, 2015 (Predecessor Company).

 

As of September 30, 2015 (Successor Company), none of the loans subject to a pooling and servicing agreement were nonperforming or restructured. We did not foreclose on any nonperforming loans subject to pooling and servicing agreement during the periods of February 1, 2015 to September 30, 2015 (Successor Company) and January 1, 2015 to January 31, 2015 (Predecessor Company).

 

We do not expect these investments to adversely affect our liquidity or ability to maintain proper matching of assets and liabilities.

 

It is our policy to cease to carry accrued interest on loans that are over 90 days delinquent. For loans less than 90 days delinquent, interest is accrued unless it is determined that the accrued interest is not collectible. If a loan becomes over 90 days delinquent, it is our general policy to initiate foreclosure proceedings unless a workout arrangement to bring the loan current is in place. For loans subject to a pooling and servicing agreement, there are certain additional restrictions and/or requirements related to workout proceedings, and as such, these loans may have different attributes and/or circumstances affecting the status of delinquency or categorization of those in nonperforming status.

 

132



Table of Contents

 

Risk Management and Impairment Review

 

We monitor the overall credit quality of our portfolio within established guidelines. The following table includes our available-for-sale fixed maturities by credit rating as of September 30, 2015 (Successor Company):

 

 

 

 

 

Percent of

 

Rating

 

Fair Value

 

Fair Value

 

 

 

(Dollars In Thousands)

 

 

 

AAA

 

$

4,531,677

 

13.8

%

AA

 

2,478,975

 

7.5

 

A

 

10,706,952

 

32.6

 

BBB

 

13,647,234

 

41.5

 

Investment grade

 

31,364,838

 

95.4

 

BB

 

1,101,984

 

3.4

 

B

 

89,962

 

0.3

 

CCC or lower

 

334,418

 

0.9

 

Below investment grade

 

1,526,364

 

4.6

 

Total

 

$

32,891,202

 

100.0

%

 

Not included in the table above are $2.4 billion of investment grade and $302.1 million of below investment grade fixed maturities classified as trading securities and $579.3 million of fixed maturities classified as held-to-maturity.

 

Limiting bond exposure to any creditor group is another way we manage credit risk. We held no credit default swaps on the positions listed below as of September 30, 2015 (Successor Company). The following table summarizes our ten largest maturity exposures to an individual creditor group as of September 30, 2015 (Successor Company):

 

 

 

Fair Value of

 

 

 

 

 

Funded

 

Unfunded

 

Total

 

Creditor

 

Securities

 

Exposures

 

Fair Value

 

 

 

(Dollars In Millions)

 

Federal National Mortgage Association

 

$

213.6

 

$

 

$

213.6

 

AT&T

 

184.0

 

 

184.0

 

Wells Fargo & Co

 

178.7

 

2.2

 

180.9

 

Berkshire Hathaway Inc.

 

173.5

 

 

173.5

 

Nextera Energy Inc.

 

164.1

 

 

164.1

 

Duke Energy Corp

 

158.7

 

 

158.7

 

JP Morgan Chase and Company

 

133.5

 

24.2

 

157.7

 

Bank of America Corp

 

154.4

 

0.9

 

155.3

 

Rio Tinto

 

152.7

 

 

152.7

 

Federal Home Loan Bank

 

151.8

 

 

151.8

 

 

Determining whether a decline in the current fair value of invested assets is an other-than-temporary decline in value is both objective and subjective, and can involve a variety of assumptions and estimates, particularly for investments that are not actively traded in established markets. We review our positions on a monthly basis for possible credit concerns and review our current exposure, credit enhancement, and delinquency experience.

 

Management considers a number of factors when determining the impairment status of individual securities. These include the economic condition of various industry segments and geographic locations and other areas of identified risks. Since it is possible for the impairment of one investment to affect other investments, we engage in ongoing risk management to safeguard against and limit any further risk to our investment portfolio. Special attention is given to correlative risks within specific industries, related parties, and business markets.

 

133



Table of Contents

 

For certain securitized financial assets with contractual cash flows, including RMBS, CMBS, and other asset-backed securities (collectively referred to as asset-backed securities or “ABS”), GAAP requires us to periodically update our best estimate of cash flows over the life of the security. If the fair value of a securitized financial asset is less than its cost or amortized cost and there has been a decrease in the present value of the expected cash flows since the last revised estimate, considering both timing and amount, an other-than-temporary impairment charge is recognized. Estimating future cash flows is a quantitative and qualitative process that incorporates information received from third party sources along with certain internal assumptions and judgments regarding the future performance of the underlying collateral. Projections of expected future cash flows may change based upon new information regarding the performance of the underlying collateral. In addition, we consider our intent and ability to retain a temporarily depressed security until recovery.

 

Securities in an unrealized loss position are reviewed at least quarterly to determine if an other-than-temporary impairment is present based on certain quantitative and qualitative factors. We consider a number of factors in determining whether the impairment is other-than-temporary. These include, but are not limited to: 1) actions taken by rating agencies, 2) default by the issuer, 3) the significance of the decline, 4) an assessment of our intent to sell the security (including a more likely than not assessment of whether we will be required to sell the security) before recovering the security’s amortized cost, 5) the time period during which the decline has occurred, 6) an economic analysis of the issuer’s industry, and 7) the financial strength, liquidity, and recoverability of the issuer. Management performs a security-by-security review each quarter in evaluating the need for any other-than-temporary impairments. Although no set formula is used in this process, the investment performance, collateral position, and continued viability of the issuer are significant measures considered, along with an analysis regarding our expectations for recovery of the security’s entire amortized cost basis through the receipt of future cash flows. Based on our analysis, for the three months ended September 30, 2015 (Successor Company) and for the period of February 1, 2015 to September 30, 2015 (Successor Company), we concluded that approximately $10.1 million and $15.8 million, respectively, of investment securities in an unrealized loss position were other-than-temporarily impaired, due to credit related factors, resulting in a charge to earnings. Additionally, we recognized $4.8 million and $12.5 million of non-credit losses previously recorded in other comprehensive income (loss) that were recorded in earnings. For the period of January 1, 2015 to January 31, 2015 (Predecessor Company), we concluded that approximately $0.5 million of investment securities in an unrealized loss position were other-than-temporarily impaired, due to credit-related factors, resulting in a charge to earnings. The $0.5 million of credit losses included $0.1 million of non-credit losses previously recorded in other comprehensive income.

 

There are certain risks and uncertainties associated with determining whether declines in fair values are other-than-temporary. These include significant changes in general economic conditions and business markets, trends in certain industry segments, interest rate fluctuations, rating agency actions, changes in significant accounting estimates and assumptions, commission of fraud, and legislative actions. We continuously monitor these factors as they relate to the investment portfolio in determining the status of each investment.

 

During 2014 and 2015, the energy and natural gas sector experienced increased volatility due to the decline in oil prices. A prolonged decline in oil prices could have a broad economic impact and put financial stress on companies in this sector. We continue to monitor our exposure to companies within and exposed to this sector closely. Our current exposure is predominantly with investment grade securities of companies with ample liquidity to weather a prolonged decline in oil prices. Many of these companies have displayed financial discipline by reducing capital expenditures to conserve cash and maintain their credit ratings.

 

During 2015, the metals and mining sector (a sub-sector of the basic industrial sector) experienced increased volatility due to the decline in precious and base metal prices. A prolonged decline in these prices could have a broad economic impact and put financial stress on companies in this sector. We continue to monitor our exposure to companies within and exposed to this sector closely. Our current exposure is predominantly with investment grade securities of companies with ample liquidity to weather a prolonged decline in these prices. Many of these companies have displayed financial discipline by reducing capital expenditures and reducing dividends to conserve cash and maintain their credit ratings. As of September 30, 2015 (Successor Company), we concluded that certain investment securities in an unrealized loss position were other-than-temporarily impaired due to credit related factors, resulting in a $14.8 million impairment recognized in net income.

 

134



Table of Contents

 

We have deposits with certain financial institutions which exceed federally insured limits. We have reviewed the creditworthiness of these financial institutions and believe that there is minimal risk of a material loss.

 

Certain European countries have experienced varying degrees of financial stress. Risks from the debt crisis in Europe could continue to disrupt the financial markets, which could have a detrimental impact on global economic conditions and on sovereign and non-sovereign obligations. There remains considerable uncertainty as to future developments in the European debt crisis and the impact on financial markets .

 

The chart shown below includes our non-sovereign fair value exposures in these countries as of September 30, 2015 (Successor Company). As September 30, 2015 (Successor Company), we had no unfunded exposure and had no direct sovereign fair value exposure.

 

 

 

 

 

 

 

Total Gross

 

 

 

Non-sovereign Debt

 

Funded

 

Financial Instrument and Country

 

Financial

 

Non-financial

 

Exposure

 

 

 

(Dollars In Millions)

 

Securities:

 

 

 

 

 

 

 

United Kingdom

 

$

515.3

 

$

790.9

 

$

1,306.2

 

Netherlands

 

161.3

 

188.3

 

349.6

 

Switzerland

 

174.9

 

149.1

 

324.0

 

France

 

106.4

 

199.4

 

305.8

 

Germany

 

115.8

 

114.4

 

230.2

 

Spain

 

23.5

 

203.5

 

227.0

 

Sweden

 

130.6

 

32.2

 

162.8

 

Norway

 

12.2

 

91.5

 

103.7

 

Italy

 

 

94.0

 

94.0

 

Belgium

 

 

90.2

 

90.2

 

Ireland

 

11.2

 

57.3

 

68.5

 

Luxembourg

 

 

49.0

 

49.0

 

Portugal

 

 

15.6

 

15.6

 

Denmark

 

13.6

 

 

13.6

 

Total securities

 

1,264.8

 

2,075.4

 

3,340.2

 

Derivatives:

 

 

 

 

 

 

 

Germany

 

38.4

 

 

38.4

 

United Kingdom

 

35.5

 

 

35.5

 

Switzerland

 

12.1

 

 

12.1

 

France

 

5.1

 

 

5.1

 

Total derivatives

 

91.1

 

 

91.1

 

Total securities

 

$

1,355.9

 

$

2,075.4

 

$

3,431.3

 

 

135



Table of Contents

 

Realized Gains and Losses

 

The following table sets forth realized investment gains and losses for the periods shown:

 

 

 

Successor

 

 

Predecessor

 

 

 

Company

 

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Fixed maturity gains - sales

 

$

663

 

$

7,551

 

 

$

6,920

 

$

22,501

 

$

50,565

 

Fixed maturity losses - sales

 

(1,967

)

(5,153

)

 

(29

)

(257

)

(753

)

Equity gains - sales

 

51

 

95

 

 

 

 

 

Equity losses - sales

 

 

(23

)

 

 

 

 

Impairments on fixed maturity securities

 

(10,064

)

(15,798

)

 

(481

)

(2,354

)

(5,405

)

Impairments on equity securities

 

 

 

 

 

 

 

Modco trading portfolio

 

8,377

 

(133,524

)

 

73,062

 

(17,225

)

110,067

 

Other

 

(1,815

)

(1,040

)

 

1,200

 

(5,135

)

(7,383

)

Total realized gains (losses) - investments

 

$

(4,755

)

$

(147,892

)

 

$

80,672

 

$

(2,470

)

$

147,091

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives related to VA contracts

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate futures - VA

 

$

12,140

 

$

(2,091

)

 

$

1,413

 

$

1,979

 

$

12,777

 

Equity futures - VA

 

40,951

 

3,215

 

 

9,221

 

861

 

(9,049

)

Currency futures - VA

 

4,000

 

1,428

 

 

7,778

 

10,185

 

6,020

 

Variance swaps - VA

 

 

 

 

 

1,570

 

(1,103

)

Equity options - VA

 

33,519

 

8,195

 

 

3,047

 

2,050

 

(31,240

)

Interest rate swaptions - VA

 

(3,618

)

(12,399

)

 

9,268

 

(2,812

)

(17,213

)

Interest rate swaps - VA

 

101,808

 

(74,150

)

 

122,710

 

22,011

 

124,548

 

Embedded derivative - GMWB

 

(71,296

)

10,543

 

 

(68,503

)

(11,407

)

(51,869

)

Funds withheld derivative

 

(52,872

)

(8,301

)

 

(9,073

)

(2,432

)

27,298

 

Total derivatives related to VA contracts

 

64,632

 

(73,560

)

 

75,861

 

22,005

 

60,169

 

Derivatives related to FIA contracts:

 

 

 

 

 

 

 

 

 

 

 

 

Embedded derivative - FIA

 

11,328

 

9,035

 

 

1,769

 

(2,462

)

(9,036

)

Equity futures - FIA

 

709

 

1,016

 

 

(184

)

117

 

1,067

 

Volatility futures - FIA

 

(24

)

6

 

 

 

(4

)

4

 

Equity options - FIA

 

(12,099

)

(6,499

)

 

(2,617

)

1,099

 

5,077

 

Total derivatives related to FIA contracts

 

(86

)

3,558

 

 

(1,032

)

(1,250

)

(2,888

)

Derivatives related to IUL contracts:

 

 

 

 

 

 

 

 

 

 

 

 

Embedded derivative - IUL

 

1,287

 

3,082

 

 

(486

)

347

 

62

 

Equity futures - IUL

 

17

 

39

 

 

3

 

16

 

16

 

Equity options - IUL

 

(1,110

)

(1,048

)

 

(115

)

(24

)

(24

)

Total derivatives related to IUL contracts

 

194

 

2,073

 

 

(598

)

339

 

54

 

Embedded derivative - Modco reinsurance treaties

 

(9,817

)

131,505

 

 

(68,026

)

20,426

 

(91,945

)

Derivatives with PLC (1)

 

(12,978

)

(16,096

)

 

15,863

 

398

 

536

 

Other derivatives

 

(50

)

33

 

 

(37

)

(149

)

(351

)

Total realized gains (losses) - derivatives

 

$

41,895

 

$

47,513

 

 

$

22,031

 

$

41,769

 

$

(34,425

)

 


(1)    These derivatives include the interest support, a yearly renewable term (“YRT”) premium support, and portfolio maintenance agreements between certain of our subsidiaries and PLC.

 

Realized gains and losses on investments reflect portfolio management activities designed to maintain proper matching of assets and liabilities and to enhance long-term investment portfolio performance. The change in net

 

136



Table of Contents

 

realized investment gains (losses), excluding impairments and Modco trading portfolio activity during the period of February 1, 2015 to September 30, 2015 (Successor Company) and the period of January 1, 2015 to January 31, 2015 (Predecessor Company), primarily reflects the normal operation of our asset/liability program within the context of the changing interest rate and spread environment, as well as tax planning strategies designed to utilize capital loss carryforwards.

 

Realized losses are comprised of both write-downs of other-than-temporary impairments and actual sales of investments. For the three months ended September 30, 2015 (Successor Company) and for the period of February 1, 2015 to September 30, 2015 (Successor Company), we concluded that approximately $10.1 million and $15.8 million, respectively, of investment securities in an unrealized loss position were other-than-temporarily impaired, due to credit related factors, resulting in a charge to earnings. Additionally, $4.8 million and $12.5 million of non-credit losses was recorded in other comprehensive income (loss). For the period of January 1, 2015 to January 31, 2015 (Predecessor Company), we recognized pre-tax other-than-temporary impairments of $0.5 million due to credit-related factors, resulting in a charge to earnings. Of the credit losses, $0.1 million were non-credit losses previously recorded in other comprehensive income. For the three and nine months ended September 30, 2014 (Predecessor Company), we recognized pre-tax other-than-temporary impairments of $2.3 million and $5.4 million, respectively. These other-than-temporary impairments resulted from our analysis of circumstances and our belief that credit events, loss severity, changes in credit enhancement, and/or other adverse conditions of the respective issuers have caused, or will lead to, a deficiency in the contractual cash flows related to these investments. These other-than-temporary impairments, net of Modco recoveries, are presented in the chart below :

 

 

 

Successor

 

Predecessor

 

 

 

Company

 

Company

 

 

 

For The Three

 

February 1, 2015

 

 

January 1, 2015

 

For The Three

 

For The Nine

 

 

 

Months Ended

 

to

 

 

to

 

Months Ended

 

Months Ended

 

 

 

September 30, 2015

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

September 30, 2014

 

 

 

(Dollars In Millions)

 

 

(Dollars In Millions)

 

Alt-A MBS

 

$

 

$

 

 

$

0.3

 

$

0.8

 

$

2.8

 

Other MBS

 

 

0.1

 

 

0.2

 

0.7

 

1.8

 

Corporate securities

 

9.9

 

15.5

 

 

 

 

 

Other

 

0.2

 

0.2

 

 

 

0.8

 

0.8

 

Total

 

$

10.1

 

$

15.8

 

 

$

0.5

 

$

2.3

 

$

5.4

 

 

137



Table of Contents

 

As previously discussed, management considers several factors when determining other-than-temporary impairments. Although we purchase securities with the intent to hold them until maturity, we may change our position as a result of a change in circumstances. Any such decision is consistent with our classification of all but a specific portion of our investment portfolio as available-for-sale. For the period of February 1, 2015 to September 30, 2015 (Successor Company) and for the period of January 1, 2015 to January 31, 2015 (Predecessor Company), we sold securities in an unrealized loss position with a fair value of $83.9 million and $0.4 million, respectively. For such securities, the proceeds, realized loss, and total time period that the security had been in an unrealized loss position are presented in the table below for the period of February 1, 2015 to September 30, 2015 (Successor Company) and for the period of January 1, 2015 to January 31, 2015 (Predecessor Company):

 

Successor Company

 

 

 

Proceeds

 

% Proceeds

 

Realized Loss

 

% Realized Loss

 

 

 

(Dollars In Thousands)

 

<= 90 days

 

$

20,682

 

24.6

%

$

(1,135

)

21.9

%

>90 days but <= 180 days

 

28,644

 

34.1

 

(2,074

)

40.1

 

>180 days but <= 270 days

 

34,591

 

41.3

 

(1,967

)

38.0

 

>270 days but <= 1 year

 

 

 

 

 

>1 year

 

 

 

 

 

Total

 

$

83,917

 

100.0

%

$

(5,176

)

100.0

%

 

 

 

 

 

 

 

 

 

 

 

Predecessor Company

 

 

 

Proceeds

 

% Proceeds

 

Realized Loss

 

% Realized Loss

 

 

 

(Dollars In Thousands)

 

<= 90 days

 

$

87

 

20.1

%

$

(6

)

20.8

%

>90 days but <= 180 days

 

 

 

 

 

>180 days but <= 270 days

 

 

 

 

 

>270 days but <= 1 year

 

4

 

0.9

 

 

1.5

 

>1 year

 

344

 

79.0

 

(23

)

77.7

 

Total

 

$

435

 

100.0

%

$

(29

)

100.0

%

 

For the three months ended September 30, 2015 (Successor Company) and for the period of February 1, 2015 to September 30, 2015 (Successor Company), we sold securities in an unrealized loss position with a fair value (proceeds) of $34.6 million and $83.9 million, respectively. The loss realized on the sale of these securities was $2.0 million and $5.2 million for the three months ended September 30, 2015 (Successor Company) and for the period of February 1, 2015 to September 30, 2015 (Successor Company). We made the decision to exit these holdings in conjunction with our overall asset liability management process.

 

For the period of January 1, 2015 to January 31, 2015 (Predecessor Company), we sold securities in an unrealized loss position with a fair value (proceeds) of $0.4 million. We had an immaterial loss for the period of January 1, 2015 to January 31, 2015 (Predecessor Company). We made the decision to exit these holdings in conjunction with our overall asset liability management process.

 

For the three months ended September 30, 2015 (Successor Company), the period of February 1, 2015 to September 30, 2015 (Successor Company) and for the period of January 1, 2015 to January 31, 2015 (Predecessor Company), we sold securities in an unrealized gain position with a fair value of $94.8 million, $807.8 million, and $172.6 million, respectively. The gain realized on the sale of these securities was $0.7 million, $7.6 million, and $6.9 million, respectively.

 

The $1.7 million of other realized losses recognized for the three months ended September 30, 2015 (Successor Company), consisted of realized losses related to mortgage loans of $0.4 million, an increase in mortgage loan reserves of $1.4 million, and partnership gains of $0.1 million. The $1.0 million of other realized losses recognized for the period of February 1, 2015 to September 30, 2015 (Successor Company), primarily consisted of realized losses related to mortgage loans and a decrease in mortgage loan reserves.

 

138



Table of Contents

 

The $1.2 million of other realized gains recognized for the period of January 1, 2015 to January 31, 2015 (Predecessor Company), primarily consisted of a decrease in the mortgage loan reserves of $2.3 million, mortgage loan losses of $1.0 million, and partnership losses of $0.1 million.

 

For the three months ended September 30, 2015 (Successor Company) and for the period of February 1, 2015 to September 30, 2015 (Successor Company) net gains of $8.4 million and net losses of $133.5 million, respectively, primarily related to changes in fair value on our Modco trading portfolios were included in realized gains and losses. Of this amount, approximately $1.1 million of losses and $3.4 million of losses, respectively, were realized through the sale of certain securities, which will be reimbursed to our reinsurance partners over time through the reinsurance settlement process for this block of business.

 

For the period of January 1, 2015 to January 31, 2015 (Predecessor Company), net gains of $73.1 million primarily related to changes in fair value on our Modco trading portfolios were included in realized gains and losses. Of this amount, approximately $1.3 million of gains were realized through the sale of certain securities, which will be reimbursed to our reinsurance partners over time through the reinsurance settlement process for this block of business.

 

The Modco embedded derivative associated with the trading portfolios had realized pre-tax losses of $9.8 million and pre-tax gains of $131.5 million, respectively, during the three months ended September 30, 2015 (Successor Company) and during the period of February 1, 2015 to September 30, 2015 (Successor Company). The losses during the three months ended September 30, 2015 (Successor Company) were due to lower treasury yields and the gains during the period of February 1, 2015 to September 30, 2015 (Successor Company) were due to higher treasury yields and credit spreads.

 

The Modco embedded derivative associated with the trading portfolios had realized pre-tax losses of $68.0 million during the period of January 1, 2015 to January 31, 2015 (Predecessor Company). These losses were due to lower treasury yields.

 

Realized investment gains and losses related to derivatives represent changes in their fair value during the period and termination gains/(losses) on those derivatives that were closed during the period.

 

We use various derivative instruments to manage risks related to certain life insurance and annuity products. We can use these derivatives as economic hedges against risks inherent in the products. These risks have a direct impact on the cost of these products and are correlated with the equity markets, interest rates, foreign currency levels, and overall volatility. The hedged risks are recorded through the recognition of embedded derivatives associated with the products. These products include the GMWB rider associated with the variable annuity, fixed indexed annuity products as well as indexed universal life products. During the three months ended September 30, 2015 (Successor Company), the period of February 1, 2015 to September 30, 2015 (Successor Company), and the period of January 1, 2015 to January 31, 2015 (Predecessor Company), we experienced net realized gains on derivatives related to VA contracts of approximately $64.6 million, net realized losses of $73.6 million, and net realized gains of $75.9 million, respectively. The impact of derivatives related to VA contracts, in addition to capital market impacts for the period of February 1, 2015 to September 30, 2015 (Successor Company) were affected by the lowering of assumed lapses used to value the GMWB embedded derivatives.

 

The Funds Withheld derivative associated with Shades Creek had a pre-tax realized loss of $52.9 million, $8.3 million, and $9.1 million for the three months ended September 30, 2015 (Successor Company), the period of February 1, 2015 to September 30, 2015 (Successor Company) and the period of January 1, 2015 to January 31, 2015 (Predecessor Company), respectively.

 

Certain of our subsidiaries have derivatives with PLC. These derivatives consist of an interest support agreement, a YRT premium support agreement, and two portfolio maintenance agreements with PLC. We recognized a pre-tax loss of $12.9 million related to the interest support agreement and a pre-tax loss of $0.1 million related to the YRT premium support agreement for the three months ended September 30, 2015 (Successor Company). We recognized a pre-tax loss of $16.3 million related to the interest support agreement and a pre-tax gain of $0.4 million related to the YRT premium support agreement for period of February 1, 2015 to September 30, 2015 (Successor Company). We recognized a pre-tax gain of $15.8 million related to the interest support agreement and an immaterial pre-tax gain related to the YRT premium support agreement for period of January 1, 2015 to January 31, 2015

 

139



Table of Contents

 

(Predecessor Company). We entered into two separate portfolio maintenance agreements in October 2012. We recognized no gains or losses for the three months ended September 30, 2015 (Successor Company), a pre-tax loss of $0.2 million for the period of February 1, 2015 to September 30, 2015 (Successor Company) and pre-tax gains of $0.1 million for the period of January 1, 2015 to January 31, 2015 (Predecessor Company), respectively, related to our portfolio maintenance agreements.

 

We also use various swaps and other types of derivatives to mitigate risk related to other exposures. These contracts generated a loss of $0.1 million for the three months ended September 30, 2015 (Successor Company), and immaterial gains for the period of February 1, 2015 to September 30, 2015 (Successor Company) and immaterial losses for the period of January 1, 2015 to January 31, 2015 (Predecessor Company).

 

Unrealized Gains and Losses — Available-for-Sale Securities

 

The information presented below relates to investments at a certain point in time and is not necessarily indicative of the status of the portfolio at any time after September 30, 2015 (Successor Company), the balance sheet date. Information about unrealized gains and losses is subject to rapidly changing conditions, including volatility of financial markets and changes in interest rates. Management considers a number of factors in determining if an unrealized loss is other-than-temporary, including the expected cash to be collected and the intent, likelihood, and/or ability to hold the security until recovery. Consistent with our long-standing practice, we do not utilize a “bright line test” to determine other-than-temporary impairments. On a quarterly basis, we perform an analysis on every security with an unrealized loss to determine if an other-than-temporary impairment has occurred. This analysis includes reviewing several metrics including collateral, expected cash flows, ratings, and liquidity. Furthermore, since the timing of recognizing realized gains and losses is largely based on management’s decisions as to the timing and selection of investments to be sold, the tables and information provided below should be considered within the context of the overall unrealized gain/(loss) position of the portfolio. We had an overall net unrealized loss of $2.2 billion, prior to tax and the related impact of certain insurance assets and liabilities offsets, as of September 30, 2015 (Successor Company), and an overall net unrealized gain of $3.1 billion as of December 31, 2014 (Predecessor Company).

 

For fixed maturity and equity securities held that are in an unrealized loss position as of September 30, 2015 (Successor Company), the fair value, amortized cost, unrealized loss, and total time period that the security has been in an unrealized loss position are presented in the table below :

 

 

 

Fair

 

% Fair

 

Amortized

 

% Amortized

 

Unrealized

 

% Unrealized

 

 

 

Value

 

Value

 

Cost

 

Cost

 

Loss

 

Loss

 

 

 

(Dollars In Thousands)

 

<= 90 days

 

$

10,756,236

 

35.8

%

$

11,479,138

 

35.5

%

$

(722,902

)

31.8

%

>90 days but <= 180 days

 

2,995,269

 

10.0

 

3,183,566

 

9.8

 

(188,297

)

8.3

 

>180 days but <= 270 days

 

16,299,452

 

54.2

 

17,658,733

 

54.7

 

(1,359,281

)

59.9

 

>270 days but <= 1 year

 

 

 

 

 

 

 

>1 year but <= 2 years

 

 

 

 

 

 

 

>2 years but <= 3 years

 

 

 

 

 

 

 

>3 years but <= 4 years

 

 

 

 

 

 

 

>4 years but <= 5 years

 

 

 

 

 

 

 

>5 years

 

 

 

 

 

 

 

Total

 

$

30,050,957

 

100.0

%

$

32,321,437

 

100.0

%

$

(2,270,480

)

100.0

%

 

The book value of our investment portfolio was marked to fair value as of February 1, 2015 (Successor Company), in conjunction with the Dai-ichi Merger which resulted in the elimination of previously unrealized gains and losses from accumulated other comprehensive income. The level of interest rates as of February 1, 2015 (Successor Company) resulted in an increase in the carrying value of our investments. Since February 1, 2015 (Successor Company) interest rates have increased resulting in net unrealized losses in our investment portfolio.

 

As of September 30, 2015 (Successor Company), the Barclays Investment Grade Index was priced at 164.8 bps versus a 10 year average of 169.7 bps. Similarly, the Barclays High Yield Index was priced at 672.3 bps versus a 10 year average of 617.6 bps. As of September 30, 2015 (Successor Company), the five, ten, and thirty-year U.S.

 

140



Table of Contents

 

Treasury obligations were trading at levels of 1.358%, 2.038%, and 2.854%, as compared to 10 year averages of 2.337%, 3.162%, and 3.92%, respectively.

 

As of September 30, 2015 (Successor Company), 95.5% of the unrealized loss was associated with securities that were rated investment grade. We have examined the performance of the underlying collateral and cash flows and expect that our investments will continue to perform in accordance with their contractual terms. Factors such as credit enhancements within the deal structures and the underlying collateral performance/characteristics support the recoverability of the investments. Based on the factors discussed, we do not consider these unrealized loss positions to be other-than-temporary. However, from time to time, we may sell securities in the ordinary course of managing our portfolio to meet diversification, credit quality, yield enhancement, asset/liability management, and liquidity requirements.

 

Expectations that investments in mortgage-backed and asset-backed securities will continue to perform in accordance with their contractual terms are based on assumptions that a market participant would use in determining the current fair value. It is reasonably possible that the underlying collateral of these investments will perform worse than current market expectations and that such an event may lead to adverse changes in the cash flows on our holdings of these types of securities. This could lead to potential future write-downs within our portfolio of mortgage-backed and asset-backed securities. Expectations that our investments in corporate securities and/or debt obligations will continue to perform in accordance with their contractual terms are based on evidence gathered through our normal credit surveillance process. Although we do not anticipate such events, it is reasonably possible that issuers of our investments in corporate securities will perform worse than current expectations. Such events may lead us to recognize potential future write-downs within our portfolio of corporate securities. It is also possible that such unanticipated events would lead us to dispose of those certain holdings and recognize the effects of any such market movements in our financial statements.

 

As of September 30, 2015 (Successor Company), there were estimated gross unrealized losses of $3.6 million related to our mortgage-backed securities collateralized by Alt-A mortgage loans. Gross unrealized losses in our securities collateralized by Alt-A residential mortgage loans as of September 30, 2015 (Successor Company), were primarily the result of continued widening spreads, representing marketplace uncertainty arising from higher defaults in Alt-A residential mortgage loans and rating agency downgrades of securities collateralized by Alt-A residential mortgage loans.

 

141



Table of Contents

 

We have no material concentrations of issuers or guarantors of fixed maturity securities. The industry segment composition of all securities in an unrealized loss position held as of September 30, 2015 (Successor Company) is presented in the following table :

 

 

 

Fair

 

% Fair

 

Amortized

 

% Amortized

 

Unrealized

 

%
Unrealized

 

 

 

Value

 

Value

 

Cost

 

Cost

 

Loss

 

Loss

 

 

 

(Dollars In Thousands)

 

Banking

 

$

2,980,513

 

9.9

%

$

3,085,575

 

9.5

%

$

(105,062

)

4.6

%

Other finance

 

408,757

 

1.4

 

426,277

 

1.3

 

(17,520

)

0.8

 

Electric

 

3,397,040

 

11.3

 

3,713,020

 

11.5

 

(315,980

)

13.9

 

Energy and natural gas

 

3,720,993

 

12.4

 

4,157,421

 

12.9

 

(436,428

)

19.2

 

Insurance

 

2,709,296

 

9.0

 

2,948,968

 

9.1

 

(239,672

)

10.6

 

Communications

 

1,235,449

 

4.1

 

1,399,099

 

4.4

 

(163,650

)

7.2

 

Basic industrial

 

1,514,889

 

5.0

 

1,690,374

 

5.2

 

(175,485

)

7.7

 

Consumer noncyclical

 

2,658,829

 

8.8

 

2,883,786

 

8.9

 

(224,957

)

9.9

 

Consumer cyclical

 

1,360,417

 

4.6

 

1,454,042

 

4.5

 

(93,625

)

4.1

 

Finance companies

 

141,404

 

0.5

 

150,870

 

0.5

 

(9,466

)

0.4

 

Capital goods

 

1,235,493

 

4.1

 

1,320,458

 

4.1

 

(84,965

)

3.7

 

Transportation

 

810,567

 

2.7

 

879,965

 

2.7

 

(69,398

)

3.1

 

Other industrial

 

273,351

 

0.9

 

294,086

 

0.9

 

(20,735

)

0.9

 

Brokerage

 

409,774

 

1.4

 

434,985

 

1.3

 

(25,211

)

1.1

 

Technology

 

1,132,437

 

3.8

 

1,203,863

 

3.7

 

(71,426

)

3.1

 

Real estate

 

191,814

 

0.5

 

195,754

 

0.6

 

(3,940

)

0.2

 

Other utility

 

169,476

 

0.6

 

187,066

 

0.6

 

(17,590

)

0.8

 

Commercial mortgage-backed securities

 

1,104,282

 

3.7

 

1,123,252

 

3.4

 

(18,970

)

0.8

 

Other asset-backed securities

 

704,678

 

2.3

 

728,421

 

2.3

 

(23,743

)

1.0

 

Residential mortgage-backed non-agency securities

 

445,298

 

1.5

 

453,747

 

1.4

 

(8,449

)

0.4

 

Residential mortgage-backed agency securities

 

438,734

 

1.5

 

444,850

 

1.4

 

(6,116

)

0.3

 

U.S. government-related securities

 

1,359,161

 

4.5

 

1,374,704

 

4.3

 

(15,543

)

0.7

 

Other government-related securities

 

18,884

 

0.1

 

19,360

 

0.1

 

(476

)

 

States, municipals, and political divisions

 

1,567,309

 

5.2

 

1,687,132

 

5.2

 

(119,823

)

5.4

 

Preferred stock

 

62,112

 

0.2

 

64,362

 

0.2

 

(2,250

)

0.1

 

Total

 

$

30,050,957

 

100.0

%

$

32,321,437

 

100.0

%

$

(2,270,480

)

100.0

%

 

142



Table of Contents

 

The percentage of our unrealized loss positions, segregated by industry segment, is presented in the following table:

 

 

 

Successor

 

Predecessor

 

 

 

Company

 

Company

 

 

 

As of

 

 

As of

 

 

 

September 30, 2015

 

 

December 31, 2014

 

 

 

 

 

 

 

 

Banking

 

4.6

%

 

9.2

%

Other finance

 

0.8

 

 

0.8

 

Electric

 

13.9

 

 

0.6

 

Energy and natural gas

 

19.2

 

 

22.9

 

Insurance

 

10.6

 

 

4.0

 

Communications

 

7.2

 

 

2.6

 

Basic industrial

 

7.7

 

 

18.4

 

Consumer noncyclical

 

9.9

 

 

3.8

 

Consumer cyclical

 

4.1

 

 

4.4

 

Finance companies

 

0.4

 

 

0.4

 

Capital goods

 

3.7

 

 

1.0

 

Transportation

 

3.1

 

 

0.1

 

Other industrial

 

0.9

 

 

0.6

 

Brokerage

 

1.1

 

 

0.2

 

Technology

 

3.1

 

 

2.8

 

Real estate

 

0.2

 

 

 

Other utility

 

0.8

 

 

 

Commercial mortgage-backed securities

 

0.8

 

 

1.1

 

Other asset-backed securities

 

1.0

 

 

16.8

 

Residential mortgage-backed non-agency securities

 

0.4

 

 

5.4

 

Residential mortgage-backed agency securities

 

0.3

 

 

0.4

 

U.S. government-related securities

 

0.7

 

 

4.3

 

Other government-related securities

 

 

 

 

States, municipals, and political divisions

 

5.4

 

 

0.2

 

Preferred stock

 

0.1

 

 

 

Total

 

100.0

%

 

100.0

%

 

The range of maturity dates for securities in an unrealized loss position as of September 30, 2015 (Successor Company), varies, with 18.1% maturing in less than 5 years, 22.1% maturing between 5 and 10 years, and 59.8% maturing after 10 years. The following table shows the credit rating of securities in an unrealized loss position as of September 30, 2015 (Successor Company):

 

S&P or Equivalent

 

Fair

 

% Fair

 

Amortized

 

% Amortized

 

Unrealized

 

% Unrealized

 

Designation

 

Value

 

Value

 

Cost

 

Cost

 

Loss

 

Loss

 

 

 

(Dollars In Thousands)

 

AAA/AA/A

 

$

15,770,309

 

52.5

%

$

16,759,824

 

51.9

%

$

(989,515

)

43.6

%

BBB

 

13,006,003

 

43.3

 

14,185,281

 

43.9

 

(1,179,278

)

51.9

 

Investment grade

 

28,776,312

 

95.8

 

30,945,105

 

95.8

 

(2,168,793

)

95.5

 

BB

 

987,833

 

3.3

 

1,071,648

 

3.3

 

(83,815

)

3.7

 

B

 

70,031

 

0.2

 

78,288

 

0.2

 

(8,257

)

0.4

 

CCC or lower

 

216,781

 

0.7

 

226,396

 

0.7

 

(9,615

)

0.4

 

Below investment grade

 

1,274,645

 

4.2

 

1,376,332

 

4.2

 

(101,687

)

4.5

 

Total

 

$

30,050,957

 

100.0

%

$

32,321,437

 

100.0

%

$

(2,270,480

)

100.0

%

 

143



Table of Contents

 

As of September 30, 2015 (Successor Company), we held a total of 2,433 positions that were in an unrealized loss position. Included in that amount were 157 positions of below investment grade securities with a fair value of $1.3 billion that were in an unrealized loss position. Total unrealized losses related to below investment grade securities were $101.7 million, none of which had been in an unrealized loss position for more than twelve months. Below investment grade securities in an unrealized loss position were 2.8% of invested assets.

 

As of September 30, 2015 (Successor Company), securities in an unrealized loss position that were rated as below investment grade represented 4.2% of the total fair value and 4.5% of the total unrealized loss. We have the ability and intent to hold these securities to maturity. After a review of each security and its expected cash flows, we believe the decline in market value to be temporary.

 

The majority of our RMBS holdings as of September 30, 2015 (Successor Company), were super senior or senior bonds in the capital structure. Our total non-agency portfolio has a weighted-average life of 7.9 years. The following table categorizes the weighted-average life for our non-agency portfolio, by category of material holdings, as of September 30, 2015 (Successor Company):

 

 

 

Weighted-Average

 

Non-agency portfolio

 

Life

 

 

 

 

 

Prime

 

9.27

 

Alt-A

 

3.66

 

Sub-prime

 

3.73

 

 

The following table includes the fair value, amortized cost, unrealized loss, and total time period that the security has been in an unrealized loss position for all below investment grade securities as of September 30, 2015 (Successor Company):

 

 

 

Fair

 

% Fair

 

Amortized

 

% Amortized

 

Unrealized

 

% Unrealized

 

 

 

Value

 

Value

 

Cost

 

Cost

 

Loss

 

Loss

 

 

 

(Dollars In Thousands)

 

<= 90 days

 

$

790,719

 

62.0

%

$

850,335

 

61.8

%

$

(59,616

)

58.6

%

>90 days but <= 180 days

 

280,348

 

22.0

 

312,391

 

22.7

 

(32,043

)

31.5

 

>180 days but <= 270 days

 

203,578

 

16.0

 

213,606

 

15.5

 

(10,028

)

9.9

 

>270 days but <= 1 year

 

 

 

 

 

 

 

>1 year but <= 2 years

 

 

 

 

 

 

 

>2 years but <= 3 years

 

 

 

 

 

 

 

>3 years but <= 4 years

 

 

 

 

 

 

 

>4 years but <= 5 years

 

 

 

 

 

 

 

>5 years

 

 

 

 

 

 

 

Total

 

$

1,274,645

 

100.0

%

$

1,376,332

 

100.0

%

$

(101,687

)

100.0

%

 

LIQUIDITY AND CAPITAL RESOURCES

 

Liquidity

 

Liquidity refers to a company’s ability to generate adequate amounts of cash to meet its needs. We meet our liquidity requirements primarily through positive cash flows from our operating subsidiaries. Primary sources of cash from the operating subsidiaries are premiums, deposits for policyholder accounts, investment sales and maturities, and investment income. Primary uses of cash include benefit payments, withdrawals from policyholder accounts, investment purchases, policy acquisition costs, interest payments, and other operating expenses. We believe that we have sufficient liquidity to fund our cash needs under normal operating scenarios.

 

In the event of significant unanticipated cash requirements beyond our normal liquidity needs, we have additional sources of liquidity available depending on market conditions and the amount and timing of the liquidity

 

144



Table of Contents

 

need. These additional sources of liquidity include cash flows from operations, the sale of liquid assets, accessing our credit facility, and other sources described herein.

 

Our decision to sell investment assets could be impacted by accounting rules, including rules relating to the likelihood of a requirement to sell securities before recovery of our cost basis. Under stressful market and economic conditions, liquidity may broadly deteriorate, which could negatively impact our ability to sell investment assets. If we require on short notice significant amounts of cash in excess of normal requirements, we may have difficulty selling investment assets in a timely manner, be forced to sell them for less than we otherwise would have been able to realize, or both.

 

While we anticipate that the cash flows of our operating subsidiaries will be sufficient to meet our investment commitments and operating cash needs in a normal credit market environment, we recognize that investment commitments scheduled to be funded may, from time to time, exceed the funds then available. Therefore, we have established repurchase agreement programs for certain of our insurance subsidiaries to provide liquidity when needed. We expect that the rate received on our investments will equal or exceed our borrowing rate. Under this program, we may, from time to time, sell an investment security at a specific price and agree to repurchase that security at another specified price at a later date. These borrowings are typically for a term less than 90 days. The market value of securities to be repurchased is monitored and collateral levels are adjusted where appropriate to protect the counterparty against credit exposure. Cash received is invested in fixed maturity securities, and the agreements provided for net settlement in the event of default or on termination of the agreements. As of September 30, 2015 (Successor Company), the fair value of securities pledged under the repurchase program was $500.5 million and the repurchase obligation of $455.7 million was included in our consolidated condensed balance sheets (at an average borrowing rate of 22 basis points). During the period of February 1, 2015 to September 30, 2015 (Successor Company) and the period of January 1, 2015 to January 31, 2015 (Predecessor Company), the maximum balance outstanding at any one point in time related to these programs was $652.2 million and $175.0 million, respectively. The average daily balance was $530.5 million and $77.4 million (at an average borrowing rate of 18 and 16 basis points, respectively) during the period of February 1, 2015 to September 30, 2015 (Successor Company) and the period of January 1, 2015 to January 31, 2015 (Predecessor Company), respectively. As of December 31, 2014 (Predecessor Company), we had a $50.0 million outstanding balance related to such borrowings. During 2014, the maximum balance outstanding at any one point in time related to these programs was $633.7 million. The average daily balance was $470.4 million (at an average borrowing rate of 11 basis points) during the year ended December 31, 2014 (Predecessor Company).

 

Additionally, we may, from time to time, sell short-duration stable value products to complement our cash management practices. Depending on market conditions, we may also use securitization transactions involving our commercial mortgage loans to increase liquidity for the operating subsidiaries .

 

Credit Facility

 

Under a revolving line of credit arrangement that was in effect until February 2, 2015 (the “Credit Facility”), we and PLC had the ability to borrow on an unsecured basis up to an aggregate principal amount of $750 million. We had the right in certain circumstances to request that the commitment under the Credit Facility be increased up to a maximum principal amount of $1.0 billion. Balances outstanding under the Credit Facility accrued interest at a rate equal to, at the option of the Borrowers, (i) LIBOR plus a spread based on the ratings of PLC’s senior unsecured long-term debt (“Senior Debt”), or (ii) the sum of (A) a rate equal to the highest of (x) the Administrative Agent’s prime rate, (y) 0.50% above the Federal Funds rate, or (z) the one-month LIBOR plus 1.00% and (B) a spread based on the ratings of PLC’s Senior Debt. The Credit Facility also provided for a facility fee at a rate, 0.175%, that could vary with the ratings of PLC’s Senior Debt and that was calculated on the aggregate amount of commitments under the Credit Facility, whether used or unused. The Credit Facility provided that PLC was liable for the full amount of any obligations for borrowings or letters of credit, including those of the Company, under the Credit Facility. The maturity date of the Credit Facility was July 17, 2017. We were not aware of any non-compliance with the financial debt covenants of the Credit Facility as of December 31, 2014 (Predecessor Company). We did not have an outstanding balance under the Credit Facility as of December 31, 2014 (Predecessor Company). PLC had an outstanding balance of $450.0 million bearing interest at a rate of LIBOR plus 1.20% under the Credit Facility as of December 31, 2014 (Predecessor Company). As of December 31, 2014 (Predecessor Company), we had used $55.0 million of borrowing capacity by executing a Letter of Credit under the Credit Facility for the benefit of an affiliated captive reinsurance

 

145



Table of Contents

 

subsidiary of the Company. This Letter of Credit had not been drawn upon as of December 31, 2014 (Predecessor Company).

 

On February 2, 2015, we and PLC amended and restated the Credit Facility (the “2015 Credit Facility”). Under the 2015 Credit Facility, we have the ability to borrow on an unsecured basis up to an aggregate principal amount of $1.0 billion. We have the right in certain circumstances to request that the commitment under the 2015 Credit Facility be increased up to a maximum principal amount of $1.25 billion. Balances outstanding under the 2015 Credit Facility accrue interest at a rate equal to, at the option of the Borrowers, (i) LIBOR plus a spread based on the ratings of PLC’s Senior Debt, or (ii) the sum of (A) a rate equal to the highest of (x) the Administrative Agent’s prime rate, (y) 0.50% above the Federal Funds rate, or (z) the one-month LIBOR plus 1.00% and (B) a spread based on the ratings of PLC’s Senior Debt. The 2015 Credit Facility also provided for a facility fee at a rate that varies with the ratings of PLC’s Senior Debt and that is calculated on the aggregate amount of commitments under the 2015 Credit Facility, whether used or unused. The initial facility fee rate was 0.15% on February 2, 2015, and was adjusted to 0.125% upon PLC’s subsequent ratings upgrade on February 2, 2015. The 2015 Credit Facility provides that PLC is liable for the full amount of any obligations for borrowings or letters of credit, including those of the Company, under the 2015 Credit Facility. The maturity date of the 2015 Credit Facility is February 2, 2020. We are not aware of any non-compliance with the financial debt covenants of the Credit Facility as of February 2, 2015 or the 2015 Credit Facility as of September 30, 2015 (Successor Company). PLC had an outstanding balance of $495.0 million bearing interest at a rate of LIBOR plus 1.00% as of September 30, 2015 (Successor Company). As of September 30, 2015 (Successor Company), we had canceled the $55.0 million Letter of Credit under the Credit Facility for the benefit of an affiliated captive reinsurance subsidiary of the Company.

 

Sources and Use of Cash

 

Our primary sources of funding are from our insurance operations and revenues from investments. These sources of cash support our operations and are used to pay dividends to PLC. The states in which we and our insurance subsidiaries are domiciled impose certain restrictions on the ability to pay dividends. These restrictions are based in part on the prior year’s statutory income and/or surplus.

 

We are a member of the FHLB of Cincinnati and FHLB of New York. FHLB advances provide an attractive funding source for short-term borrowing and for the sale of funding agreements. Membership in the FHLB requires that we purchase FHLB capital stock based on a minimum requirement and a percentage of the dollar amount of advances outstanding. Our borrowing capacity is determined by criteria established by each respective bank .

 

We held $65.7 million of FHLB common stock as of September 30, 2015 (Successor Company), which is included in equity securities. In addition, our obligations under the advances must be collateralized. We maintain control over any such pledged assets, including the right of substitution. As of September 30, 2015 (Successor Company), we had $822.1 million of funding agreement-related advances and accrued interest outstanding under the FHLB program .

 

As of September 30, 2015 (Successor Company), we reported approximately $585.8 million (fair value) of Auction Rate Securities (“ARS”) in non-Modco portfolios. As of September 30, 2015 (Successor Company), 100% of these ARS were rated Aaa/AA+. While the auction rate market has experienced liquidity constraints, we believe that based on our current liquidity position and our operating cash flows, any lack of liquidity in the ARS market will not have a material impact on our liquidity, financial condition, or cash flows. For information on how we determine the fair value of these securities refer to Note 15, Fair Value of Financial Instruments , of the consolidated condensed financial statements.

 

The liquidity requirements of our regulated insurance subsidiaries primarily relate to the liabilities associated with their various insurance and investment products, operating expenses, and income taxes. Liabilities arising from insurance and investment products include the payment of policyholder benefits, as well as cash payments in connection with policy surrenders and withdrawals, policy loans, and obligations to redeem funding agreements .

 

Our insurance subsidiaries maintain investment strategies intended to provide adequate funds to pay benefits and expected surrenders, withdrawals, loans, and redemption obligations without forced sales of investments. In addition, our insurance subsidiaries hold highly liquid, high-quality short-term investment securities and other liquid

 

146



Table of Contents

 

investment grade fixed maturity securities to fund our expected operating expenses, surrenders, and withdrawals . We were committed as of September 30, 2015 (Successor Company), to fund mortgage loans in the amount of $774.3 million.

 

Our positive cash flows from operations are used to fund an investment portfolio that provides for future benefit payments. We employ a formal asset/liability program to manage the cash flows of our investment portfolio relative to our long-term benefit obligations. As of September 30, 2015 (Successor Company), we held cash and short-term investments of approximately $751.2 million.

 

The following chart includes the cash flows provided by or used in operating, investing, and financing activities for the following periods :

 

 

 

Successor

 

Predecessor

 

 

 

Company

 

Company

 

 

 

February 1, 2015

 

 

January 1, 2015

 

For The Nine

 

 

 

to

 

 

to

 

Months Ended

 

 

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

 

 

(Dollars In Thousands)

 

 

(Dollars In Thousands)

 

Net cash provided by operating activities

 

$

393,160

 

 

$

148,060

 

$

538,090

 

Net cash (used in) provided by investing activities

 

(710,602

)

 

33,475

 

(456,749

)

Net cash provided by (used in) financing activities

 

456,439

 

 

(70,918

)

(217,005

)

Total

 

$

138,997

 

 

$

110,617

 

$

(135,664

)

 

For The Period of February 1, 2015 to September 30, 2015 (Successor Company) and For the Period of January 1, 2015 to January 31, 2015 (Predecessor Company)

 

Net cash provided by operating activities - Cash flows from operating activities are affected by the timing of premiums received, fees received, investment income, and expenses paid. Principal sources of cash include sales of our products and services. We typically generate positive cash flows from operating activities, as premiums and policy fees collected from our insurance and investment products exceed benefit payments and redemptions, and we invest the excess. Accordingly, in analyzing our cash flows we focus on the amount of cash provided by or used in investing and financing activities.

 

Net cash (used in) provided by investing activities - Changes in cash from investing activities primarily related to the activity in our investment portfolio.

 

Net cash provided by (used in) financing activities - Changes in cash from financing activities included $405.7 million of inflows from repurchase program borrowings for the period of February 1, 2015 to September 30, 2015 (Successor Company) and $230.7 million of inflows of investment product and universal life net activity for the period of February 1, 2015 to September 30, 2015 (Successor Company). Net issuance of non-recourse funding obligations was $50.0 million during the period of February 1, 2015 to September 30, 2015 (Successor Company).

 

Changes in cash from financing activities included $70.9 million outflows of investment product and universal life net activity for the period of January 1, 2015 to January 31, 2015 (Predecessor Company).

 

Capital Resources

 

Our primary sources of capital are from retained income from our insurance operations and capital infusions from our parent, PLC. Additionally, we have access to the Credit Facility discussed above.

 

Captive Reinsurance Companies

 

Our life insurance subsidiaries are subject to a regulation entitled “Valuation of Life Insurance Policies Model Regulation,” commonly known as “Regulation XXX,” and a supporting guideline entitled “The Application of the Valuation of Life Insurance Policies Model Regulation,” commonly known as “Guideline AXXX.” The regulation and

 

147



Table of Contents

 

supporting guideline require insurers to establish statutory reserves for term and universal life insurance policies with long-term premium guarantees that are consistent with the statutory reserves required for other individual life insurance policies with similar guarantees. Many market participants believe that these levels of reserves are non-economic. We use captive reinsurance companies to implement reinsurance and capital management actions to satisfy these reserve requirements by financing the non-economic reserves either through the issuance of non-recourse funding obligations by the captives or obtaining Letters of Credit from third-party financial institutions. For more information regarding our use of captives and their impact on our financial statements, please refer to Note 9, Debt and Other Obligations .

 

Our captive reinsurance companies assume business from affiliates only. Our captives are capitalized to a level we believe is sufficient to support the contractual risks and other general obligations of the respective captive entity. All of our captive reinsurance companies, with the exception of Shades Creek, are wholly owned subsidiaries and are located domestically. The captive insurance companies are subject to regulations in the state of domicile.

 

The National Association of Insurance Commissioners (“NAIC”), through various committees, subgroups and dedicated task forces, is reviewing the use of captives and special purpose vehicles used to transfer insurance risk in relation to existing state laws and regulations, and several committees have adopted or exposed for comment white papers and reports that, if or when implemented, could impose additional requirements on the use of captives and other reinsurers. The Financial Condition (E) Committee of the NAIC recently established a Variable Annuity Issues Working Group to examine company use of variable annuity captives.

 

The Principles Based Reserving Implementation (EX) Task Force of the NAIC, charged with analysis of the adoption of a principles-based reserving methodology, adopted the “conceptual framework” contained in a report issued by Rector & Associates, Inc., dated June 4, 2014 (as modified or supplemented, the “Rector Report”), that contains numerous recommendations pertaining to the regulation and use of certain captive reinsurers. Certain high-level recommendations have been adopted and assigned to various NAIC working groups, which working groups are in various stages of discussions regarding recommendations. One recommendation of the Rector Report has been adopted as Actuarial Guideline XLVIII (“AG48”). AG48 sets more restrictive standards on the permitted collateral utilized to back reserves of a captive. Other recommendations in the Rector Report are subject to ongoing comment and revision. It is unclear at this time to what extent the recommendations in the Rector Report, or additional or revised recommendations relating to captive transactions or reinsurance transactions in general, will be adopted by the NAIC. If the recommendations proposed in the Rector Report are implemented, it will likely be difficult for the Company to establish new captive financing arrangements on a basis consistent with past practices. As a result of AG48 and the Rector Report, the implementation of new captive structures in the future may be less capital efficient, may lead to lower product returns and/or increased product pricing or result in reduced sales of certain products. Additionally, in some circumstances AG48 and the implementation of the recommendations in the Rector Report could impact the Company’s ability to engage in certain reinsurance transactions with non-affiliates.

 

We also use a captive reinsurance company to reinsure risks associated with GMWB and GMDB riders which helps us to manage those risks on an economic basis. In an effort to mitigate the equity market risks relative to our RBC ratio, in the fourth quarter of 2012, PLC established a direct wholly owned subsidiary, Shades Creek Captive Insurance Company (“Shades Creek”), to which we have reinsured GMWB and GMDB riders related to its VA contracts. The purpose of Shades Creek is to reduce the volatility in RBC due to non-economic variables included within the RBC calculation.

 

During 2012, PLC entered into an intercompany capital support agreement with Shades Creek. The agreement provides through a guarantee that PLC will contribute assets or purchase surplus notes (or cause an affiliate or third party to contribute assets or purchase surplus notes) in amounts necessary for Shades Creek’s regulatory capital levels to equal or exceed minimum thresholds as defined by the agreement. Under this support agreement, we issued a $55 million Letter of Credit on December 31, 2014 (Predecessor Company). As of September 30, 2015 (Successor Company), this Letter of Credit was no longer issued and outstanding. On June 15, 2015, PLC made a cash contribution to Shades Creek of $85 million to satisfy obligations under this support agreement. The maximum potential future payment amount which could be required under the capital support agreement will be dependent on numerous factors, including the performance of equity markets, the level of interest rates, performance of associated hedges, and related policyholder behavior.

 

148



Table of Contents

 

A life insurance company’s statutory capital is computed according to rules prescribed by the NAIC, as modified by state law. Generally speaking, other states in which a company does business defer to the interpretation of the domiciliary state with respect to NAIC rules, unless inconsistent with the other state’s regulations. Statutory accounting rules are different from GAAP and are intended to reflect a more conservative view, for example, requiring immediate expensing of policy acquisition costs. The NAIC’s risk-based capital requirements require insurance companies to calculate and report information under a risk-based capital formula. The achievement of long-term growth will require growth in the statutory capital of our insurance subsidiaries. We and our subsidiaries may secure additional statutory capital through various sources, such as retained statutory earnings or our equity contributions. In general, dividends up to specified levels are considered ordinary and may be paid thirty days after written notice to the insurance commissioner of the state of domicile unless such commissioner objects to the dividend prior to the expiration of such period. Dividends in larger amounts are considered extraordinary and are subject to affirmative prior approval by such commissioner. The maximum amount that would qualify as an ordinary dividend from our insurance subsidiaries in 2015 is approximately $138.4 million.

 

State insurance regulators and the NAIC have adopted risk-based capital (“RBC”) requirements for life insurance companies to evaluate the adequacy of statutory capital and surplus in relation to investment and insurance risks. The requirements provide a means of measuring the minimum amount of statutory surplus appropriate for an insurance company to support its overall business operations based on its size and risk profile. A company’s risk-based statutory surplus is calculated by applying factors and performing calculations relating to various asset, premium, claim, expense, and reserve items. Regulators can then measure the adequacy of a company’s statutory surplus by comparing it to RBC. We manage our capital consumption by using the ratio of our total adjusted capital, as defined by the insurance regulators, to our company action level RBC (known as the RBC ratio), also as defined by insurance regulators.

 

Statutory reserves established for VA contracts are sensitive to changes in the equity markets and are affected by the level of account values relative to the level of any guarantees and product design. As a result, the relationship between reserve changes and equity market performance may be non-linear during any given reporting period. Market conditions greatly influence the capital required due to their impact on the valuation of reserves and derivative investments mitigating the risk in these reserves. Risk mitigation activities may result in material and sometimes counterintuitive impacts on statutory surplus and RBC ratio. Notably, as changes in these market and non-market factors occur, both our potential obligation and the related statutory reserves and/or required capital can vary at a non-linear rate.

 

Our statutory surplus is impacted by credit spreads as a result of accounting for the assets and liabilities on our fixed MVA annuities. Statutory separate account assets supporting the fixed MVA annuities are recorded at fair value. In determining the statutory reserve for the fixed MVA annuities, we are required to use current crediting rates based on U.S. Treasuries. In many capital market scenarios, current crediting rates based on U.S. Treasuries are highly correlated with market rates implicit in the fair value of statutory separate account assets. As a result, the change in the statutory reserve from period to period will likely substantially offset the change in the fair value of the statutory separate account assets. However, in periods of volatile credit markets, actual credit spreads on investment assets may increase or decrease sharply for certain sub-sectors of the overall credit market, resulting in statutory separate account asset market value gains or losses. As actual credit spreads are not fully reflected in current crediting rates based on U.S. Treasuries, the calculation of statutory reserves will not substantially offset the change in fair value of the statutory separate account assets resulting in a change in statutory surplus.

 

We cede material amounts of insurance and transfer related assets to other insurance companies through reinsurance. However, notwithstanding the transfer of related assets, we remain liable with respect to ceded insurance should any reinsurer fail to meet the obligations that it assumed. We evaluate the financial condition of our reinsurers and monitor the associated concentration of credit risk. For the three months ended September 30, 2015 (Successor Company), the period of February 1, 2015 to September 30, 2015 (Successor Company), and for the period of January 1, 2015 to January 31, 2015 (Predecessor Company), we ceded premiums to third party reinsurers amounting to $312.3 million, $810.3 million, and $91.6 million, respectively. In addition, we had receivables from reinsurers amounting to $5.4 billion as of September 30, 2015 (Successor Company). We review reinsurance receivable amounts for collectability and establish bad debt reserves if deemed appropriate.

 

149



Table of Contents

 

Ratings

 

Various Nationally Recognized Statistical Rating Organizations (“rating organizations”) review the financial performance and condition of insurers, including our insurance subsidiaries, and publish their financial strength ratings as indicators of an insurer’s ability to meet policyholder and contract holder obligations. These ratings are important to maintaining public confidence in an insurer’s products, its ability to market its products and its competitive position. The following table summarizes the current financial strength ratings of our significant member companies from the major independent rating organizations:

 

 

 

 

 

 

 

Standard &

 

 

 

Ratings

 

A.M. Best

 

Fitch

 

Poor’s

 

Moody’s

 

 

 

 

 

 

 

 

 

 

 

Insurance company financial strength rating:

 

 

 

 

 

 

 

 

 

Protective Life Insurance Company

 

A+

 

A

 

AA-

 

A2

 

West Coast Life Insurance Company

 

A+

 

A

 

AA-

 

A2

 

Protective Life and Annuity Insurance Company

 

A+

 

A

 

AA-

 

 

Lyndon Property Insurance Company

 

A-

 

 

 

 

MONY Life Insurance Company

 

A+

 

A

 

A+

 

A2

 

 

Our ratings are subject to review and change by the rating organizations at any time and without notice. A downgrade or other negative action by a ratings organization with respect to the financial strength ratings of our insurance subsidiaries could adversely affect sales, relationships with distributors, the level of policy surrenders and withdrawals, competitive position in the marketplace, and the cost or availability of reinsurance. The rating agencies may take various actions, positive or negative, with respect to the debt and financial strength ratings of PLC and its subsidiaries, including as a result of PLC’s status as a subsidiary of Dai-ichi Life.

 

On April 28, 2015, Fitch announced a one-notch downgrade of the insurance financial strength ratings of the Company, West Coast Life Insurance Company, Protective Life and Annuity Insurance Company and MONY Life Insurance Company to A from A+ following the downgrade of Japan’s Long-Term Local Currency Issuer Default Rating (IDR) to A from A+.  Fitch stated that such life insurance companies cannot be rated above the sovereign currency rating applicable to their ultimate parent company, Dai-ichi Life, based in Japan. The ratings downgrades announced by Fitch did not trigger any requirements for the Company or its affiliates to post collateral or otherwise negatively impact current obligations.

 

LIABILITIES

 

Many of our products contain surrender charges and other features that are designed to reward persistency and penalize the early withdrawal of funds. Certain stable value and annuity contracts have market-value adjustments that protect us against investment losses if interest rates are higher at the time of surrender than at the time of issue.

 

As of September 30, 2015 (Successor Company), we had policy liabilities and accruals of approximately $30.4 billion. Our interest-sensitive life insurance policies have a weighted average minimum credited interest rate of approximately 3.49%.

 

Contractual Obligations

 

We enter into various obligations to third parties in the ordinary course of our operations. However, we do not believe that our cash flow requirements can be assessed solely based upon an analysis of these obligations. The most significant factors affecting our future cash flows are our ability to earn and collect cash from our customers, and the cash flows arising from our investment program. Future cash outflows, whether they are contractual obligations or not, will also vary based upon our future needs. Although some outflows are fixed, others depend on future events. Examples of fixed obligations include our obligations to pay principal and interest on fixed-rate borrowings. Examples of obligations that will vary include obligations to pay interest on variable-rate borrowings and insurance liabilities that depend on future interest rates, market performance, or surrender provisions. Many of our obligations are linked to

 

150



Table of Contents

 

cash-generating contracts. In addition, our operations involve significant expenditures that are not based upon contractual obligations. These include expenditures for income taxes and payroll.

 

As of September 30, 2015 (Successor Company), we carried a $23.7 million liability for uncertain tax positions. These amounts are not included in the long-term contractual obligations table because of the difficulty in making reasonably reliable estimates of the occurrence or timing of cash settlements with the respective taxing authorities.

 

The table below sets forth future maturities of our contractual obligations:

 

 

 

 

 

Payments due by period

 

 

 

 

 

Less than

 

 

 

 

 

More than

 

 

 

Total

 

1 year

 

1-3 years

 

3-5 years

 

5 years

 

 

 

(Dollars In Thousands)

 

Non-recourse funding obligations (1)

 

$

4,422,041

 

$

98,839

 

$

209,144

 

$

222,018

 

$

3,892,040

 

Stable value products (2)

 

1,949,343

 

639,192

 

1,090,132

 

164,193

 

55,826

 

Operating leases (3)

 

33,121

 

5,196

 

7,506

 

6,689

 

13,730

 

Home office lease (4)

 

79,096

 

1,265

 

2,523

 

75,308

 

 

Mortgage loan and investment commitments

 

1,003,302

 

1,003,302

 

 

 

 

Repurchase program borrowings (5)

 

455,725

 

455,725

 

 

 

 

Policyholder obligations (6)

 

41,154,664

 

1,592,613

 

3,069,523

 

3,334,901

 

33,157,627

 

Total

 

$

49,097,292

 

$

3,796,132

 

$

4,378,828

 

$

3,803,109

 

$

37,119,223

 

 


(1)

Non-recourse funding obligations include all undiscounted principal amounts owed and expected future interest payments due over the term of the notes. Of the total undiscounted cash flows, $1.8 billion relates to the Golden Gate V transaction. These cash outflows are matched and predominantly offset by the cash inflows Golden Gate V receives from notes issued by a nonconsolidated variable interest entity. Additionally, $2.2 billion of the total undiscounted cash flows are obligations to PLC. The remaining amounts are associated with the Golden Gate II notes held by third parties as well as certain obligations assumed with the acquisition of MONY Life Insurance Company.

(2)

Anticipated stable value products cash flows including interest.

(3)

Includes all lease payments required under operating lease agreements.

(4)

The lease payments shown assume we exercise our option to purchase the building at the end of the lease term. Additionally, the payments due by the periods above were computed based on the terms of the renegotiated lease agreement, which was entered in December 2013.

(5)

Represents secured borrowings as part of our repurchase program as well as related interest.

(6)

Estimated contractual policyholder obligations are based on mortality, morbidity, and lapse assumptions comparable to our historical experience, modified for recent observed trends. These obligations are based on current balance sheet values and include expected interest crediting, but do not incorporate an expectation of future market growth, or future deposits. Due to the significance of the assumptions used, the amounts presented could materially differ from actual results. As variable separate account obligations are legally insulated from general account obligations, the variable separate account obligations will be fully funded by cash flows from variable separate account assets. We expect to fully fund the general account obligations from cash flows from general account investments.

 

FAIR VALUE OF FINANCIAL INSTRUMENTS

 

FASB guidance defines fair value for GAAP and establishes a framework for measuring fair value as well as a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. The term “fair value” in this document is defined in accordance with GAAP. The standard describes three levels of inputs that may be used to measure fair value. For more information, see Note 2 , Summary of Significant Accounting Policies and Note 14, Fair Value of Financial Instruments.

 

151



Table of Contents

 

OFF-BALANCE SHEET ARRANGEMENTS

 

We have entered into operating leases that do not result in an obligation being recorded on the balance sheet. Refer to Note 11, Commitments and Contingencies , of the consolidated financial statements for more information.

 

MARKET RISK EXPOSURES

 

Our financial position and earnings are subject to various market risks including changes in interest rates, the yield curve, spreads between risk-adjusted and risk-free interest rates, foreign currency rates, used vehicle prices, and equity price risks and issuer defaults. We analyze and manage the risks arising from market exposures of financial instruments, as well as other risks, through an integrated asset/liability management process. Our asset/liability management programs and procedures involve the monitoring of asset and liability durations for various product lines; cash flow testing under various interest rate scenarios; and the continuous rebalancing of assets and liabilities with respect to yield, credit and market risk, and cash flow characteristics. These programs also incorporate the use of derivative financial instruments primarily to reduce our exposure to interest rate risk, inflation risk, currency exchange risk, volatility risk, and equity market risk. See Note 15, Derivative Financial Instruments to the consolidated condensed financial statements included in this report for additional information on our financial instruments.

 

The primary focus of our asset/liability program is the management of interest rate risk within the insurance operations. This includes monitoring the duration of both investments and insurance liabilities to maintain an appropriate balance between risk and profitability for each product category, and for us as a whole. It is our policy to maintain asset and liability durations within one year of one another, although, from time to time, a broader interval may be allowed.

 

We are exposed to credit risk within our investment portfolio and through derivative counterparties. Credit risk relates to the uncertainty of an obligor’s continued ability to make timely payments in accordance with the contractual terms of the instrument or contract. We manage credit risk through established investment policies which attempt to address quality of obligors and counterparties, credit concentration limits, diversification requirements, and acceptable risk levels under expected and stressed scenarios. Derivative counterparty credit risk is measured as the amount owed to us, net of collateral held, based upon current market conditions. In addition, we periodically assess exposure related to potential payment obligations between us and our counterparties. We minimize the credit risk in derivative financial instruments by entering into transactions with high quality counterparties, (A-rated or higher at the time we enter into the contract), and we maintain credit support annexes with certain of those counterparties.

 

We utilize a risk management strategy that includes the use of derivative financial instruments. Derivative instruments expose us to credit market and basis risk. Such instruments can change materially in value from period- to-period. We minimize our credit risk by entering into transactions with highly rated counterparties. We manage the market and basis risks by establishing and monitoring limits as to the types and degrees of risk that may be undertaken. We monitor our use of derivatives in connection with our overall asset/liability management programs and procedures. In addition, all derivative programs are monitored by our risk management department.

 

Derivative instruments that are used as part of our interest rate risk management strategy include interest rate swaps, interest rate futures, interest rate caps, and interest rate options. Our inflation risk management strategy involves the use of swaps that require us to pay a fixed rate and receive a floating rate that is based on changes in the Consumer Price Index (“CPI”).

 

We may use the following types of derivative contracts to mitigate our exposure to certain guaranteed benefits related to variable annuity, fixed indexed annuity, and indexed universal life contracts:

 

·                   Foreign Currency Futures

·                   Variance Swaps

·                   Interest Rate Futures

·                   Equity Options

·                   Equity Futures

·                   Credit Derivatives

·                   Interest Rate Swaps

 

152



Table of Contents

 

·                   Interest Rate Swaptions

·                   Volatility Futures

·                   Volatility Options

·                   Funds Withheld Agreement

·                   Total Return Swaps

 

Other Derivatives

 

Certain of our subsidiaries have derivatives with PLC. These derivatives consist of an interest support agreement, a YRT premium support arrangement, and portfolio maintenance agreements with PLC.

 

We have a funds withheld account that consists of various derivative instruments held by us that is used to hedge the GMWB and GMDB riders. The economic performance of derivatives in the funds withheld account is ceded to Shades Creek. The funds withheld account is accounted for as a derivative financial instrument.

 

We believe that our asset/liability management programs and procedures and certain product features provide protection against the effects of changes in interest rates under various scenarios. Additionally, we believe our asset/liability management programs and procedures provide sufficient liquidity to enable us to fulfill our obligation to pay benefits under our various insurance and deposit contracts. However, our asset/liability management programs and procedures incorporate assumptions about the relationship between short-term and long-term interest rates (i.e., the slope of the yield curve), relationships between risk-adjusted and risk-free interest rates, market liquidity, spread movements, implied volatility, policyholder behavior, and other factors, and the effectiveness of our asset/liability management programs and procedures may be negatively affected whenever actual results differ from those assumptions.

 

In the ordinary course of our commercial mortgage lending operations, we may commit to provide a mortgage loan before the property to be mortgaged has been built or acquired. The mortgage loan commitment is a contractual obligation to fund a mortgage loan when called upon by the borrower. The commitment is not recognized in our financial statements until the commitment is actually funded. The mortgage loan commitment contains terms, including the rate of interest, which may be different than prevailing interest rates. As of September 30, 2015 (Successor Company), we had outstanding mortgage loan commitments of $774.3 million at an average rate of 4.4%.

 

Impact of continued low interest rate environment

 

Significant changes in interest rates expose us to the risk of not realizing anticipated spreads between the interest rate earned on investments and the interest rate credited to in-force policies and contracts. In addition, certain of our insurance and investment products guarantee a minimum guaranteed interest rate (“MGIR”). In periods of prolonged low interest rates, the interest spread earned may be negatively impacted to the extent our ability to reduce policyholder crediting rates is limited by the guaranteed minimum credited interest rates. Additionally, those policies without account values may exhibit lower profitability in periods of prolonged low interest rates due to reduced investment income.

 

153



Table of Contents

 

The table below presents account values by range of current minimum guaranteed interest rates and current crediting rates for our universal life and deferred fixed annuity products as of September 30, 2015 (Successor Company) and December 31, 2014 (Predecessor Company):

 

Credited Rate Summary

 

As of September 30, 2015 (Successor Company)

 

 

 

 

 

 

1-50 bps

 

More than

 

 

 

Minimum Guaranteed Interest Rate

 

At

 

above

 

50 bps

 

 

 

Account Value

 

MGIR

 

MGIR

 

above MGIR

 

Total

 

 

 

(Dollars In Millions)

 

Universal Life Insurance

 

 

 

 

 

 

 

 

 

>2% - 3%

 

$

192

 

$

1,006

 

$

2,017

 

$

3,215

 

>3% - 4%

 

3,641

 

1,629

 

26

 

5,296

 

>4% - 5%

 

1,997

 

14

 

 

2,011

 

>5% - 6%

 

218

 

 

 

218

 

Subtotal

 

6,048

 

2,649

 

2,043

 

10,740

 

 

 

 

 

 

 

 

 

 

 

Fixed Annuities

 

 

 

 

 

 

 

 

 

1%

 

$

657

 

$

170

 

$

154

 

$

981

 

>1% - 2%

 

577

 

506

 

134

 

1,217

 

>2% - 3%

 

1,914

 

475

 

16

 

2,405

 

>3% - 4%

 

284

 

 

 

284

 

>4% - 5%

 

288

 

 

 

288

 

>5% - 6%

 

3

 

 

 

3

 

Subtotal

 

3,723

 

1,151

 

304

 

5,178

 

Total

 

$

9,771

 

$

3,800

 

$

2,347

 

$

15,918

 

 

 

 

 

 

 

 

 

 

 

Percentage of Total

 

61

%

24

%

15

%

100

%

 

 

 

Credited Rate Summary

 

As of December 31, 2014 (Predecessor Company)

 

 

 

 

 

 

1-50 bps

 

More than

 

 

 

Minimum Guaranteed Interest Rate

 

At

 

above

 

50 bps

 

 

 

Account Value

 

MGIR

 

MGIR

 

above MGIR

 

Total

 

 

 

(Dollars In Millions)

 

Universal Life Insurance

 

 

 

 

 

 

 

 

 

>2% - 3%

 

$

188

 

$

958

 

$

2,018

 

$

3,164

 

>3% - 4%

 

3,526

 

1,670

 

138

 

5,334

 

>4% - 5%

 

2,035

 

15

 

 

2,050

 

>5% - 6%

 

224

 

 

 

224

 

Subtotal

 

5,973

 

2,643

 

2,156

 

10,772

 

 

 

 

 

 

 

 

 

 

 

Fixed Annuities

 

 

 

 

 

 

 

 

 

1%

 

$

602

 

$

179

 

$

239

 

$

1,020

 

>1% - 2%

 

597

 

516

 

197

 

1,310

 

>2% - 3%

 

2,005

 

368

 

203

 

2,576

 

>3% - 4%

 

297

 

 

 

297

 

>4% - 5%

 

295

 

 

 

295

 

>5% - 6%

 

3

 

 

 

3

 

Subtotal

 

3,799

 

1,063

 

639

 

5,501

 

Total

 

$

9,772

 

$

3,706

 

$

2,795

 

$

16,273

 

 

 

 

 

 

 

 

 

 

 

Percentage of Total

 

60

%

23

%

17

%

100

%

 

154



Table of Contents

 

We are active in mitigating the impact of a continued low interest rate environment through product design, as well as adjusting crediting rates on current in-force policies and contracts. We also manage interest rate and reinvestment risks through our asset/liability management process. Our asset/liability management programs and procedures involve the monitoring of asset and liability durations; cash flow testing under various interest rate scenarios; and the regular rebalancing of assets and liabilities with respect to yield, credit and market risk, and cash flow characteristics. These programs also incorporate the use of derivative financial instruments primarily to reduce our exposure to interest rate risk, inflation risk, currency exchange risk, volatility risk, and equity market risk.

 

IMPACT OF INFLATION

 

Inflation increases the need for life insurance. Many policyholders who once had adequate insurance programs may increase their life insurance coverage to provide the same relative financial benefit and protection. Higher interest rates may result in higher sales of certain of our investment products.

 

The higher interest rates that have traditionally accompanied inflation could also affect our operations. Policy loans increase as policy loan interest rates become relatively more attractive. As interest rates increase, disintermediation of stable value and annuity account balances and individual life policy cash values may increase. The market value of our fixed-rate, long-term investments may decrease, we may be unable to implement fully the interest rate reset and call provisions of our mortgage loans, and our ability to make attractive mortgage loans, including participating mortgage loans, may decrease. In addition, participating mortgage loan income may decrease. The difference between the interest rate earned on investments and the interest rate credited to life insurance and investment products may also be adversely affected by rising interest rates. During the periods covered by this report, we believe inflation has not had a material impact on our business.

 

RECENTLY ISSUED ACCOUNTING STANDARDS

 

See Note 2, Summary of Significant Accounting Policies , t o the consolidated condensed financial statements for information regarding recently issued accounting standards.

 

155



Table of Contents

 

Item 3.                      Quantitative and Qualitative Disclosures about Market Risk

 

See Part I, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations , “Liquidity and Capital Resources” and Part II, Item 1A, Risk Factors of this report for market risk disclosures.

 

Item 4.                      Controls and Procedures

 

(a)                                  Disclosure controls and procedures

 

In order to ensure that the information the Company must disclose in its filings with the Securities and Exchange Commission is recorded, processed, summarized, and reported on a timely basis, the Company’s management, with the participation of its Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of its disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), except as otherwise noted below. Based on their evaluation as of the end of the period covered by this Form 10-Q, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective. It should be noted that any system of controls, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of any control system is based in part upon certain judgments, including the costs and benefits of controls and the likelihood of future events. Because of these and other inherent limitations of control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within the Company have been detected.

 

(b)                              Changes in internal control over financial reporting

 

During the period from February 1, 2015 through September 30, 2015 (Successor Company), the Company updated its internal controls over financial reporting to ensure the accuracy of information disclosed as a result of the Merger, including but not limited to internal controls over reporting of goodwill and intangible assets. Other than the updates mentioned, there have been no changes in the Company’s internal control over financial reporting during the period of January 1, 2015 to January 31, 2015 (Predecessor Company) or the period of February 1, 2015 to September 30, 2015 (Successor Company), that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. The Company’s internal controls exist within a dynamic environment and the Company continually strives to improve its internal controls and procedures to enhance the quality of its financial reporting.

 

156



Table of Contents

 

PART II

 

Item 1A.  Risk Factors

 

The operating results of companies in the insurance industry have historically been subject to significant fluctuations. The factors which could affect the Company’s future results include, but are not limited to, general economic conditions and known trends and uncertainties. In addition to other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A, Risk Factors in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 (Successor Company), which could materially affect the Company’s business, financial condition, or future results of operations .

 

The Company may not be able to achieve the expected results from its recently announced reinsurance transaction or obtain financing on terms currently anticipated.

 

On September 30, 2015, the Company, entered into a Master Agreement (the “Master Agreement”) with Genworth Life and Annuity Insurance Company (“GLAIC”). Pursuant to the Master Agreement, the Company agreed to enter into a reinsurance agreement (the “Reinsurance Agreement”) pursuant to which the Company will coinsure certain term life insurance business of GLAIC. In connection with the reinsurance transaction, the Company intends to enter into a financing transaction with a term of up to 20 years involving, among other parties, its indirect wholly owned subsidiary, Golden Gate Captive Insurance Company (“Golden Gate”), and a syndicate of third-party risk takers, to finance up to $2.2 billion of “XXX” reserves related to the GLAIC business to be reinsured and the other term life insurance business currently reinsured by Golden Gate. Although the Company intends to execute the financing transaction concurrently with its entry into the Reinsurance Agreement, the closing of the transactions contemplated by the Master Agreement is not conditioned upon the consummation of the financing transaction.

 

The transaction is conditioned on, among other things, the satisfaction of various closing conditions, including the receipt of required regulatory approvals. If the transaction is not completed, the Company may be required to pay its costs relating to the transaction, such as legal, accounting and actuarial fees, and the time and resources committed by the Company’s management to matters relating to the transaction could otherwise have been devoted to the Company’s existing business or to pursuing other beneficial opportunities. A delay in the closing of the transaction may negatively impact the expected results from the transaction. In addition, the Company may not be able to obtain financing on terms currently anticipated, and the source of funds for the transaction may be different than currently contemplated and could consume capital resources that would no longer be available for other corporate purposes. If completed, the actual financial results of the transaction could differ materially from the Company’s expectations and may be impacted by items not taken into account in its forecasts and calculations. In addition, the Company’s expectations regarding the performance and administration of the business, and the parties’ ability to satisfy their respective legal and compliance obligations in relation to the transaction, may prove to be incorrect.  The occurrence or realization of the foregoing could have an adverse impact on the Company’s financial condition or results of operations.

 

Assets allocated to the MONY Closed Block benefit only the holders of certain policies; adverse performance of Closed Block assets or adverse experience of Closed Block liabilities may negatively affect the Company.

 

On October 1, 2013, the Company completed the acquisition of MONY Life Insurance Company from AXA Financial, Inc. MONY was converted from a mutual insurance company to a stock corporation in accordance with its Plan of Reorganization dated August 14, 1998, as amended. In connection with its demutualization, an accounting mechanism known as a closed block (the “Closed Block”) was established for the benefit of policyholders who owned certain individual insurance policies of MONY in force as of the date of demutualization. Please refer to Note 4, MONY Closed Block of Business , to the consolidated financial statements for a more detailed description of the Closed Block.

 

Assets allocated to the Closed Block inure solely to the benefit of the Closed Block’s policyholders and will not revert to the benefit of the Company. However, if the Closed Block has insufficient funds to make guaranteed policy benefit payments, such payments must be made from assets outside the Closed Block. Adverse financial or investment performance of the Closed Block, or adverse mortality or lapse experience on policies in the Closed Block, may require MONY to pay policyholder benefits using assets outside the Closed Block, which events could have a material adverse impact on the Company’s financial condition or results of operations and negatively affect the

 

157



Table of Contents

 

Company’s risk-based capital ratios. In addition, regulatory actions could require payment of dividends to policyholders in a larger amount than is anticipated by the Company, which could have a material adverse impact on the Company.

 

The Company is dependent on the performance of others.

 

The Company’s results may be affected by the performance of others because the Company has entered into various arrangements involving other parties. For example, most of the Company’s products are sold through independent distribution channels, variable annuity deposits are invested in funds managed by third parties, and certain modified coinsurance assets are managed by third parties. Also, the Company may rely upon third parties to administer certain portions of its business or business that it reinsures. Additionally, the Company’s operations are dependent on various technologies, some of which are provided and/or maintained by other parties. Any of the other parties upon which the Company depends may default on their obligations to the Company due to bankruptcy, insolvency, lack of liquidity, adverse economic conditions, operational failure, fraud, or other reasons. Such defaults could have a material adverse effect on the Company’s financial condition and results of operations.

 

Certain of these other parties may act on behalf of the Company or represent the Company in various capacities. Consequently, the Company may be held responsible for obligations that arise from the acts or omissions of these other parties. As with all financial services companies, the Company’s ability to conduct business is dependent upon consumer confidence in the industry and its products. Actions of competitors and financial difficulties of other companies in the industry could undermine consumer confidence and adversely affect retention of existing business and future sales of the Company’s insurance and investment products.

 

A ratings downgrade or other negative action by a ratings organization could adversely affect the Company.

 

Various Nationally Recognized Statistical Rating Organizations (“rating organizations”) review the financial performance and condition of insurers, including the Company’s insurance subsidiaries, and publish their financial strength ratings as indicators of an insurer’s ability to meet policyholder and contract holder obligations. While financial strength ratings are not a recommendation to buy the Company’s securities or products, these ratings are important to maintaining public confidence in the Company, its products, its ability to market its products, and its competitive position. A downgrade or other negative action by a ratings organization with respect to the financial strength ratings of the Company’s insurance subsidiaries or the debt ratings of the Company could adversely affect the Company in many ways, including the following: reducing new sales of insurance and investment products; adversely affecting relationships with distributors and sales agents; increasing the number or amount of policy surrenders and withdrawals of funds; requiring a reduction in prices for the Company’s insurance products and services in order to remain competitive; and adversely affecting the Company’s ability to obtain reinsurance at a reasonable price, on reasonable terms or at all. A downgrade of sufficient magnitude could result in the Company, its insurance subsidiaries, or both being required to collateralize reserves, balances or obligations under reinsurance, funding, swap, and securitization agreements. A downgrade of sufficient magnitude could also result in the termination of certain funding and swap agreements.

 

Rating organizations also publish credit ratings for issuers of debt securities, including the Company. Credit ratings are indicators of a debt issuer’s ability to meet the terms of debt obligations in a timely manner. These ratings are important to the Company’s overall ability to access credit markets and other types of liquidity. Credit ratings are not recommendations to buy the Company’s securities or products. Downgrades of the Company’s credit ratings, or an announced potential downgrade or other negative action, could have a material adverse effect on the Company’s financial conditions and results of operations in many ways, including, but not limited to, the following: limiting the Company’s access to capital markets; increasing the cost of debt; impairing its ability to raise capital to refinance maturing debt obligations; limiting its capacity to support the growth of its insurance subsidiaries; requiring it to pay higher amounts in connection with certain existing or future financing arrangements or transactions; and making it more difficult to maintain or improve the current financial strength ratings of its insurance subsidiaries. A downgrade of sufficient magnitude, in combination with other factors, could require the Company to post collateral pursuant to certain contractual obligations.

 

Rating organizations assign ratings based upon several factors. While most of the factors relate to the rated company, some of the factors relate to the views of the rating organization, general economic conditions, ratings of parent companies, and circumstances outside the rated company’s control. Factors identified by rating agencies that

 

158



Table of Contents

 

could lead to negative rating actions with respect to the Company or its insurance subsidiaries include, but are not limited to, weak growth in earnings, a deterioration of earnings (including deterioration due to spread compression in interest-sensitive lines of business), significant impairments in investment portfolios, heightened financial leverage, lower interest coverage ratios, risk-based capital ratios falling below ratings thresholds, a material reinsurance loss, underperformance of an acquisition, and the rating of a parent company. In addition, rating organizations use various models and formulas to assess the strength of a rated company, and from time to time rating organizations have, in their discretion, altered the models. Changes to the models could impact the rating organizations’ judgment of the rating to be assigned to the rated company. Rating organizations may take various actions, positive or negative, with respect to our debt and financial strength ratings, including as a result of our status as a subsidiary of Dai-ichi Life. Any negative action by a ratings agency could have a material adverse impact on the Company’s financial condition or results of operations. The Company cannot predict what actions the rating organizations may take, or what actions the Company may take in response to the actions of the rating organizations.

 

The business of the Company is highly regulated and is subject to routine audits, examinations and actions by regulators, law enforcement agencies and self-regulatory organizations.

 

The Company is subject to government regulation in each of the states in which it conducts business. In many instances, the regulatory models emanate from the National Association of Insurance Commissioners (“NAIC”). Such regulation is vested in state agencies having broad administrative and in some instances discretionary power dealing with many aspects of the Company’s business, which may include, among other things, premium rates and increases thereto, underwriting practices, reserve requirements, marketing practices, advertising, privacy, policy forms, reinsurance reserve requirements, insurer use of captive reinsurance companies, acquisitions, mergers, capital adequacy, claims practices and the remittance of unclaimed property. In addition, some state insurance departments may enact rules or regulations with extra-territorial application, effectively extending their jurisdiction to areas such as permitted insurance company investments that are normally the province of an insurance company’s domiciliary state regulator.

 

At any given time, a number of financial, market conduct, or other examinations or audits of the Company’s subsidiaries may be ongoing. It is possible that any examination or audit may result in payments of fines and penalties, payments to customers, or both, as well as changes in systems or procedures, any of which could have a material adverse effect on the Company’s financial condition or results of operations. The Company’s insurance subsidiaries are required to obtain state regulatory approval for rate increases for certain health insurance products. The Company’s profits may be adversely affected if the requested rate increases are not approved in full by regulators in a timely fashion.

 

State insurance regulators and the NAIC regularly re-examine existing laws and regulations applicable to insurance companies and their products. Changes in these laws and regulations, or in interpretations thereof, are often made for the benefit of the consumer and may lead to additional expense for the insurer and, thus, could have a material adverse effect on the Company’s financial condition and results of operations.

 

The NAIC and the Company’s state regulators may be influenced by the initiatives of international regulatory bodies, and those initiatives may not translate readily into the legal system under which U.S. insurers must operate. There is increasing pressure to conform to international standards due to the globalization of the business of insurance and the most recent financial crisis.

 

In addition to developments at the NAIC and in the United States, the Financial Stability Board (“FSB”), consisting of representatives of national financial authorities of the G20 nations, and the G20 have issued a series of proposals intended to produce significant changes in how financial companies, particularly companies that are members of large and complex financial groups, should be regulated.

 

The International Association of Insurance Supervisors (“IAIS”), at the direction of the FSB, has published a methodology for identifying “global systemically important insurers” (“G-SIIs”) and high level policy measures that will apply to G-SIIs. The FSB, working with national authorities and the IAIS, has designated nine insurance groups as G-SIIs. The IAIS is working on the policy measures which include higher capital requirements and enhanced supervision. Although neither the Company nor Dai-ichi Life has been designated a G-SII, the list of designated insurers will be updated annually by the FSB. It is possible that the greater size and reach of the combined group as a

 

159



Table of Contents

 

result of the Company becoming a subsidiary of Dai-ichi Life, or a change in the methodologies or their application, could lead to the combined group’s designation as a G-SII.

 

The IAIS is also in the process of developing a common framework for the supervision of internationally active insurance groups (“IAIGs”), which is targeted to be implemented in 2019. Under the proposed framework, insurance groups deemed to be IAIGs may be required by their regulators to comply with new global capital requirements, which may exceed the sum of state or other local capital requirements. In addition, the IAIS is developing a model framework for the supervision of IAIGs that contemplates “group wide supervision” across national boundaries, which requires each IAIG to conduct its own risk and solvency assessment to monitor and manage its overall solvency. It is possible that, as a result of the Merger, the combined group may be deemed an IAIG, in which case it may be subject to supervision and capital requirements beyond those applicable to any competitors who are not designated as an IAIG.

 

While it is not yet known how or if these actions will impact the Company, such regulation could result in increased costs of compliance, increased disclosure, less flexibility in capital management and more burdensome regulation and capital requirements for specific lines of business, and could impact the Company and its reserve and capital requirements, financial condition or results of operations.

 

Although some NAIC pronouncements, particularly as they affect accounting, reserving and risk-based capital issues, may take effect automatically without affirmative action taken by the states, the NAIC is not a governmental entity and its processes and procedures do not comport with those to which governmental entities typically adhere. Therefore, it is possible that actions could be taken by the NAIC that become effective without the procedural safeguards that would be present if governmental action was required. In addition, with respect to some financial regulations and guidelines, states sometimes defer to the interpretation of the insurance department of a non-domiciliary state. Neither the action of the domiciliary state nor the action of the NAIC is binding on a non-domiciliary state. Accordingly, a state could choose to follow a different interpretation. The Company is also subject to the risk that compliance with any particular regulator’s interpretation of a legal, accounting or actuarial issue may result in non-compliance with another regulator’s interpretation of the same issue, particularly when compliance is judged in hindsight. There is an additional risk that any particular regulator’s interpretation of a legal, accounting or actuarial issue may change over time to the Company’s detriment, or that changes to the overall legal or market environment may cause the Company to change its practices in ways that may, in some cases, limit its growth or profitability. Statutes, regulations, interpretations, and instructions may be applied with retroactive impact, particularly in areas such as accounting, reserve and risk-based capital requirements. Also, regulatory actions with prospective impact can potentially have a significant impact on currently sold products.

 

The NAIC has announced more focused inquiries on certain matters that could have an impact on the Company’s financial condition and results of operations. Such inquiries concern, for example, examination of statutory accounting disclosures for separate accounts, insurer use of captive reinsurance companies, certain aspects of insurance holding company reporting and disclosure, reserving for universal life products with secondary guarantees, reinsurance, and risk-based capital calculations. In addition, the NAIC continues to consider various initiatives to change and modernize its financial and solvency requirements and regulations. It is considering changing to, or has considered and passed, a principles-based reserving method for life insurance and annuity reserves, changes to the accounting and risk-based capital regulations, changes to the governance practices of insurers, and other items. Some of these proposed changes, including implementing a principles-based reserving methodology, would require the approval of state legislatures. The Company cannot provide any estimate as to what impact these more focused inquiries or proposed changes, if they occur, will have on its product mix, product profitability, reserve and capital requirements, financial condition or results of operations.

 

With respect to reserving requirements for universal life policies with secondary guarantees (“ULSG”), in 2012 the NAIC adopted revisions to Actuarial Guideline XXXVIII (“AG38”) addressing those requirements. Also, the NAIC established a working group to consider interpretations of AG38, and any adopted interpretations are binding on reserve calculations for policies within the scope of AG38.  Some of the regulatory participants in the AG38 revision process appeared to believe that one of the purposes of the revisions was to calculate reserves for ULSG similarly to reserves for guaranteed level term life insurance contracts with the same guarantee period. The effect of the revisions was to increase the level of reserves that must be held by insurers on ULSG with certain product designs that are issued on and after January 1, 2013, and to cause insurers to test the adequacy of reserves, and possibly increase the reserves,

 

160



Table of Contents

 

on ULSG with certain product designs that were issued before January 1, 2013. The Company developed and introduced a new ULSG product for sales in 2013. The Company cannot predict future regulatory actions that could negatively impact the Company’s ability to market this or other products. Such regulatory reactions could include, for example, withdrawal of state approvals of the product, or adoption of further changes to AG38 or other adverse action including retroactive regulatory action that could negatively impact the Company’s product. A disruption of the Company’s ability to sell financially viable life insurance products or an increase in reserves on ULSG policies issued either before or after January 1, 2013, could have a material adverse impact on the Company’s financial condition or results of operations.

 

The Company currently uses affiliated captive reinsurance companies in various structures to finance certain statutory reserves based on a regulation entitled “Valuation of Life Insurance Policies Model Regulation,” commonly known as “Regulation XXX,” and a supporting guideline entitled “The Application of the Valuation of Life Insurance Policies Model Regulation,” commonly known as “Guideline AXXX, which are associated with term life insurance and universal life insurance with secondary guarantees, respectively, as well as to reduce the volatility in statutory risk based capital associated with certain guaranteed minimum withdrawal and death benefit riders associated with the Company’s variable annuity products. The NAIC, through various committees, subgroups and dedicated task forces, is reviewing the use of captives and special purpose vehicles used to transfer insurance risk in relation to existing state laws and regulations, and several committees have adopted or exposed for comment white papers and reports that, if or when implemented, could impose additional requirements on the use of captives and other reinsurers (including traditional reinsurers) (the “Affected Business”). The Financial Condition (E) Committee of the NAIC recently established a Variable Annuity Issues Working Group to examine company use of variable annuity captives. In addition, the Principles Based Reserving Implementation (EX) Task Force of the NAIC, charged with analysis of the adoption of a principles-based reserving methodology, adopted the “conceptual framework” contained in a report issued by Rector & Associates, Inc., dated June 4, 2014 (as modified or supplemented, the “Rector Report”), that contains numerous recommendations pertaining to the regulation and use of certain captive reinsurers. Certain high-level recommendations have been adopted and assigned to various NAIC working groups, which working groups are in various stages of discussions regarding recommendations. One recommendation of the Rector Report has been adopted as Actuarial Guideline XLVIII (“AG48”). AG48 sets more restrictive standards on the permitted collateral utilized to back reserves of a captive. Other recommendations in the Rector Report are subject to ongoing comment and revision. It is unclear at this time to what extent the recommendations in the Rector Report, or additional or revised recommendations relating to captive transactions or reinsurance transactions in general, will be adopted by the NAIC. If the recommendations proposed in the Rector Report are implemented, it will likely be difficult for the Company to establish new captive financing arrangements on a basis consistent with past practices. As a result of AG48 and the Rector Report, the implementation of new captive structures in the future may be less capital efficient, may lead to lower product returns and/or increased product pricing or result in reduced sales of certain products. Additionally, in some circumstances AG48 and the implementation of the recommendations in the Rector Report could impact the Company’s ability to engage in certain reinsurance transactions with non-affiliates.

 

The NAIC’s Financial Regulation Standards and Accreditation (F) Committee is considering a proposal to include certain insurer-owned captives and special purpose vehicles that are single-state licensed but assume reinsurance from cedants operating in multiple states within the definition of “multi-state insurer” found in the preambles to Parts A and B of the NAIC Financial Regulation Standards and Accreditation Program. If adopted, the revised definition would subject certain captives to all of the Accreditation Standards applicable to other traditional multi-state insurers, including standards related to capital and surplus requirements, risk-based capital requirements, investment laws and credit for reinsurance laws. Although we do not expect the revised definition, if adopted, to affect our existing life insurance captives (or our ability to engage in life insurance captive transactions in the future), such application would likely prevent us from engaging in variable annuity captive transactions on the same or a similar basis as in the past and, if applied retroactively, would likely cause us to recapture business from and unwind our existing variable annuity captive (“VA Captive”).  While the recapture of business from our existing VA Captive would not have a material adverse effect on the Company given current market conditions, in the future the Company could experience fluctuations in its RBC ratio due to market volatility if it were prohibited from engaging in similar transactions or required to unwind its existing VA Captive, which could adversely affect our future financial condition and results of operations .

 

The NAIC established a Variable Annuity Issues Working Group (VAIWG) in 2015 to oversee the NAIC’s efforts to study and address regulatory issues resulting in variable annuity captive reinsurance transactions.  The

 

161



Table of Contents

 

VAIWG has developed a draft report to the Financial Condition (E) Committee that includes a Variable Annuities - Framework for Change (the “Framework”). The Framework suggests numerous changes to current NAIC rules and regulations that are intended to decrease incentives for insurers to establish variable annuities captives, with such changes to be applied to both inforce and new business. The Framework proposes that various NAIC groups consider and adopt recommended changes to current rules and regulations (with an anticipated effective date in January 2017) and that, upon adoption, domestic regulators request that insurers ceding business to variable annuity captives recapture such business and dissolve such captives.  If the Framework is adopted, both the changes proposed by the Framework and the recapture of business and dissolution of our VA Captive could adversely affect our future financial condition and results of operations.

 

Any regulatory action or changes in interpretation that materially adversely affects the Company’s use or materially increases the Company’s cost of using captives or reinsurers for the Affected Business, either retroactively or prospectively, could have a material adverse impact on the Company’s financial condition or results of operations. If the Company were required to discontinue its use of captives for intercompany reinsurance transactions on a retroactive basis, adverse impacts would include early termination fees payable with respect to certain structures, diminished capital position and higher cost of capital. Additionally, finding alternative means to support policy liabilities efficiently is an unknown factor that would be dependent, in part, on future market conditions and the Company’s ability to obtain required regulatory approvals. On a prospective basis, discontinuation of the use of captives could impact the types, amounts and pricing of products offered by the Company’s insurance subsidiaries.

 

Recently, new laws and regulations have been adopted in certain states that require life insurers to search for unreported deaths. The National Conference of Insurance Legislators (“NCOIL”) has adopted the Model Unclaimed Life Insurance Benefits Act (the “Unclaimed Benefits Act”) and legislation has been enacted in various states that is similar to the Unclaimed Benefits Act, although each state’s version differs in some respects. The Unclaimed Benefits Act would impose new requirements on insurers to periodically compare their in-force life insurance and annuity contracts and retained asset accounts against a Death Database, investigate any potential matches to confirm the death and determine whether benefits are due, and to attempt to locate the beneficiaries of any benefits that are due or, if no beneficiary can be located, escheat the benefit to the state as unclaimed property. Other states in which the Company does business may also consider adopting legislation similar to the Unclaimed Benefits Act. The Company cannot predict whether such legislation will be proposed or enacted in additional states. Additionally, the NAIC Unclaimed Life Insurance Benefits (A) Working Group is developing a model unclaimed property law that overlaps with the NCOIL-based laws already adopted in several states. Other life insurance industry associations and regulatory associations are also considering these matters.

 

A number of state treasury departments and administrators of unclaimed property have audited life insurance companies for compliance with unclaimed property laws. The focus of the audits has been to determine whether there have been maturities of policies or contracts, or policies that have exceeded limiting age with respect to which death benefits or other payments under the policies should be treated as unclaimed property that should be escheated to the state. In addition, the audits have sought to identify unreported deaths of insureds. There is no clear basis in previously existing law for treating an unreported death as giving rise to a policy benefit that would be subject to unclaimed property procedures. A number of life insurers, however, have entered into resolution agreements with state treasury departments under which the life insurers agreed to procedures for comparing their previously issued life insurance and annuity contracts and retained asset accounts against a Death Database, treating confirmed deaths as giving rise to a death benefit under their policies, locating beneficiaries and paying them the benefits and interest, and escheating the benefits and interest to the state if the beneficiary could not be found. The amounts publicly reported to have been paid to beneficiaries and/or escheated to the states have been substantial.

 

The NAIC has established an Investigations of Life/Annuity Claims Settlement Practices (D) Task Force to coordinate targeted multi-state examinations of life insurance companies on claims settlement practices. The state insurance regulators on the Task Force have initiated targeted multi-state examinations of life insurance companies with respect to the companies’ claims paying practices and use of a Death Database to identify unreported deaths in their life insurance policies, annuity contracts and retained asset accounts. There is no clear basis in previously existing law for requiring a life insurer to search for unreported deaths in order to determine whether a benefit is owed. A number of life insurers, however, have entered into settlement or consent agreements with state insurance regulators under which the life insurers agreed to implement systems and procedures for periodically comparing their life insurance and annuity contracts and retained asset accounts against a Death Database, treating confirmed deaths as giving rise to a death

 

162



Table of Contents

 

benefit under their policies, locating beneficiaries and paying them the benefits and interest, and escheating the benefits and interest to the state if the beneficiary could not be found. It has been publicly reported that the life insurers have paid substantial administrative and/or examination fees to the insurance regulators in connection with the settlement or consent agreements.

 

Certain of the Company’s subsidiaries as well as certain other insurance companies from whom the Company has coinsured blocks of life insurance and annuity policies are subject to unclaimed property audits and/or targeted multistate examinations by insurance regulators similar to those described above. It is possible that the audits, examinations and/or the enactment of state laws similar to the Unclaimed Benefits Act could result in additional payments to beneficiaries, additional escheatment of funds deemed abandoned under state laws, payment of administrative penalties and/or examination fees to state authorities, and changes to the Company’s procedures for identifying unreported deaths and escheatment of abandoned property. It is possible any such additional payments and any costs related to changes in Company procedures could materially impact the Company’s financial results from operations. It is also possible that life insurers, including the Company, may be subject to claims, regulatory actions, law enforcement actions, and civil litigation arising from their prior business practices. Any resulting liabilities, payments or costs, including initial and ongoing costs of changes to the Company’s procedures or systems, could be significant and could have a material adverse effect on the Company’s financial condition or results of operations.

 

During December 2012, the West Virginia Treasurer filed actions against the Company’s subsidiaries Protective Life Insurance Company and West Coast Life Insurance Company in West Virginia state court ( State of West Virginia ex rel. John D. Perdue v. Protective Life Insurance Company, State of West Virginia ex rel. John D. Perdue v. West Coast Life Insurance Company; Defendants’ Motions to Dismiss granted on December 27, 2013; Notice of Appeal filed on January 27, 2014; dismissal reversed by the West Virginia Supreme Court of Appeals on June 16, 2015; Petition for Rehearing filed by Defendant insurance companies denied on September 21, 2015) . The actions, which also name numerous other life insurance companies, allege that the companies violated the West Virginia Uniform Unclaimed Property Act, seek to compel compliance with the Act, and seek payment of unclaimed property, interest, and penalties. While the legal theory or theories that may give rise to liability in the West Virginia Treasurer litigation are uncertain, it is possible that other jurisdictions may pursue similar actions. The Company does not currently believe that losses, if any, arising from the West Virginia Treasurer litigation will be material. The Company cannot, however, predict whether other jurisdictions will pursue similar actions or, if they do, whether such actions will have a material impact on the Company’s financial results from operations. Additionally, the California Controller has sued several insurance carriers for alleged failure to comply with audit requests from an appointed third party auditor. The Company cannot predict whether California or other jurisdictions might pursue a similar action against the Company. The Company does not believe however that any such action would have a material impact on the Company’s financial condition or results of operations.

 

Under insurance guaranty fund laws in most states, insurance companies doing business therein can be assessed up to prescribed limits for policyholder losses incurred by insolvent companies. From time to time, companies may be asked to contribute amounts beyond prescribed limits. The Company cannot predict the amount or timing of any future assessments.

 

The purchase of life insurance products is limited by state insurable interest laws, which in most jurisdictions require that the purchaser of life insurance name a beneficiary that has some interest in the sustained life of the insured. To some extent, the insurable interest laws present a barrier to the life settlement, or “stranger-owned” industry, in which a financial entity acquires an interest in life insurance proceeds, and efforts have been made in some states to liberalize the insurable interest laws. To the extent these laws are relaxed, the Company’s lapse assumptions may prove to be incorrect.

 

At the federal level, bills are routinely introduced in both chambers of the United States Congress (“Congress”) that could affect life insurers. In the past, Congress has considered legislation that would impact insurance companies in numerous ways, such as providing for an optional federal charter or a federal presence for insurance, preempting state law in certain respects regarding the regulation of reinsurance, increasing federal oversight in areas such as consumer protection and other matters. The Company cannot predict whether or in what form legislation will be enacted and, if so, whether the enacted legislation will positively or negatively affect the Company or whether any effects will be material.

 

163



Table of Contents

 

The Company’s sole stockholder, Dai-ichi Life, is subject to regulation by the Japanese Financial Services Authority (“JFSA”). Under applicable laws and regulations, Dai-ichi Life is required to provide notice to or obtain the consent of the JFSA prior to taking certain actions or engaging in certain transactions, either directly or indirectly through its subsidiaries, including the Company and its consolidated subsidiaries.

 

The Company is subject to various conditions and requirements of the Healthcare Act. The Healthcare Act makes significant changes to the regulation of health insurance and may affect the Company in various ways. The Healthcare Act may affect the small blocks of business the Company has offered or acquired over the years that are, or are deemed to constitute, health insurance. The Healthcare Act may also affect the benefit plans the Company sponsors for employees or retirees and their dependents, the Company’s expense to provide such benefits, the tax liabilities of the Company in connection with the provision of such benefits, and the Company’s ability to attract or retain employees. In addition, the Company may be subject to regulations, guidance or determinations emanating from the various regulatory authorities authorized under the Healthcare Act. The Company cannot predict the effect that the Healthcare Act, or any regulatory pronouncement made thereunder, will have on its results of operations or financial condition.

 

The Dodd-Frank Wall Street Reform and Consumer Protection Act (“Dodd-Frank”) enacted in July 2010 made sweeping changes to the regulation of financial services entities, products and markets. Certain provisions of Dodd-Frank are or may become applicable to the Company, its competitors or those entities with which the Company does business. Such provisions include, but are not limited to the following: the establishment of the Federal Insurance Office, changes to the regulation and standards applicable to broker-dealers and investment advisors, changes to the regulation of reinsurance, changes to regulations affecting the rights of shareowners, and the imposition of additional regulation over credit rating agencies.

 

Dodd-Frank also created the Financial Stability Oversight Council (the “FSOC”), which has issued a final rule and interpretive guidance setting forth the methodology by which it will determine whether a non-bank financial company is a systemically important financial institution (“SIFI”). A non-bank financial company, such as the Company, that is designated as a SIFI by the FSOC will become subject to supervision by the Board of Governors of the Federal Reserve System (the “Federal Reserve”). The Company is not currently supervised by the Federal Reserve. Such supervision could impact the Company’s requirements relating to capital, liquidity, stress testing, limits on counterparty credit exposure, compliance and governance, early remediation in the event of financial weakness and other prudential matters, and in other ways the Company currently cannot anticipate. FSOC-designated non-bank financial companies will also be required to prepare resolution plans, so- called “living wills,” that set out how they could most efficiently be liquidated if they endangered the U.S. financial system or the broader economy. The FSOC has conducted two rounds of SIFI designation consideration. However, this process is still very new, and the FSOC continues to make changes to its process for designating a company as a SIFI. The FSOC has made its initial SIFI designations, and the Company was not designated as such. However, the Company could be considered and designated at any time. Because the process is in its initial stages, the Company is at this time unable to predict the impact on an entity that is supervised as a SIFI by the Federal Reserve Board. The Company is not able to predict whether the capital requirements or other requirements imposed on SIFIs may impact the requirements applicable to the Company even if it is not designated as a SIFI. The uncertainty about regulatory requirements could influence the Company’s product line or other business decisions with respect to some product lines. There is a similarly uncertain international designation process. The Financial Stability Board, appointed by the G-20 Summit, recently designated nine insurers as “G-SIIs,” or global systemically-important insurers. As with the designation of SIFI’s, it is unclear at this time how additional capital and other requirements affect the insurance and financial industries. The insurers designated as G-SIIs to date represent organizations larger than the Company, but the possibility remains that the Company could be so designated.

 

Additionally, Dodd-Frank created the Consumer Financial Protection Bureau (“CFPB”), an independent division of the Department of Treasury with jurisdiction over credit, savings, payment, and other consumer financial products and services, other than investment products already regulated by the United States Securities and Exchange Commission (the “SEC”) or the U.S. Commodity Futures Trading Commission. CFPB has issued a rule to bring under its supervisory authority certain non-banks whose activities or products it determines pose risks to consumers. It is unclear at this time which activities or products will be covered by this rule. Certain of the Company’s subsidiaries sell products that may be regulated by the CFPB. CFPB continues to bring enforcement actions involving a growing number of issues, including actions using state Attorney’s General, which could directly or indirectly affect the Company or use any of its subsidiaries. Additionally, the CFPB is exploring the possibility of helping Americans

 

164



Table of Contents

 

manage their retirement savings and is considering the extent of its authority in that area. The Company is unable at this time to predict the impact of these activities on the Company.

 

Dodd-Frank includes a new framework of regulation of over-the-counter (“OTC”) derivatives markets which requires clearing of certain types of transactions which have been or are currently traded OTC by the Company. The types of transactions to be cleared are expected to increase in the future. The new framework could potentially impose additional costs, including increased margin requirements and additional regulation on the Company. Increased margin requirements on the Company’s part, combined with restrictions on securities that will qualify as eligible collateral, could continue to reduce its liquidity and require an increase in its holdings of cash and government securities with lower yields causing a reduction in income. The Company uses derivative financial instruments to mitigate a wide range of risks in connection with its businesses, including those arising from its variable annuity products with guaranteed benefit features. The derivative clearing requirements of Dodd-Frank could continue to increase the cost of the Company’s risk mitigation and expose it to the risk of a default by a clearinghouse with respect to the Company’s cleared derivative transactions.

 

Numerous provisions of Dodd-Frank require the adoption of implementing rules and/or regulations. The process of adopting such implementing rules and/or regulations have in some instances been delayed beyond the timeframes imposed by Dodd-Frank. Until the various final regulations are promulgated pursuant to Dodd-Frank, the full impact of the regulations on the Company will remain unclear. In addition, Dodd-Frank mandates multiple studies, which could result in additional legislation or regulation applicable to the insurance industry, the Company, its competitors or the entities with which the Company does business. Legislative or regulatory requirements imposed by or promulgated in connection with Dodd-Frank may impact the Company in many ways, including but not limited to the following: placing the Company at a competitive disadvantage relative to its competition or other financial services entities, changing the competitive landscape of the financial services sector and/or the insurance industry, making it more expensive for the Company to conduct its business, requiring the reallocation of significant company resources to government affairs, legal and compliance-related activities, causing historical market behavior or statistics utilized by the Company in connection with its efforts to manage risk and exposure to no longer be predictive of future risk and exposure or otherwise have a material adverse effect on the overall business climate as well as the Company’s financial condition and results of operations.

 

Broker-dealers, insurance agencies and other financial institutions sell the Company’s annuities to employee benefit plans and individual retirement accounts that are governed by the Employee Retirement Income Security Act (“ERISA”) and the Internal Revenue Code. Consequently, our activities and those of such parties are subject to restrictions that require ERISA fiduciaries to perform their duties solely in the interests of ERISA plan participants and beneficiaries, and that prohibit ERISA fiduciaries from causing a covered plan to engage in certain prohibited transactions. In general, the prohibited transaction rules restrict the provision of investment advice to ERISA plans and participants and Individual Retirement Accounts (“IRAs”) if fees are paid to the individual advisor, his or her firm or their affiliates in respect of the investment recommendation that vary according to the recommendation chosen.

 

In April 2015, the Department of Labor proposed new regulations that, if enacted, will significantly expand the definition of “investment advice” and increase the circumstances in which the Company and broker-dealers, insurance agencies and other financial institutions that sell the Company’s products could be deemed a fiduciary when providing investment advice with respect to ERISA plans or Individual Retirement Accounts. The Department of Labor also proposed amendments to long standing exemptions from the prohibited transaction provisions under ERISA that would increase fiduciary requirements in connection with transactions involving ERISA plans, plan participants and IRAs, and that would apply more onerous disclosure and contract requirements to such transactions. If the foregoing proposals are adopted, the Company may find it necessary to change sales representative and/or broker compensation, to limit the assistance or advice it can provide to owners of the Company’s annuities, or otherwise change the manner in which it designs and supports sales of its annuities.  This could have a material adverse impact on our ability to sell annuities and other products.

 

Certain life insurance policies, contracts, and annuities offered by the Company’s subsidiaries are subject to regulation under the federal securities laws administered by the SEC. The federal securities laws contain regulatory restrictions and criminal, administrative, and private remedial provisions. From time to time, the SEC and the Financial Industry Regulatory Authority (“FINRA”) examine or investigate the activities of broker-dealers and investment advisors, including the Company’s affiliated broker-dealers and investment advisors. These examinations or

 

165



Table of Contents

 

investigations often focus on the activities of the registered representatives and registered investment advisors doing business through such entities and the entities’ supervision of those persons. It is possible that any examination or investigation could lead to enforcement action by the regulator and/or may result in payments of fines and penalties, payments to customers, or both, as well as changes in systems or procedures of such entities, any of which could have a material adverse effect on the Company’s financial condition or results of operations.

 

In addition, the SEC is reviewing the standard of conduct applicable to brokers, dealers, and investment advisers when those entities provide personalized investment advice about securities to retail customers. FINRA has also issued a report addressing how its member firms might identify and address conflicts of interest including conflicts related to the introduction of new products and services and the compensation of the member firms’ associated persons. These regulatory initiatives could have an impact on Company operations and the manner in which broker-dealers and investment advisers distribute the Company’s products.

 

The Company may also be subject to regulation by governments of the countries in which it currently does, or may in the future, do, business, as well as regulation by the U.S. Government with respect to its operations in foreign countries, such as the Foreign Corrupt Practices Act. Penalties for violating the various laws governing the Company’s business in other countries may include restrictions upon business operations, fines and imprisonment, both within the U.S. and abroad. U.S. enforcement of anti-corruption laws continues to increase in magnitude, and penalties may be substantial.

 

The Company is subject to conditions and requirements set forth in the Telephone Consumer Protection Act (“TCPA”) which places restrictions on the use of automated telephone and facsimile machines. Class action lawsuits alleging violations of the act have been filed against a number of companies, including life insurance carriers. These class action lawsuits contain allegations that defendant carriers were vicariously liable for the alleged wrongful conduct of agents who violated the TCPA. Some of the class actions have resulted in substantial settlements against other insurers. Any such actions against the Company could result in a material adverse effect upon our financial condition or results of operations.

 

Other types of regulation that could affect the Company and its subsidiaries include insurance company investment laws and regulations, state statutory accounting and reserving practices, antitrust laws, minimum solvency requirements, enterprise risk requirements, state securities laws, federal privacy laws, cybersecurity regulation, insurable interest laws, federal anti-money laundering and anti-terrorism laws, employment and immigration laws (including laws in Alabama where over half of the Company’s employees are located), and because the Company owns and operates real property, state, federal, and local environmental laws. Under some circumstances, severe penalties may be imposed for breach of these laws.

 

The Company cannot predict what form any future changes to laws and/or regulations affecting participants in the financial services sector and/or insurance industry, including the Company and its competitors or those entities with which it does business, may take, or what effect, if any, such changes may have.

 

New accounting rules, changes to existing accounting rules, or the grant of permitted accounting practices to competitors could negatively impact the Company.

 

The Company is required to comply with accounting principles generally accepted in the United States (“GAAP”). A number of organizations are instrumental in the development and interpretation of GAAP such as the SEC, the Financial Accounting Standards Board (“FASB”), and the American Institute of Certified Public Accountants (“AICPA”). GAAP is subject to constant review by these organizations and others in an effort to address emerging accounting rules and issue interpretative accounting guidance on a continual basis. The Company can give no assurance that future changes to GAAP will not have a negative impact on the Company. GAAP includes the requirement to carry certain assets and liabilities at fair value. These fair values are sensitive to various factors including, but not limited to, interest rate movements, credit spreads, and various other factors. Because of this, changes in these fair values may cause increased levels of volatility in the Company’s financial statements.

 

The FASB and the International Accounting Standards Board are working on several projects that could result in significant changes to GAAP and International Financial Reporting Standards (“IFRS”). Furthermore, the SEC is considering whether and how to incorporate IFRS into the U.S. financial reporting system. The changes to GAAP and

 

166



Table of Contents

 

potential incorporation of IFRS into the U.S. financial reporting system will impose special demands on issuers in the areas of governance, employee training, internal controls, contract fulfillment and disclosure and will likely affect how we manage our business, as it will likely affect other business processes such as design of compensation plans, product design, etc. The Company is unable to predict whether, and if so, when these projects and ultimately convergence with IFRS will be adopted and/or implemented.

 

In addition, the Company’s insurance subsidiaries are required to comply with statutory accounting principles (“SAP”). SAP and various components of SAP (such as actuarial reserving methodology) are subject to constant review by the NAIC and its task forces and committees as well as state insurance departments in an effort to address emerging issues and otherwise improve or alter financial reporting. Various proposals either are currently or have previously been pending before committees and task forces of the NAIC, some of which, if enacted, would negatively affect the Company. The NAIC is also currently working to reform model regulation in various areas, including comprehensive reforms relating to life insurance reserves and the accounting for such reserves. The Company cannot predict whether or in what form reforms will be enacted by state legislatures and, if so, whether the enacted reforms will positively or negatively affect the Company. In addition, the NAIC Accounting Practices and Procedures manual provides that state insurance departments may permit insurance companies domiciled therein to depart from SAP by granting them permitted accounting practices. The Company cannot predict whether or when the insurance departments of the states of domicile of its competitors may permit them to utilize advantageous accounting practices that depart from SAP, the use of which is not permitted by the insurance departments of the states of domicile of the Company’s insurance subsidiaries. With respect to regulations and guidelines, states sometimes defer to the interpretation of the insurance department of the state of domicile. Neither the action of the domiciliary state nor action of the NAIC is binding on a state. Accordingly, a state could choose to follow a different interpretation. The Company can give no assurance that future changes to SAP or components of SAP or the grant of permitted accounting practices to its competitors will not have a negative impact on the Company. For additional information regarding pending NAIC reforms, please see Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations .

 

167



Table of Contents

 

Item 6.                      Exhibits

 

Item

 

 

Number

 

Document

3(a)

 

2011 Amended and Restated Charter of Protective Life Insurance Company dated as of June 27,2011, incorporated by reference to Exhibit 3(a) to the Company’s Annual Report on Form 10-K for the year ended December 31, 2011 filed March 29, 2012.

3(b)

 

2011 Amended and Restated By-Laws of Protective Life Insurance Company dated as of June 27, 2011, incorporated by reference to Exhibit 3(b) to the Company’s Annual Report on Form 10-K for the year ended December 31, 2011 filed March 29, 2012.

10*

 

Master Agreement by and among Protective Life Insurance Company and Genworth Life and Annuity Insurance Company, dated as of September 30, 2015, filed herewith.

12

 

Consolidated Earnings Ratio

31(a)

 

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31(b)

 

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32(a)

 

Certification Pursuant to 18 U.S.C Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32(b)

 

Certification Pursuant to 18 U.S.C Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101

 

Financial statements from the quarterly report on Form 10-Q of Protective Life Insurance Company for the quarter ended September 30, 2015, filed on November 10, 2015, formatted in XBRL: (i) the Consolidated Condensed Statements of Income, (ii) the Consolidated Condensed Statements of Comprehensive Income (Loss), (iii) the Consolidated Condensed Balance Sheets, (iv) the Consolidated Condensed Statements of Shareowner’s Equity, (v) the Consolidated Condensed Statements of Cash Flows, and (iv) the Notes to Consolidated Condensed Financial Statements.

 


 

 

*The registrant to furnish the Commission supplementally upon request a copy of any omitted exhibit or schedule to this agreement.

 

168



Table of Contents

 

SIGNATURE

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

PROTECTIVE LIFE INSURANCE COMPANY

 

 

 

 

Date:     November 10, 2015

 

By:

/s/ Steven G. Walker

 

 

Steven G. Walker

 

 

Senior Vice President, Controller

 

 

and Chief Accounting Officer

 

169


Exhibit 10

 

EXECUTION VERSION

 

 

 

MASTER AGREEMENT

 

BY AND BETWEEN

 

GENWORTH LIFE AND ANNUITY INSURANCE COMPANY

 

AND

 

PROTECTIVE LIFE INSURANCE COMPANY

 

DATED AS OF SEPTEMBER 30, 2015

 

 



 

TABLE OF CONTENTS

 

 

 

Page

 

 

 

ARTICLE I. DEFINITIONS

2

 

 

 

SECTION 1.1.

Definitions

2

 

 

 

ARTICLE II. CLOSING; INITIAL REINSURANCE PREMIUM AND CEDING ALLOWANCE

11

 

 

 

SECTION 2.1.

Closing

11

SECTION 2.2.

Closing Deliveries

12

SECTION 2.3.

Payment at Closing

12

SECTION 2.4.

Post-Closing Adjustments

13

 

 

 

ARTICLE III. REPRESENTATIONS AND WARRANTIES OF CEDENT

15

 

 

 

SECTION 3.1.

Organization, Standing and Corporate Power

15

SECTION 3.2.

Authority

15

SECTION 3.3.

Actions and Proceedings

16

SECTION 3.4.

No Conflict or Violation

16

SECTION 3.5.

Governmental Consents

17

SECTION 3.6.

Compliance

17

SECTION 3.7.

Permits

17

SECTION 3.8.

Insurance Matters

18

SECTION 3.9.

Reserved

19

SECTION 3.10.

Reinsurance

19

SECTION 3.11.

Absence of Certain Changes

19

SECTION 3.12.

Cedent Financial Statements; Reserves

20

SECTION 3.13.

Books and Records

21

SECTION 3.14.

No Undisclosed Material Liabilities

21

SECTION 3.15.

Brokers and Finders

21

 

 

 

ARTICLE IV. REPRESENTATIONS AND WARRANTIES OF REINSURER

22

 

 

 

SECTION 4.1.

Organization, Standing and Corporate Power

22

SECTION 4.2.

Authority

22

SECTION 4.3.

Actions and Proceedings

22

SECTION 4.4.

No Conflict or Violation

22

SECTION 4.5.

Governmental Consents

23

SECTION 4.6.

Compliance

23

SECTION 4.7.

Licensing Status

23

SECTION 4.8.

Brokers and Finders

24

 

 

 

ARTICLE V. COVENANTS

24

 

 

 

SECTION 5.1.

Conduct of Business of the Company

24

SECTION 5.2.

Access to Information; Confidentiality

25

SECTION 5.3.

Confidentiality of Business Information

25

 

i



 

SECTION 5.4.

Commercially Reasonable Efforts

26

SECTION 5.5.

Consents, Approvals and Filings

26

SECTION 5.6.

Ceded Reinsurance Agreements

28

SECTION 5.7.

Reserved

29

SECTION 5.8.

Restructuring Transactions

29

SECTION 5.9.

Public Announcements

29

SECTION 5.10.

Further Assurances

29

 

 

 

 

ARTICLE VI. CONDITIONS PRECEDENT

30

 

 

 

SECTION 6.1.

Conditions to Each Party’s Obligations

30

SECTION 6.2.

Conditions to Obligations of Reinsurer

30

SECTION 6.3.

Conditions to Obligations of Cedent

31

 

 

 

 

ARTICLE VII. INDEMNIFICATION

32

 

 

 

 

SECTION 7.1.

Survival of Representations, Warranties and Covenants

32

SECTION 7.2.

Indemnification

32

SECTION 7.3.

Certain Limitations

33

SECTION 7.4.

Procedures for Third Party Claims

34

SECTION 7.5.

Direct Claims

35

SECTION 7.6.

Certain Other Matters

36

 

 

 

 

ARTICLE VIII. TERMINATION PRIOR TO CLOSING

36

 

 

 

 

SECTION 8.1.

Termination of Agreement

36

SECTION 8.2.

Effect of Termination

36

 

 

 

 

ARTICLE IX. GENERAL PROVISIONS

37

 

 

 

 

SECTION 9.1.

Fees and Expenses

37

SECTION 9.2.

Notices

37

SECTION 9.3.

Construction

38

SECTION 9.4.

Entire Agreement

39

SECTION 9.5.

Third Party Beneficiaries

39

SECTION 9.6.

Governing Law

39

SECTION 9.7.

Jurisdiction; Enforcement

39

SECTION 9.8.

Assignment

40

SECTION 9.9.

Amendments

41

SECTION 9.10.

Severability

41

SECTION 9.11.

Waiver

41

SECTION 9.12.

Certain Limitations

41

SECTION 9.13.

Currency

42

SECTION 9.14.

Counterparts

42

 

ii



 

EXHIBIT A — Reinsured Policies as of June 30, 2015

 

EXHIBIT B — Initial Net Settlement

 

EXHIBIT C — Form of Reinsurance Agreement

 

ANNEX A — Reserve Methodology

 

ANNEX B — Restructuring Transactions

 

Cedent Disclosure Schedule

Section 1.1 — Knowledge of Cedent

Section 3.3 — Actions and Proceedings

Section 3.4 — No Conflict or Violations

Section 3.5 — Governmental Consents

Section 3.6(a) — Compliance with Applicable Laws

Section 3.6(b) — Compliance — Personal Information

Section 3.7 — Permits

Section 3.8(a) — Examinations by Governmental Authorities

Section 3.8(b) — Forms for Reinsured Policies

Section 3.8(d) — Compliance with Certain Insurance Laws Applicable to Reinsured Policies

Section 3.10(a) — Ceded Reinsurance Agreements

Section 3.10(b) — Assumed Reinsurance Agreements

Section 3.10(c) — Recapture Rights

Section 3.11 — Absence of Certain Changes

Section 3.12(b) — Actuarial Report

Section 3.12(c) — Excess Reinsurance Rate Increases

Section 3.12(d) — Security Interest in the Recoveries

Section 3.14 — Material Liabilities

Section 5.1 — Conduct of Business of the Company

 

Reinsurer Disclosure Schedule

Section 1.1 — Knowledge of Reinsurer

Section 2.1 — Financing Approvals

Section 4.5 — Governmental Consents

Section 4.6 — Compliance

 

iii



 

MASTER AGREEMENT

 

This MASTER AGREEMENT, dated as of September 30, 2015 (this “ Agreement ”), is made by and between Genworth Life and Annuity Insurance Company, a Virginia-domiciled life insurance company (“ Cedent ”), and Protective Life Insurance Company, a Tennessee-domiciled life insurance company (“ Reinsurer ”).

 

WHEREAS, Cedent, Genworth Life Insurance Company, a Delaware-domiciled life insurance company (“ GLIC ”), and Genworth Life Insurance Company of New York, a New York-domiciled life insurance company (“ GLICNY ”), each have issued certain Reinsured Policies (as defined herein);

 

WHEREAS, GLIC has ceded to Cedent, and Cedent has reinsured from GLIC, certain risks and liabilities arising under the Reinsured Policies issued by GLIC pursuant to (i) the Reinsurance Agreement, dated as of July 1, 2003, by and between GLIC, as ceding company, and Cedent, as reinsurer, as amended prior to the date hereof or as contemplated hereby (the “ 2003 GLIC Reinsurance Agreement ”); and (ii) the Reinsurance Agreement, dated as of October 1, 2004, by and between GLIC, as ceding company, and Cedent, as reinsurer, as amended prior to the date hereof or as contemplated hereby (the “ 2004 GLIC Reinsurance Agreement ” and, together with the 2003 GLIC Reinsurance Agreement, the “ GLIC Reinsurance Agreements ”);

 

WHEREAS, GLICNY has ceded to Cedent, and Cedent has reinsured from GLICNY, certain risks and liabilities arising under the Reinsured Policies issued by GLICNY pursuant to the Reinsurance Agreement, dated as of July 1, 2003, by and between GLICNY, as ceding company and as successor by merger to American Mayflower Life Insurance Company, and Cedent, as reinsurer, as amended prior to the date hereof (the “ GLICNY Reinsurance Agreement ”);

 

WHEREAS, Cedent has reinsured or retroceded, as applicable, (i) to River Lake Insurance Company, a South Carolina-domiciled captive insurance company subsidiary of Cedent (“ RLI ”), certain of Cedent’s risks and liabilities arising under certain of the Reinsured Policies issued or reinsured by Cedent, pursuant to an Amended and Restated Reinsurance Agreement, effective July 1, 2003, between Cedent and RLI (the “ River Lake I Reinsurance Agreement ”); and (ii) to River Lake Insurance Company II, a South Carolina-domiciled captive insurance company subsidiary of Cedent (“ RLII ”), certain of Cedent’s risks and liabilities arising under the remainder of the Reinsured Policies issued or reinsured by Cedent, pursuant to an Amended and Restated Reinsurance Agreement, effective October 1, 2004, between Cedent and RLII (the “ River Lake II Reinsurance Agreement ” and, together with the River Lake I Reinsurance Agreement, the “ RL Captive Reinsurance Agreements ”);

 

WHEREAS, on or prior to the Closing Date, with effect as of the Effective Date, Cedent will recapture from each of RLI and RLII all of the risks and liabilities reinsured or retroceded, as applicable, to RLI or RLII pursuant to the RL Captive Reinsurance Agreements;

 

WHEREAS, Cedent has reinsured to Jamestown Life Insurance Company, a Virginia-domiciled life insurance company subsidiary of Cedent (“ Jamestown ”), a 10% quota share of Cedent’s risk and liabilities arising out of certain of the Reinsured Policies issued by

 

1



 

Cedent, pursuant to the Automatic Coinsurance Agreement, effective January 1, 2001, by and between Cedent and Jamestown (the “ Jamestown Reinsurance Agreement ”);

 

WHEREAS, on or prior to the Closing Date, with effect as of the Effective Date, Cedent will recapture from Jamestown all of the risks and liabilities reinsured to Jamestown pursuant to the Jamestown Reinsurance Agreement;

 

WHEREAS, on or prior to the Closing Date, with effect as of Effective Date, GLIC and Cedent will amend the GLIC Reinsurance Agreements as contemplated by Annex B to this Agreement, in order to, among other things, cede to Cedent the 10% quota share of GLIC’s risks and liabilities arising out of certain of the Reinsured Policies issued by GLIC that is currently retained by GLIC; and

 

WHEREAS, on the Closing Date, Cedent and Reinsurer will enter into a Reinsurance Agreement substantially in the form attached as Exhibit C hereto (the “ Reinsurance Agreement ”), such that Reinsurer will reinsure from Cedent, on a 100% indemnity basis, as of the Effective Date, the Reinsured Benefits (as defined therein), subject to the terms, conditions and limitations set forth in the Reinsurance Agreement.

 

NOW, THEREFORE, in consideration of the representations, warranties, covenants and agreements contained in this Agreement, the parties hereto agree as follows:

 

ARTICLE I.

DEFINITIONS

 

SECTION 1.1.    Definitions . For purposes of this Agreement, the following terms shall have the respective meanings set forth below:

 

Action ” means any civil, criminal or administrative action, arbitration, suit, claim, litigation, investigation, examination or similar proceeding, in each case before a Governmental Authority or an arbitrator.

 

Affiliate ” means any entity which is controlled by, controls or is under common control with, a given entity. For purposes of the foregoing, “control,” including the terms “controlling,” “controlled by” and “under common control” means the possession, direct or indirect, of the power to direct or cause the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

 

Affiliate Policies ” means the fully underwritten level term life insurance policies but not any riders thereto (a) issued by GLIC or GLICNY and described in Section B of Exhibit A, (b) in-force as of December 31, 2014 and as of the Effective Time and (c) identified by policy number in the file referenced in Section A of Exhibit A (as such file may be replaced in accordance with the Reinsurance Agreement).

 

Applicable Law ” means any domestic or foreign, federal, state, county or local statute, law, ordinance or code, or any written rules, regulations or administrative interpretations issued by any Governmental Authority pursuant to any of the foregoing, in each case applicable

 

2



 

to any party hereto, and any order, writ, injunction, directive, judgment or decree of a court of competent jurisdiction applicable to any party hereto.

Assumed IMR ” means, as of any date, the aggregate statutory liability for interest maintenance reserve assumed by Reinsurer as of such date pursuant to the Reinsurance Agreement, as would be reported in the statutory financial statements of the Reinsurer using the NAIC-approved practices and procedures in force in Reinsurer’s Domicile as of such date.

 

Assumed Policies ” means the Affiliate Policies ceded to Cedent under the GLIC Reinsurance Agreements or the GLICNY Reinsurance Agreement.

 

Assumed Reinsurance Agreements ” means, together, the GLICNY Reinsurance Agreement and the GLIC Reinsurance Agreements.

 

Base Ceding Commission ” means $62,700,000.

 

Books and Records ” means all books and records (including computer generated, recorded or stored records) maintained primarily for or primarily relating to the Business that are in the possession or control of Cedent or any of its Affiliates, including any books and records used by Cedent or its Affiliates in the computation of Insurance Reserves or used to generate the factual data provided to Milliman in writing for use in connection with the preparation of the Actuarial Report; provided, however , that Books and Records excludes: (1) Tax Returns and Tax records and all other data and information with respect to Taxes; (2) files, records, data and information with respect to the employees of Cedent or its Affiliates; (3) records, data and information with respect to any employee benefit plan established, maintained or contributed to by Cedent or any of its Affiliates; (4) any materials prepared for the boards of directors or similar governing bodies of Cedent or any of its Affiliates; (5) any corporate minute books, stock records or similar corporate records of Cedent or its Affiliates; (6) any materials that are legally privileged for which Cedent or its Affiliates do not have a common interest with Reinsurer; (7) any information that is not permitted to be disclosed by Cedent to Reinsurer or its Affiliates pursuant to Applicable Law or pursuant to any contract to which Cedent or any of its Affiliates is a party; (8) any internal drafts, opinions, valuations, correspondence or other materials produced by, or provided between or among, Cedent and its Affiliates or Representatives with respect to the negotiation, valuation and consummation of the transactions contemplated under this Agreement and the other Transaction Agreements or the terms of engagement of such Representatives with respect thereto; (9) consolidated financial records (including general ledgers) of Cedent or its Affiliates, consolidated regulatory filings made by Cedent or its Affiliates and any related correspondence with Governmental Authorities, except to the extent the information contained therein specifically and separately identifies the Business and is not otherwise included in a Book and Record; and (10) contracts between third party vendors and Cedent or any of its Affiliates, except to the extent relating to the operation of the Business; provided , with respect to the foregoing clauses (6) and (7), that Cedent shall use commercially reasonable efforts to obtain waivers or make other arrangements (including redacting information and entering into joint defense agreements) that would enable such materials to be made available to Reinsurer; provided, further , that to the extent Books and Records contain information that relates to any business of Cedent and its Affiliates other than

 

3



 

the Business, then such information shall not constitute “Books and Records” for purposes of this Agreement and may be redacted from the Books and Records for purposes of Section 2.4(d)  and Section 5.2 .

 

Business ” means the operation, administration, marketing, underwriting, sale, distribution, and reinsurance of the Reinsured Policies as conducted by Cedent or its applicable Affiliates on or prior to the date hereof.

 

Business Day ” means any day other than a Saturday, a Sunday, or any other day on which banking institutions in Richmond, Virginia, Birmingham, Alabama or New York, New York are required or authorized by Applicable Law to be closed.

 

Ceded Reinsurance Agreements ” means the reinsurance agreements under which Cedent, GLIC, GLICNY, Jamestown, RLI or RLII has ceded to reinsurers risks arising in respect of the Reinsured Policies, in each case that are (a) in force on the date hereof or (b) terminated on the date hereof but under which there remains any outstanding liability or obligation from any reinsurer thereunder; provided , that Ceded Reinsurance Agreements shall not include the RL Captive Reinsurance Agreements, the Assumed Reinsurance Agreements or the Jamestown Reinsurance Agreement.

 

Ceded Reserves ” shall equal (a) with respect to a Direct Policy, the Statutory Reserves for such Direct Policy, properly adjusted by Reinsurer’s Share, and then reduced by 100% of the reserves allocable to Excess Reinsurance with respect to such Direct Policy, and (b) with respect to an Assumed Policy, the Statutory Reserves as would be calculated using NAIC-approved statutory accounting practices and procedures in force in Cedent’s Domicile for such Assumed Policy, properly adjusted by Reinsurer’s Share, and then reduced by 100% of the reserves allocable to Excess Reinsurance with respect to such Assumed Policy.

 

Ceded Total Reserves ” shall equal (a) the Ceded Reserves for all then in-force Reinsured Policies minus (b) the amount of the deferred net premium asset for the in-force Reinsured Policies on a direct mode premium basis as would be calculated using NAIC-approved statutory accounting practices and procedures in force in Cedent’s Domicile.

 

Cedent Disclosure Schedule ” means the disclosure schedule (including any attachments thereto) delivered by Cedent to Reinsurer concurrently with the execution and delivery of, and constituting a part of, this Agreement.

 

Ceding Commission ” means (a) the Base Ceding Commission plus (b) the Adjusted Initial Discounted IMR (as finally determined pursuant to Section 2.4 ).

 

Confidentiality Agreement ” means the confidentiality agreement dated March 23, 2015 between Protective Life Corporation and Genworth Financial, Inc.

 

Covered Benefits ” means the sum of (a) all death benefits arising under a Reinsured Policy (including all interest required under such Reinsured Policy or by Applicable Law whether payable to a beneficiary or escheated) and (b) all cash surrender values arising

 

4



 

under a Reinsured Policy; provided, however, that Covered Benefits shall not include Excluded Interest.

 

Covered Liabilities ” means all liabilities and obligations incurred by Cedent, GLIC or GLICNY for Covered Benefits (a) under the express terms of the Reinsured Policies or (b) as a result of the payment of Covered Benefits consistent with then current standard industry practices with respect to the payment of claims and Existing Practices or, if applicable, Then Current Practices (each as defined in the Reinsurance Agreement).

 

Credit for Reinsurance ” means that Cedent is able to take full statutory financial statement credit for the reinsurance provided by the Reinsurance Agreement in its statutory financial statements filed in Cedent’s Domicile and any other jurisdiction in which Cedent is required by Applicable Law to file statutory financial statements, other than New York.

 

Data Room ” means the electronic data room named “Project Genesis” established by or on behalf of the Cedent and maintained by Intralinks, Inc.

 

Direct Policies ” means the fully underwritten level term life insurance policies but not any riders thereto (a) issued by Cedent and described in Section B of Exhibit A, (b) in-force as of December 31, 2014 and as of the Effective Time and (c) as identified by policy number in the file referenced in Section A of Exhibit A (as such file may be replaced in accordance with the Reinsurance Agreement).

 

Discounted IMR ” means, as of any date of determination, the present value, as of such date, of the Assumed IMR, determined using an amortization schedule consistent with the NAIC-approved practices and procedures in force in Reinsurer’s Domicile and applying an annual discount rate of 10%.

 

Domicile ” means the state or commonwealth in which a particular entity is domiciled; provided , however , that if Cedent’s domicile is the State of New York, Cedent’s domicile shall be deemed to be the Commonwealth of Virginia.

 

Domicile SAP ” means the statutory accounting practices and procedures prescribed in Cedent’s Domicile from time to time.

 

Economic Reserves ” shall have the meaning set forth in the Reinsurance Agreement.

 

Effective Time ” shall have the meaning set forth in the Reinsurance Agreement.

 

Estimated Ceding Commission ” means (a) the Base Ceding Commission plus (b) the Estimated Initial Discounted IMR.

 

Estimated Initial Allowance ” means an amount equal to the Estimated Initial Ceded Total Reserves, as set forth in Cedent’s Estimated Net Settlement Statement, minus the Estimated Initial Economic Reserves.

 

5



 

Estimated Initial Economic Reserves ” means $388,500,000.

 

Excess Reinsurance ” shall have the meaning set forth in the Reinsurance Agreement.

 

Excluded Interest ” means (a) interest on a death benefit arising under a Reinsured Policy to the extent such interest arises as a direct result of the failure by Cedent, GLIC, GLICNY or their respective delegees or subcontractors to act in accordance with (i) Applicable Law or, to the extent consistent therewith, (ii) then current standard industry practices with respect to the payment of claims or (iii) Existing Practices or, if applicable, Then Current Practices (each as defined in the Reinsurance Agreement); or (b) interest that accrues under a settlement option elected by the beneficiary of a death benefit.

 

Extra-Contractual Obligations ” shall have the meaning set forth in the Reinsurance Agreement.

 

Governmental Authority ” means any domestic or foreign, federal, state, county or local governmental or public agency, instrumentality, commission, authority or self-regulatory organization, board or body.

 

Indemnitee ” means any Person entitled to indemnification under this Agreement.

 

Indemnitor ” means any Person required to provide indemnification under this Agreement.

 

Indemnifiable Losses ” means any and all damages, losses, liabilities, obligations, interest, penalties, costs, and expenses (including reasonable attorneys’ fees and expenses); provided that any Indemnity Payment (x) shall in no event include any amounts constituting consequential, indirect, special or punitive damages (except to the extent incurred by a third party and actually paid to such third party in connection with a Third Party Claim), or any damages for lost profits, unless (1) such damages for lost profits do not constitute consequential, indirect, special or punitive damages of any Reinsurer Indemnified Person; (2) such damages for lost profits are recoverable under the laws of the State of New York; (3) the Indemnitee satisfies all elements necessary for proof of such damages for lost profits under such laws; and (4) such lost profits can be demonstrated by reference to the Actuarial Report and therefore to be within the reasonable contemplation of the parties (it being understood that nothing in this definition is intended to limit the effect of the statement set forth in the last sentence of Section 3.12(b) , and that lost profits damages with respect to the reduction or elimination of any profits contemplated by the Actuarial Report shall in no event exceed the present value ascribed to any such remaining profits contemplated by the Actuarial Report as of the date of the Indemnifiable Loss giving rise to the related claim, calculated based on the assumptions on which the Actuarial Report was prepared and discounted using a discount rate of 10%), and (y) shall be net of any (1) amounts recovered by the Indemnitee for the Indemnifiable Losses for which such Indemnity Payment is made under any insurance policy, reinsurance agreement, warranty, or indemnity or otherwise from any Person other than a party hereto, and the Indemnitee shall promptly reimburse the Indemnitor for any such amount that is received by it from any such other Person with respect to an Indemnifiable Loss after any indemnification with respect thereto has actually been paid

 

6



 

pursuant to this Agreement; and (2) amounts specifically included in the calculation of the Adjusted Initial Ceded Total Reserves.

 

Indemnity Payment ” means any amount of Indemnifiable Losses required to be paid pursuant to this Agreement.

 

Initial Assumed IMR ” means the Assumed IMR as of the Effective Time.

 

Initial Ceded Total Reserves ” means the Ceded Total Reserves as of the Effective Time.

 

Initial Discounted IMR ” means the Discounted IMR as of the Effective Time.

 

Initial Economic Reserves ” means the Economic Reserves as of the Effective Time.

 

Initial Net Settlement ” means an amount equal to the result of (a) the Estimated Initial Ceded Total Reserves, plus (b) the Estimated Initial Assumed IMR, minus (c) the Estimated Initial Allowance, minus (d) the Estimated Ceding Commission, each as set forth in Cedent’s Estimated Net Settlement Statement.

 

Insurance Regulator ” means, with respect to any jurisdiction, the Governmental Authority charged with the supervision of insurance companies in such jurisdiction.

 

Insurance Reserves ” means the reserves for the payment of benefits, losses, claims, unearned premium and expenses under the Reinsured Policies.

 

Knowledge of Cedent ” means the actual knowledge, after reasonable investigation, of those persons identified in Schedule 1.1 of the Cedent Disclosure Schedule.

 

Knowledge of Reinsurer ” means the actual knowledge, after reasonable investigation, of those persons identified in Schedule 1.1 of the Reinsurer Disclosure Schedule.

 

Liabilities ” means any and all debts, liabilities, commitments or obligations, whether direct or indirect, accrued or fixed, known or unknown, absolute or contingent, matured or unmatured or determined or determinable, whether arising in the past, present or future.

 

Material Adverse Effect ” means a material adverse effect on (a) the business, condition (financial or otherwise) or results of operations of the Business, taken as a whole, but for purposes of this clause (a) excluding any such effect to the extent resulting from or arising out of: (i) any change, development, event or occurrence in general political, economic, or securities or financial market conditions (including changes in interest rates, changes in currency exchange rates, or changes in equity prices); (ii) any change, development, event or occurrence generally affecting participants in the life insurance, annuity or financial services industries; (iii) any change or proposed change in Domicile SAP or Applicable Law, or the interpretation or enforcement thereof; (iv) natural disasters, catastrophic events, pandemics, hostilities, acts of war or terrorism, or any escalation or worsening thereof; (v) the public announcement of any of the

 

7



 

transactions contemplated by the Transaction Agreements; (vi) the identity of or facts related to Reinsurer; (vii) any action (A) taken by Cedent or any of its Affiliates, agents or representatives at the written instruction of or with the written consent of Reinsurer or (B) failed to be taken by Cedent or any of its Affiliates, agents or representatives because Reinsurer has withheld its consent in breach of an obligation under this Agreement not to withhold such consent; (viii) any downgrade or threatened downgrade in the rating assigned to GLICNY, GLIC or Cedent by any rating agency (but not the facts or circumstances giving rise to such downgrade or threatened downgrade); or (ix) any failure of GLICNY, GLIC or Cedent to meet any financial projections, forecasts, predictions, or targets ( provided that this clause (ix) shall not by itself exclude the underlying causes of any such failure); except, in the case of clause (i) (ii), (iii) and (iv), to the extent such effect has a disproportionate effect on the Business taken as a whole relative to comparable businesses of other life insurance companies; or (b) the ability of Cedent and its Affiliates to perform their respective obligations under the Transaction Agreements, including consummation of the transactions contemplated hereby or thereby. For the avoidance of doubt, the inability of the Reinsurer to timely obtain the Financing Approvals, if applicable, will not be a Material Adverse Effect.

 

NAIC ” means the National Association of Insurance Commissioners or any successor thereto.

 

Permits ” means licenses, permits, orders, approvals, registrations, authorizations and qualifications with Governmental Authorities.

 

Person ” means an individual, corporation, partnership, joint venture, limited liability company, association, trust, unincorporated organization, Governmental Authority, or other entity.

 

Personal Information ” means personal, private, health or financial information about individual policyholders or benefit recipients under the Reinsured Policies.

 

Premiums ” means the direct term premium, including policy fees, additional substandard premiums and modal loadings payable to GLIC, GLICNY or the Cedent with respect to the Reinsured Policies.

 

Producers ” means the brokers, insurance agents, producers, distributors or other persons involved in the marketing and production of the Reinsured Policies.

 

Reinsured Benefits ” means (i) all Covered Liabilities payable by Cedent, GLIC or GLICNY under the Reinsured Policies after the Effective Date on account of dates of death or surrender on or after the Effective Date, appropriately adjusted by the Reinsurer’s Share, and then reduced by 100% of the death or surrender benefits which are payable to Cedent or GLIC in respect of such Reinsured Policy under the terms of Excess Reinsurance (including interest on and claims expenses with respect to such death or surrender benefits if such interest or such claims expenses are payable to Cedent or GLIC in respect of such Reinsured Policy under the terms of Excess Reinsurance), regardless of whether such amounts are actually paid to Cedent or GLIC by such Excess Reinsurance; and (ii) all Reinsurer Extra-Contractual Obligations.

 

8



 

Reinsured Policies ” means the Direct Policies and the Assumed Policies together.

 

Reinsurer Disclosure Schedule ” means the disclosure schedule (including any attachments thereto) delivered by Reinsurer to Cedent concurrently with the execution and delivery of, and constituting a part of, this Agreement.

 

Reinsurer Extra-Contractual Obligations ” shall have the meaning set forth in the Reinsurance Agreement.

 

Reinsurer Material Adverse Effect ” means a material adverse effect on the ability of Reinsurer to perform its obligations under the Transaction Agreements, including consummation of the transactions contemplated hereby or thereby.

 

Reinsurer’s Share ” has the meaning set forth in the Reinsurance Agreement.

 

Representative ” means, with respect to any Person, such Person’s Affiliates and any directors, officer, employee, agent attorney or consultant of such Person or any such Affiliate.

 

Reserve Methodology ” means the methodologies, procedures, judgments and estimates for determining Economic Reserves set forth in Annex A .

 

Restructuring Transactions ” means the transactions set forth on Annex B .

 

Statutory Reserves ” shall equal the aggregate statutory reserves (including deficiency reserves and unearned premium reserves) in respect of the Reinsured Benefits as calculated by Cedent using the NAIC approved practices and procedures in force in Cedent’s Domicile from time to time. For the purposes of calculating the Initial Net Settlement, Cedent shall use the NAIC-approved practices and procedures in force in the Commonwealth of Virginia as of the Closing.

 

Tax Return ” means any report, estimate, extension request, information statement, claim for refund, or return relating to, or required to be filed in connection with, any Tax, including any schedule or attachment thereto, and any amendment thereof.

 

Taxes ” means any and all federal, state, local, or foreign income, premium, property (real or personal), sales, excise, employment, payroll, withholding, gross receipts, license, severance, stamp, occupation, windfall profits, environmental, customs duties, capital stock, franchise, profits, social security (or similar, including FICA), unemployment, disability, use, transfer, registration, value added, alternative or add-on minimum, estimated, or other tax of any kind or any charge of any kind in the nature of (or similar to) taxes whatsoever, including any interest, penalty, or addition thereto.

 

Third Party Claim ” means any claim, action, suit, or proceeding made or brought by any Person that is not a party to this Agreement or an Affiliate thereof.

 

9



 

Transaction Agreements ” means this Agreement and the Reinsurance Agreement.

 

Transaction Expenses ” means, without duplication, all liabilities (except for any Taxes) incurred by any party hereto for fees, expenses, costs, or charges as a result of the contemplation, negotiation, efforts to consummate, or consummation of the transactions contemplated by this Agreement, including any fees and expenses of investment bankers, attorneys, accountants, or other advisors, and any fees payable by such parties to Governmental Authorities or other third parties, in each case, in connection with the consummation of the transactions contemplated by this Agreement.

 

In addition, the following terms shall have the respective meanings set forth in the following sections of this Agreement:

 

Term

 

Section

2003 GLIC Reinsurance Agreement

 

Recitals

2004 GLIC Reinsurance Agreement

 

Recitals

Actuarial Firm

 

2.4(c)

Actuarial Report

 

3.12(b)

Adjusted Allowance

 

2.4(e)(iv)

Adjusted Initial Assumed IMR

 

2.4(e)

Adjusted Initial Ceded Total Reserves

 

2.4(e)

Adjusted Initial Discounted IMR

 

2.4(e)

Adjusted Initial Economic Reserves

 

2.4(e)

Agreement

 

Preamble

Audited 2014 Financial Statements

 

3.12(a)(i)

Burdensome Condition

 

5.5(a)

Cedent

 

Preamble

Cedent Factual Data

 

3.12(b)

Cedent Financial Statements

 

3.12(a)(i)

Cedent Fundamental Representations

 

7.1(a)

Cedent Indemnified Persons

 

7.2(b)

Cedent’s Estimated Net Settlement Statement

 

2.3(a)

Cedent’s Final Reserve Statement

 

2.4(a)

Closing

 

2.1

Closing Date

 

2.1

Condition Satisfaction

 

2.1

Deadline Date

 

8.1(b)

Deductible

 

7.3(a)

Disputed Item

 

2.4(b)

Effective Date

 

2.1

Enforceability Exceptions

 

3.2

Estimated Initial Assumed IMR

 

2.3(a)

Estimated Initial Ceded Total Reserves

 

2.3(a)

Estimated Initial Discounted IMR

 

2.3(a)

Financing Approvals

 

2.1

 

10



 

Term

 

Section

GLIC

 

Recitals

GLIC Reinsurance Agreements

 

Recitals

GLICNY

 

Recitals

GLICNY Reinsurance Agreement

 

Recitals

Jamestown

 

Recitals

Jamestown Reinsurance Agreement

 

Recitals

Milliman

 

3.12(b)

New York Court

 

9.7(a)

Notice of Disagreement

 

2.4(b)

Order

 

3.3(a)

Policyholder Personal Information

 

5.3

Reinsurance Agreement

 

Recitals

Reinsurer

 

Preamble

Reinsurer Fundamental Representations

 

7.1(a)

Reinsurer Indemnified Persons

 

7.2(a)

Reserve Funding Transaction

 

5.5(d)

Resolution Period

 

2.4(c)

River Lake I Reinsurance Agreement

 

Recitals

River Lake II Reinsurance Agreement

 

Recitals

RL Captive Reinsurance Agreements

 

Recitals

RLI

 

Recitals

RLII

 

Recitals

Threshold Amount

 

7.3(a)

Unresolved Items

 

2.4(c)

 

ARTICLE II.

CLOSING; INITIAL REINSURANCE PREMIUM AND CEDING ALLOWANCE

 

SECTION 2.1.   Closing . The closing of the transactions contemplated hereby (the “ Closing ”) shall take place at the offices of Willkie Farr & Gallagher LLP, 787 Seventh Avenue, New York, New York 10019, at 10:00 a.m., New York City time, (i) on January 6, 2016 subject to (A) all the conditions set forth in Article VI having been satisfied or waived in accordance with this Agreement prior to such date and time (other than those conditions that by their terms are to be satisfied at the Closing but subject to the satisfaction or waiver of such conditions) (the “ Condition Satisfaction ”) and (B) Reinsurer and its applicable Affiliates having received each of the approvals of Governmental Authorities set forth in Section 2.1 of the Reinsurer Disclosure Schedule (the “ Financing Approvals ”) not later than the date that is three (3) Business Days prior to January 6, 2016; or (ii) if the Condition Satisfaction does not occur prior to the date and time specified in the foregoing clause (i)(A) and/or Reinsurer and its applicable Affiliates have not received the Financing Approvals by the date specified in the foregoing clause (i)(B), then on the fifth (5 th ) Business Day following the later of (A) the date on which the Condition Satisfaction has occurred and (B) the date on which Reinsurer and its applicable Affiliates have received the Financing Approvals; or (iii) if the Condition Satisfaction has occurred but Reinsurer and its applicable Affiliates have not received all of the Financing

 

11



 

Approvals by June 22, 2016, then on June 30, 2016; in each case, subject to the satisfaction or waiver of all of the conditions set forth in Article VI in accordance with this Agreement prior to the date and time of the Closing (other than those conditions that by their terms are to be satisfied at the Closing but subject to the satisfaction or waiver of such conditions); or such other date, time, or place as is agreed to in writing by the parties hereto. The actual date and time on which the Closing occurs are referred to herein as the “ Closing Date .” The “ Effective Date ” for purposes of this Agreement and the Reinsurance Agreement shall be the first day of the month in which the Closing occurs.

 

SECTION 2.2.   Closing Deliveries .

 

(a)           Cedent’s Closing Deliveries . At the Closing, Cedent shall make the payment contemplated by Section 2.3 and also deliver to Reinsurer:

 

(i)            a certificate of Cedent duly executed by an authorized officer of Cedent, dated as of the Closing Date, certifying that the conditions set forth in Section 6.2(a)  and Section 6.2(b)  have been satisfied; and

 

(ii)           counterparts of the Reinsurance Agreement, duly executed by Cedent.

 

(b)           Reinsurer’s Closing Deliveries . At the Closing, Reinsurer shall make the payment contemplated by Section 2.3 and also deliver to Cedent:

 

(i)            a certificate of Reinsurer duly executed by an authorized officer of Reinsurer, dated as of the Closing Date, certifying that the conditions set forth in Section 6.3(a)  and Section 6.3(b)  have been satisfied; and

 

(ii)           counterparts of the Reinsurance Agreement, duly executed by Reinsurer.

 

SECTION 2.3.   Payment at Closing .

 

(a)           No later than five Business Days prior to the anticipated Closing Date, Cedent shall deliver to Reinsurer a statement, substantially in the form attached as Exhibit B (“ Cedent’s Estimated Net Settlement Statement ”), which shall be prepared as an estimate in good faith by Cedent in accordance with the Reserve Methodology and the definitions thereof after giving effect to the Restructuring Transactions on a pro forma basis, and shall set forth, in reasonable detail, Cedent’s estimated calculations of the Initial Ceded Total Reserves (the “ Estimated Initial Ceded Total Reserves ”), the Estimated Initial Economic Reserves, the Estimated Initial Allowance, the Initial Assumed IMR (“ Estimated Initial Assumed IMR ”), the Initial Discounted IMR (the “ Estimated Initial Discounted IMR ”), the Estimated Ceding Commission and the Initial Net Settlement. Cedent’s Estimated Net Settlement Statement shall be accompanied by a certificate signed by a senior officer of Cedent that Cedent’s Estimated Net Settlement Statement was prepared in accordance with this Section 2.3(a) .

 

12



 

(b)           As consideration for the reinsurance by Reinsurer of the Reinsured Policies and the Assumed IMR under the Reinsurance Agreement, on the Closing Date, Cedent shall pay to Reinsurer, pursuant to clause (d) of this Section 2.3 an amount equal to the sum of (i) the Estimated Initial Ceded Total Reserves and (ii) the Estimated Initial Assumed IMR, each as reflected on Cedent’s Estimated Net Settlement Statement.

 

(c)           Simultaneously with the transfer described in the foregoing clause (b), Reinsurer shall pay to Cedent, pursuant to clause (d) of this Section 2.3 , an amount equal to the sum of (A) the Estimated Initial Allowance and (B) the Estimated Ceding Commission, each as reflected on Cedent’s Estimated Net Settlement Statement and.

 

(d)           On the Closing Date, Cedent and Reinsurer shall settle payments described in the foregoing clauses (b) and (c) on a net basis with Cedent paying to Reinsurer the Initial Net Settlement as reflected on Cedent’s Estimated Net Settlement Statement in cash by wire transfer of immediately available funds to an account designated by Reinsurer at least two Business Days prior to the Closing Date.

 

SECTION 2.4.   Post-Closing Adjustments .

 

(a)           No later than ninety (90) days following the Closing Date, Cedent shall deliver to Reinsurer a statement, substantially in the form attached as Exhibit B (the “ Cedent’s Final Reserve Statement ”), setting forth in reasonable detail Cedent’s calculation of the Initial Ceded Total Reserves, the Initial Economic Reserves, the Initial Assumed IMR and the Initial Discounted IMR in accordance with the Reserve Methodology and the definitions thereof, which amounts shall be calculated, to the extent applicable, based upon the inventory of Reinsured Policies in-force as of the Effective Date that is included in the in force cession file to be delivered by Cedent to Reinsurer within ten (10) Business Days following the Closing Date pursuant to Section 3(a) of Article II and Exhibit VI-A of the Reinsurance Agreement. The Cedent’s Final Reserve Statement shall be accompanied by a certificate signed by a senior officer of Cedent that Cedent’s Final Reserve Statement was prepared in accordance with this Section 2.4(a) .

 

(b)           If Reinsurer reasonably disagrees that Cedent’s Final Reserve Statement was not determined in accordance with Section 2.4(a)  or believes that Cedent’s Final Reserve Statement contains mathematical errors, Reinsurer may, within thirty (30) days after receipt of Cedent’s Final Reserve Statement, deliver a notice of disagreement (a “ Notice of Disagreement ”) to Cedent disagreeing with Cedent’s Final Reserve Statement and specifying in reasonable detail each item that Reinsurer in good faith disputes (each, a “ Disputed Item ”) and the amount in dispute for each such Disputed Item (determined in accordance with the Reserve Methodology). If Reinsurer does not deliver a Notice of Disagreement within such thirty (30) day period, then the Initial Ceded Total Reserves, the Initial Economic Reserves, the Initial Assumed IMR and the Initial Discounted IMR shall be deemed to equal the amount provided in Cedent’s Final Reserve Statement.

 

(c)           If a Notice of Disagreement was timely delivered pursuant to Section 2.4(b) , Cedent and Reinsurer shall, during the fifteen (15) days following Cedent’s receipt of such Notice of Disagreement (the “ Resolution Period ”), seek in good faith to reach agreement on the

 

13



 

Disputed Items. If, by the end of the Resolution Period, Cedent and Reinsurer are unable to reach such agreement with respect to all of the Disputed Items, they shall promptly thereafter engage and submit the unresolved Disputed Items (the “ Unresolved Items ”) to Milliman (other than the Chicago office thereof) or other firm mutually agreed by the parties (the “ Actuarial Firm ”) which shall promptly review this Agreement and the Unresolved Items. The Actuarial Firm shall issue its written determination with respect to each Unresolved Item within thirty (30) days after the Unresolved Items are submitted for review. The Actuarial Firm’s determination of the Unresolved Items shall be in accordance with the Reserve Methodology and within the range of Cedent’s and Reinsurer’s disagreement with respect to each Unresolved Item, and the Actuarial Firm shall recalculate the Initial Ceded Total Reserves, the Initial Economic Reserves, the Initial Assumed IMR and the Initial Discounted IMR (as applicable) after giving effect to its resolution of the Unresolved Items. Each party shall use commercially reasonable efforts to furnish to the Actuarial Firm such work papers, books, records and documents and other information pertaining to the Unresolved Items as the Actuarial Firm may request. Absent manifest error, the determination of the Actuarial Firm shall be final, binding and conclusive on Cedent and Reinsurer. Judgment may be entered upon the determination by the Actuarial Firm in accordance with Section 9.7 . The fees, expenses and costs of the Actuarial Firm incurred in rendering any determination pursuant to this Section 2.4 shall be split equally between Cedent and Reinsurer.

 

(d)           Each party shall use commercially reasonable efforts to provide promptly to the other party all relevant information and reasonable access to employees as such other party may reasonably request in connection with its review of the Cedent’s Estimated Net Settlement Statement, the Cedent’s Final Reserve Statement or the Notice of Disagreement, as the case may be, including all work papers of the accountants who audited, compiled or reviewed such statements or notices (subject to the requesting party and its Representatives entering into any reasonable customary undertakings required by the other party’s accountants in connection therewith), and shall otherwise cooperate in good faith with such other party to arrive at a final determination of the Initial Ceded Total Reserves, the Initial Economic Reserves, the Initial Assumed IMR and the Initial Discounted IMR; provided , that Cedent shall not be required to provide Reinsurer with any information set forth in the provisos to the definition of “Books and Records.”

 

(e)           As used herein, the “ Adjusted Initial Ceded Total Reserves ,” “ Adjusted Initial Economic Reserves ,” “ Adjusted Initial Assumed IMR ” and “ Adjusted Initial Discounted IMR ” shall be Initial Ceded Total Reserves, Initial Economic Reserves, Initial Assumed IMR and/or Initial Discounted IMR, respectively, each as finally determined pursuant to this Section 2.4 . Following final determination of the Adjusted Initial Ceded Total Reserves, Adjusted Initial Economic Reserves, Adjusted Initial Assumed IMR and Adjusted Initial Discounted IMR, whether by the absence of timely delivery of Notice of Disagreement or pursuant to Section 2.4(c) :

 

(i)            Cedent shall pay to Reinsurer the excess, if any, of the Adjusted Initial Ceded Total Reserves over the Estimated Initial Ceded Total Reserves; and Reinsurer shall pay to Cedent the excess, if any, of the Estimated Initial Ceded Total Reserves over the Adjusted Initial Ceded Total Reserves;

 

14



 

(ii)           Cedent shall pay to Reinsurer the excess, if any, of the Adjusted Initial Assumed IMR over the Estimated Initial Assumed IMR; and Reinsurer shall pay to Cedent the excess, if any, of the Estimated Initial Assumed IMR over the Adjusted Initial Assumed IMR;

 

(iii)          Cedent shall pay to Reinsurer the excess, if any, of the Estimated Initial Discounted IMR over the Adjusted Initial Discounted IMR; and Reinsurer shall pay to Cedent the excess, if any, of the Adjusted Initial Discounted IMR over the Estimated Initial Discounted IMR; and

 

(iv)          Cedent shall pay to Reinsurer the excess, if any, of the Estimated Initial Allowance over the Adjusted Allowance; and Reinsurer shall pay to Cedent the excess, if any, of the Adjusted Allowance over the Estimated Initial Allowance. “ Adjusted Allowance ” means the difference of the Adjusted Initial Ceded Total Reserves and the Adjusted Initial Economic Reserves.

 

The payments contemplated by the foregoing clauses (i)-(iv) of this Section 2.4(e)  shall be settled on a net basis within five (5) Business Days after such amounts have been resolved pursuant to this Section 2.4, by wire transfer of immediately available funds to an account designated by Reinsurer or Cedent, as applicable. The amount of any payment to be made pursuant to this Section 2.4(e)  shall not bear any interest.

 

ARTICLE III.

REPRESENTATIONS AND WARRANTIES OF CEDENT

 

Subject to and as qualified by the matters set forth in the Cedent Disclosure Schedule (subject to Section 9.3(g) ), Cedent represents and warrants to Reinsurer as of the date hereof and as of the Closing Date as follows:

 

SECTION 3.1.      Organization, Standing and Corporate Power .  Cedent is a life insurance company duly organized, validly existing and in good standing under the laws of the Commonwealth of Virginia.  Cedent has all requisite corporate power and authority to carry on the operations of its business as they are now being conducted and to own, lease and operate its properties and assets. Cedent is duly qualified or licensed to do business as a foreign company in good standing in each jurisdiction in which the conduct of its business or the ownership, leasing or operation of its properties or assets makes such qualification necessary, except where the failure to be so qualified or licensed would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. As of the Closing Date, Cedent will have obtained all authorizations and approvals required under Applicable Law to perform the obligations contemplated of Cedent under the Transaction Agreements.

 

SECTION 3.2.      Authority . Cedent has the requisite corporate power and authority to enter into the Transaction Agreements, to consummate the transactions contemplated thereby and to perform the obligations thereunder. The execution and delivery by Cedent of the Transaction Agreements, the consummation by Cedent of the transactions contemplated thereby and the performance by Cedent of its obligations thereunder have been duly authorized by all necessary corporate or other organizational action on the part of Cedent. Each of the Transaction

 

15



 

Agreements has been or, with respect to the Transaction Agreements to be executed and delivered at the Closing, will be duly executed and delivered by Cedent and, assuming the Transaction Agreements constitute legal, valid and binding agreements of the other parties thereto, constitute legal, valid and binding obligations of Cedent, enforceable against Cedent in accordance with their terms, except that (a) such enforcement may be subject to applicable bankruptcy, insolvency, reorganization, moratorium, or other similar laws, now or hereafter in effect, affecting creditors’ rights generally and (b) the remedy of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and to the discretion of the court before which any proceeding therefor may be brought (clauses (a) and (b) shall be referred to as, the “ Enforceability Exceptions ”).

 

SECTION 3.3.   Actions and Proceedings . Except as set forth in Section 3.3 of Cedent Disclosure Schedule, there are no:

 

(a)           outstanding orders, decrees, injunctions or judgments by or with any Governmental Authority (“ Orders ”) in effect against the Cedent, GLIC or GLICNY that restrict materially the conduct of the Business or that, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect; or

 

(b)           Actions pending or, to the Knowledge of Cedent, threatened in writing with respect to the Business (other than Actions solely involving claims under or in connection with Reinsured Policies in the ordinary course of business seeking only damages that are within applicable policy limits) that would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

SECTION 3.4.   No Conflict or Violation . Except as set forth in Section 3.4 of Cedent Disclosure Schedule, the execution, delivery and performance by Cedent of the Transaction Agreements and the consummation of the transactions contemplated thereby in accordance with the respective terms and conditions thereof will not:

 

(a)           violate any provision of the Articles of Incorporation, Bylaws or other organizational documents of Cedent;

 

(b)           violate, conflict with, result in the breach of any of the terms of, any loss of rights under or modification of the effect of, otherwise give any other contracting party the right to accelerate, terminate or cancel, or constitute (or with notice or lapse of time or both, constitute) a default under, any contract with respect to the Business to which Cedent is a party or by or to which any of its or their properties may be bound or subject;

 

(c)           violate any Order, judgment, injunction, condition, agreement, award or decree of any court, arbitrator or Governmental Authority, foreign or domestic, against or imposed or binding upon, Cedent; or

 

(d)           subject to obtaining the consents and approvals, making the filings and giving the notices referred to in Section 3.5 , violate any Applicable Law; or

 

16



 

(e)           result in a breach or violation of any of the terms or conditions of, constitute a default under, or otherwise cause an impairment or revocation of, any Permit related to the Business;

 

except, in the case of clauses (b), (c), (d) and (e) of this Section 3.4 , for such breaches, losses of rights, accelerations, conflicts, modifications, terminations, violations, defaults, impairments or revocations that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

SECTION 3.5.   Governmental Consents . No consent, approval or authorization of, or declaration or filing with, or notice to, any Governmental Authority is required by or with respect to Cedent in connection with the execution, delivery and performance of this Agreement or the Reinsurance Agreement by Cedent, or the consummation by Cedent of the transactions contemplated hereby or thereby, except for the approvals, filings, and notices set forth in Section 3.5 of the Cedent Disclosure Schedule and such consents, approvals, authorizations, declarations, filings, or notices that, if not obtained or made, would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

SECTION 3.6.   Compliance .

 

(a)           Except as disclosed in Section 3.6(a) of the Cedent Disclosure Schedule, since January 1, 2013, the Business has been conducted in compliance in all material respects with Applicable Laws. Except as disclosed in Section 3.6 of the Cedent Disclosure Schedule, since January 1, 2013, none of Cedent or any of its Affiliates has received any written notice from any Governmental Authority regarding any actual or alleged violation of, or failure on the part of any Cedent or any of its Affiliates to comply with, any Applicable Law in any material respect with respect to the Business.

 

(b)           Except as disclosed in Section 3.6(b) of the Cedent Disclosure Schedule, the collection, storage, use and dissemination by Cedent or its Affiliates in the operation of the Business of any Personal Information is and has, since January 1, 2013, been in compliance with all applicable privacy policies, terms of use, contractual requirements and Applicable Law except to the extent such failure to comply would not reasonably be expected to result in a Material Adverse Effect. Cedent and its Affiliates use commercially reasonable measures to protect the secrecy of Personal Information that they collect and maintain in connection with the Business and to prevent unauthorized access to such Personal Information by any Person. With respect to the Business, Cedent and its Affiliates engaged in the Business have implemented and maintain a security plan which (i) is designed to implement and monitor effective and commercially reasonable administrative, electronic and physical safeguards to ensure that confidential information and Personal Information are protected against unauthorized access, disclosure, use, modification or other misuse or misappropriation thereof and (ii) prescribes notification procedures in compliance with Applicable Laws in the case of any breach of security compromising Personal Information.

 

SECTION 3.7.   Permits . Except as set forth in Section 3.7 of Cedent Disclosure Schedule, (a) to the Knowledge of Cedent, each of Cedent, GLIC and GLICNY, as applicable,

 

17



 

held, at the time it issued any Reinsured Policies, all material Permits required under Applicable Law in order to issue such Reinsured Policies, and (b) each of Cedent, GLIC and GLICNY, as applicable, holds all material Permits required under Applicable Law that are necessary to entitle them to conduct the Business as currently conducted. All such material Permits referred to under clause (b) of this Section 3.7 are valid and in full force and effect. Cedent is not an investment company subject to registration under the Investment Company Act of 1940, as amended.

 

SECTION 3.8.   Insurance Matters .

 

(a)           Except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, since January 1, 2013, each of Cedent, GLIC and GLICNY has filed all reports, statements, registrations, filings or submissions that are required under Applicable Law to be filed with any Governmental Authority and that relate in whole or in substantial part to the Business, and all such reports, statements, documents, registrations, filings or submissions were true, complete and accurate when filed in all material respects. To the Knowledge of Cedent, Cedent has made available to Reinsurer true, correct and complete copies of all material reports, statements, documents, registrations, filings or submissions, and all reports on financial examination, market conduct reports and other reports (in final form) delivered by any Governmental Authority in respect of the Business since January 1, 2013. As of the date of this Agreement, none of Cedent, GLIC, GLICNY or any of their Affiliates is subject to any pending financial or market conduct examination by any Governmental Authority in connection with the Business except as set forth in Section 3.8(a) of Cedent Disclosure Schedule.

 

(b)           Except as set forth in Section 3.8(b) of Cedent Disclosure Schedule, to the Knowledge of Cedent, the Reinsured Policies, to the extent required under Applicable Law, have been issued on forms approved by the applicable insurance regulatory authority or filed and not objected to by such insurance regulatory authority within the period provided for objection, in each case except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. No material deficiencies have been asserted in writing by any Governmental Authority with respect to any such filings which have not been cured or otherwise resolved.

 

(c)           Since January 1, 2013, the Reinsured Policies have been administered in all material respects in accordance with the applicable policy forms and requirements of Applicable Law.

 

(d)           Except as set forth in Section 3.8(d) of Cedent Disclosure Schedule, and to the extent applicable to the Reinsured Policies, to the Knowledge of Cedent, each of Cedent, GLIC, GLICNY and their respective Affiliates is and has been in compliance in all material respects with all Applicable Laws regulating the marketing and sale of life insurance policies, regulating advertisements, requiring mandatory disclosure of policy information, requiring employment of standards to determine if the purchase of a policy or contract is suitable for an applicant, prohibiting the use of unfair methods of competition and deceptive acts or practices and regulating replacement transactions. For purposes of this Section 3.8(d), (i) “advertisement” means any material designed to create public interest in life insurance policies

 

18



 

or in an insurer, or in an insurance producer, or to induce the public to purchase, increase, modify, reinstate, borrow on, surrender, replace or retain such a policy or contract, and (ii) “replacement transaction” means a transaction in which a new life insurance policy is to be purchased by a prospective insured and the proposing producer knows or should know that one or more existing life insurance policies will lapse, or will be forfeited, surrendered, reduced in value or pledged as collateral.

 

SECTION 3.9.   Reserved .

 

SECTION 3.10.   Reinsurance .

 

(a)           Section 3.10(a)(i) of Cedent Disclosure Schedule sets forth a complete list of Ceded Reinsurance Agreements in effect as of the date hereof. Cedent has made available to the Reinsurer true and correct copies of each of the Ceded Reinsurance Agreements. Except as set forth in Section 3.10(a)(ii) of Cedent Disclosure Schedule, no party to any Ceded Reinsurance Agreement has given the other party written notice of termination (provisional or otherwise) under any Ceded Reinsurance Agreement with respect to the Reinsured Policies. None of Cedent, GLIC or GLICNY, or, to the Knowledge of Cedent, any other party is in material breach or default under any Ceded Reinsurance Agreement. Except as set forth in Section 3.10(a)(iii) of Cedent Disclosure Schedule, each such Ceded Reinsurance Agreement with respect to the Reinsured Policies is in full force and effect and is valid and enforceable against Cedent, GLIC or GLICNY, as applicable, and, to the Knowledge of Cedent, each other party thereto in accordance with its terms, subject to the Enforceability Exceptions.

 

(b)           Except for the Assumed Reinsurance Agreements or as set forth on Section 3.10(b) of the Cedent Disclosure Schedule, neither Cedent, GLIC nor GLICNY is a party to any reinsurance, retrocession or similar contracts under which any Person cedes to Cedent, GLIC or GLICNY any risks included in the Business, whether or not any such contract is currently accepting new business.

 

(c)           As of the Closing Date, GLICNY will have no present right under the terms of the GLICNY Reinsurance Agreement to recapture all or any part of the reinsurance ceded thereunder, with or without giving of notice, as a result of the event described in Section 3.10(c) of the Cedent Disclosure Schedule.

 

(d)           As of December 31, 2014, each Reinsured Policy was ceded, in whole or in part, pursuant to either the River Lake I Reinsurance Agreement or the River Lake II Reinsurance Agreement.

 

SECTION 3.11.  Absence of Certain Changes . Except as set forth in Section 3.11 of Cedent Disclosure Schedule, from December 31, 2014 through the date hereof, (a) the Business has been conducted in all material respects in the ordinary course of business consistent with past practices, (b) there has not been any event, occurrence or condition of any character that has had, or which would, individually or in the aggregate, reasonably be expected to have, a Material Adverse Effect and (c) none of Cedent, GLIC, GLICNY, or any of their Affiliates has taken any action or failed to take any action that would have resulted in a breach of any of the covenants set forth in Section 5.1 , had Section 5.1 been in effect since December 31, 2014.

 

19



 

SECTION 3.12.  Cedent Financial Statements; Reserves .

 

(a)           Financial Statements .

 

(i)            Cedent has made available to Reinsurer true, correct and complete copies of the following statutory statements, as filed with the insurance regulatory authority of Cedent’s state of domicile, together with the exhibits, schedules and notes thereto and any affirmations and certifications filed therewith: (A) Cedent’s unaudited annual statutory financial statements, as of and for the years ended December 31, 2013 and December 31, 2014, (B) Cedent’s audited annual statutory financial statements as of and for the year ended December 31, 2013, (C) Cedent’s audited annual statutory financial statements as of and for the year ended December 31, 2014 (the “ Audited 2014 Financial Statements ”) and (C) the unaudited quarterly statutory financial statements of Cedent as of and for the quarter ended June 30, 2015 (collectively, the “ Cedent Financial Statements ”). The Cedent Financial Statements have been prepared in accordance with the Domicile SAP applied on a consistent basis (except as may be indicated in the notes thereto) and present fairly, in all material respects, the statutory financial position, results of operations and cash flows of Cedent at and for the respective periods indicated therein. To the Knowledge of Cedent, no material deficiency has been asserted in writing by any Governmental Authority with respect to any Cedent Financial Statements that remains unresolved prior to the date hereof.

 

(ii)           Subject to Section 9.12 , the Insurance Reserves as of December 31, 2014 reflected on the Audited 2014 Financial Statements: (A) were computed in all material respects in accordance with generally accepted actuarial standards consistently applied and (B) were fairly stated in accordance with Domicile SAP and Applicable Law.

 

(b)           Cedent has made available to Reinsurer a true, complete and correct copy of the “Actuarial Appraisal of River Lake I and River Lake II Blocks of Business” prepared by Milliman, Inc. (“ Milliman ”) with respect to the Business dated April 20, 2015, and all supplements and addenda thereto (the “ Actuarial Report ”). Except as set forth in Section 3.12(b) of Cedent Disclosure Schedule, to the Knowledge of Cedent, the factual data furnished by Cedent and its Affiliates in writing to Milliman with respect to the Business for its use in connection with the preparation of the Actuarial Report (the “ Cedent Factual Data ”) was (i) derived from the Books and Records, (ii) generated from the same underlying systems that were utilized by Cedent or its applicable Affiliates to prepare the Audited 2014 Financial Statements to the extent applicable and (iii) accurate in all material respects as of the date such Cedent Factual Data was furnished to Milliman. In the good faith judgment of Cedent and in the context of industry practices for the preparation of third party actuarial reports to be used in the sale of a block of life insurance business, the Cedent Factual Data was complete in all material respects as of the date furnished to Milliman. Except as set forth in Section 3.12(b) of the Cedent Disclosure Schedule, as of the date hereof, Milliman has not issued to Cedent or its Affiliates any new or revised report with respect to the Business or any errata with respect to the Actuarial

 

20



 

Report nor has it notified Cedent or any of its Affiliates that the Actuarial Report is inaccurate in any material respect. Notwithstanding anything in this Agreement to the contrary, Cedent does not guarantee the projected results included in the Actuarial Report, or make any representation or warranty (x) with respect to any estimates, projections, predications, forecasts, assumptions, methodologies and judgments in the Actuarial Report or the assumptions on the basis of which such information or data was prepared (including, without limitation, as to future mortality, policyholder behavior, expense, investment experience and other actuarial factors with respect to the Business or its associated liabilities or assets) or (y) to the effect that the projected profits set forth in the Actuarial Report will be realized.

 

(c)           Except as set forth in Section 3.12(c) of the Cedent Disclosure Schedule or included in the Cedent Factual Data, from January 1, 2015 to the date hereof, none of Cedent or any of its Affiliates has received any written notice of any actual or proposed increase in the reinsurance rates payable under any Excess Reinsurance with respect to the Reinsured Policies, and no such increase has occurred.

 

(d)           Except as set forth in Section 3.12(d) of the Cedent Disclosure Schedule or as contemplated by the Reinsurance Agreement, Cedent has not granted a security interest in the Recurring Reinsurance Premiums (as defined in the Reinsurance Agreement) to any Person.

 

SECTION 3.13.  Books and Records . The Books and Records (i) have been maintained in all material respects in accordance with sound business practices and Applicable Law and (ii) to the Knowledge of Cedent, have been prepared using processes and procedures for which there are no material weaknesses or significant deficiencies in internal controls over financial reporting that adversely affect the ability of Cedent to accurately present and reflect in all material respects all of the Business and other transactions and actions related thereto.

 

SECTION 3.14.  No Undisclosed Material Liabilities . The Business does not have any material Liabilities of a type that are required to be set forth on a balance sheet prepared in accordance with Domicile SAP, except (a) as set forth in Section 3.14 of Cedent Disclosure Schedule, (b) Liabilities disclosed or reserved against in the Cedent Financial Statements, or (c) liabilities and obligations that (x) were incurred after December 31, 2014 in the ordinary course of business and (y) would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect.

 

SECTION 3.15.  Brokers and Finders . No broker, finder or financial adviser has acted directly or indirectly as such for, or is entitled to any compensation from, Cedent or any of its Affiliates in connection with this Agreement or the transactions contemplated hereby, except Goldman Sachs & Co., whose fees for services rendered in connection therewith will be paid by Cedent.

 

21



 

ARTICLE IV.

REPRESENTATIONS AND WARRANTIES OF REINSURER

 

Subject to and as qualified by the matters set forth in the Reinsurer Disclosure Schedule (subject to Section 9.3(g) ), Reinsurer represents and warrants to Cedent as of the date hereof and as of the Closing Date as follows:

 

SECTION 4.1.   Organization, Standing and Corporate Power . Reinsurer is a life insurance company duly organized, validly existing and in good standing under the laws of the State of Tennessee, and has all requisite corporate power and authority to carry on the operations of its business as they are now being conducted and to own, lease and operate its properties and assets. Reinsurer is duly qualified or licensed to do business as a foreign company in good standing in each jurisdiction in which the conduct of its business or the ownership, leasing or operation of its properties or assets makes such qualification necessary, except where the failure to be so qualified or licensed would not, individually or in the aggregate, reasonably be expected to have a Reinsurer Material Adverse Effect. As of the Closing Date, Reinsurer will have obtained all authorizations and approvals required under Applicable Law to perform the obligations contemplated of Reinsurer under the Transaction Agreements.

 

SECTION 4.2.   Authority . Reinsurer has the requisite corporate power and authority to enter into the Transaction Agreements, to consummate the transactions contemplated thereby and to perform the obligations thereunder. The execution and delivery by Reinsurer of the Transaction Agreements, the consummation by Reinsurer of the transactions contemplated thereby and the performance by the Reinsurer of its obligations thereunder have been duly authorized by all necessary corporate or other organizational action on the part of Reinsurer. Each of the Transaction Agreements has been or, with respect to the Transaction Agreements to be executed and delivered at the Closing, will be duly executed and delivered by Reinsurer and, assuming the Transaction Agreements constitute legal, valid and binding agreements of the other parties thereto, constitute legal, valid and binding obligations of Reinsurer, enforceable against Reinsurer in accordance with their terms, except that enforcement may be subject to the Enforceability Exceptions.

 

SECTION 4.3.   Actions and Proceedings . There are no:

 

(a)           outstanding Orders in effect against Reinsurer that, individually or in the aggregate, would reasonably be expected to have a Reinsurer Material Adverse Effect; or

 

(b)           Actions pending or, to the Knowledge of Reinsurer, threatened in writing against Reinsurer of any kind that would, individually or in the aggregate, reasonably be expected to have a Reinsurer Material Adverse Effect.

 

SECTION 4.4.   No Conflict or Violation . The execution, delivery and performance by Reinsurer of the Transaction Agreements and the consummation of the transactions contemplated thereby in accordance with the respective terms and conditions thereof will not:

 

22



 

(a)           violate any provision of the Articles of Incorporation, Bylaws or other organizational documents of Reinsurer;

 

(b)           violate, conflict with, result in the breach of any of the terms of, any loss of rights under or modification of the effect of, otherwise give any other contracting party the right to accelerate, terminate or cancel, or constitute (or with notice or lapse of time or both, constitute) a default under, any contract to which Reinsurer is a party or by or to which any of its or their properties may be bound or subject;

 

(c)           violate any Order, judgment, injunction, condition, agreement, award or decree of any court, arbitrator or Governmental Authority, foreign or domestic, against or imposed or binding upon, Reinsurer; or

 

(d)           subject to obtaining the consents and approvals, making the filings and giving the notices referred to in Section 4.5 , violate any Applicable Law; or

 

(e)           result in a breach or violation of any of the terms or conditions of, constitute a default under, or otherwise cause an impairment or revocation of, any Permit related to the Reinsurer’s business;

 

except, in the case of clauses (b), (c), (d) and (e) of this Section 4.4 , for such breaches, losses of rights, accelerations, conflicts, modifications, terminations, violations, defaults, impairments or revocations that would not, individually or in the aggregate, reasonably be expected to have a Reinsurer Material Adverse Effect.

 

SECTION 4.5.   Governmental Consents . No consent, approval or authorization of, or declaration or filing with, or notice to, any Governmental Authority is required by or with respect to Reinsurer in connection with the execution, delivery and performance of this Agreement or the Reinsurance Agreement by Reinsurer, or the consummation by Reinsurer of the transactions contemplated hereby or thereby, except for the approvals, filings, and notices set forth in Section 4.5 of the Reinsurer Disclosure Schedule and such consents, approvals, authorizations, declarations, filings, or notices that, if not obtained or made, would not, individually or in the aggregate, reasonably be expected to have a Reinsurer Material Adverse Effect.

 

SECTION 4.6.   Compliance . Except as disclosed in Section 4.6 of the Reinsurer Disclosure Schedule, since January 1, 2013 Reinsurer is and has been in compliance in all material respects with all Applicable Laws, its Articles of Incorporation and Bylaws or other organizational documents and all material Permits issued to Reinsurer by any Governmental Authority, except for any non-compliance which would not, individually or in the aggregate, reasonably be expected to have a Reinsurer Material Adverse Effect.

 

SECTION 4.7.   Licensing Status . Reinsurer is licensed in Cedent’s Domicile such that Cedent could take Credit For Reinsurance if the cession contemplated by the Reinsurance Agreement occurred on the date hereof (with respect to this representation and warranty given as of the date hereof) and on the Closing Date (with respect to this representation and warranty given as of the Closing Date).

 

23



 

SECTION 4.8.   Brokers and Finders . No broker, finder or financial adviser has acted directly or indirectly as such for, or is entitled to any compensation from, Reinsurer or its Affiliates in connection with this Agreement or the transactions contemplated hereby, except for any such broker, finder or financial adviser, whose fees for services rendered in connection herewith will be paid by Reinsurer.

 

ARTICLE V.

COVENANTS

 

SECTION 5.1.   Conduct of Business of the Company . Except as expressly permitted by this Agreement, as required by Applicable Law or Domicile SAP, as set forth in Section 5.1 of the Cedent Disclosure Schedule, as Reinsurer otherwise consents in writing (which consent shall not be unreasonably withheld, conditioned, or delayed) or in the event Reinsurer fails to respond to a written request for consent within five (5) Business Days after receipt of such request, from the date of this Agreement to the Closing Date, Cedent shall operate the Business in the ordinary course of business consistent with past practice and use commercially reasonable efforts to preserve intact the current relationships of the Business with its employees, policyholders, Insurance Regulators and others having material relationships with the Business. Without limiting the generality of the foregoing, from the date of this Agreement to the Closing Date, except as expressly permitted by this Agreement, as required by Applicable Law or Domicile SAP, as set forth in Section 5.1 of the Cedent Disclosure Schedule, as Reinsurer otherwise consents in writing (which consent shall not, other than with respect to clauses (e) or (g) of this Section 5.1 , be unreasonably withheld, conditioned, or delayed) or in the event Reinsurer fails to respond to a written request for consent within five (5) Business Days after receipt of such request, Cedent shall not, and shall not cause or permit any of its Affiliates to, do any of the following without the consent of Reinsurer:

 

(a)           make any material change in the conduct of the Business, including the licensure of Cedent as an insurer or reinsurer in the State of Delaware, Commonwealth of Virginia or change the Domicile of Cedent to the State of New York;

 

(b)           make any material change in the accounting, actuarial, financial reporting, reserving or claims administration policies, practices, or principles used in connection with the Business;

 

(c)           (A) waive or release any material claim or litigation or waive any material right with respect to the Business, other than in the ordinary course of business consistent with past practice, or (B) enter into any settlement or release with respect to any Action or Order with respect to the Business (except for claims under Reinsured Policies in the ordinary course of business consistent with past practice and within applicable policy limits), unless such settlement or release contemplates only the payment of money without ongoing limits on the conduct or operation of the Business;

 

(d)           abandon, modify, waive or terminate any material Permit to the extent used in the Business;

 

24



 

(e)           (A) amend, terminate (or consent to the termination of), waive any material rights under or, other than pursuant to its current terms and in the ordinary course of business consistent with past practice, renew or extend, any Ceded Reinsurance Agreements with respect to the Reinsured Policies or settle any disputes thereunder to the extent that any such actions relate in whole or in part to the Reinsured Policies or (B) enter into any new reinsurance agreement that would constitute a Ceded Reinsurance Agreement with respect to any Reinsured Policy or, in each case, cause or permit GLIC, GLICNY, Jamestown, RLI or RLII to take any such action;

 

(f)            except in the ordinary course of business consistent with past practice, make any material changes in the terms or policies with respect to the payment of commissions or other compensation to any Producers with respect to the Business;

 

(g)           terminate, recapture any liabilities ceded under, commute, modify, supplement, amend or waive compliance with any material provision of the Assumed Reinsurance Agreements; or

 

(h)           enter into a binding agreement to take any of the foregoing actions.

 

SECTION 5.2.   Access to Information; Confidentiality . From and after the date hereof until the earlier of the Closing Date or the termination of this Agreement, Reinsurer, at its own expense, shall have the right to inspect all Books and Records and to interview employees or officers of Cedent or its Affiliates having knowledge of the Business at any reasonable time during normal business hours at the office of Cedent, in each case as Reinsurer may reasonably request; provided , however , that Cedent shall not be obligated to provide access to any such Books and Records if doing so would violate a contract, agreement or obligation of confidentiality owing to a third party or jeopardize the protection of an attorney-client privilege, it being understood that Cedent shall use commercially reasonable efforts to obtain waivers or make other arrangements (including by redacting information or entering into joint defense agreements) to enable such information to be furnished or made available to Reinsurer without so jeopardizing privilege or contravening such obligation. Without limiting the terms thereof, the Confidentiality Agreement shall govern the obligations of Reinsurer and its Representatives with respect to all information of any type furnished or made available to them pursuant to this Section 5.2 .

 

SECTION 5.3.   Confidentiality of Policyholder Personal Information . From and after the date hereof, Cedent shall not, and shall cause its Affiliates and its and their directors, officers and employees not to, disclose to any Person (including any of the Producers or any other insurance agent, broker or other producer) any personally identifiable information pertaining to the holders of Reinsured Policies (“ Policyholder Personal Information ”), including in connection with any “program of internal replacement”, except for disclosures (a) to any Producers in connection with the ordinary course administration of the Reinsured Policies produced or marketed by such Producers, consistent with past practices, (b) required by Applicable Law or any Governmental Authority after prior notice has been given to Reinsurer, if reasonably practicable (including any report, statement, testimony or other submission to such Governmental Authority), or (c) as may be reasonably necessary to be disclosed in connection

 

25



 

with any dispute with respect to the Transaction Agreements (including in response to any summons, subpoena or other legal process or formal or informal investigative demand issued to Cedent or its Affiliates in the course of any litigation, investigation, arbitration or administrative proceeding). Cedent shall instruct its directors, officers and employees having access to Policyholder Personal Information of the confidentiality obligations set forth in this Section 5.3 , and Cedent shall be liable to Reinsurer for any violation of such obligations by such Persons. Notwithstanding anything in this Section to the contrary, the parties acknowledge and agree that each party may share any Policyholder Personal Information with (i) any Insurance Regulator or (ii) the Internal Revenue Service or any other taxing authority as each party deems necessary or advisable in its good faith judgment.

 

SECTION 5.4.   Commercially Reasonable Efforts . Upon the terms and subject to the conditions and other agreements set forth in this Agreement, each of the parties agrees to use commercially reasonable efforts to take, or cause to be taken, all actions, and to do, or cause to be done, and to assist and cooperate with the other parties in doing, all things necessary, proper, or advisable to consummate and make effective, in the most expeditious manner practicable, the transactions contemplated by the Transaction Agreements.

 

SECTION 5.5.   Consents, Approvals and Filings .

 

(a)            Subject to the terms and conditions hereof, Cedent and Reinsurer shall each use its reasonable best efforts, and shall cooperate fully with each other: (i) to comply as promptly as practicable with all requirements of Government Authorities applicable to the transactions contemplated by the Transaction Agreements; and (ii) to obtain as promptly as practicable all necessary permits, orders, or other consents, approvals or authorizations of Governmental Authorities and consents or waivers of all other third parties necessary in connection with the consummation of the transactions contemplated by the Transaction Agreements (including, for all purposes of this Section 5.5 , those set forth in Section 3.5 of the Cedent Disclosure Schedule and those set forth in Section 4.5 of the Reinsurer Disclosure Schedule, and, except as otherwise expressly provided in this Section 5.5 , the Financing Approvals). In connection therewith, Cedent and Reinsurer shall make and cause their respective Affiliates to make all legally required filings as promptly as practicable in order to facilitate prompt consummation of the transactions contemplated by the Transaction Agreements, shall provide and shall cause their respective Affiliates to provide such information and communications to Governmental Authorities as such Governmental Authorities may request, shall take and shall cause their respective Affiliates to take all steps that are necessary, proper or advisable to avoid any Action by any Governmental Authority with respect to the transactions contemplated by the Transaction Agreements, and shall defend or contest in good faith any Action by any third party (including any Governmental Authority), whether judicial or administrative, challenging any of the Transaction Agreements or the transactions contemplated thereby, or that could otherwise prevent, impede, interfere with, hinder, or delay in any material respect the consummation of the transactions contemplated thereby, and shall consent to and comply with any condition imposed by any Governmental Authority on its grant of any such permit, order, consent, approval, or authorization, other than any such condition that, in the case of Cedent, results in a material impairment of the aggregate economic benefits, taken as a whole, that, as of the date hereof, Cedent and its Affiliates reasonably expect to obtain from the

 

26



 

transactions contemplated by the Transaction Agreements (a “ Burdensome Condition ”). Subject to Section 5.5(d) , each of the parties shall provide to the other party copies of all applications or other communications to Governmental Authorities in connection with this Agreement in advance of the filing or submission thereof; provided , in no event will any party be required to disclose to the other party any trade secrets or personally identifiable information or personal financial information in respect of itself or any of its Representatives.

 

(b)           Without limiting the generality of the foregoing, promptly following the date hereof, each of Reinsurer and Cedent shall, and shall cause their respective Affiliates to, file with all applicable Insurance Regulators requests for approval that are required to be obtained by Reinsurer, Cedent or such Affiliates, respectively, in connection with the transactions contemplated by the Transaction Agreements. Subject to Section 5.5(d) :

 

(i)            a reasonable time prior to furnishing any written materials to any Insurance Regulator in connection with the transactions contemplated by the Transaction Agreements, each party shall furnish to the other party a copy thereof ( provided , in no event will any party be required to disclose to the other party any trade secrets or personally identifiable information or personal financial information in respect of itself or any of its Representatives), and such other party shall have a reasonable opportunity to provide comments thereon, which comments shall be considered in good faith by the party furnishing such information to the Insurance Regulator;

 

(ii)           each party shall give to the other party prompt written notice if it receives any notice or other communication from any Insurance Regulator in connection with the transactions contemplated by the Transaction Agreements, and, in the case of any such notice or communication that is in writing, shall promptly furnish the other party with a copy thereof, provided that any such notice or communication may be redacted by the receiving party to the extent related to matters other than approvals of Governmental Authorities necessary in connection with the consummation of the transactions contemplated by the Transaction Agreements; and

 

(iii)          each party shall give to the other party reasonable prior written notice of the time and place when any meetings, telephone calls (except with respect to routine administrative matters), or other conferences may be held by it with any Insurance Regulator in connection with the transactions contemplated by the Transaction Agreements, and the other party shall have the right to have a representative or representatives attend or otherwise participate in any such meeting, telephone call, or other conference.

 

(c)           Reinsurer and Cedent shall, upon request, furnish each other with all information concerning themselves, their respective Affiliates, directors, officers and shareholders, the Business and such other matters as may be reasonably necessary or advisable in connection with the preparation of any statement, filing, notice or application made by or on

 

27



 

their behalf to any Governmental Authority in connection with the transactions contemplated by the Transaction Agreements.

 

(d)           Without limiting the generality of the foregoing, Reinsurer will use its reasonable best efforts to take, or cause to be taken, all actions, and to do, or cause to be done, all things necessary, proper or advisable to obtain by December 31, 2015 all of the Financing Approvals; it being understood that if the Financing Approvals are not obtained prior to December 31, 2015, Reinsurer shall continue to use its reasonable best efforts to so obtain such approvals as promptly as practicable thereafter. Reinsurer shall keep Cedent generally informed on an ongoing basis with regard to the status of its efforts to obtain the Financing Approvals; but Reinsurer shall have no obligation to disclose to Cedent any filings or applications with, or other communications made to or received from, any Governmental Authority to the extent related to the Financing Approvals or the reserve funding transaction contemplated thereby (the “ Reserve Funding Transaction ”), or to afford Cedent the opportunity to comment thereon. Cedent shall not be entitled to participate in any meeting, telephone call or other conference between Reinsurer (or any of its Representatives) and any Governmental Authority, in each case to the extent relating to the Financing Approvals or the Reserve Funding Transaction.

 

SECTION 5.6.   Ceded Reinsurance Agreements.

 

(a)           From the date hereof until the earlier to occur of the Closing Date and the termination of this Agreement, Cedent will use its reasonable best efforts to seek consents from the reinsurers under the Ceded Reinsurance Agreements to waive any retention requirements applicable to the Reinsured Policies under the applicable Ceded Reinsurance Agreements or to seek such other consents, waivers or the taking of such other actions from or by such reinsurers as may be reasonable, necessary or appropriate in furtherance of the transactions contemplated by this Agreement and the Reinsurance Agreement, it being understood and agreed that “reasonable best efforts” for purposes of this Section 5.6(a)  shall not be deemed to obligate Cedent or any of its Affiliates to make any payments or otherwise pay any consideration to any Person in connection with any such consents, waivers or other actions under the Ceded Reinsurance Agreements. Reinsurer shall, at the request of Cedent, reasonably cooperate in good faith with Cedent in seeking such consents, waivers and the taking of such other actions; provided , that the Reinsurer shall not be obligated to make any payments or otherwise pay any consideration to any Person in connection with any such consents, waivers or other actions.

 

(b)           Notwithstanding anything in this Section 5.6 to the contrary, the failure to obtain any approval described in Section 5.6(a)  shall not (i) constitute a failure to satisfy any condition set forth in Article VI or (ii) otherwise relieve any Person from its obligation to consummate the transactions contemplated by the Transaction Agreements.

 

(c)           In the event that Cedent is unable to obtain a waiver of any retention requirement described in Section 5.6(a) , the parties shall negotiate in good faith revisions to the Reinsurance Agreement to provide for the retention by Cedent and/or its Affiliates of the minimum amount of Reinsured Benefits required in order for Cedent or its Affiliates, as applicable, to comply with such retention requirements.

 

28



 

(d)           From the date hereof until the earlier to occur of the Closing Date and the termination of this Agreement, in the event Cedent, GLIC, GLICNY or any of their respective Affiliates receives written notice of a proposed increase in the reinsurance rates with respect to the Reinsured Policies payable under any Ceded Reinsurance Agreement, Cedent shall, as promptly as practicable, give to the Reinsurer, or ensure that the Reinsurer is given, written notice of such proposed rate increase and copies of any related written correspondence from the reinsurer under such Ceded Reinsurance Agreement with respect to such proposed rate increase. To the extent reasonably practicable, Cedent shall, or shall cause the applicable ceding company under such Ceded Reinsurance Agreement to, request an extension of time to respond to such proposed increase until after the Closing (at which time the applicable provisions of Section 4 of Article II of the Reinsurance Agreement shall apply). To the extent that such an extension of time has not been obtained, Cedent shall respond to such proposed increase (to the extent applicable to risks arising in respect of the Reinsured Policies) in good faith and in a manner consistent with past practice.

 

SECTION 5.7.   Reserved .

 

SECTION 5.8.   Restructuring Transactions . Cedent shall use its reasonable best efforts to complete each of the Restructuring Transactions on or prior to the Closing. Reinsurer shall, at the request of Cedent and at Cedent’s sole cost and expense, reasonably cooperate in good faith with Cedent to complete the Restructuring Transactions. To the extent that any Restructuring Transactions have not been completed upon the Closing, Cedent shall continue to use its reasonable best efforts to complete any remaining Restructuring Transactions as soon as possible following the Closing; provided , that such obligation shall terminate upon the issuance of a final written decision of any applicable Governmental Authority, the approval of which is reasonably necessary to consummate such Restructuring Transaction, denying such approval.

 

SECTION 5.9.   Public Announcements . Reinsurer and Cedent, and their respective Affiliates, shall consult with each other before issuing, and provide each other the opportunity to review and comment upon, any press release or other public statement with respect to the transactions contemplated by the Transaction Agreements and shall not issue any such press release or make any such public statement with respect to such matters without the advance approval of the other party following such consultation (such approval not to be unreasonably withheld, delayed, or conditioned), except as may be required by Applicable Law or by the requirements of any securities exchange; provided that, in the event that any party is required by Applicable Law or the requirements of any securities exchange to issue any such press release or make any public statement and it is not feasible to obtain the advance approval of the other party hereto as required by this Section 5.9 , the party that issues such press release or makes such statement shall provide the other party with notice and a copy of such press release or statement as soon as reasonably practicable.

 

SECTION 5.10.  Further Assurances . Cedent and Reinsurer shall execute and deliver, or shall cause to be executed and delivered, such documents, certificates, agreements, and other writings and shall take, or shall cause to be taken, such further actions as may be reasonably required or requested by any party or its Affiliates to carry out the provisions of the

 

29



 

Transaction Agreements and consummate or implement expeditiously the transactions contemplated by the Transaction Agreements.

 

ARTICLE VI.

CONDITIONS PRECEDENT

 

SECTION 6.1.   Conditions to Each Party’s Obligations . The obligations of Reinsurer and Cedent to consummate the transactions contemplated hereby shall be subject to the satisfaction or waiver in writing at or prior to the Closing of the following conditions:

 

(a)           Approvals . All consents, approvals or authorizations of, declarations or filings with, or notices to any Governmental Authority in connection with the transactions contemplated hereby that are set forth in Section 3.5 of the Cedent Disclosure Schedule or Section 4.5 of the Reinsurer Disclosure Schedule, other than the Financing Approvals, shall have been obtained or made and shall be in full force and effect, and all waiting periods required under Applicable Law with respect thereto shall have expired or been terminated.

 

(b)           No Injunctions or Restraints . No temporary restraining order, preliminary or permanent injunction, or other order issued by any court of competent jurisdiction and no statute, rule, or regulation of any Governmental Authority preventing the consummation of the material transaction contemplated by the Transaction Agreements shall be in effect.

 

SECTION 6.2.   Conditions to Obligations of Reinsurer . The obligations of Reinsurer to consummate the transactions contemplated hereby shall be subject to the satisfaction or waiver in writing at or prior to the Closing of the following additional conditions:

 

(a)           Representations and Warranties . (i) The representations and warranties of Cedent set forth in this Agreement, other than the Cedent Fundamental Representations (without giving effect to any limitation set forth therein as to materiality or Material Adverse Effect) shall be true and correct on and as of the date hereof and on and as of the Closing Date as though made on and as of the Closing Date (except to the extent any such representation and warranty speaks only as of an earlier date, in which event such representation and warranty shall have been true and correct as of such date), except where the failure of all such representations and warranties to be so true and correct would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, and (ii) the Cedent Fundamental Representations shall be true and correct in all respects on and as of the date hereof and on and as of the Closing Date with the same effect as though made on and as of the Closing Date (except for representations and warranties that are made as of a specific date, which representations and warranties shall be true and correct at and as of such date).

 

(b)           Performance of Obligations of Cedent . Cedent shall have performed and complied in all material respects with all agreements, obligations, and covenants required to be performed or complied with by it under this Agreement on or prior to the Closing Date.

 

30



 

(c)           Closing Deliveries . Cedent shall have delivered or caused to be delivered to Reinsurer each of the documents required to be delivered by it pursuant to Section 2.2 .

 

(d)           Restructuring Transactions . Each of the Restructuring Transactions identified in Annex B shall have been completed in accordance with Annex B .

 

(e)           No Material Adverse Effect . Since the date of this Agreement, there shall not have occurred any fact, event, circumstance, effect, development, occurrence or condition of any character that would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

 

SECTION 6.3.   Conditions to Obligations of Cedent . The obligations of Cedent to consummate the transactions contemplated hereby shall be subject to the satisfaction or waiver in writing at or prior to the Closing of the following additional conditions:

 

(a)           Representations and Warranties . (i) The representations and warranties of Reinsurer set forth in this Agreement, other than the Reinsurer Fundamental Representations (without giving effect to any limitation set forth therein as to materiality) shall be true and correct on and as of the date hereof and on and as of the Closing Date as though made on and as of the Closing Date (except to the extent any such representation and warranty speaks only as of an earlier date, in which event such representation and warranty shall have been true and correct as of such date), except where the failure of all such representations and warranties to be so true and correct would not, individually or in the aggregate, reasonably be expected to have a Reinsurer Material Adverse Effect, and (ii) the Reinsurer Fundamental Representations shall be true and correct in all respects on and as of the date hereof and on and as of the Closing Date with the same effect as though made on and as of the Closing Date (except for representations and warranties that are made as of a specific date, which representations and warranties shall be true and correct at and as of such date).

 

(b)           Performance of Obligations of Reinsurer . Reinsurer shall have performed and complied in all material respects with all agreements, obligations, and covenants required to be performed or complied with by it under this Agreement on or prior to the Closing Date.

 

(c)           Closing Deliveries . Reinsurer shall have delivered or caused to have delivered to Cedent each of the documents required to be delivered by it pursuant to Section 2.2 .

 

(d)           Absence of Burdensome Condition . The consents, approvals or authorizations of, declarations or filings with, or notices to any Governmental Authority described in Section 6.1(a)  shall have been obtained or made without the imposition of a Burdensome Condition.

 

31



 

ARTICLE VII.

INDEMNIFICATION

 

SECTION 7.1.   Survival of Representations, Warranties and Covenants .

 

(a)           The representations and warranties of Cedent and Reinsurer contained in this Agreement shall survive the Closing solely for purposes of this Article VII and shall terminate and expire on the date that is eighteen (18) months following the Closing Date; provided that the representations and warranties made in Sections 3.1 (Organization, Standing and Corporate Power) , 3.2 (Authority) and 3.15 (Brokers and Finders) (the “ Cedent Fundamental Representations ”) and Sections 4.1 (Organization, Standing and Corporate Power) , 4.2 (Authority) and 4.8 (Brokers and Finders) (the “ Reinsurer Fundamental Representations ”) shall survive until the expiration of the applicable statute of limitations.

 

(b)           To the extent that it is to be performed after the Closing, each covenant in this Agreement will, for purposes of this Article VII , survive and remain in effect in accordance with its terms plus a period of six (6) months thereafter, after which no claim for indemnification with respect thereto may be brought hereunder. All covenants in this Agreement that by their terms are required to be fully performed prior to the Closing will survive until the date that is six (6) months after the Closing Date, after which time no claim for indemnification with respect thereto may be brought hereunder.

 

(c)           Any claim for indemnification in respect of any breach of representation, warranty or covenant that is not asserted by notice given as required herein prior to the expiration of the applicable survival period specified in this Section 7.1 shall not be valid and any right to indemnification is hereby irrevocably waived after the expiration of such period of survival. Any claim properly made for an Indemnifiable Loss in respect of such a breach asserted within such period of survival as herein provided will be timely made for purposes hereof.

 

SECTION 7.2.   Indemnification .

 

(a)           Cedent shall indemnify, defend and hold harmless Reinsurer, its Affiliates and their respective directors, officers, employees, successors and permitted assigns (collectively, the “ Reinsurer Indemnified Persons ”) from and against any and all Indemnifiable Losses resulting from or arising out of:

 

(i)            any breach of any representation or warranty of Cedent made in Article III of this Agreement (other than Section 3.12(b) and Section 3.12(c)); or

 

(ii)           any breach or nonfulfillment of any agreement or covenant of Cedent under this Agreement.

 

(b)           Reinsurer shall indemnify, defend and hold harmless Cedent, its Affiliates and their respective directors, officers, employees, successors and permitted assigns

 

32



 

(collectively, the “ Cedent Indemnified Persons ”) from and against any and all Indemnifiable Losses resulting from or arising out of:

 

(i)            any breach of any representation or warranty of Reinsurer made in Article IV of this Agreement; or

 

(ii)           any breach or nonfulfillment of any agreement or covenant of Reinsurer under this Agreement.

 

(c)           For purposes of determining whether any representation or warranty has been breached and the amount of any Indemnifiable Losses under this Article VII , each representation and warranty contained in this Agreement shall be read without regard to any materiality or Material Adverse Effect (which instead will be read as an adverse effect or change) qualifier contained therein, except for any such limitation or qualification contained in Section 3.11(b) .

 

SECTION 7.3.   Certain Limitations .

 

(a)           No party shall be obligated to indemnify and hold harmless its respective Indemnitees under Section 7.2(a)(i)  (in the case of Cedent) or Section 7.2(b)(i)  (in the case of Reinsurer), other than in respect of any breach of any Cedent Fundamental Representations or Reinsurer Fundamental Representations (as applicable) (i) with respect to any claim or claims based on substantially similar facts, events or circumstances, unless such claim or claims involve Indemnifiable Losses in excess of $50,000 (the “ Threshold Amount ”) (nor shall any claim that does not exceed the Threshold Amount be applied to or considered for purposes of calculating the amount of Indemnifiable Losses for which the Indemnitor is responsible under clause (ii) below), and (ii) unless and until the aggregate amount of all Indemnifiable Losses of the Indemnitees under such Sections 7.2(a)(i)  (except in respect of Cedent Fundamental Representations) or such Section 7.2(b)(i)  (except in respect of Reinsurer Fundamental Representations), as the case may be, exceeds $1,050,000 for all Indemnifiable Losses (the “ Deductible ”), at which point such Indemnitor shall be liable to its respective Indemnitees for the value of such claims under Sections 7.2(a)(i)  or such Section 7.2(b)(i) , as the case may be, that is in excess of the Deductible, subject to the limitations set forth in this Article VII . The maximum aggregate liability of Cedent, on the one hand, and Reinsurer, on the other hand, to their respective Indemnitees for any and all Indemnifiable Losses under Section 7.2(a)(i)  (except in respect of a breach of the Cedent Fundamental Representations), in the case of Cedent, or Section 7.2(b)(i)  (except in respect of a breach of the Reinsurer Fundamental Representations), in the case of Reinsurer, shall be an amount equal to $14,000,000.

 

(b)           No Reinsurer Indemnified Person shall be entitled to indemnification with respect to any particular Indemnifiable Loss to the extent the related damages, losses, liabilities, obligations, costs, or expenses were included in the calculation of the Adjusted Initial Ceded Total Reserves.

 

(c)           In the event a claim or any Action for indemnification under this Article VII has been finally determined, the amount of such final determination shall be paid (i) if the Indemnified Party is a Reinsurer Indemnified Person, by Cedent to the Reinsurer

 

33



 

Indemnified Person and, (ii) if the Indemnified Party is a Cedent Indemnified Person, by Reinsurer to the Cedent Indemnified Person, in each case on demand by wire transfer of immediately available funds to an account designated by Cedent or Reinsurer, as applicable. A claim or an Action, and the liability for and amount of damages therefor, shall be deemed to be “finally determined” for purposes of this Article VII when the parties to this Agreement have so determine by mutual agreement or, if disputed, when a final order, judgment, or decree of any Governmental Authority has been entered into with respect to such claim or Action.

 

(d)           Notwithstanding anything contained in this Agreement to the contrary, in the event that any fact, event, or circumstance that results in an adjustment under Section 2.4 would also constitute a breach of or inaccuracy in any of Cedent’s representations, warranties, covenants, or agreement under this Agreement, Cedent shall have no obligation to indemnify any Reinsurer Indemnified Person with respect to such breach or inaccuracy to the extent such indemnification would result in a duplicate recovery.

 

(e)           The parties hereto acknowledge and agree that, except as set forth in (i)  Article II , (ii)  Section 9.7(b) , (iii) the Reinsurance Agreement and (iv) with respect to causes of action arising out from actual fraud, if the Closing occurs, their sole and exclusive remedy following the Closing at law or equity with respect to this Agreement, the transactions contemplated hereby, or any other matter relating to any party or its Affiliates prior to the Closing, in each case regardless of the legal theory under which such liability or obligation may be sought to be imposed, whether sounding in contract or in tort, whether at law or in equity, or otherwise, shall be pursuant to the provisions set forth in this Article VII .

 

(f)            Notwithstanding anything contained in this Agreement to the contrary, the Reinsurer shall have no rights and remedies whatsoever under this Agreement, including any claim for indemnification under this Article VII or injunctive relief, in connection with any breach by Cedent of the representations and warranties contained in Section 3.12(b)  or Section 3.12(c) , except as expressly set forth in Section 6.2(a)(i) .

 

SECTION 7.4.   Procedures for Third Party Claims .

 

(a)           If any Indemnitee receives notice of assertion or commencement of any Third Party Claim against such Indemnitee in respect of which an Indemnitor may be obligated to provide indemnification under this Agreement, the Indemnitee shall give such Indemnitor reasonably prompt written notice (but in no event later than thirty (30) calendar days after becoming aware) thereof and such notice shall include a reasonable description of the claim and any documents relating to the claim and an estimate of the Indemnifiable Loss and shall reference the specific sections of this Agreement that form the basis of such claim; provided that no delay on the part of the Indemnitee in notifying any Indemnitor shall relieve the Indemnitor from any obligation hereunder unless (and then solely to the extent) the Indemnitor is actually prejudiced by such delay (except that the Indemnitor shall not be liable for any expenses incurred during the period in which the Indemnitee failed to give such notice). Thereafter, the Indemnitee shall deliver to the Indemnitor, within five calendar days after the Indemnitee’s receipt thereof, copies of all notices and documents (including court papers) received by the Indemnitee relating to the Third Party Claim.

 

34



 

(b)           The Indemnitor shall be entitled to participate in the defense of any Third Party Claim and, if it so chooses, to assume the defense thereof with counsel selected by the Indemnitor. Any election by the Indemnitor to assume the defense of a Third Party Claim must be delivered by the Indemnitor to the Indemnitee within fifteen (15) Business Days after receipt by the Indemnitor of the Indemnitee’s notice delivered pursuant to Section 7.4(a) . Such assumption of defense shall not be deemed to be an admission or assumption of liability by the Indemnitor. Should the Indemnitor so elect to assume the defense of a Third Party Claim, the Indemnitor shall not as long as it conducts such defense be liable to the Indemnitee for legal expenses subsequently incurred by the Indemnitee in connection with the defense thereof. If the Indemnitor assumes such defense, the Indemnitee shall have the right to participate in the defense thereof and to employ counsel, at its own expense, separate from the counsel employed by the Indemnitor, it being understood that the Indemnitor shall control such defense. The Indemnitor shall be liable for the reasonable fees and expenses of counsel employed by the Indemnitee for any period during which the Indemnitor has not assumed the defense thereof (other than during any period in which the Indemnitee shall have not yet given notice of the Third Party Claim as provided above). If the Indemnitor chooses to defend any Third Party Claim, all of the parties hereto shall, and shall cause their respective Affiliates to, cooperate in the defense thereof. Such cooperation shall include the retention and (upon the Indemnitor’s request at the Indemnitor’s expense) the provision to the Indemnitor of records and information that are relevant to such Third Party Claim, and making employees available on a mutually convenient basis to provide additional information and explanation of any material provided hereunder. Whether or not the Indemnitor shall have assumed the defense of a Third Party Claim, the Indemnitee shall not admit any liability with respect to, or pay, settle, compromise, or discharge, such Third Party Claim without the Indemnitor’s prior written consent, and any such admission, payment, settlement, compromise, or discharge without the Indemnitor’s prior written consent shall be deemed to be a waiver by the Indemnitee of any right to indemnity for all Indemnifiable Losses related to such Third Party Claim. If the Indemnitor has assumed the defense of a Third Party Claim, the Indemnitor may only pay, settle, compromise, or discharge a Third Party Claim with the Indemnitee’s prior written consent (which consent shall not be unreasonably withheld, conditioned, or delayed); provided that the Indemnitor may pay, settle, compromise, or discharge such a Third Party Claim without the written consent of the Indemnitee if such settlement (i) includes a release of the Indemnitee from all liability in respect of such Third Party Claim, (ii) does not subject the Indemnitee to any injunctive relief or other equitable remedy, and (iii) does not include a statement or admission of fault, culpability, or failure to act by or on behalf of the Indemnitee. If the Indemnitor submits to the Indemnitee a bona fide settlement offer that satisfies the requirements set forth in the proviso of the immediately preceding sentence and the Indemnitee refuses to consent to such settlement, then thereafter the Indemnitor’s liability to the Indemnitee with respect to such Third Party Claim shall not exceed the Indemnitor’s portion of the settlement amount included in such settlement offer, and the Indemnitee shall either assume the defense of such Third Party Claim or pay the Indemnitor’s attorney’s fees and other out-of-pocket costs incurred thereafter in continuing the defense of such Third Party Claim.

 

SECTION 7.5.   Direct Claims . The Indemnitor will have a period of thirty (30) days within which to respond in writing to any claim by an Indemnitee on account of an Indemnifiable Loss that does not result from a Third Party Claim. If the Indemnitor does not so

 

35



 

respond within such 30-day period, the Indemnitor will be deemed to have rejected such claim, in which event the Indemnitee will be entitled to pursue such remedies as may be available to the Indemnitee.

 

SECTION 7.6.   Certain Other Matters . Upon making any Indemnity Payment, Indemnitor will, to the extent of such Indemnity Payment, be subrogated to all rights of Indemnitee against any third Person (other than any Tax authority) in respect of the Indemnifiable Loss to which the Indemnity Payment related. Without limiting the generality or effect of any other provision hereof, each such Indemnitee and Indemnitor will duly execute upon request all instruments reasonably necessary to evidence and perfect the above-described subrogation rights.

 

ARTICLE VIII.

TERMINATION PRIOR TO CLOSING

 

SECTION 8.1.   Termination of Agreement . This Agreement may be terminated at any time prior to the Closing:

 

(a)           by Cedent or Reinsurer in writing, if there shall be any order, injunction, or decree of any Governmental Authority that prohibits or restrains any party from consummating the transactions contemplated hereby, and such order, injunction or decree shall have become final and non-appealable; provided that the party seeking to terminate this Agreement pursuant to this Section 8.1(a)  shall have performed in all material respects its obligations under this Agreement, acted in good faith, and, if binding on such party, used reasonable best efforts to prevent the entry of, and to remove, such order, injunction, or decree in accordance with its obligations under this Agreement;

 

(b)           by Cedent or Reinsurer in writing, if the Closing has not occurred on or prior to June 30, 2016 (as it may be extended, the “ Deadline Date ”), unless the failure of the Closing to occur is the result of a material breach of this Agreement by the party seeking to terminate this Agreement;

 

(c)           by either Cedent or Reinsurer (but only so long as Cedent or Reinsurer, as applicable, is not in material breach of its obligations under this Agreement) in writing, if a breach of any provision of this Agreement that has been committed by the other party would cause the failure of any mutual condition to Closing or any condition to Closing for the benefit of the non-breaching party and such breach is not subsequently waived by the non-breaching party or capable of being cured or is not cured within 30 calendar days after the breaching party receives written notice from the non-breaching party that the non-breaching party intends to terminate this Agreement pursuant to this Section 8.1(c) ; or

 

(d)           by mutual written consent of Cedent and Reinsurer.

 

SECTION 8.2.   Effect of Termination . If this Agreement is terminated pursuant to Section 8.1 , this Agreement shall become null and void and of no further force and effect without liability of either party (or any Representative of such party) to the other party to this Agreement; provided that no such termination shall relieve a party from liability for any breach

 

36



 

of this Agreement prior to such termination or for actual fraud. Notwithstanding the foregoing, Section 1.1 , this Section 8.2 and Article IX shall survive termination hereof pursuant to Section 8.1 . If this Agreement is terminated pursuant to Section 8.1 , (a) Reinsurer shall return all documents received from Cedent, its Affiliates, and its Representatives relating to the transactions contemplated hereby, whether obtained before or after the execution hereof, to Cedent, and (b) all confidential information received by Reinsurer with respect to Cedent and its Affiliates shall be treated in accordance with the Confidentiality Agreement, which shall remain in full force and effect notwithstanding the termination of this Agreement.

 

ARTICLE IX.

GENERAL PROVISIONS

 

SECTION 9.1.      Fees and Expenses . Each party hereto shall, except as otherwise provided in this Agreement, pay its own Transaction Expenses incident to preparing for, entering into, and carrying out the Transaction Agreements and the consummation of the transactions contemplated thereby.

 

SECTION 9.2.      Notices . Notices and other communications required or permitted to be given under this Agreement shall be effective if in writing and (i) mailed by United States registered or certified mail, return receipt requested, (ii) delivered by overnight express mail, (iii) e-mailed (with confirmation of receipt) or (iv) sent by facsimile transmission (followed by a confirmation mailed by first class or overnight mail) to:

 

(a)           if to Reinsurer:

 

Protective Life Insurance Company

2801 Highway 280 South

Birmingham, Alabama 35223

Attention: General Counsel

Email: Debbie.Long@protective.com

Facsimile: (205) 268-3597

 

with a copy (which shall not constitute notice) to:

 

Debevoise & Plimpton LLP

919 Third Avenue

New York, New York 10022

Attention: Marilyn Lion, Esq.

E-mail: malion@debevoise.com

Facsimile: (212) 521-7108

 

(b)           if to Cedent:

 

37



 

Genworth Life and Annuity Insurance Company

6620 West Broad Street

Richmond, Virginia 23230

Attn: Legal Department

Facsimile: (804) 662-2414

 

with a copy (which shall not constitute notice) to:

 

Genworth Life and Annuity Insurance Company

700 Main Street

P.O. Box 1280

Lynchburg, Virginia 24505-1280

Attn: General Counsel

Facsimile: (434) 948-5819

 

and

 

Willkie Farr & Gallagher LLP

787 Seventh Avenue

New York, New York 10019

Attention: Alexander M. Dye

E-mail: adye@willkie.com

Facsimile: (212) 728-9642

 

Either party hereto may change the names or addresses where notice is to be given by providing notice to the other party of such change in accordance with this Section.

 

SECTION 9.3.   Construction .

 

(a)           Any reference herein to “days” (as opposed to “Business Days”) shall be deemed to mean calendar days.

 

(b)           Any reference herein to a “consent” shall be deemed to mean prior written consent.

 

(c)           Any reference herein to “notice” shall be deemed to mean prior written notice.

 

(d)           Any reference herein to “including” and words of similar import shall mean “including without limitation,” unless otherwise specified.

 

(e)           When a reference is made in this Agreement to a Section, Exhibit, or Schedule, such reference shall be to a Section of, or an Exhibit or Schedule to, this Agreement, unless otherwise indicated.

 

(f)            Unless otherwise specified, all references herein to any statute, rule, or regulation are to the statute, rule, or regulation as amended, modified, supplemented or replaced from time to time (and, in the case of statutes, includes any rules and regulations promulgated under said statutes) and to any section of any statute, rule, or regulation, including any successor to said

 

38



 

section.

 

(g)           Any fact or item disclosed in any section of each of the Reinsurer Disclosure Schedule or the Cedent Disclosure Schedule shall be deemed disclosed in all other sections of such Disclosure Schedule to the extent the applicability of such fact or item to such other section of such Disclosure Schedule is reasonably apparent. Disclosure of any item in the Reinsurer Disclosure Schedule or the Cedent Disclosure Schedule, as the case may be, shall not be deemed an admission that such item represents a material item, fact, exception of fact, event, or circumstance or that occurrence or non-occurrence of any change or effect related to such item would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

(h)           The table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.

 

(i)            Whenever the singular is used herein, the same shall include the plural, and whenever the plural is used herein, the same shall include the singular, where appropriate.

 

(j)            All time periods within or following which any payment is to be made or act is to be done shall be calculated by excluding the date on which the period commences and including the date on which the period ends and by extending the period to the first succeeding Business Day if the last day of the period is not a Business Day.

 

(k)           This Agreement has been fully negotiated by the parties hereto and shall not be construed by any Governmental Authority or other Person against either party by virtue of the fact that such party was the drafting party.

 

SECTION 9.4.      Entire Agreement . This Agreement (including all exhibits and schedules hereto), the Confidentiality Agreement and the Reinsurance Agreement constitute the entire agreement, and supersede all prior agreements, understandings, representations, and warranties, both written and oral, among the parties with respect to the subject matter of this Agreement.

 

SECTION 9.5.      Third Party Beneficiaries . Except as set forth in Article VII with respect to the Reinsurer Indemnified Persons and the Cedent Indemnified Persons, this Agreement is not intended to confer upon any Person other than the parties hereto any rights or remedies.

 

SECTION 9.6.      Governing Law . This Agreement and any dispute arising hereunder shall be governed by, and construed in accordance with, the laws of the State of New York, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof.

 

SECTION 9.7.      Jurisdiction; Enforcement .

 

(a)           Each of the parties hereto hereby irrevocably and unconditionally submits to the exclusive jurisdiction of any court of the United States or any state court, which in either case is located in the City of New York (each, a “ New York Court ”) for purposes of enforcing this Agreement or determining any claim arising from or related to the transactions contemplated by this Agreement. In any such action, suit, or other proceeding, each of the

 

39



 

parties hereto irrevocably and unconditionally waives and agrees not to assert by way of motion, as a defense or otherwise any claim that it is not subject to the jurisdiction of any such New York Court, that such action, suit, or other proceeding is not subject to the jurisdiction of any such New York Court, that such action, suit, or other proceeding is brought in an inconvenient forum or that the venue of such action, suit, or other proceeding is improper; provided that nothing set forth in this sentence shall prohibit any of the parties hereto from removing any matter from one New York Court to another New York Court. Each of the parties hereto also agrees that any final and unappealable judgment against a party hereto in connection with any action, suit, or other proceeding will be conclusive and binding on such party and that such award or judgment may be enforced in any court of competent jurisdiction, either within or outside of the United States. A certified or exemplified copy of such award or judgment will be conclusive evidence of the fact and amount of such award or judgment. Any process or other paper to be served in connection with any action or proceeding under this Agreement shall, if delivered or sent in accordance with Section 9.2 , constitute good, proper, and sufficient service thereof.

 

(b)           The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that, without the necessity of posting bond or other undertaking, the parties hereto shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in accordance with this Agreement, this being in addition (subject to the terms of this Agreement) to any other remedy to which such party is entitled at law or in equity. In the event that any Action is brought in equity to enforce the provisions of this Agreement, no party hereto shall allege, and each party hereto hereby waives any defense or counterclaim, that there is an adequate remedy at law.

 

(c)           EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT, OR ATTORNEY OR ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (II) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVER, (III) IT MAKES SUCH WAIVER VOLUNTARILY AND (IV) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 9.7 .

 

SECTION 9.8.    Assignment . Neither this Agreement nor any of the rights, interests or obligations under this Agreement shall be novated, transferred or assigned, in whole or in part, by either party without the non-transferring party’s consent; provided that the merger of Cedent with an entity which was under common control with it before such merger, regardless of whether Cedent is the survivor of such merger, shall not be deemed to be an assignment; any such resulting merged entity shall be considered to be Cedent under this Agreement. Upon assignment, this Agreement will be binding upon the respective successors and assigns.

 

40



 

SECTION 9.9.        Amendments . This Agreement may be amended only by written agreement of the parties. Any change or modification to this Agreement shall be null and void unless made by amendment to this Agreement and signed by both parties.

 

SECTION 9.10.     Severability . If any provision of this Agreement is held to be illegal, invalid or unenforceable under any present or future law or if determined by a court of competent jurisdiction to be unenforceable, and if the rights or obligations of Cedent or Reinsurer under this Agreement will not be materially and adversely affected thereby, such provision shall be fully severable, and this Agreement will be construed and enforced as if such illegal, invalid or unenforceable provision had never comprised a part of this Agreement, and the remaining provisions of this Agreement shall remain in full force and effect and will not be affected by the illegal, invalid or unenforceable provision or by its severance herefrom.

 

SECTION 9.11.     Waiver . Either party may choose not to enforce or insist upon the strict adherence to any provision or right under this Agreement. If either party so elects, it will not be considered to be a permanent waiver of such provision nor in any way affect the validity of this Agreement. The applicable party will still have the right to insist upon the strict adherence to that provision or any other provision of this Agreement in the future. Any waiver of provisions by a party under this Agreement must be in writing and signed by a duly authorized representative of the party.

 

SECTION 9.12.     Certain Limitations .

 

(a)           Notwithstanding anything to the contrary contained herein, the other Transaction Agreements, the Cedent Disclosure Schedule, or any of the Schedules or Exhibits hereto or thereto, Reinsurer acknowledges and agrees that neither Cedent nor any of its Affiliates, nor any Representative of any of them, makes or has made, and Reinsurer has not relied on, any inducement, promise, representation or warranty, oral or written, express or implied, other than except as expressly made by Cedent in Article III . Without limiting the generality of the foregoing, other than as expressly set forth in Article III , no Person has made any representation or warranty to Reinsurer with respect to the Business or any other matter, including with respect to (i) the probable success or profitability of the Business after the Closing, or (ii) any information, documents, or material made available to Reinsurer, its Affiliates, or their respective Representatives in any “data rooms,” information memoranda, management presentations, functional “break-out” discussions, or in any other form or forum in connection with the transactions contemplated by this Agreement, including any estimation, valuation, appraisal, projection, or forecast. With respect to any such estimation, valuation, appraisal, projection, or forecast (including and confidential information memoranda prepared by or on behalf of Cedent in connection with the transactions contemplated by this Agreement), Reinsurer acknowledges that: (i) there are uncertainties inherent in attempting to make such estimations, valuations, appraisals, projections, and forecasts; (ii) it is familiar with such uncertainties; (iii) except as expressly set forth in Section 3.12(b)  and Section 5(a) of Article VIII of the Reinsurance Agreement it is not acting and has not acted in reliance on any such estimation valuation, appraisal, projection, or forecast delivered by or on behalf of Cedent to Reinsurer, its Affiliates or their respective Representatives; (iv) such estimations, valuations, appraisals, projections, and forecasts are not and shall not be deemed to be representations or warranties of Cedent or any of its Affiliates except as expressly set forth in Section 3.12(b)  and

 

41



 

Section 5(a) of Article VIII of the Reinsurance Agreement; and (v) it shall have no claim against any Person with respect to any such valuation, appraisal, projection, or forecast except with respect to representations and warranties expressly set forth in Section 3.12(b)  and Section 5(a) of Article VIII of the Reinsurance Agreement.

 

(b)           Notwithstanding anything in this Agreement to the contrary, Cedent makes no express or implied representation or warranty hereby or otherwise under this Agreement as to the future experience, success or profitability of the Business, whether or not conducted in a manner similar to the manner in which such business was conducted prior to the Closing, that the Insurance Reserves or the assets supporting such Insurance Reserves have been or will be adequate or sufficient for the purposes for which they were established or that the reinsurance recoverables taken into account in determining the amount of such reserves will be collectible, or except as expressly set forth in Section 3.12(a)(ii)(A)  and (B) , whether such reserves were calculated, established, or determined in accordance with any actuarial, statutory or other standard.

 

(c)           Reinsurer further acknowledges and agrees that it (i) has made its own inquiry and investigation into and, based thereon, has formed an independent judgment concerning the Business, (ii) has been provided adequate access to such information as it has deemed necessary to enable it to form such independent judgment, (iii) has had such time as it deems necessary and appropriate fully and completely to review and analyze such information, documents, and other materials, and (iv) has been provided an opportunity to ask questions of Cedent with respect to such information, documents, and other materials and has received answers to such questions that it considers satisfactory.

 

(d)           Under no circumstances does any of the content of this Agreement or the Reinsurance Agreement constitute an express or implied representation or warranty with respect to the future performance of the Reinsured Policies or of the experience, success or profitability of the Reinsured Policies.

 

SECTION 9.13.     Currency . All financial data required to be provided pursuant to the terms of this Agreement shall be expressed in United States dollars. All settlements of account between Cedent and Reinsurer shall be in cash.

 

SECTION 9.14. No Offset . No party to this Agreement may offset any amount due to the other party hereto or any of such other party’s Affiliates under this Agreement against any amount owed or alleged to be owed from such other party or its Affiliates under this Agreement or any other Transaction Agreement without the written consent of such other party. For clarity, this Section 9.14 shall not be construed to limit or otherwise affect the rights of any such party to offset any mutual debits and credits arising under the Reinsurance Agreement to the extent permitted thereunder.

 

SECTION 9.15. Counterparts . This Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument. Cedent and Reinsurer agree that transmission of copies of original signatures via electronic means, either by facsimile or as a “scanned” document attached to electronic mail, shall constitute valid execution of this Agreement. In the event of an

 

42



 

electronic exchange of signatures for this Agreement, Cedent and Reinsurer agree to subsequently exchange original “wet” execution signatures of this Agreement within a reasonable time following the electronic exchange of signatures; provided that the failure of any party to exchange original “wet” execution signatures of this Agreement shall in no event affect the validity or enforceability of this Agreement. Such “wet” execution signatures will reflect the date of original execution and thus will be executed in counterpart.

 

(remainder of page intentionally left blank)

 

43



 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their respective duly authorized officers, all as of the date first written above.

 

 

GENWORTH LIFE AND ANNUITY
INSURANCE COMPANY

 

 

 

 

 

By:

/s/ Lou E. Hensley

 

Name:

Lou E. Hensley

 

Title:

President & CEO

 

 

 

PROTECTIVE LIFE INSURANCE COMPANY

 

 

 

 

 

By:

/s/ Nancy Kane Curreri

 

Name:

Nancy Kane Curreri

 

Title:

Senior Vice President, Acquisitions

 

[Signature Page to Master Agreement]

 



 

EXHIBIT C

 

Reinsurance Agreement

 

by and between

 

Genworth Life and Annuity Insurance Company

 

Richmond, Virginia

 

and

 

Protective Life Insurance Company

 

Brentwood, Tennessee

 



 

Table of Contents

 

Article I

 

Definitions

 

 

 

Article II

 

Reinsurance

 

 

 

Article III

 

Notification and Administration

 

 

 

Article IV

 

Reinsurance Premiums and Allowances

 

 

 

Article V

 

Taxes

 

 

 

Article VI

 

Claims

 

 

 

Article VII

 

Reinstatements, Conversions, Risk Classification Changes and Reductions

 

 

 

Article VIII

 

Accounting and Reserves

 

 

 

Article IX

 

Errors and Omissions

 

 

 

Article X

 

Inspection of Records

 

 

 

Article XI

 

Insolvency

 

 

 

Article XII

 

Dispute Resolution

 

 

 

Article XIII

 

Confidentiality; Privacy Requirements

 

 

 

Article XIV

 

Duration of Agreement; Termination

 

 

 

Article XV

 

Miscellaneous

 

Exhibit I

 

Excess Reinsurance

Exhibit II

 

Allowances

Exhibit III

 

Identification of Reinsured Policies

Exhibit IV

 

Reinsurer’s Share

Exhibit V

 

Net Settlement

Exhibit VI-A

 

Reinsurance Reporting

Exhibit VI-B

 

Operational Reporting

Exhibit VII

 

Premium Rates Description

Exhibit VIII

 

Economic Reserves

Exhibit IX

 

Reinsurance Credit Event Recapture Payment

Exhibit X

 

Commissions

 

i



 

Appendix I

 

Management Representation Letter

 

 

 

Schedule 1

 

Schedule 1 Excess Reinsurance

 

ii



 

This REINSURANCE AGREEMENT (this “ Agreement ”) is made by and between Genworth Life and Annuity Insurance Company, a Virginia-domiciled stock life insurance company (“ Cedent ”), and Protective Life Insurance Company, a Tennessee-domiciled life insurance company (“ Reinsurer ”, and together with Cedent, the “ Parties ”, and each of them a “ Party ”).

 

WHEREAS, Cedent is engaged in the business of both issuing life insurance policies on a direct basis and reinsuring life insurance risks under policies issued by other insurers;

 

WHEREAS, Cedent desires to cede or retrocede, as the case may be, to Reinsurer on an indemnity reinsurance basis certain liabilities with respect to certain fully underwritten single level term life insurance policies written or reinsured by Cedent;

 

WHEREAS, Reinsurer is willing to reinsure on an indemnity reinsurance basis the liabilities that Cedent desires to cede or retrocede hereunder on the terms provided herein; and

 

WHEREAS, Cedent and Reinsurer have entered into that certain Master Agreement, dated as of [         ], 2015 (the “ Master Agreement ”), which contemplates, among other things, that the Parties will enter into this Agreement at the closing of the transactions contemplated thereby.

 

NOW, THEREFORE, in consideration of the mutual and several promises and undertakings herein contained, and for good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, Cedent and Reinsurer agree as follows:

 

Article I           Definitions . The following capitalized terms mean as follows:

 

1.              Accounting Period . Each “Accounting Period” under this Agreement shall be a calendar quarter commencing on January 1 st , April 1 st , July 1 st  and October 1 st ; provided that the final Accounting Period shall be the part of a calendar quarter commencing on such applicable date and ending on the Termination Date.

 

2.              Adjusted Recurring Reinsurance Premium . “Adjusted Recurring Reinsurance Premium” for a given Accounting Period means the Recurring Reinsurance Premium for such Accounting Period calculated without reduction for any premiums payable by Cedent or GLIC in respect of Excess Reinsurance for such Accounting Period.

 

3.              Affiliate . “Affiliate” means any entity which is controlled by, controls or is under common control with, a given entity. For purposes of the foregoing, “control,” including the terms “controlling,” “controlled by” and “under common control” means the possession, direct or indirect, of the power to direct or cause the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

 

4.              Affiliate Policies . “Affiliate Policies” means the fully underwritten level term life insurance policies but not any riders thereto (i) issued by GLIC or GLICNY and described in Section B of Exhibit III and (ii) in-force as of December 31, 2014 and as of the Effective Time and (iii) identified by policy number in the file referenced in Section A of Exhibit III (as such file may be replaced in accordance with Section 3(a) of Article II).

 

5.              Applicable Law . “Applicable Law” means any domestic or foreign, federal, state, county or local statute, law, ordinance or code, or any written rules, regulations or administrative interpretations issued by any Governmental Authority pursuant to any of the foregoing, in each case applicable to any party hereto, and any order, writ, injunction, directive, judgment or decree of a court of competent jurisdiction applicable to any party hereto.

 

1



 

6.              Assumed Policies . “Assumed Policies” means the Affiliate Policies ceded to Cedent under the GLIC Reinsurance Agreements or the GLICNY Reinsurance Agreement.

 

7.              Assumed Policy Premiums . “Assumed Policy Premiums” means, for any given Accounting Period, (i) the aggregate sum across all Affiliate Policies issued by GLIC of the product of (a) times (b), where (a) is equal to the Reinsurer’s Share, and (b) is equal to the direct term premium, including policy fees, additional substandard premiums, flat extra amounts and modal loadings, payable to GLIC with respect to such Affiliate Policies and with respect to such Accounting Period plus (ii) the aggregate sum across all Affiliate Policies issued by GLICNY having policy effective date anniversaries in such Accounting Period of the product of (a) times (b), where (a) is equal to the Reinsurer’s Share and (b) is equal to the gross annual premiums, including policy fees, additional substandard premiums and flat extra amounts, payable to GLICNY with respect to such Affiliate Policies and with respect to such Accounting Period (without regard to the actual mode of payment of such premiums).

 

8.              Assumed Reinsurance Agreements . “Assumed Reinsurance Agreements” means together, the GLICNY Reinsurance Agreement and the GLIC Reinsurance Agreements.

 

9.              Base Ceding Commission . “Base Ceding Commission” shall have the meaning set forth in the Master Agreement.

 

10.           Business Day . “Business Day” means any day that is not a Saturday, Sunday or other day on which commercial banks in New York City, Birmingham, Alabama or Richmond, Virginia are authorized or required by Law to remain closed.

 

11.           Ceded Reinsurance Agreements . “Ceded Reinsurance Agreements” shall have the meaning set forth in the Master Agreement.

 

12.           Ceded Reserves . “Ceded Reserves” shall equal (a) with respect to a Direct Policy, the Statutory Reserves of Cedent for such Direct Policy, properly adjusted by Reinsurer’s Share, and then reduced by 100% of the reserves allocable to Excess Reinsurance with respect to such Direct Policy, and (b) with respect to an Assumed Policy, the Statutory Reserves as would be calculated using NAIC-approved statutory accounting practices and procedures in force in Cedent’s Domicile for such Assumed Policy, properly adjusted by Reinsurer’s Share, and then reduced by 100% of the reserves allocable to Excess Reinsurance with respect to such Assumed Policy.

 

13.           Ceded Total Reserves . “Ceded Total Reserves” shall equal (a) the Ceded Reserves for all then in-force Reinsured Policies minus (b) the amount of the deferred net premium asset for the in-force Reinsured Policies on a direct mode premium basis as would be calculated using NAIC-approved statutory accounting practices and procedures in force in Cedent’s Domicile.

 

14.           Cedent . “Cedent” shall have the meaning specified in the Preamble.

 

15.           Cedent Recapture Notice . “Cedent Recapture Notice” shall mean a written notice delivered from Cedent to Reinsurer advising Reinsurer of a recapture under Section 4(b)(ii) of Article VIII and specifying:

 

(a)           the effective date of such recapture; and

 

(b)                                  the Subject Risks being recaptured, including, where such recapture is a partial recapture, the pro rata portion of all Reinsured Policies to be recaptured.

 

2



 

16.           Change of Control . “Change of Control” of a Party means any of the following transactions: (x) a merger, reorganization, restructuring, or consolidation of such Party which results in the holders, together with any such Person’s Affiliates, of the voting securities or membership interests in that relevant entity outstanding immediately prior thereto ceasing to hold at least fifty percent (50%) of the combined voting power or membership interests of the surviving entity or its parent immediately after such merger, reorganization, or consolidation; or (y) any one Person, together with such Person’s Affiliates (other than such Party and its Affiliates, any trustee or other fiduciary holding securities under an employee benefit plan of such Party, or any corporation owned directly or indirectly by the stockholders of such Party, in substantially the same proportion as their ownership of stock of such Party), becomes the beneficial owner of fifty percent (50%) or more of the combined voting power or membership interests of the outstanding securities of a Party or by contract or otherwise obtaining the right to control the board of directors or similar governing body of a Party. For the avoidance of doubt, no transaction solely between a Party and one or more of its Affiliates shall be deemed a “Change of Control.”

 

17.           Ceding Commission . “Ceding Commission” shall have the meaning set forth in the Master Agreement.

 

18.           Commissions . “Commissions” means, with respect to an Accounting Period, the aggregate amount equal to the product of (a) 2% and (b) the Adjusted Recurring Reinsurance Premium for such Accounting Period for each Reinsured Policy having a plan code set forth on Exhibit X .

 

19.           Closing . “Closing” shall have the meaning set forth in the Master Agreement.

 

20.           Closing Date . “Closing Date” shall have the meaning set forth in the Master Agreement.

 

21.           Company Action Level RBC . “Company Action Level RBC” means, at any date of determination, two hundred percent (200%) of the authorized control level risk based capital of Cedent determined in accordance with the most current formula for calculating such amount adopted by the insurance regulatory authority in Cedent’s Domicile.

 

22.           Confidential Information . “Confidential Information” means all documents and information concerning one party, any of its Affiliates, the Covered Liabilities or the Reinsured Policies, including any information relating to any Person insured directly or indirectly under the Reinsured Policies, furnished to the other party or such other party’s Representatives in connection with this Agreement or the transactions contemplated hereby, except that Confidential Information shall not include information which: (a) at the time of disclosure or thereafter is generally available to and known by the public other than by way of a wrongful disclosure by a party hereto or their respective Representatives; (b) was available on a non-confidential basis from a source other than the parties hereto or their respective Representatives, provided that such source is not and was not bound by a confidentiality agreement with a party hereto; or (c) was independently developed without violating any obligations under this Agreement and without the use of any Confidential Information.

 

23.           Contestable Policy . “Contestable Policy” means, as of any given date, a Reinsured Policy (a) that is subject to reinsurance coverage under the Excess Reinsurance and (b) which, as of such date, has been issued as a reinstatement within the immediately preceding two (2) years where such issuance as a reinstatement has caused such Reinsured Policy to become subject to a new two (2) year period of contestability.

 

3



 

24.           Covered Benefits . “Covered Benefits” means the sum of (a) all death benefits arising under a Reinsured Policy (including all interest required under the Reinsured Policy or by Applicable Law whether payable to a beneficiary or escheated) and (b) all cash surrender values arising under a Reinsured Policy; provided , however , that Covered Benefits shall not include Excluded Interest.

 

25.           Covered Liabilities . “Covered Liabilities” means all liabilities and obligations incurred by Cedent, GLIC or GLICNY for Covered Benefits (a) under the express terms of the Reinsured Policies or (b) as a result of the payment of Covered Benefits consistent with then current standard industry practices with respect to the payment of claims and Existing Practices or, if applicable, Then Current Practices.

 

26.           Credit Collateral . “Credit Collateral” shall have the meaning set forth in Section 4(b) of Article VIII.

 

27.           Credit For Reinsurance . “Credit For Reinsurance” shall have the meaning set forth in Section 4(a) of Article VIII.

 

28.           Credit Laws . “Credit Laws” shall have the meaning set forth in Section 4(b) of Article VIII.

 

29.           Direct Policies . “Direct Policies” means the fully underwritten level term life insurance policies but not any riders thereto (i) issued by Cedent and described in Section B of Exhibit III, (ii) in-force as of December 31, 2014 and as of the Effective Time and (iii) as identified by policy number in the file referenced in Section A of Exhibit III (as such file may be replaced in accordance with Section 3(a) of Article II) that are in-force as of the Effective Time).

 

30.           Dispute . “Dispute” shall have the meaning set forth in Section 1 of Article XII.

 

31.           Domicile . “Domicile” means (a) with respect to any entity other than Cedent, the state or commonwealth in which the particular entity is domiciled or (b) with respect to Cedent, “Domicile” means the Commonwealth of Virginia or if Cedent changes its domicile to another state or commonwealth within the United States, such other state or commonwealth; provided , however , that if such other state is New York, Cedent’s Domicile shall be deemed to be the Commonwealth of Virginia for purposes of Section 4 of Article VIII if, in the reasonable judgment of Reinsurer, such change of domicile to the state of New York materially and adversely affects the rights and obligations of Reinsurer under Section 4 of Article VIII.

 

32.           Economic Reserves . “Economic Reserves” has the meaning set forth in Exhibit VIII .

 

33.           Effective Date . “Effective Date” means [January 1, 2016]. 1

 

34.           Effective Time . “Effective Time” shall have the meaning set forth in Section 1(a) of Article II.

 

35.           Excess Reinsurance . “Excess Reinsurance” means (a) the existing reinsurance agreements to the extent they provide reinsurance coverage in respect of the Reinsured Policies for amounts in excess of the amount retained by Cedent or GLIC, as identified and summarized in Exhibit I , as amended in accordance with the terms of this Agreement, and (b) any reinsurance agreement entered into by Cedent, GLIC or GLICNY with the prior written

 


1  In accordance with Section 2.1 of the Master Agreement, the Effective Date will be the first day of the month in which the Closing occurs.

 

4



 

approval of Reinsurer to replace any of such arrangements following any termination or recapture thereof. For the avoidance of doubt, from and after any partial recapture or bifurcation and novation of any Excess Reinsurance pursuant to clause (ii) of Section 4(b) of Article II, such recaptured or bifurcated and novated reinsurance, as applicable, shall cease to be Excess Reinsurance.

 

36.           Excluded Interest . “ Excluded Interest ” means (a) interest on a death benefit arising under a Reinsured Policy to the extent such interest arises as a direct result of the failure by Cedent, GLIC, GLICNY or their respective delegees or subcontractors to act in accordance with (i) Applicable Law or, to the extent consistent therewith, (ii) then current standard industry practices with respect to the payment of claims or (iii) Existing Practices or, if applicable, Then Current Practices; or (b) interest that accrues under a settlement option elected by the beneficiary of a death benefit.

 

37.           Excluded Liabilities . “Excluded Liabilities” means (a) any Extra-Contractual Obligations (other than Reinsurer Extra-Contractual Obligations), (b) any Indebtedness of the Cedent or any of its Affiliates, (c) any Liabilities of the Cedent or its Affiliates to the extent related to the Restructuring Transactions or (d) Liabilities of the Cedent, GLIC, GLICNY or any of their respective Affiliates to the extent related to (i) any failure of the Cedent, GLIC, GLICNY or their respective delegees or subcontractors to comply with Applicable Laws or settlements with Governmental Authorities (x) requiring such Person to report and remit abandoned or unclaimed property in respect of the Reinsured Policies to Governmental Authorities or (y) requiring the investigation into amounts that may be due and unpaid in respect of the Reinsured Policies, including with respect to unreported deaths, or (ii) any audit, investigation or examination by or on behalf of any Governmental Authority or third party (whenever performed) relating to compliance by Cedent, GLIC, GLICNY or their respective delegees or subcontractors with such Applicable Laws or settlements in respect of the Reinsured Policies, in the case of each of (a), (b), (c) and (d), other than the Covered Liabilities or other Liabilities expressly assumed by the Reinsurer or an Affiliate of the Reinsurer under the Reinsurance Agreement.

 

38.           Existing Practice . “Existing Practice” shall have the meaning set forth in Section 2(a) of Article III.

 

39.           Extra-Contractual Obligations . “Extra-Contractual Obligations” means all liability for fines, penalties, Taxes, fees, forfeitures, compensatory, punitive, exemplary, special, treble, bad faith, tort or any other form of extra-contractual damages, as well as all legal fees and expenses relating thereto, payable to any Person arising out of or relating to Reinsured Policies (other than Covered Liabilities), which liabilities arise out of, or result from, any act, error or omission, whether or not intentional, negligent, in bad faith or otherwise, including, without limitation, any such act, error or omission relating to (i) the form, design, sale, marketing, distribution, underwriting, production, issuance, cancellation or administration of the Reinsured Policies, (ii) the investigation, defense, trial, settlement or handling of claims, benefits, or payments under the Reinsured Policies, or (iii) the failure to pay or the delay in payment or errors in calculating or administering the payment of benefits, claims or any other amounts due or alleged to be due under or in connection with the Reinsured Policies.

 

40.           Family . “Family” shall have the meaning set forth on Exhibit I .

 

41.           GLIC . “GLIC” means Genworth Life Insurance Company, a Delaware domestic life insurer.

 

5



 

42.           GLIC Reinsurance Agreements . “GLIC Reinsurance Agreements” means, collectively: (i) the Reinsurance Agreement, dated as of July 1, 2003, by and between GLIC, as ceding company, and Cedent, as reinsurer, as amended; and (ii) the Reinsurance Agreement, dated as of October 1, 2004, by and between GLIC, as ceding company, and Cedent, as reinsurer, as amended.

 

43.           GLICNY . “GLICNY” means Genworth Life Insurance Company of New York, a New York domestic life insurer.

 

44.           GLICNY Reinsurance Agreement . “GLICNY Reinsurance Agreement” means the Reinsurance Agreement dated as of July 1, 2003, by and between GLICNY, as ceding company and as successor by merger to American Mayflower Life Insurance Company, and Cedent, as reinsurer, as amended.

 

45.           Governmental Authority . “Governmental Authority” means any domestic or foreign, federal, state, county or local governmental or public agency, instrumentality, commission, authority or self-regulatory organization, board or body.

 

46.           IMR Recapture Amount . “IMR Recapture Amount” means the Net Unamortized IMR plus the Net Reinsurer IMR, each determined as of the Termination Date.

 

47.           Indebtedness . “Indebtedness” means (i) all indebtedness for borrowed money, and (ii) any guarantees of the foregoing indebtedness of any other Person; including, in each case, any accrued and unpaid interest or penalty thereon.

 

48.           Indemnifiable Losses . “Indemnifiable Losses” means any and all damages, losses, liabilities, obligations, interest, penalties, costs, and expenses (including reasonable attorneys’ fees and expenses); provided that any Indemnity Payment (x) shall in no event include any amounts constituting consequential, indirect, special or punitive damages (except to the extent incurred by a third party and actually paid to such third party in connection with a Third Party Claim), or any damages for lost profits, unless (1) such damages for lost profits do not constitute consequential, indirect, special or punitive damages of any Reinsurer Indemnified Person; (2) such damages for lost profits are recoverable under the laws of the State of New York; (3) the Indemnitee satisfies all elements necessary for proof of such damages for lost profits under such laws; and (4) such lost profits can be demonstrated by reference to the Actuarial Report and therefore to be within the reasonable contemplation of the parties (it being understood that nothing in this definition is intended to limit the effect of the statement set forth in Section 5(b)(v) of Article VIII , and that lost profits damages with respect to the reduction or elimination of any profits contemplated by the Actuarial Report shall in no event exceed the present value ascribed to any s uch remaining profits contemplated by the Actuarial Report as of the date of the Indemnifiable Loss giving rise to the related claim, calculated based on the assumptions on which the Actuarial Report was prepared and discounted using a discount rate of 10%), and (y) shall be net of any (1) amounts recovered by the Indemnitee for the Indemnifiable Losses for which such Indemnity Payment is made under any insurance policy, reinsurance agreement, warranty, or indemnity or otherwise from any Person other than a party hereto, and the Indemnitee shall promptly reimburse the Indemnitor for any such amount that is received by it from any such other Person with respect to an Indemnifiable Loss after any indemnification with respect thereto has actually been paid pursuant to this Agreement; and (2) amounts specifically included in the calculation of the Adjusted Initial Ceded Total Reserves (as defined in the Master Agreement).

 

49.           Indemnitee . “Indemnitee” means any Person entitled to indemnification under this

 

6



 

Agreement.

 

50.           Indemnitor . “Indemnitor” means any Person required to provide indemnification under this Agreement.

 

51.           Indemnity Payment . “Indemnity Payment” means any amount of Indemnifiable Losses required to be paid pursuant to this Agreement.

 

52.           Insolvency . “Insolvency” means a supervision, rehabilitation, liquidation or proceeding that is in substance the same type of proceeding as the aforementioned, but conducted under a different name, whether involuntary or otherwise.

 

53.           Insolvent . “Insolvent” means that a given entity has entered into a supervision, rehabilitation, liquidation or proceeding that is in substance the same type of proceeding as the aforementioned, but conducted under a different name, whether involuntary or otherwise.

 

54.           Issuing Company . “Issuing Company” means (a) with respect to any Direct Policy, Cedent, and (b) with respect to any Affiliate Policy, the company that wrote or issued such Affiliate Policy.

 

55.           List of Risks Reinsured . “List of Risks Reinsured” shall have the meaning specified in Section 1 of Article III.

 

56.           NAIC . “NAIC” means the National Association of Insurance Commissioners or any successor thereto.

 

57.           Net Reinsurer IMR . “Net Reinsurer IMR” means the difference of (a) the Reinsurer IMR, minus (b) the present value of such interest maintenance reserve, determined using an amortization schedule consistent with the NAIC approved practices and procedures in force in Reinsurer’s Domicile and applying an annual discount rate of 10%.

 

58.           Net Settlement . “Net Settlement” shall have the meaning set forth in Section 1 of Article VIII.

 

59.           Net Unamortized IMR . “Net Unamortized IMR” means the difference of (a) the Initial Assumed IMR (as defined in the Master Agreement) to the extent not amortized in the statutory financial statements of Reinsurer minus (b) the present value of such unamortized Initial Assumed IMR, determined using an amortization schedule consistent with the NAIC approved practices and procedures in force in Reinsurer’s Domicile and applying an annual discount rate of 10%.

 

60.           Novation Trigger Event . “Novation Trigger Event” means the occurrence of Cedent’s RBC Ratio falling below 150% as of a calendar quarter-end and Cedent has not cured such shortfall as of the forty-fifth (45 th ) calendar day following such calendar quarter-end.

 

61.           Post Transition Extra-Contractual Obligations . “Post Transition Extra-Contractual Obligations” means all Extra-Contractual Obligations that arise from and after the transfer of Administrative Services pursuant to Section 4 of Article III to Reinsurer, an Affiliate of Reinsurer or a third party.

 

62.           Partial Settlement . “Partial Settlement” shall have the meaning set forth in Section 4 of Article XIV.

 

7



 

63.           Percentage of Company Action Level . “Percentage of Company Action Level” means, with respect to any date of determination, the percentage equal to (i) the quotient of the Total Adjusted Capital of Cedent as of such date of determination divided by the Company Action Level RBC determination, multiplied by (ii) 100.

 

64.           Person . “Person” means an individual, corporation, partnership, joint venture, limited liability company, association, trust, unincorporated organization, Governmental Authority, or other entity.

 

65.           Personal Information . “Personal Information” shall have the meaning set forth in Section 2 of Article XIII.

 

66.           Policyholders . “Policyholders” means the holders of one or more of the Reinsured Policies.

 

67.           RBC Ratio . “RBC Ratio” means (i) with respect to a calendar year end, the Percentage of Company Action Level as of such calendar year end and (ii) with respect to a quarter end that does not fall on a calendar year end, Cedent’s good faith estimate of the Percentage of Company Action Level as of such quarter end using to the extent any factors are not reasonably available, reasonable hypothetical amounts.

 

68.           Rate Guarantee Period . “Rate Guarantee Period” means, for a Reinsured Policy, the period of time for which premium amounts for such Reinsured Policy are fixed and constant.

 

69.           Recapture Actuary . “Recapture Actuary” means a senior employee or partner at a nationally recognized independent actuarial firm that is mutually acceptable to Cedent and Reinsurer, or, if the Parties are unable to agree on such an actuarial firm, such individual appointed by the American Arbitration Association.

 

70.           Recurring Reinsurance Allowances . “Recurring Reinsurance Allowances” shall have the meaning set forth on Exhibit II .

 

71.           Recurring Reinsurance Premiums . “Recurring Reinsurance Premiums” for a given Accounting Period means reinsurance premiums equal to the difference between (a) and (b), where: (a) is the sum of (i) Cedent’s direct term premiums, including policy fees, additional substandard premiums, flat extra amounts and modal loadings, payable to Cedent with respect to the Direct Policies and with respect to such Accounting Period, each appropriately adjusted by Reinsurer’s Share, and then reduced by 100% of any premiums payable by Cedent in respect of Excess Reinsurance for Direct Policies for such Accounting Period, plus (ii) Assumed Policy Premiums with respect to such Accounting Period, reduced by 100% of any premiums payable by Cedent or GLIC in respect of Excess Reinsurance for Assumed Policies for such Accounting Period; and (b) equals all refunds of unearned premiums for such Accounting Period as a result of the termination of any Reinsured Policies, whether due to lapse or death. The premium rates from which the Recurring Reinsurance Premiums are calculated are those set forth in Exhibit VII .

 

72.           Reinstatement Allowance . “Reinstatement Allowance” shall have the meaning set forth on Exhibit II .

 

73.           Reinsurance Credit Event Recapture Payment . “Reinsurance Credit Event Recapture Payment” means an amount equal to the economic reserves for the Subject Risks as of the recapture effective date, calculated by the Recapture Actuary in accordance with the procedures

 

8



 

set forth in Exhibit IX.

 

74.           Reinsured Benefits . “Reinsured Benefits” means (i) all Covered Liabilities payable by Cedent, GLIC or GLICNY under the Reinsured Policies on or after the Effective Date on account of dates of death or surrender on or after the Effective Date, appropriately adjusted by the Reinsurer’s Share, and then reduced by 100% of the death or surrender benefits which are payable to Cedent or GLIC in respect of such Reinsured Policy under the terms of Excess Reinsurance (including interest on and claims expenses with respect to such death or surrender benefits if such interest or such claims expenses are payable to Cedent or GLIC in respect of such Reinsured Policy under the terms of Excess Reinsurance), regardless of whether such amounts are actually paid to Cedent or GLIC by such Excess Reinsurance; and (ii) all Reinsurer Extra-Contractual Obligations.

 

75.           Reinsured Policies . “Reinsured Policies” means the Direct Policies and the Assumed Policies together, as more specifically described on Exhibit III .

 

76.           Reinsurer . “Reinsurer” shall have the meaning specified in the Preamble.

 

77.           Reinsurer Extra-Contractual Obligations . “Reinsurer Extra-Contractual Obligations” shall have the meaning set forth in Section 6 of Article VI.

 

78.           Reinsurer IMR . “Reinsurer IMR” means the aggregate statutory liability for interest maintenance reserve generated from and after the Closing Date in respect of the reinsurance assumed hereunder, as reflected in the statutory financial statements of Reinsurer, including any such reserve generated as a result of the disposition of assets in connection with the recapture payment under 3 of Article XIV.

 

79.           Reinsurer’s Share . “Reinsurer’s Share” means the participation of Reinsurer under this Agreement as determined in accordance with Exhibit IV .

 

80.           Representative . “Representative” of a Person means such Person’s Subsidiaries and any director, officer, employee, agent, attorney or consultant of any of them.

 

81.           Restructuring Transactions . “Restructuring Transactions” shall have the meaning set forth in the Master Agreement.

 

82.           Schedule 1 Base Rates . “Schedule 1 Base Rates” means the reinsurance rates payable with respect to the Reinsured Policies under the Excess Reinsurance identified in Schedule 1 as in effect as of the date of the Master Agreement.

 

83.           Schedule 1 Excess Reinsurance . “Schedule 1 Excess Reinsurance” means the Excess Reinsurance identified in Schedule 1.

 

84.           Security Incident . “Security Incident” shall have the meaning set forth in Section 3 of Article XIII.

 

85.           Settled . “Settled” means (i) the payment by or on behalf of Cedent, GLIC or GLICNY of Reinsured Benefits, whether in the form of cash payment, deposit to a retained asset account or other settlement option; or (ii) in the event of a Contested claim for Reinsured Benefits, Reinsurer has not agreed (whether affirmatively or by default) with Cedent’s decision to Contest such claim in accordance with the terms of Section 3 of Article VI. For the avoidance of doubt, as required by Section 3 of Article VI, the failure of Reinsurer to agree with Cedent’s decision to Contest a claim as described in clause (ii) above requires Reinsurer to discharge its

 

9



 

liability for such claim by paying to Cedent the full amount of the Reinsured Benefits that are the subject of such claim.

 

86.           Statutory Reserves . “Statutory Reserves” shall equal the aggregate gross statutory reserves (including deficiency reserves and unearned premium reserves) in respect of the Reinsured Benefits as calculated by Cedent using the NAIC-approved practices and procedures in force in Cedent’s Domicile from time to time.

 

87.           Subject Risks . “Subject Risks” means the risks being recaptured by Cedent pursuant to Section 4(b)(ii) of Article VIII.

 

88.           Taxes . “Taxes” means all forms of taxation, whether of the United States or elsewhere and whether imposed by a local, municipal, state, federal, foreign or other body or instrumentality, and shall include income, sales, use, gross receipts, value added and premium taxes, together with any related interest, penalties and additional amounts imposed by any taxing authority.

 

89.           Terminal Accounting and Settlement . “Terminal Accounting and Settlement” means a net accounting and settlement for the termination of this Agreement.

 

90.           Termination Date . “Termination Date” shall mean the date on which this Agreement terminates, whether through a full recapture or otherwise.

 

91.           Then Current Practice . “Then Current Practice” shall have the meaning set forth in Section 2(a) of Article III.

 

92.           Total Adjusted Capital . “ Total Adjusted Capital ” means, with respect to Cedent, its total adjusted capital as calculated in accordance with the most current formula for calculating such amount adopted by the insurance regulatory authority in Cedent’s Domicile.

 

Article II                Reinsurance .

 

1.             Reinsurance .

 

(a)           Subject to the other terms and conditions of this Agreement, including subsections (b) and (c) of this Section, Cedent hereby cedes on an indemnity reinsurance basis to Reinsurer, and Reinsurer hereby accepts and agrees to reinsure on a first dollar quota share indemnity reinsurance basis, the Reinsured Benefits. Reinsurer’s liability with respect to any Reinsured Policy will begin on the Closing Date, retroactive to 12:00:01 a.m. Richmond, Virginia time on the Effective Date (the “ Effective Time ”). This Agreement shall remain in force unless modified or terminated as provided herein.

 

(b)           This Agreement is net of Excess Reinsurance for each of claims, premiums and reserves, as incorporated in the applicable Sections of this Agreement and as illustrated by way of the examples set forth on Exhibit IV .

 

(c)           Reinsurer’s liability shall attach as set forth in Section 1(a) of this Article and shall be subject in all respects to the same risks, terms, conditions, interpretations, waivers, modifications, alterations, and cancellations as the respective insurances (or, in the case of Assumed Policies, reinsurances) of Cedent, GLIC or GLICNY, as applicable, the true intent of this Agreement being that Reinsurer shall, subject to the terms, conditions and limits of this Agreement, follow the fortunes of Cedent, GLIC or GLICNY, as applicable, and be bound by all payments and settlements under the Reinsured Policies entered into by or on behalf of Cedent, GLIC or GLICNY in accordance with the terms of this Agreement.

 

10



 

2.             Parties . This Agreement is an agreement solely between Cedent and Reinsurer. Reinsurer’s acceptance of reinsurance hereunder will not create any right or legal relationship whatsoever between Reinsurer and any other Person, including (a) the Policyholder or beneficiary under any Reinsured Policy or (b) any cedent under any Assumed Reinsurance Agreement.

 

3.             Reinsured Policies; No Other Policies .

 

(a)                                  The Parties acknowledge and agree that, as of the date of this Agreement, the file referenced in Section A of Exhibit III hereto has been prepared to reflect the Reinsured Policies based on policies in-force as of June 30, 2015 and that Cedent shall prepare and deliver to Reinsurer an updated version of such file based on policies in-force as of the Effective Time within ten (10) Business Days following the Closing Date, which updated version of such file shall replace the version of such file as of the date of this Agreement for all purposes of this Agreement.

 

(b)                                  Except (i) as contemplated above in Section 3(a) of this Article II, and (ii) in the case of Reinsured Policy reinstatements as described in Section 1 of Article VII, in no event shall Reinsured Policies be deemed to include insurance policies that are not identified by policy number in the file referenced in Section A of Exhibit III . Notwithstanding the preceding, after the Closing Date, Cedent may seek the approval of Reinsurer to include additional insurance policies as Reinsured Policies hereunder, which Reinsurer may accept or reject in its absolute discretion. Reinsurer’s approval will be applied on a per policy basis and will be final with respect to the inclusion of such additional policies.

 

4.             Excess Reinsurance .

 

(a)           Cedent and its Affiliates shall be permitted to modify the terms of or replace Excess Reinsurance to the extent set forth in Exhibit I . Subject to the foregoing, except as otherwise expressly permitted by the terms of this Agreement, including in Section 4(b)(vi) of this Article II, or to the extent that the reinsurance of the Reinsured Policies hereunder would not be affected thereby, Cedent shall not, and shall ensure that its Affiliates do not (i) recapture, terminate (or consent to the termination of), waive any material rights under, or, other than pursuant to its current terms and in the ordinary course of business consistent with past practice, renew or extend, any Excess Reinsurance, or (ii) enter into any new reinsurance agreement that would constitute Excess Reinsurance with respect to any Reinsured Policy, in each case of (i) and (ii), without the prior written consent of Reinsurer, which consent shall not be unreasonably withheld, conditioned or delayed. Notwithstanding the foregoing, Cedent and its Affiliates may so recapture, terminate, waive any material rights under, renew or extend or enter into any new reinsurance agreement without Reinsurer’s consent, except that, in such circumstances, the liabilities of Reinsurer and Cedent hereunder shall be determined as if no such recapture, termination, waiver, renewal, extension or entry into new reinsurance had occurred. 2

 

(b)

 

(i)            In the event that following the Closing, Cedent or any of its Affiliates receives written notice from a reinsurer of a proposed increase in the reinsurance rates with respect to the Reinsured Policies payable under any Excess Reinsurance, Cedent shall, as

 


2  A provision will be added to the GLIC feeder treaty prior to closing, such that GLIC will have corresponding obligations to Cedent.

 

11



 

promptly as practicable, give to Reinsurer, or ensure that Reinsurer is given, written notice of such proposed rate increase and copies of any related written correspondence from the reinsurer under such Excess Reinsurance with respect to such proposed rate increase. Cedent shall ensure that Reinsurer has an opportunity to consult with Cedent and its applicable Affiliates, with respect to the decision of whether to accept or negotiate such proposed rate increase and shall ensure that any recommendations of Reinsurer with respect thereto are considered by Cedent and such Affiliates. Cedent shall, and shall ensure that its Affiliates, as applicable, act reasonably and in good faith in determining the course of action with respect to such proposed rate increase, including, to the extent available, partial recapture or bifurcation of the treaty with respect to such Excess Reinsurance as contemplated by clause (ii) of this Section 4(b) of Article II. In furtherance of the foregoing (x) Cedent shall give to Reinsurer, or ensure that Reinsurer is given, a copy of any proposed written response or other material written communications to the reinsurer under such Excess Reinsurance with respect to such proposed rate increase and Reinsurer shall have a reasonable opportunity to provide comments thereon, which comments shall be considered in good faith by Cedent and its applicable Affiliates, and (y) Cedent shall give to Reinsurer, or ensure that Reinsurer is given, reasonable prior written notice of the time and place when any meetings or telephone calls are scheduled with the reinsurer under such Excess Reinsurance with respect to such proposed rate increase and shall ensure that Reinsurer has the opportunity to have representatives attend and participate in any such meeting or telephone call.

 

(ii)           In the event that any such notice of a proposed rate increase in the reinsurance rates with respect to the Reinsured Policies payable under any Excess Reinsurance is received, at Reinsurer’s reasonable request and sole cost and expense, Cedent shall, and shall ensure that its applicable Affiliates, cooperate with Reinsurer and use its commercially reasonable efforts to (x) execute a partial recapture of such Excess Reinsurance with respect to coverage for the Reinsured Policies if and to the extent that recapture of only the Reinsured Policies (without the requirement to recapture any other policies) is available under the terms of the Excess Reinsurance or (y) bifurcate and novate such Excess Reinsurance such that the Reinsured Policies are ceded pursuant to a separate reinsurance agreement between Reinsurer and the reinsurer under such Excess Reinsurance on substantially the same terms as the Excess Reinsurance. For the avoidance of doubt, neither of Cedent nor any of its Affiliates shall be required to compromise any right, asset or benefit or expend any of its own costs or incur any liabilities or provide any other consideration in connection with the obligations set forth in this clause (ii) of this Section 4(b) of Article II. In the event of any such partial recapture or bifurcation and novation, all liabilities with respect to the Reinsured Policies that were ceded to the reinsurer under the applicable Excess Reinsurance prior to such partial recapture or bifurcation and novation, as applicable, shall automatically be ceded to Reinsurer under this Agreement.

 

(iii)      Notwithstanding anything to the contrary herein, the amount of the Recurring Reinsurance Premiums hereunder shall be determined as if the first increase in the rates payable under the Schedule 1 Excess Reinsurance above the Schedule 1 Base Rates has not occurred and, with respect to any subsequent increases in the rates payable under the Schedule 1 Excess Reinsurance permitted to be included in the Recurring Reinsurance Premiums pursuant to Section 4(b) of Article II, shall be determined by applying the percentage increase to the Schedule 1 Base Rates, if applicable as such rates may have been previously increased in accordance with this Section 4(b)(iii) of Article II.

 

(iv)             Except to the extent that the reinsurance of the Reinsured Policies hereunder would not be affected thereby, Cedent shall not, and shall ensure its Affiliates do not, take any action or fail to take any action with the intent that such action or failure to take action will

 

12



 

result in any increase in the reinsurance rates payable under any Excess Reinsurance discriminating against or disadvantaging the Reinsured Policies in favor of other business written or reinsured by Cedent or its Affiliates for its or their own account without the prior written consent of Reinsurer, which consent shall not be unreasonably withheld, conditioned or delayed.

 

(v)              Upon a Change of Control of GLIC, if applicable, Cedent shall (i) promptly forward to Reinsurer copies of all written notices and other written correspondence Cedent receives from GLIC under Section [ ] 3  of the GLIC Reinsurance Agreements, (ii) designate Reinsurer as Cedent’s representative with respect to Section [ ] of the GLIC Reinsurance Agreements, such that Reinsurer shall be entitled to exercise all of Cedent’s rights and remedies under Section [ ] of the GLIC Reinsurance Agreements, (iii) use commercially reasonable efforts to cause GLIC to perform its obligations under Section [ ] of the GLIC Reinsurance Agreements, (ii) seek to enforce Section [ ] of the GLIC Reinsurance Agreements in the event of a breach thereof by GLIC and (iii) not waive Section [ ] of the GLIC Reinsurance Agreements without the prior written consent of Reinsurer.

 

(vi)             Notwithstanding anything to the contrary herein, at any time during the term of this Agreement, Cedent or GLIC, as applicable, may recapture the Schedule 1 Excess Reinsurance. In such event, the liabilities of Reinsurer and Cedent shall be determined from and after the date of such recapture as if no such recapture had occurred on such date. For the avoidance of doubt, any increases in the rates payable under the Schedule 1 Excess Reinsurance permitted to be included in the Recurring Reinsurance Premiums pursuant to Section 4(b) of Article II shall continue to be included in the calculation of Recurring Reinsurance Premiums from and after such recapture. Nothing in this Agreement shall prohibit Cedent or GLIC from reinsuring to any other Person all or any portion of the risks so recaptured under the Schedule 1 Excess Reinsurance.

 

5.             Affiliate Reinsurance . Cedent shall (i) not amend and shall maintain in full force and effect the Assumed Reinsurance Agreements and (ii) perform fully each of its respective obligations thereunder, except, in each case of (i) and (ii), to the extent that the reinsurance of the Reinsured Policies hereunder would not be affected thereby.

 

6.             Novation of Reinsured Policies .

 

(a)           Following the occurrence of a Novation Trigger Event and prior written notification to Cedent, Reinsurer shall have the right, but not the obligation, to the extent permitted by Applicable Law, to assume and novate, in whole (but not in part), some or all of the Reinsured Policies so as to substitute Reinsurer or an Affiliate of Reinsurer reasonably acceptable to Cedent as the insurer directly liable to the payees under such Reinsured Policies. Cedent shall, upon Reinsurer’s reasonable request, cooperate with Reinsurer with respect to such assumptions and novations of the Reinsured Policies by Reinsurer or such an Affiliate of Reinsurer, including by cooperating and using commercially reasonable efforts to assist Reinsurer in seeking the necessary consents to assign or novate to Reinsurer or such Affiliate of Reinsurer the portion of the Excess Reinsurance that provides coverage to Reinsured Policies that are so assumed and novated. Any costs and expenses of such assumptions and novations of Reinsured Policies or assignments and novations of Excess Reinsurance shall be borne by Reinsurer and Reinsurer shall promptly reimburse Cedent for all costs and expenses incurred by Cedent or its Affiliates in connection therewith.

 


3  A provision will be added to the GLIC feeder treaty prior to closing, such that GLIC will have corresponding obligations to Cedent.

 

13



 

(b)           The Cedent shall provide to Reinsurer the RBC Ratio as of the last day of each Accounting Period during the term hereof by the date that is either: (i) 75 calendar days after the end of the Accounting Period if such Accounting Period is the last Accounting Period of a calendar year, or (ii) 60 calendar days after the end of the Accounting Period otherwise.

 

7.             Interest Maintenance Reserve . The Parties agree and acknowledge that Reinsurer assumes hereunder Cedent’s aggregate statutory liability for interest maintenance reserve in respect of the Reinsured Benefits as of the Effective Time. In the event of a recapture or termination of the reinsurance hereunder, Cedent shall recapture the unamortized portion of such liability (or, in the case of a partial recapture under Section 4(b)(ii) of Article VIII, the applicable pro rata share thereof), and shall assume from Reinsurer the Reinsurer IMR (or, in the case of a partial recapture under Section 4(b)(ii) of Article VIII, the applicable pro rata share thereof).

 

Article III              Notification and Administration .

 

1.             Notice of Reinsured Risks; Additional Reports . Pursuant to Section 3 of Article II, Cedent shall provide Reinsurer, within ten (10) Business Days after the Closing Date, with an updated version of the file referenced in Section A of Exhibit III based on the Reinsured Policies in-force (a “ List of Risks Reinsured ”) as of the Effective Time, which file shall contain the information shown in Section 1 of Exhibit VI-A for each Reinsured Policy. From and after the Closing Date, Cedent shall deliver to Reinsurer, at the times specified in Exhibit VI-A , the reports set forth in Exhibit VI-A , including a “List of Risks Reinsured” containing the information shown in Section 5 of Exhibit VI-A with respect to all in-force Reinsured Policies and the other reports and information set forth in Exhibit VI-A . In addition, (a) Reinsurer may reasonably request in writing from Cedent any reports related to the Reinsured Policies necessary in order to comply with the requirements of Applicable Law or Governmental Authority or respond to a request from a Governmental Authority and, subject to Cedent’s receipt of reasonable written notice of such request, Cedent shall use its commercially reasonable efforts to provide any such reports on a timely basis in order for Reinsurer to comply with any filing deadlines and (b) Reinsurer may reasonably request any additional reports relating to the Reinsured Policies (other than the reports set forth in Exhibit VI-A or Exhibit VI-B or referenced in clause (a) of this Section 1 of Article II) (“ Additional Reports ”) for internal or external audit or reporting functions, or for any other reasonable business purpose, and Cedent and Reinsurer shall negotiate in good faith and in a commercially reasonable manner for Cedent to prepare such Additional Reports on fair and reasonable terms. Cedent shall be permitted to satisfy the notice and delivery requirements set forth in this Section 1 of this Article III by making such information available to Reinsurer in a commercially reasonable format reasonably acceptable to Reinsurer.

 

2.             Administration and Management Actions .

 

(a)           Cedent shall ensure that all administrative and related services that are necessary or appropriate with respect to the Reinsured Policies written by Cedent, GLIC or GLICNY, including the billing and collection of premiums in respect of the Reinsured Policies, the administration of claims thereunder and the investigation into amounts that may be due and unpaid in respect of the Reinsured Policies (together, the “ Administrative Services ”), are provided in accordance with the terms hereof, and Cedent shall administer reinsurance ceded under this Agreement through its reinsurance administration system. In the event that GLIC and/or GLICNY assign to Cedent such Administrative Services with respect to the Affiliate Policies issued by them, all references in this Section 2(a) to “direct writing company” shall mean to Cedent. With respect to the Administrative Services, Cedent shall ensure that each direct writing company acts with the skill, diligence and expertise that would reasonably be expected from experienced and qualified personnel performing such duties with respect to such

 

14



 

direct writing company’s business generally, in accordance with the terms of the Reinsured Policies and Applicable Law and with substantially the same priority as the direct writing company accords its own operations with respect to similar business for its own account. To the extent consistent with the standards set forth in the immediately preceding sentence, in undertaking the Administrative Services, Cedent shall ensure that the Administrative Services are performed in all material respects in accordance and consistent with the direct writing company’s existing administrative and claims practices in effect with respect to similar business for its own account during the twelve (12) months prior to the date of the Master Agreement (such practices, an “ Existing Practice ”), except that, to the extent the direct writing company modifies an Existing Practice from time to time following date of the Master Agreement (an Existing Practice, as modified from time to time to the extent consistent with the standards set forth in the immediately preceding sentence, a “ Then Current Practice ”), Cedent shall ensure that the direct writing company shall act in accordance and consistent with the Then Current Practice. The Cedent shall ensure that the Administrative Services with respect to Reinsured Policies written by Cedent and GLIC are not administered from a location within the State of New York in violation of Applicable Law, including any insurance laws of the State of New York that prohibit unauthorized insurers from conducting an insurance business in the State of New York. From and after the Closing Date, Cedent shall deliver to Reinsurer at the times specified in Exhibit VI-B operational reports containing the information shown in Exhibit VI-B with respect to the Administrative Services provided hereunder. Cedent shall provide Reinsurer at least [30] calendar days written notice prior to any direct writing company delegating or subcontracting (a) decision making authority with respect to the payment of claims, (b) the collection of premium or (c) all or substantially all of the Administrative Services, in each case of (a), (b) or (c), to any Person other than an Affiliate of Cedent and following any such delegation or subcontracting provide any additional operational reports with respect to the provision of such subcontracted or delegated Administrative Services by such delegee or subcontractor customarily provided by third party administrators performing the duties to be performed by such delegate or subcontractor as Reinsurer may reasonably request. To the extent the direct writing company delegates any of its duties to provide Administrative Services to a third party or an Affiliate, such delegee shall be subject to the same standards as are set forth in this paragraph, and Cedent shall remain fully responsible for such duties to the extent such delegee fails to comply with the applicable administrative provisions of this Agreement..

 

(b)           (i)            Except (A) as directed by or consented to by Reinsurer, which consent shall not be unreasonably withheld, conditioned or delayed, (B) for any change initiated by the holder of such Reinsured Policy, or required by any Governmental Authority or Applicable Law, or (C) with respect to non-guaranteed elements of the Reinsured Policies, including setting the premium amount for any Reinsured Policy for which the Rate Guarantee Period has expired (which is subject to clause (ii) of this Section 2(b)), Cedent shall ensure that neither Cedent, GLIC or GLICNY change the terms or conditions of any Reinsured Policy to the extent that such change would affect the Reinsured Benefits reinsured hereunder. If Cedent’s liability under any of the Reinsured Policies is changed because of changes made on or after the Closing Date in the terms and conditions of the Reinsured Policies, including to any endorsements thereto, that are required by any Governmental Authority or Applicable Law or otherwise permitted or required by the foregoing provisions of this Section 2(b), such changes shall be shared by Cedent and Reinsurer proportionately based on the Reinsurer’s Share, subject to the terms and conditions of this Agreement.

 

(ii)           Cedent shall notify Reinsurer in writing at least sixty (60) calendar days prior to changes being made to premium rates for Reinsured Policies for which the Rate Guarantee Period has expired or to any other non-guaranteed elements of the Reinsured

 

15



 

Policies; provided , however , that Cedent shall not be required to so notify Reinsurer of changes to such post-level term premium rates if such changes are consistent with the rates illustrated in the Reinsured Policies as the post-level term premium rates expected to be charged by the direct writing company, which are not, for the avoidance of doubt, the guaranteed maximum post-level term premium rates set forth in the Reinsured Policies. Following receipt of such notice, Reinsurer may make recommendations to Cedent with respect to such post-level term premium rates or other non-guaranteed elements; provided that such recommendations shall comply and be consistent with (A) Applicable Law, (B) the terms of the Reinsured Policies and (C) to the extent applicable, Actuarial Standards of Practice promulgated by the Actuarial Standard Board governing redetermination of non-guaranteed charges, and Cedent shall consider any such recommendations in good faith and act reasonably in determining whether any such recommendations should be accepted. The parties acknowledge and agree that in considering any such recommendations in good faith, Cedent shall be permitted to take into account, among other factors, (A) the terms of the Ceded Reinsurance Agreements, (B) all other reinsurance agreements to which Cedent, GLIC or GLICNY is a party that provide coverage for level term life insurance policies not reinsured hereunder, and (C) Cedent’s expected future mortality, interest, expense or persistency under the Reinsured Policies.

 

3.             Internal Control Reporting . Within twenty (20) calendar days following the end of each calendar year during the term of this Agreement, Cedent shall prepare and provide to Reinsurer, with respect to the prior year, a Management Attestation Letter on internal controls, signed by an authorized officer of Cedent, in substantially the form set forth in Appendix I .

 

4.             Transfer of Administration . In addition to and without limiting any other remedies contemplated by this Agreement, in the event that Cedent has (i) exhibited a pattern and practice of deficient performance of its material obligations set forth in this Article III that has had, or would reasonably be expected to have, a material adverse impact on the aggregate economic benefits Reinsurer reasonably expected to obtain from this Agreement, and (ii) failed to return to compliance with respect to the performance of such obligations within ninety (90) days following written notice from Reinsurer, then Reinsurer, at its own cost and expense, shall have the right, but not the obligation, to transfer all (but not less than all) of the Administrative Services to Reinsurer or an Affiliate or third party designated by Reinsurer and reasonably acceptable to Cedent, and Cedent shall cooperate with Reinsurer, and take all actions reasonably necessary, at Reinsurer’s cost and expense, to transfer such Administrative Services. From and after the date that all of the Administrative Services have been so transferred, Reinsurer shall be responsible for providing all Administrative Services in accordance with the standards set forth in Section 2 of this Article III, and Reinsurer shall bear all costs and expenses for the provision of such Administrative Services. Cedent shall not be entitled to receive the Recurring Reinsurance Allowance for any periods from and after the date that the Administrative Services have been so transferred in accordance with this Section 4.

 

Article IV              Reinsurance Premiums and Allowances .

 

1.             Closing Date Payments . As consideration for the reinsurance of the Reinsured Policies to Reinsurer, Reinsurer has paid to Cedent, on the Closing Date, the Ceding Commission as contemplated in Section 2.3 of the Master Agreement, and Cedent has paid or has caused the payment of cash on the Closing Date to Reinsurer in accordance with Section 2.3 of the Master Agreement, subject to adjustment therein.

 

2.             Recurring Reinsurance Premiums . As additional consideration for the reinsurance provided herein, Cedent shall pay to Reinsurer the Recurring Reinsurance Premiums in accordance with Section 1 of Article VIII.

 

3.             Recurring Reinsurance Allowances . As reimbursement for Reinsurer’s share of

 

16



 

expenses incurred in issuing and administering the Reinsured Policies, Reinsurer shall pay Cedent the Recurring Reinsurance Allowances in accordance with Section 1 of Article VIII.

 

4.             Commissions . As reimbursement for Reinsurer’s share of Commissions incurred by Cedent, GLIC or GLICNY, as applicable, Reinsurer shall pay Cedent Commissions in accordance with Section 1 of Article VIII.

 

Article V                Taxes .

 

1.             Premium Taxes and Guaranty Fund Assessments . Reinsurer shall not reimburse Cedent for any premium and other Taxes or guaranty fund assessments arising on account of premiums on the Reinsured Policies. For the sake of greater clarity, reimbursement for premium taxes and guaranty fund assessments arising on account of premiums on the Reinsured Policies is embedded in the Recurring Reinsurance Allowances.

 

2.             DAC Tax Election . Both parties hereto hereby enter into an election under Treasury Regulations Section 1.848-2(g)(8) whereby:

 

(a)           For each taxable year under this Agreement, the party with net positive consideration, as defined in Treasury Regulations Section 1.848-2, will capitalize specified policy acquisition expenses with respect to this Agreement without regard to the general deductions limitation of Section 848(c)(1) of the Internal Revenue Code of 1986, as amended. The parties shall each attach a schedule to their federal income tax returns stating that an election under Treasury Regulations Section 1.848-2(g)(8) has been made for this Agreement.

 

(b)           Both parties agree to exchange information about the amount of net consideration for all reinsurance agreements in force between them to ensure consistency for purposes of computing specified policy acquisition expenses.

 

(c)           This election will be made for the taxable year of each party that includes the Effective Date. This election will remain in effect for all future taxable years for which this Agreement remains in effect.

 

(d)           Cedent and Reinsurer represent and warrant that they are subject to United States taxation under Subchapter L of the Internal Revenue Code of 1986, as amended.

 

Article VI              Claims .

 

1.             Notice of Claims . Cedent shall give Reinsurer prompt notice of any claim for Covered Benefits made against Cedent on a Reinsured Policy and notice of any claim for Covered Benefits made against GLIC or GLICNY promptly after Cedent receives notice of such claim. For any claim for Covered Benefits, Cedent shall, as soon as reasonably practicable, provide Reinsurer with copies of such proofs of loss, underwriting reports, investigative reports or other documents bearing on such claims as Reinsurer may reasonably request.

 

2.             Claims . Subject to Section 3 of this Article, claims payments for Reinsured Benefits will be made by Reinsurer to Cedent in accordance with Section 1 of Article VII; provided , however , that Reinsurer will have no obligation to make payment for Reinsured Benefits with respect to Contestable Policies. Reinsurer shall accept the decision of Cedent, GLIC and GLICNY, as applicable, in the settlement and payment of claims in accordance with the terms of this Agreement. Reinsurer will make one lump sum payment under its reinsurance for all Reinsured Benefits for each Reinsured Policy in accordance with Section 1 of Article VIII, regardless of the mode of settlement effected under the reinsured risk by Cedent, GLIC or GLICNY, as applicable. Such payment will include all Reinsured Benefits Settled in respect of such claim, plus related claim expenses, appropriately adjusted by the Reinsurer’s Share. Related claim expenses include, but may not be limited to, fees and expenses of third parties utilized by or on behalf of Cedent, GLIC or GLICNY in connection with the claim investigation (other than routine processing of Covered Benefits). For the avoidance of doubt,

 

17



 

related claims expenses do not include interest or compensation of the Issuing Company’s or its Affiliate’s salaried officers and employees, or third party administrators performing services that, as of the date hereof, are being conducted by salaried officers or employees of the Issuing Company or its Affiliates and, apart from the payment of the Recurring Reinsurance Allowance, in no event shall Reinsurer be liable for any expenses incurred in connection with conflicting claims of entitlement to Reinsured Policy benefits that the Issuing Company admits are payable.

 

3.             Disputed Claims . Cedent will notify Reinsurer if Cedent intends to contest, compromise or litigate a claim involving a policy reinsured under this Agreement (a “ Contest ”), including where Cedent has been given the option under the Assumed Reinsurance Agreements to opt out of a Contest with respect to an Assumed Policy but has elected to participate with GLIC or GLICNY, as applicable, in such Contest. Reinsurer will provide written notice to Cedent no later than five (5) Business Days following receipt of such notice indicating whether or not it agrees with Cedent’s intention to Contest the claim. In the event of any failure of Reinsurer to provide such notice within such five (5) Business Day period, Reinsurer shall be deemed to have not agreed with Cedent’s intention to Contest the claim and shall result in default non-participation by Reinsurer. If Reinsurer agrees with Cedent, the parties shall share the claims expenses of such claim in proportion to the economic benefits that would inure to the parties if such Contest were successful, and Reinsurer shall be liable for such Extra-Contractual Obligations arising out of the Contested claim to the extent set forth in Section 6 of this Article VI. If Reinsurer does not agree with Cedent’s decision to Contest a claim, Reinsurer shall, as part of the Net Settlement for the Accounting Period during which Reinsurer has not agreed with Cedent’s decision (whether affirmatively or by default), discharge its liability for such claim by paying to Cedent the full amount of the Reinsured Benefits that are the subject of such claim. In such case, Reinsurer shall not be liable for any portion of any claims expense of the Contest incurred by Cedent.

 

4.             Settlement Authority . Subject to the foregoing Section 3, Cedent, GLIC and GLICNY, as applicable, shall have full authority to determine liability on any claim reinsured hereunder and may settle losses as it deems appropriate, but in so doing it shall act in accordance with Section 2(a) of Article III.

 

5.             Misstatement of Age or Sex . In the event of an increase or reduction in the amount of Cedent’s, GLIC’s or GLICNY’s insurance in respect of any Reinsured Policy because of an overstatement or understatement of age or misstatement of sex, established during the life, or after the death, of the insured, Cedent and Reinsurer will share in such increase or reduction proportionately based on Reinsurer’s Share.

 

6.             Extra-Contractual Obligations . Where (a) Reinsurer has agreed in writing to Cedent’s course of conduct giving rise to Extra-Contractual Obligations; or (b) Extra-Contractual Obligations arise out of any actions, omissions or course of conduct relating to a claim which Reinsurer has agreed, in accordance with Section 3 of Article VI, with Cedent’s decision to Contest, Reinsurer shall be liable for the Reinsurer’s Share of the portion of such Extra-Contractual Obligations that arise from, in the case of clause (a), such course of conduct agreed in writing to by Reinsurer or, in the case of clause (b), such decision to Contest, reduced by 100% of the benefits payable to Cedent or GLIC in respect of such Extra-Contractual Obligations under the terms of the Excess Reinsurance (such portion of Extra-Contractual Obligations for which Reinsurer is liable, together with Post Transition Extra-Contractual Obligations, the “ Reinsurer Extra-Contractual Obligations ”). In no event shall Reinsurer be liable for any Extra-Contractual Obligations other than Reinsurer Extra-Contractual Obligations..

 

18



 

Article VII             Reinstatements, Conversions, Risk Classification Changes and Reductions .

 

1.             Reinstatements .

 

(a)           Reinsured Policies which were issued as a reinstatement prior to the Effective Date shall be ceded under this Agreement. Reinsured Policies which lapse on or after the Effective Date and which are issued as reinstatements on or after the Effective Date, shall be ceded under this Agreement.

 

(b)           Reinstatements must abide by Cedent’s, GLIC’s or GLICNY’s, as applicable, established procedures and rules governing reinstatements. Cedent will pay Reinsurer the Reinsurer’s Share of amounts collected or charged for the reinstatement of such policies, less any premiums payable by the Issuing Company to reinsurers under Excess Reinsurance for such reinstated policies.

 

2.             Conversions . Any insurance policy which is issued upon the contractually permitted conversion of a Reinsured Policy shall be treated as a lapsed Reinsured Policy and shall be removed from coverage under this Agreement. In the case of a partial policy conversion, that portion of the policy which is converted shall be treated as a lapsed Reinsured Policy and shall be removed from coverage under this Agreement. That portion which remains under the original Reinsured Policy shall continue to be covered under this Agreement. Cedent agrees not to, and to ensure its Affiliates do not, intentionally solicit, or support any Person in soliciting, owners, beneficiaries or policyholders under any Reinsured Policies through any “program of internal replacement” without the prior written consent of Reinsurer. Cedent agrees not to, and shall ensure that its Affiliates do not, provide any information regarding the Reinsured Policies or any Personal Information to any Affiliate or other Person that would enable such Person to implement any such program of internal replacement. Upon a Change of Control of GLIC, if applicable, Cedent shall (i) use commercially reasonable efforts not to permit GLIC to be in breach of Section [ ] 4  of the GLIC Reinsurance Agreements, (ii) seek to enforce Section [ ] of the GLIC Reinsurance Agreements in the event of a breach thereof by GLIC and (iii) not waive Section [ ] of the GLIC Reinsurance Agreements without the prior written consent of Reinsurer. The term “program of internal replacement” shall mean any Issuing Company- or Affiliate-sponsored or supported program offered to a class of policy or contract owners with the intent that a group of Reinsured Policies are exchanged for other policies written by the Issuing Company or its Affiliates or any of their respective successors or assigns and that are not reinsured hereunder.

 

3.             Risk Classification Changes. If a Policyholder requests a table rating reduction or removal of a flat extra, before agreeing to any such request, the change will be underwritten in all material respects is accordance with Cedent’s, GLIC’s or GLICNY’s, as applicable, underwriting guidelines and standards in effect with respect to similar business for its own account at such time.

 

4.                                       Reductions .

 

(a)

 


4  A provision will be added to the GLIC feeder treaty prior to closing, such that GLIC will have corresponding obligations to Cedent.

 

19



 

(i)            If the face amount of any in force insurance with Cedent, GLIC or GLICNY on any particular standard or preferred (not impaired) class life is reduced, a corresponding reduction will apply to reduce any in force reinsurance on the life. Such reduction will be applied first to any Excess Reinsurance (dollar for dollar with the reduction). If such reduction reduces Excess Reinsurance coverage to zero, the Reinsurer’s Share of any remaining reduction will be allocated to Reinsurer and the balance of such reduction shall be allocated to Cedent.

 

(ii)           If the face amount of any in force insurance with Cedent, GLIC or GLICNY on any particular impaired class life is reduced, such reduction shall be allocated to Excess Reinsurance, Reinsurer and Cedent in proportion to the percentages of the face amount covered by each of Excess Reinsurance, Reinsurer (based on the Reinsurer’s Share) and Cedent (for all risks retained by the Family) before such reduction occurred.

 

(b)           If a reduction is made to the face amount of any Reinsured Policy which is not subject to coverage under Excess Reinsurance, the Reinsurer’s Share of such reduction shall be allocated to Reinsurer and the balance of such reduction shall be allocated to Cedent.

 

(c)           If there is more than one insurance policy on the life, the reduction will apply first to any reinsurance on the policy being reduced, and then on a chronological, FIFO basis to reinsurance on the other in force policies, beginning with the policies preceding the policy being reduced.

 

Article VIII           Accounting and Reserves .

 

1.             Settlements .

 

(a)           During the term of this Agreement, a settlement amount between Cedent and Reinsurer as of the last day of each Accounting Period (the “ Net Settlement ”) shall be calculated by Cedent in accordance with clause (b) below.

 

(b)           (i)            Within fifteen (15) calendar days after the end of each Accounting Period, Cedent shall deliver to Reinsurer a statement in the form set forth in Exhibit V , setting forth the following information: in-force counts and amounts, policy exhibit information, billing summaries and transaction data (lapses, surrenders, deaths) similar to that shown in Exhibit V and including details of the calculation of the Net Settlement (the “ Settlement Statement ”).

 

(ii)           The Net Settlement with respect to any Accounting Period shall be equal to (A) Recurring Reinsurance Premiums for such Accounting Period, minus (B) Reinsured Benefits Settled during such Accounting Period, minus (C) Recurring Reinsurance Allowances for such Accounting Period, minus (D) Reinstatement Allowances for such Accounting Period, minus (E) Commissions for such Accounting Period. If the Net Settlement is greater than zero, then coincident with the delivery of the Settlement Statement, Cedent shall transmit a payment to Reinsurer equal to the Net Settlement. If the Net Settlement is less than zero, the absolute value of the Net Settlement shall be due from Reinsurer to Cedent within five Business Days after delivery to Reinsurer of the Settlement Statement.

 

(c)           The Settlement Statement for each Accounting Period shall include in-force counts and amounts of Contestable Policies that reinstated in such Accounting Period and Contestable Policies that had a one-year anniversary of reinstatement in such Accounting Period.

 

(d)           For purposes of Section 1(b)(ii) of this Article, a payment will be considered overdue on the date which is ten (10) Business Days after the date such payment is due hereunder. If there is a delayed settlement of any payment due hereunder, interest will accrue on such payment from the original due date through the date of such payment at a rate equal to

 

20



 

50 basis points plus the London Interbank Offered Rate (or any successor rate) for deposits in United States dollars having a maturity of three (3) months that appears on Bloomberg Page US0003M (or any successor page) as of 11:00 a.m., London, England time, on the original due date.

 

2.             Offset . Any undisputed debits or credits, matured or unmatured, liquidated or unliquidated, in favor of or against either Cedent or Reinsurer which arise solely under this Agreement will be deemed mutual debits or credits, as the case may be, and will be set off, and only the balance may be allowed or paid. The right of offset will not be affected or diminished because of the insolvency of either party to the full extent permitted under the laws of the state of domicile of the insolvent party.

 

3.             Currency . All financial data required to be provided pursuant to the terms of this Agreement shall be expressed in United States dollars. All settlements of account between Cedent and Reinsurer shall be in cash.

 

4.             Reserve Credit .

 

(a)           Intent of Parties . Reinsurer and Cedent intend that Cedent be able to (i) take full statutory financial statement credit for the reinsurance provided by this Agreement in all United States jurisdictions in which Cedent is required by Applicable Law to file statutory financial statements other than New York, (ii) for the entire term of this Agreement and (iii) in an amount, at all times, at least equal to the Ceded Total Reserves ((i), (ii) and (iii) collectively, “ Credit For Reinsurance ”). Reinsurer agrees to take all commercially reasonable efforts to ensure that during the term of this Agreement Cedent will be able to take Credit for Reinsurance without the need for Reinsurer to provide Credit Collateral or other accommodation required below in Section 4(b) of this Article VIII.

 

(b)           Collateral; Remedy .

 

(i)            In the event that Cedent would be unable to take Credit For Reinsurance (a “ Credit Event ”), then Reinsurer, at its own expense, shall provide collateral to ensure Cedent’s ability to take Credit For Reinsurance (“ Credit Collateral ”) or otherwise provide an accommodation, either of which must be reasonably acceptable to Cedent and under Applicable Law of Cedent’s Domicile (the “ Credit Laws ”) to enable Cedent to take Credit For Reinsurance, in each case, no later than the earlier of: (i) thirty (30) calendar days from the occurrence of the Credit Event and (ii) the last day of the then current Accounting Period. Such Credit Collateral or accommodations may, at the Reinsurer’s option, take the form of: (A) a clean, unconditional, irrevocable and qualifying letter of credit at Reinsurer’s sole expense for Cedent’s benefit which complies with the Credit Laws for Cedent to take Credit For Reinsurance; (B) the establishment of a trust complying with Credit Laws to permit Cedent to take Credit For Reinsurance; (C) the provision of some other Credit Collateral acceptable under the Credit Laws; (D) the amendment of this Agreement to provide for the withholding of funds by Cedent and the transfer by Reinsurer of the appropriate amount of cash and/or assets (such asset selection subject to Cedent’s approval, not to be unreasonably withheld) with an aggregate fair market value at the time of transfer equal to the amount necessary for Cedent to take Credit For Reinsurance; (E) a novation, to be consented to by Cedent in its sole discretion, to another reinsurer that would enable Cedent to take Credit For Reinsurance under the Credit Laws; or (F) some other accommodation acceptable to Cedent in its sole discretion for it to be able to take Credit For Reinsurance under the Credit Laws. The remedy may be in the form of any one of the aforementioned alternatives, or, with the consent of Cedent (not to be unreasonably withheld), a combination of such alternatives, so long as Cedent is able to take Credit For Reinsurance.

 

(ii)           In the event that Reinsurer fails to satisfy its obligations in Section 4(b)(i) above and Cedent would not be able to take Credit for Reinsurance under the Credit

 

21



 

Laws, Cedent may recapture, by delivery of a Cedent Recapture Notice, all of the reinsurance ceded hereunder. In lieu of a full recapture, Cedent may also recapture, by delivery of a Cedent Recapture Notice, a pro rata share of each Reinsured Policy such that, after giving effect to such recapture, Cedent would be able to take Credit For Reinsurance under the Credit Laws for the portion of the reinsurance hereunder that is not so recaptured. In consideration of a recapture pursuant to this Section 4(b)(ii), Reinsurer shall pay to Cedent the Reinsurance Credit Event Recapture Payment in accordance with Section 3 or Section 4, as applicable, of Article XIV. Cedent’s right to recapture pursuant to this Section of this Agreement shall not be in any way be limited or waived by the passage of time from the event giving rise to such rights.

 

(iii)          Notwithstanding the remedies contemplated by Section 4(b)(ii) of this Article VIII , Cedent may, in its sole discretion, require Reinsurer’s compliance with the requirements of Sections 4(a) and 4(b)(i) of this Article VIII in lieu of exercising the remedies in this Section 4(b)(ii) of this Article VIII , and it shall be no defense to any such claim that Cedent might have had other recourse.

 

5.             Representations and Warranties; Indemnification .

 

(a)                                  Representations and Warranties . Subject to Section 5(b) of this Article VIII , Cedent represents and warrants to Reinsurer, as of the date of this Agreement, that:

 

(i)                                      Prior to the date of the Master Agreement, Cedent made available to Reinsurer a true, complete and correct copy of the “Actuarial Appraisal of River Lake I and River Lake II Blocks of Business” prepared by Milliman with respect to the Business dated April 20, 2015, and all supplements and addenda thereto (the “ Actuarial Report ”).

 

(ii)                                   Except as set forth in Section 3.12(b) of Cedent Disclosure Schedule, to the Knowledge of Cedent, the factual data furnished by Cedent and its Affiliates in writing to Milliman with respect to the Business for its use in connection with the preparation of the Actuarial Report (the “ Cedent Factual Data ”) was (x) derived from the Books and Records, (y) generated from the same underlying systems that were utilized by Cedent or its applicable Affiliates to prepare the Audited 2014 Financial Statements to the extent applicable and (z) accurate in all material respects as of the date such Cedent Factual Data was furnished to Milliman.

 

(iii)                                In the good faith judgment of Cedent and in the context of industry practices for the preparation of third-party actuarial reports to be used in the sale of a block of life insurance business, the Cedent Factual Data was complete in all material respects as of the date furnished to Milliman.

 

(iv)                               Except as set forth in Section 3.12(b) of the Cedent Disclosure Schedule, as of the date of the Master Agreement, Milliman had not issued to Cedent or its Affiliates any new or revised report with respect to the Business or any errata with respect to the Actuarial Report nor had it notified Cedent or any of its Affiliates that the Actuarial Report was inaccurate in any material respect.

 

(v)                                  Except as set forth in Section 3.12(c) of the Cedent Disclosure Schedule or included in the Cedent Factual Data, from January 1, 2015 to the date of the Master Agreement, none of Cedent or any of its Affiliates has received any written notice of any actual or proposed increase in the reinsurance rates payable under any Excess Reinsurance, and no such increase occurred.

 

22



 

Capitalized terms used but not defined in this Section 5 of Article VIII have the respective meanings set forth in the Master Agreement.

 

(b)           Limitations to Cedent Representations and Warranties .

 

(i)            Notwithstanding anything to the contrary contained in this Agreement, the Master Agreement, the Cedent Disclosure Schedule, or any of the Schedules, Appendices or Exhibits hereto or thereto, Reinsurer acknowledges and agrees that neither Cedent nor any of its Affiliates, nor any Representative of any of them, makes or has made, and Reinsurer has not relied on, any inducement, promise, representation or warranty, oral or written, express or implied, other than except as expressly made by Cedent in Section 5(a) of this Article VIII and Article III of the Master Agreement. Without limiting the generality of the foregoing, other than as expressly set forth in Section 5(a) of this Article VIII and Article III of the Master Agreement, no Person has made any representation or warranty to Reinsurer with respect to the Business or any other matter, including with respect to (A) the probable success or profitability of the Business after the Closing, or (B) any information, documents, or material made available to Reinsurer, its Affiliates, or their respective Representatives in any “data rooms,” information memoranda, management presentations, functional “break-out” discussions, or in any other form or forum in connection with the transactions contemplated by the Master Agreement and this Agreement, including any estimation, valuation, appraisal, projection, or forecast. With respect to any such estimation, valuation, appraisal, projection, or forecast (including and confidential information memoranda prepared by or on behalf of Cedent in connection with the transactions contemplated by the Master Agreement and this Agreement), Reinsurer acknowledges that: (A) there are uncertainties inherent in attempting to make such estimations, valuations, appraisals, projections, and forecasts; (B) it is familiar with such uncertainties; (C) except as expressly set forth in Section 5(a) of this Article VIII and Section 3.12(b) of the Master Agreement, it is not acting and has not acted in reliance on any such estimation valuation, appraisal, projection, or forecast delivered by or on behalf of Cedent to Reinsurer, its Affiliates or their respective Representatives; (D) such estimations, valuations, appraisals, projections, and forecasts are not and shall not be deemed to be representations or warranties of Cedent or any of its Affiliates except as expressly set forth in Section 5(a) of this Article VIII and Section 3.12(b) of the Master Agreement; and (E) it shall have no claim against any Person with respect to any such valuation, appraisal, projection, or forecast except with respect to representations and warranties expressly set forth in Section 5(a) of this Article VIII and Section 3.12(b) of the Master Agreement.

 

(ii)           Notwithstanding anything in this Agreement to the contrary, Cedent makes no express or implied representation or warranty hereby or otherwise under this Agreement as to the future experience, success or profitability of the Business, whether or not conducted in a manner similar to the manner in which such business was conducted prior to the Closing, that the Insurance Reserves or the assets supporting such Insurance Reserves have been or will be adequate or sufficient for the purposes for which they were established or that the reinsurance recoverables taken into account in determining the amount of such reserves will be collectible or whether such reserves were calculated, established, or determined in accordance with any actuarial, statutory or other standard.

 

(iii)          Reinsurer further acknowledges and agrees that it (A) has made its own inquiry and investigation into and, based thereon, has formed an independent judgment

 

23



 

concerning the Business, (B) has been provided adequate access to such information as it has deemed necessary to enable it to form such independent judgment, (C) has had such time as it deems necessary and appropriate fully and completely to review and analyze such information, documents, and other materials, and (D) has been provided an opportunity to ask questions of Cedent with respect to such information, documents, and other materials and has received answers to such questions that it considers satisfactory.

 

(iv)          Under no circumstances does any of the content of this Agreement or the Master Agreement constitute an express or implied representation or warranty with respect to the future performance of the Reinsured Policies or of the experience, success or profitability of the Reinsured Policies.

 

(v)           Notwithstanding anything in this Agreement or the Master Agreement to the contrary, Cedent does not guarantee the projected results included in the Actuarial Report, or make any representation or warranty (x) with respect to any estimates, projections, predications, forecasts, assumptions, methodologies or judgments in the Actuarial Report or the assumptions on the basis of which such information or data was prepared (including, without limitation, as to future mortality, policyholder behavior, expense, investment experience and other actuarial factors with respect to the Business or its associated liabilities or assets) or (y) to the effect that the projected profits set forth in the Actuarial Report will be realized.

 

(c)                                   Survival . The representations and warranties set forth in Section 5(a) of this Article VIII shall survive the date hereof solely for purposes of Section 5(d) of this Article VIII and shall terminate and expire on the date that is 24 months following the date hereof. Any claim for indemnification in respect of any breach of the representations and warranties set forth in Section 5(a) of this Article VIII that is not asserted by notice given as required herein prior to the expiration of the survival period specified above shall not be valid and any right to such indemnification is hereby irrevocably waived after the expiration of such period of survival. Any claim properly made for an Indemnifiable Loss in respect of such a breach asserted within such period of survival as herein provided will be timely made for purposes hereof.

 

(d)           Indemnification by Cedent .

 

(i)                                      Cedent agrees to indemnify, defend and hold harmless Reinsurer and its Representatives from and against all losses, liabilities, claims, expenses (including reasonable attorneys’ fees and expenses) and damages incurred by Reinsurer and its Representatives to the extent arising from (x) any breach of the covenants and agreements of Cedent contained in this Agreement (other than any breach of the representations and warranties set forth in Section 5(a) of this Article VIII), (y) all Extra-Contractual Obligations other than Reinsurer Extra-Contractual Obligations or (z) any successful enforcement of this indemnity.

 

(ii)                                   Cedent agrees to indemnify, defend and hold harmless Reinsurer, its Affiliates and their respective directors, officers, employees, successors and permitted assigns (such Persons, and the indemnified Persons described in clause (i) of this Section 5(d) of this Article VIII, as applicable, the “ Reinsurer Indemnified Persons ”) from and against any and all Indemnifiable Losses resulting from or arising out of (x) any Excluded Liabilities or (y) any breach of the representations and warranties set forth in Section 5(a) of this Article VIII.

 

24



 

(e)                                   Indemnification by Reinsurer . Reinsurer agrees to indemnify, defend and hold harmless Cedent and its Representatives (the “ Cedent Indemnified Persons ”) from and against all losses, liabilities, claims, expenses (including reasonable attorneys’ fees and expenses) and damages incurred by Cedent and its Representatives to the extent arising from (i) any breach of the covenants and agreements of Reinsurer contained in this Agreement, (ii) all Reinsurer Extra-Contractual Obligations or (iii) any successful enforcement of this indemnity.

 

6.             Certain Limitations .

 

(a)                                  Cedent shall not be obligated to indemnify and hold harmless the Reinsurer Indemnified Parties under Section 5(d)(ii)(y)  of this Article VIII (i) with respect to any claim or claims based on substantially similar facts, events or circumstances, unless such claim or claims involve Indemnifiable Losses in excess of $50,000 (the “ Threshold Amount ”) (nor shall any claim that does not exceed the Threshold Amount be applied to or considered for purposes of calculating the amount of Indemnifiable Losses for which Cedent is responsible under clause (ii) below), and (ii) unless and until the aggregate amount of (x) all Indemnifiable Losses of the Reinsurer Indemnified Parties under such Section 5(d)(ii)(y)  plus (y) all Indemnifiable Losses of the Reinsurer Indemnified Parties under Section 7.2(a)(i) of the Master Agreement exceeds $1,050,000 for all Indemnifiable Losses (the “ Deductible ”), at which point Cedent shall be liable to the Reinsurer Indemnified Parties for the value of such claims under Section 5(d)(ii)(y)  that is in excess of the Deductible, subject to the limitations set forth in this section. The maximum aggregate liability of Cedent to the Reinsurer Indemnified Parties for any and all Indemnifiable Losses under Section 5(d)(ii)(y)  shall be an amount equal to $25,000,000.

 

(b)                                  No Reinsurer Indemnified Person shall be entitled to indemnification with respect to any particular Indemnifiable Loss under Section 5(d)(ii)  to the extent the related damages, losses, liabilities, obligations, costs, or expenses were included in the calculation of the Adjusted Initial Ceded Total Reserves (as defined and finally calculated pursuant to the Master Agreement).

 

(c)                                   In the event a claim or any Action for indemnification under this Section 5 of Article VIII has been finally determined, the amount of such final determination shall be paid (i) if the indemnified party is a Reinsurer Indemnified Person, by Cedent to the Reinsurer Indemnified Person and, (ii) if the indemnified party is a Cedent Indemnified Person, by Reinsurer to the Cedent Indemnified Person, in each case on demand by wire transfer of immediately available funds to an account designated by Cedent or Reinsurer, as applicable. A claim or an Action, and the liability for and amount of damages therefor, shall be deemed to be “finally determined” for purposes of this Section 5 of Article VIII when the Parties have so determine by mutual agreement or, if disputed, when a final order, judgment, or decree of any Governmental Authority has been entered into with respect to such claim or action or an award is rendered by an arbitral tribunal.

 

(d)                                  Notwithstanding anything contained in this Agreement to the contrary, in the event that any fact, event, or circumstance that results in an adjustment under Section 2.4 of the Master Agreement would also constitute a breach of or inaccuracy in any of Cedent’s representations or warranties made in Section 5(a) of this Article VIII of this Agreement, Cedent shall have no obligation to indemnify any Reinsurer Indemnified Person with respect to such breach or inaccuracy to the extent such indemnification would result in a duplicate recovery.

 

25



 

(e)                                   Reinsurer acknowledges and agrees that, except with respect to causes of action arising out from actual fraud, its sole and exclusive remedy at law or equity with respect to the matters subject to indemnification pursuant to Section 5(d)(ii) of this Article VIII , regardless of the legal theory under which the relevant liability or obligation may be sought to be imposed, whether sounding in contract or in tort, whether at law or in equity, or otherwise, shall be pursuant to the provisions set forth in this Article VIII.

 

7.             Indemnification Procedures .

 

(a)           Third-Party Claims .

 

(i)                                      If any Reinsurer Indemnified Person or Cedent Indemnified Person (an “ Indemnitee ”) receives notice of assertion or commencement of any claim, action, suit, or proceeding made or brought by any Person that is not a party to this Agreement or an Affiliate thereof against such Indemnitee in respect of which an indemnifying Party (an “ Indemnitor ”) may be obligated to provide indemnification under Section 5(d) of this Article VIII (a “ Third Party Claim ”), the Indemnitee shall give such Indemnitor reasonably prompt written notice (but in no event later than 30 calendar days after becoming aware) thereof and such notice shall include a reasonable description of the claim and any documents relating to the claim and an estimate of the Indemnifiable Loss and shall reference the specific sections of this Agreement that form the basis of such claim; provided that no delay on the part of the Indemnitee in notifying any Indemnitor shall relieve the Indemnitor from any obligation hereunder unless (and then solely to the extent) the Indemnitor is actually prejudiced by such delay (except that the Indemnitor shall not be liable for any expenses incurred during the period in which the Indemnitee failed to give such notice). Thereafter, the Indemnitee shall deliver to the Indemnitor, within five calendar days after the Indemnitee’s receipt thereof, copies of all notices and documents (including court papers) received by the Indemnitee relating to the Third Party Claim.

 

(ii)                                   The Indemnitor shall be entitled to participate in the defense of any Third Party Claim and, if it so chooses, to assume the defense thereof with counsel selected by the Indemnitor. Any election by the Indemnitor to assume the defense of a Third Party Claim must be delivered by the Indemnitor to the Indemnitee within fifteen Business Days after receipt by the Indemnitor of the Indemnitee’s notice delivered pursuant to Section 7(a)(i) of this Article VIII . Such assumption of defense shall not be deemed to be an admission or assumption of liability by the Indemnitor. Should the Indemnitor so elect to assume the defense of a Third Party Claim, the Indemnitor shall not as long as it conducts such defense be liable to the Indemnitee for legal expenses subsequently incurred by the Indemnitee in connection with the defense thereof. If the Indemnitor assumes such defense, the Indemnitee shall have the right to participate in the defense thereof and to employ counsel, at its own expense, separate from the counsel employed by the Indemnitor, it being understood that the Indemnitor shall control such defense. The Indemnitor shall be liable for the reasonable fees and expenses of counsel employed by the Indemnitee for any period during which the Indemnitor has not assumed the defense thereof (other than during any period in which the Indemnitee shall have not yet given notice of the Third Party Claim as provided above). If the Indemnitor chooses to defend any Third Party Claim, the Parties shall, and shall cause their respective Affiliates to, cooperate

 

26



 

in the defense thereof. Such cooperation shall include the retention and (upon the Indemnitor’s request at the Indemnitor’s expense) the provision to the Indemnitor of records and information that are relevant to such Third Party Claim, and making employees available on a mutually convenient basis to provide additional information and explanation of any material provided hereunder. Whether or not the Indemnitor shall have assumed the defense of a Third Party Claim, the Indemnitee shall not admit any liability with respect to, or pay, settle, compromise, or discharge, such Third Party Claim without the Indemnitor’s prior written consent, and any such admission, payment, settlement, compromise, or discharge without the Indemnitor’s prior written consent shall be deemed to be a waiver by the Indemnitee of any right to indemnity for all Indemnifiable Losses related to such Third Party Claim. If the Indemnitor has assumed the defense of a Third Party Claim, the Indemnitor may only pay, settle, compromise, or discharge a Third Party Claim with the Indemnitee’s prior written consent (which consent shall not be unreasonably withheld, conditioned, or delayed); provided that the Indemnitor may pay, settle, compromise, or discharge such a Third Party Claim without the written consent of the Indemnitee if such settlement (i) includes a release of the Indemnitee from all liability in respect of such Third Party Claim, (ii) does not subject the Indemnitee to any injunctive relief or other equitable remedy, and (iii) does not include a statement or admission of fault, culpability, or failure to act by or on behalf of the Indemnitee. If the Indemnitor submits to the Indemnitee a bona fide settlement offer that satisfies the requirements set forth in the proviso of the immediately preceding sentence and the Indemnitee refuses to consent to such settlement, then thereafter the Indemnitor’s liability to the Indemnitee with respect to such Third Party Claim shall not exceed the Indemnitor’s portion of the settlement amount included in such settlement offer, and the Indemnitee shall either assume the defense of such Third Party Claim or pay the Indemnitor’s attorney’s fees and other out-of-pocket costs incurred thereafter in continuing the defense of such Third Party Claim.

 

(b)                                  Direct Claims . The Indemnitor will have a period of 30 days within which to respond in writing to any claim by an Indemnitee for indemnification under Section 5(d) of this Article VIII that does not result from a Third Party Claim. If the Indemnitor does not so respond within such 30-day period, the Indemnitor will be deemed to have rejected such claim, in which event the Indemnitee will be entitled to pursue such remedies as may be available to the Indemnitee.

 

(c)                                   Certain Other Matters . Upon making any indemnity payment pursuant to Section 5(d) of Article VIII, Indemnitor will, to the extent of such payment, be subrogated to all rights of Indemnitee against any third Person (other than any Tax authority) in respect of the losses, liabilities, claims, expenses and damages to which the payment related. Without limiting the generality or effect of any other provision hereof, each such Indemnitee and Indemnitor will duly execute upon request all instruments reasonably necessary to evidence and perfect the above-described subrogation rights.

 

Article IX              Errors and Omissions .

 

1.             Errors and Omissions . Errors and omissions on any statement or reinsurance record shall not affect either party’s liability under this Agreement. Any such error shall be rectified promptly after discovery.

 

2.             Unintentional Errors and Omissions . If the failure of either party to comply with any

 

27



 

provision of this Agreement is unintentional or the result of a misunderstanding or oversight, then both parties shall be restored as closely as possible to the positions they would have occupied if no such failure had occurred. Any such error or omission shall be rectified promptly after discovery.

 

Article X                Inspection of Records .

 

Upon any reasonable request, each Party, at its own expense, shall have the right to inspect all books, records, and documents of the other party relating to the reinsurance under this Agreement at any reasonable time during normal business hours at the office of the other party; provided , however , that neither party shall be obligated to provide access to any such books, records or documents if such party determines, in its reasonable judgment, that doing so would violate Applicable Law or a contract, agreement or obligation of confidentiality owing to a third party, jeopardize the protection of an attorney-client privilege, or expose such party to liability for disclosure of sensitive or personal information, it being understood that such party shall use its commercially reasonable efforts to enable such information to be furnished or made available to the other party without so jeopardizing privilege, contravening such Applicable Law or obligation or exposing such party to such liability. Each Party shall maintain its respective books and records relating to the Reinsured Policies (A) in accordance with any and all Applicable Laws and (B) with a degree of care and diligence similar to that used in the internal record retention procedures and policies for its other businesses; provided that the Cedent shall maintain such books and records until at least the sixth anniversary of the Effective Date; provided that Cedent may destroy such records in its discretion following the third anniversary of the Effective Date after giving reasonable prior written notice to Reinsurer of its intent to destroy such documents.

 

Article XI              Insolvency .

 

1.             Cedent . If Cedent is judged Insolvent, Reinsurer will pay all reinsurance under this Agreement directly to Cedent, its liquidator, receiver or statutory successor on the basis of Cedent’s liability under the Reinsured Policies without diminution because of Cedent’s Insolvency. It is understood, however, that in the event of Cedent’s Insolvency, the liquidator, receiver or statutory successor will give Reinsurer written notice of a pending claim on a Reinsured Policy within a reasonable time after the claim is filed in the Insolvency proceedings. While the claim is pending, Reinsurer may investigate and interpose, at its own expense in the proceedings where the claim is to be adjudicated, any defense which Reinsurer may deem available to Cedent, its liquidator, receiver or statutory successor. It is further understood that the expense Reinsurer incurs will be chargeable, subject to court approval, against Cedent as part of the expense of liquidation to the extent of a proportionate share of the benefit which may accrue to Cedent solely as a result of the defense Reinsurer has undertaken. Where two or more reinsurers are involved in the same claim and a majority in interest elect to interpose defense to the claim, the expenses will be apportioned in accordance with the terms of the reinsurance agreement as though Cedent had incurred the expense.

 

2.             Reinsurer . If Reinsurer becomes Insolvent, Reinsurer shall immediately notify, in writing, Cedent of its Insolvency. In such event, Cedent may recapture all Reinsured Policies ceded under this Agreement on thirty (30) calendar days’ notice with Reinsurer and Cedent effecting a Terminal Accounting and Settlement under Section 3 of Article XIV.

 

Article XII            Dispute Resolution .

 

1.             General Provisions .

 

(a)           Any dispute, controversy or claim arising out of or relating to this Agreement, including its formation, or the validity, interpretation, breach or termination thereof (a “ Dispute ”) shall be resolved in accordance with the procedures set forth in this Article, which

 

28



 

shall be the sole and exclusive procedures for the resolution of any such Dispute unless otherwise specified below; provided , however , that any disputes of the kind described in Section 5 of Article XIV shall be resolved in the manner described therein. Upon either party providing an initial written notice to the other containing a statement of the Dispute and outlining the position of each party (an “ Initial Notice ”), all communications between the parties or their Representatives in connection with the attempted resolution of any Dispute shall be deemed to have been delivered in furtherance of a Dispute settlement and shall be exempt from discovery and production, and shall not be admissible in evidence for any reason (whether as an admission or otherwise), in any arbitral or other proceeding for the resolution of the Dispute.

 

(b)           The specific procedures set forth below, including but not limited to the time limits referenced therein, may be modified by agreement of the parties in writing.

 

(c)           All applicable statutes of limitations and defenses based upon the passage of time shall be tolled while the procedures specified in this Article are pending. The parties will take such action, if any, required to effectuate such tolling.

 

(d)           Except as otherwise set forth in this Agreement, each party will bear its own attorneys’ fees and costs incurred in connection with the resolution of any Dispute in accordance with this Article.

 

2.             Arbitration .

 

(a)           Subject to Sections 3 and 4 of this Article XII, if a Dispute other than a Litigated Dispute is not resolved by negotiation as provided in Section 1 of this Article within thirty (30) calendar days from the delivery of the Initial Notice, either party may submit such Dispute to be finally resolved by arbitration pursuant to the CPR Institute for Dispute Resolution (the “ CPR ”) Rules for Non-Administered Arbitration as then in effect (the “ CPR Arbitration Rules ”) as modified by this Agreement. The parties consent to a single, consolidated arbitration for all known Disputes other than Litigated Disputes existing at the time of the arbitration and for which arbitration is permitted.

 

(b)           The neutral organization for purposes of the CPR Arbitration Rules will be the CPR. The arbitral tribunal shall be composed of three arbitrators who are each experienced in the U.S. reinsurance business, of whom each party shall appoint one in accordance with the “ screened ” appointment procedure provided in Rule 5.4 of the CPR Arbitration Rules. The non-party appointed arbitrators must have prior U.S. reinsurance experience as a present or former officer or management employee of an insurance company, but not of the Issuing Company, or Reinsurer, or any of their respective Affiliates. The arbitration shall be conducted in New York City. Each party shall be permitted to present its case, witnesses and evidence, if any, in the presence of the other party. A written transcript of the proceedings shall be made and furnished to the parties. The arbitrators shall determine the Dispute in accordance with the law of the Commonwealth of Virginia, without giving effect to any conflict of law rules or other rules that might render such law inapplicable or unavailable, and shall apply this Agreement according to its terms, provided that the provisions relating to arbitration shall be governed by the Federal Arbitration Act, 9 U.S.C. §§ 1 et seq. The arbitral tribunal shall endeavor to render its award or order resulting from any arbitration within thirty (30) calendar days following the termination of the arbitration proceedings.

 

(c)           The parties agree to be bound by any award or order resulting from any arbitration conducted hereunder and further agree that judgment on any award or order resulting from an arbitration conducted under this Section may be entered and enforced in any court having jurisdiction thereof.

 

(d)           Except as expressly permitted by this Agreement, no party will commence or

 

29



 

voluntarily participate in any court action or proceeding concerning a Dispute, except (i) for enforcement as contemplated by Section 2(c) of this Article, (ii) to restrict or vacate an arbitral decision based on the grounds specified under Applicable Law, or (iii) for interim relief as provided in Section 2(e) of this Article. For purposes of the foregoing the parties hereto submit to the non-exclusive jurisdiction of the New York Courts.

 

(e)           In addition to the authority otherwise conferred on the arbitral tribunal, the tribunal shall have the authority to make such orders for interim relief, including injunctive relief, as it may deem just and equitable. If the tribunal shall not have been appointed, either party may seek interim relief from a court having jurisdiction if the award to which the applicant may be entitled may be rendered ineffectual without such interim relief. Upon appointment of the tribunal following any grant of interim relief by a court, the tribunal may affirm or disaffirm such relief, and the parties will seek modification or rescission of the court action as necessary to accord with the tribunal’s decision.

 

(f)            In case of any arbitration in respect of a claim for indemnification pursuant to clause (y) of Section 5(d)(ii) of Article VIII, the Parties shall be entitled to discovery as broad as that permitted under the US Federal Rules of Civil Procedure. Nothing in this clause (f) shall be construed to limit any discovery otherwise available under the CPR Arbitration Rules in case of any other arbitration of a Dispute under this Agreement.

 

3.             Litigation .

 

(a)           Notwithstanding the foregoing, any claim by a Reinsurer Indemnified Party for indemnification for Excluded Liabilities pursuant to clause (x) of Section 5(c)(ii) of Article VIII (a “ Litigated Dispute ”) shall be heard and determined by a New York Court pursuant to Section 3(b) of this of this Article XII, provided , to the extent such Excluded Liabilities are Extra-Contractual Obligations, and such Extra-Contractual Obligations relate to a Disputed claim subject to arbitration pursuant to Section 2 of this Article XII, then such claim for Excluded Liabilities shall be consolidated with any such arbitral proceeding then pending and shall be heard and determined in accordance with Section 2 of this Article XII, and shall not be a Litigated Dispute hereunder.

 

(b)           The Parties hereby irrevocably submit to the jurisdiction of the courts of the State of New York and the federal courts of the United States of America located in the State, City and County of New York (the “ New York Courts ”) in any Litigated Dispute. The Parties irrevocably agree that such jurisdiction of such courts with respect to Litigated Disputes shall be exclusive, except solely to the extent that all such courts shall lawfully decline to exercise such jurisdiction. Each Party hereby waives, and agrees not to assert, as a defense in any Litigated Dispute, that it is not subject to such jurisdiction. The Parties hereby waive, and agree not to assert, to the maximum extent permitted by law, as a defense in any Litigated Dispute, that such Litigated Dispute may not be brought or is not maintainable in such courts or that the venue thereof may not be appropriate or that this Agreement may not be enforced in or by such courts. The Parties hereby consent to and grant any such court jurisdiction over the person of such parties and agrees that mailing of process or other papers in connection with any such Litigated Dispute in the manner provided in Section 6 of Article XV or in such other manner as may be permitted by law, shall be valid and sufficient service thereof. The Parties agree that final judgment in any such Litigated Dispute shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.

 

4.             Overlapping Matters . The Parties acknowledge that Litigated Disputes and other Disputes under this Agreement may contain common issues of fact or law and, in such event, any such common issues shall be heard and determined in accordance with the procedures applicable to Litigated Disputes set forth in Section 3 of this Article XII. In the event of any

 

30



 

overlap between a Dispute under this Agreement and a dispute relating to the Master Agreement, the dispute resolution procedures set forth in the Master Agreement shall control.

 

Article XIII           Confidentiality; Privacy Requirements .

 

1.               Confidentiality . From and after the Closing Date, Reinsurer and its Affiliates, on the one hand, and Cedent and its Affiliates, on the other hand, shall, and shall cause their respective Representatives to, maintain in confidence any written, oral or other information relating to or obtained from the other party or its Affiliates, except that the foregoing requirements of this Section shall not apply to the extent that (a) any such information is or becomes generally available to the public, other than (i) in the case of Reinsurer’s Confidential Information, as a result of disclosure by Cedent or its Affiliates or any of their respective Representatives, and (ii) in the case of Cedent’s Confidential Information, as a result of disclosure by Reinsurer or its Affiliates or any of their respective Representatives, (b) any such information is required by Applicable Law or a Governmental Authority to be disclosed after prior notice has been given to the other party, if reasonably practicable (including any report, statement, testimony or other submission to such Governmental Authority), (c) any such information is reasonably necessary to be disclosed in connection with any dispute with respect to this Agreement (including in response to any summons, subpoena or other legal process or formal or informal investigative demand issued to the disclosing party in the course of any litigation, investigation or administrative proceeding), or (d) any such information was or becomes available to such party on a non-confidential basis and from a source (other than a party to this Agreement or its Affiliates or any of their respective Representatives) that is not known to such party to be bound by a confidentiality agreement with respect to such information. Each of the parties hereto shall instruct its Representatives having access to such information of such obligation of confidentiality, and each party shall be liable to the other party for any violation of this Article by its Representatives. Notwithstanding anything in this Agreement to the contrary, the parties acknowledge and agree that each party may share any information relating to or obtained from the other party with (i) any insurance regulatory authority or (ii) the Internal Revenue Service or any other taxing authority as each party deems necessary or advisable in its good faith judgment. Upon a Change of Control of GLIC, if applicable, Cedent shall (i) use commercially reasonable efforts not to permit GLIC to be in breach of Section [ ] 5  of the GLIC Reinsurance Agreements, (ii) seek to enforce Section [ ] of the GLIC Reinsurance Agreements in the event of a breach thereof by GLIC and (iii) not waive Section [ ] of the GLIC Reinsurance Agreements without the prior written consent of Reinsurer. Except as would not impair Cedent’s rights under Section [ ] of the GLIC Reinsurance Agreement, Cedent shall not amend, modify, supplement or terminate Section [ ] of the GLIC Reinsurance Agreement without the prior written consent of Reinsurer.

 

2.             Compliance . In connection with maintaining, administering, handling and transferring the data of the Policyholders and other recipients of benefits under the Reinsured Policies, Cedent and Reinsurer shall, and shall cause their respective Affiliates to, comply with all confidentiality and security obligations applicable to them in connection with the collection, use, disclosure, maintenance and transmission of personal, private, health or financial information about individual Policyholders or benefit recipients under the Reinsured Policies (collectively, “ Personal Information ”), including the provisions of privacy policies under which such information was gathered and those Applicable Laws currently in place and which may become effective during the term of this Agreement, including the Health Insurance Portability and Accountability Act of 1996. Reinsurer and Cedent shall permit each other and their

 


5  A provision will be added to the GLIC feeder treaty prior to closing, such that GLIC will have corresponding obligations to Cedent.

 

31



 

respective agents and Representatives, as well as Governmental Authorities to the extent required by Applicable Law, to audit Reinsurer’s and Cedent’s compliance herewith, such audit not to be conditioned or delayed. Cedent shall also permit and enable individual subjects of Personal Information, upon request from such individuals, to review and correct such Personal Information maintained by Cedent about them. Reinsurer and Cedent agree that Personal Information shall be disclosed only (a) as required by Applicable Law or a Governmental Authority, (b) as required or appropriate to perform their respective duties and obligations hereunder, (c) as required to perform Cedent, GLIC or GLICNY’s respective obligations, or enforce their respective rights, under the Ceded Reinsurance Agreements, or (d) as otherwise agreed by the Parties. Upon a Change of Control of GLIC, if applicable, Cedent shall (i) use commercially reasonable efforts not to permit GLIC to be in breach of Section [ ] 6  of the GLIC Reinsurance Agreements, (ii) seek to enforce Section [ ] of the GLIC Reinsurance Agreements in the event of a breach thereof by GLIC and (iii) not waive Section [ ] of the GLIC Reinsurance Agreements without the prior written consent of Reinsurer. Any costs and expenses incurred by Cedent in enforcing Section [ ] of the GLIC Reinsurance Agreements shall be borne by Reinsurer and Reinsurer shall promptly reimburse Cedent for all costs and expenses incurred by Cedent in connection therewith. Except as would not impair Cedent’s rights under Section [ ] of the GLIC Reinsurance Agreement, Cedent shall not amend, modify, supplement or terminate Section [ ] of the GLIC Reinsurance Agreement without the prior written consent of Reinsurer.

 

3.             Privacy Breach . If either Party discovers a security breach that has resulted or may reasonably result in unauthorized access to or disclosure of, or have a material adverse affect on, Personal Information or would require a breach notification to a Policyholder under Applicable Law (a “ Security Incident ”), such Party shall, at its own expense, (a) notify the other Party as promptly as reasonably practicable, (b) promptly (and in any event within two (2) Business Days) investigate such Security Incident, (c) promptly (and in any event within two (2) Business Days) take commercially reasonable steps to restore the security of such Personal Information, notifying the other Party with respect to such measures, (d) deliver any required or requested notifications or other communications to third parties (including Policyholders) with respect to such Security Incident in a timely manner, and (e) cooperate with the other Party and any Governmental Authority investigating such Security Incident. The Parties shall in good faith seek to resolve disputes arising under this Section on an expedited basis.

 

1.             Security Precautions . Reinsurer and Cedent shall take all commercially reasonable steps to (a) maintain the confidentiality and security of all Confidential Information of the other party and Personal Information, (b) prevent unauthorized access to Confidential Information of the other party and Personal Information and (c) protect the Confidential Information of the other party and Personal Information from anticipated security threats or hazards.

 

Article XIV           Duration of Agreement; Termination .

 

1.             Duration . This Agreement shall be indefinite as to its duration. Each Reinsured Policy shall continue to be reinsured until the earliest of: (a) such Reinsured Policy terminates in accordance with its contractual provisions or, in the case of an Assumed Policy, ceases to be ceded to Cedent by GLIC or GLICNY; (b) the date on which all Reinsured Benefits with respect to such Reinsured Policy are fully satisfied; (c) termination of liability pursuant to Section 2 of this Article; and (d) all Reinsured Benefits in respect of such Reinsured Policy are recaptured by Cedent (i) for reason of a failure to provide Credit Collateral as required by Section 4 of Article VIII or (ii) due to Reinsurer’s Insolvency under Section 2 of Article XI. In

 


6  A provision will be added to the GLIC feeder treaty prior to closing, such that GLIC will have corresponding obligations to Cedent.

 

32



 

the event that Reinsurer’s liability terminates with respect to all Reinsured Policies, whether by recapture or otherwise, or there is a partial recapture under Section 4 of Article VIII, the resulting termination of Reinsurer’s liability is contingent upon the Parties effecting a Terminal Accounting and Settlement or Partial Settlement in accordance with Section 3 of this Article XIV or a Partial Settlement in accordance with Section 4 of this Article XIV, as applicable. In no event shall the interpretation of this Section imply a unilateral right of either Party to terminate any portion of this Agreement.

 

2.             Termination by Reinsurer for Non-Payment of Premiums . In the event that any material undisputed amounts that are included in the Net Settlement calculation are due to Reinsurer hereunder (including any Recurring Reinsurance Premiums) but not paid when due pursuant to the terms hereof, Reinsurer may notify Cedent in writing of the failure to pay such amounts. Cedent will have thirty (30) calendar days within which to pay any such amounts that are in arrears. If all such amounts that are in arrears are not paid by the end of the thirty (30) calendar day period, including any that came to be in arrears during the thirty (30) calendar day period, Reinsurer will have the right to terminate this Agreement by providing written notice to Cedent, which termination shall be effective on the date specified in such notice, which date shall be at least thirty (30) calendar days following Cedent’s receipt of such notice.

 

3.             Payments on Full Termination or Recapture of this Agreement . If this Agreement is terminated by Reinsurer pursuant to the foregoing Section 2, or if Cedent recaptures all of the Reinsured Benefits ceded hereunder pursuant to Section 4 of Article VIII or Section 2 of Article XI, the parties will effect a Terminal Accounting and Settlement as of the Termination Date in accordance with this Section 3. In connection with such Terminal Accounting and Settlement:

 

(a)                                  Cedent shall pay to Reinsurer all Recurring Reinsurance Premiums for the Accounting Period in which the Termination Date occurs; and

 

(b)                                  Reinsurer shall pay to Cedent an amount equal to the sum of (i) all Recurring Reinsurance Allowances for the Accounting Period in which the Termination Date occurs, (ii) all Reinsured Benefits Settled but not yet paid by Reinsurer to Cedent, (iii) all Reinstatement Allowances arising for the Accounting Period in which the Termination Date occurs, (iv) all Commissions for the Accounting Period in which the Termination Date occurs, (v) the IMR Recapture Amount, (vi) in the event of a termination under Section 2 of Article XIV, an amount equal to (A) the Economic Reserves as of the Termination Date for all then in-force Reinsured Policies, minus (B) the unamortized portion of the Base Ceding Commission, (vii) in the event of a recapture under Section 4(b)(ii) of Article VIII, an amount equal to the Reinsurance Credit Event Recapture Payment, and (viii) in the event of a recapture under Section 2 of Article XI, an amount equal to the Economic Reserves as of the Termination Date for all then in-force Reinsured Policies. For purposes hereof, the “unamortized portion of the Base Ceding Commission” means the product of (x) the Base Ceding Commission times (y) a fraction, the numerator of which is the Ceded Total Reserves as of the Termination Date and the denominator of which is the Ceded Total Reserves as of the Effective Time; provided , in each case, that “Ceded Total Reserves” shall be determined without

 

33



 

giving effect to any reduction in reserves attributable to Excess Reinsurance.

 

Cedent shall calculate the amounts set forth in (a) and (b) above and provide them, with reasonable supporting information, to Reinsurer within thirty (30) calendar days after the Termination Date. Cedent and Reinsurer shall settle all undisputed amounts calculated under (a) and (b) above on a net basis. If the amount calculated under (a) exceeds the amount calculated under (b), Cedent shall pay such difference to Reinsurer with the delivery of such calculations. Otherwise, Reinsurer shall remit such difference to Cedent within ten (10) Business Days after Reinsurer’s receipt of Cedent’s calculations of (a) and (b).

 

4.             Partial Recapture and Termination . If Cedent effects a partial recapture under this Agreement of the Subject Risks under Section 4(b)(ii) of Article VIII, Cedent and Reinsurer will effect a partial terminal settlement (a “ Partial Settlement ”) of this Agreement with the effective date of such Partial Settlement being the effective date of the partial recapture. Cedent shall effect the Partial Settlement using the same mechanism set forth in Section 3 of this Article except that the amounts called for under Sections 3(a), 3(b)(i), 3(b)(ii), 3(b)(iii) 3(b)(v) and 3(b)(vii) shall be multiplied (and thus reduced) by the pro rata share of the Reinsured Policies to be recaptured under such recapture and Sections 3(b)(vi) and 3(b)(viii) shall be disregarded. Following such partial recapture, this Agreement shall remain in full force and effect for the Reinsured Policies or portions of the Reinsured Policies, as applicable, not recaptured.

 

5.             Terminal Accounting Disputes . Except with respect to the calculation of the Reinsurance Credit Event Recapture Payment (which is subject to the procedures set forth in Exhibit IV), in the event that Reinsurer disagrees with Cedent’s calculation of the Terminal Accounting and Settlement, Reinsurer shall, within ten (10) Business Days after its receipt of such calculation, deliver written notice to Cedent of such disagreement and the Parties shall attempt in good faith to resolve such disagreement. Any resolution agreed to in writing by the Parties shall be final and binding upon the Parties. If the Parties are unable to resolve any such disagreement within ten (10) Business Days after Reinsurer delivers written notice of any such disagreement to Cedent, the Parties shall jointly request the Recapture Actuary to determine the Terminal Accounting and Settlement. The Recapture Actuary’s determination of the Terminal Accounting and Settlement shall be final and binding upon the Parties. The fees, costs and expenses associated with the Recapture Actuary’s determination shall be allocated between Cedent and Reinsurer in accordance with the Recapture Actuary’s judgment as to the relative merits of the Parties’ proposals in respect of the dispute. After a final and binding resolution of any dispute described in this Section 5 is reached, the Parties agree to make any necessary adjustments under Section 3 of this Article XIV.

 

6.             Survival . Notwithstanding the other provisions of this Article, the terms and conditions of Articles I, V,XII, XIII, XIV and XV, and Section 7 of Article II, shall remain in full force and effect after termination of this Agreement.

 

Article XV             Miscellaneous .

 

1.             Entire Agreement . This Agreement, together with the Master Agreement, represent the entire agreement between Reinsurer and Cedent concerning the subject matter hereof, including with respect to the business reinsured hereunder, and supersede all prior agreements, written or oral, with respect thereto.

 

2.             Amendments . This Agreement may be amended only by written agreement of the parties. Any change or modification to this Agreement shall be null and void unless made by amendment to this Agreement and signed by both parties.

 

3.             Severability . If any provision of this Agreement is held to be illegal, invalid or

 

34



 

unenforceable under any present or future law or if determined by a court of competent jurisdiction to be unenforceable, and if the rights or obligations of Cedent or Reinsurer under this Agreement will not be materially and adversely affected thereby, such provision shall be fully severable, and this Agreement will be construed and enforced as if such illegal, invalid or unenforceable provision had never comprised a part of this Agreement, and the remaining provisions of this Agreement shall remain in full force and effect and will not be affected by the illegal, invalid or unenforceable provision or by its severance herefrom.

 

4.             Waiver . Either party may choose not to enforce or insist upon the strict adherence to any provision or right under this Agreement. If either party so elects, it will not be considered to be a permanent waiver of such provision nor in any way affect the validity of this Agreement. The applicable party will still have the right to insist upon the strict adherence to that provision or any other provision of this Agreement in the future. Any waiver of provisions by a party under this Agreement must be in writing and signed by a duly authorized representative of the party.

 

5.             Governing Law . This agreement shall be governed by the laws of the Commonwealth of Virginia, without regard to its conflicts of law doctrine.

 

6.             Notices . (a)            Except as set forth in paragraph (b) of this Section 6, notices and other communications required or permitted to be given under this Agreement shall be effective if in writing and (i) mailed by United States registered or certified mail, return receipt requested, (ii) delivered by overnight express mail, (iii) e-mailed (with confirmation of receipt) or (iv) sent by facsimile transmission (followed by a confirmation mailed by first class or overnight mail) to:

 

If to Cedent:

 

If to Reinsurer:

 

 

 

Genworth Life and Annuity Insurance Company

 

Protective Life Insurance Company

6620 West Broad Street

 

2801 Highway 280 South

Richmond, VA 23230

 

Birmingham, AL 35233

Attn: General Counsel

 

Attention: General Counsel

 

 

Facsimile: 205-268-3597

 

 

Email: Debbie.Long@protective.com

 

 

 

With a copy to:

 

With a copy to:

 

 

 

Genworth Life and Annuity Insurance Company

 

Debevoise & Plimpton LLP

3100 Albert Lankford Dr.

 

919 Third Avenue

Lynchburg, VA 24501

 

New York, NY 10022

Attn: [Reinsurance Operations]

 

Attention: Marilyn A. Lion

 

 

Facsimile: 212-909-6836

 

 

Email: malion@debevoise.com

 

Either party hereto may change the names and addresses where notice is to be given pursuant to this Section 6(a) by providing notice to the other party of such change in accordance with this Section.

 

(b)           The written notice required to be delivered by Cedent to Reinsurer pursuant to Section 3 of Article VI in the event that Cedent intends to Contest a claim shall be effective upon the later of (i) the date (A) mailed by United States registered or certified mail, return receipt requested or (B) mailed by overnight express mail, and (ii) the date e-mailed (with confirmation of receipt), in each case, to the address of Reinsurer specified in Section 6(a) of this Article XV and to:

 

35



 

Protective Life Insurance Company

1620 Westgate Circle, Suite 200

Brentwood, TN 37027

Attention: AVP of Life Claims

Email: contestable.claims@protective.com

 

Reinsurer may change the name or address where notice is to be given pursuant to this Section 6(b) by providing notice to the other party of such change in accordance with this Section.

 

7.             Consent to Jurisdiction . Without limiting the parties’ obligations under Article VIII, the parties agree that in the event of any action, suit or proceeding arising in connection with this Agreement, each of the Parties submits to the jurisdiction of the state and federal courts sitting in the State, City and County of New York. Each of the Parties shall comply with all requirements necessary to give such courts jurisdiction, and shall abide by the final decision of such court or of any appellate court in the event of an appeal

 

8.             No Trial by Jury . EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

9.             Assignment . The reinsurance under this Agreement may not be novated, transferred, or assigned by either party without the non-transferring party’s consent; provided , however , that the merger of Cedent with an entity which was under common control with it before such merger, regardless of whether Cedent is the survivor of such merger, shall not be deemed to be an assignment; any such resulting merged entity shall be considered to be Cedent under this Agreement. Upon assignment, this Agreement will be binding upon the respective successors and assigns.

 

10.          Captions . The captions contained in this Agreement are for reference only and are not part of the Agreement.

 

11.          Counterparts . This Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument. Cedent and Reinsurer agree that transmission of copies of original signatures via electronic means, either by facsimile or as a “scanned” document attached to electronic mail, shall constitute valid execution of this Agreement. In the event of an electronic exchange of signatures for this Agreement, Cedent and Reinsurer agree to subsequently exchange original, “wet” execution signatures of this Agreement within a reasonable time following the electronic exchange of signatures; provided , however , that the failure of any party to exchange original “wet” execution signatures of this Agreement shall in no event affect the validity or enforceability of this Agreement. Such “wet” execution signatures will reflect the date of original execution and thus will be executed in counterpart.

 

12.          Conditions . The reinsurance hereunder is subject to the same limitations and conditions specified in the policies issued by Cedent, GLIC or GLICNY, as applicable, which are reinsured hereunder, except as otherwise provided in this Agreement.

 

13.          No Third Party Beneficiaries . This Agreement is solely between Reinsurer and Cedent. There is no third party beneficiary to this Agreement. Reinsurance under this Agreement shall not create any right or legal relationship between Reinsurer and any other Person, for example, GLIC, GLICNY, any insured, Policyholder, agent, beneficiary, other cedent or other reinsurer. Cedent or, as applicable, the Issuing Company shall be and remain directly liable to any insured, Policyholder, agent, beneficiary and other cedent of the Reinsured Policies.

 

36



 

14.          Waiver of Duty of Utmost Good Faith . In recognition that the consummation of the transactions among the Parties contemplated by this Agreement and the Master Agreement was based on mutually negotiated representations, warranties, covenants, remedies and other terms and conditions, each of Cedent and Reinsurer hereby absolutely and irrevocably waives resort to the duty of “utmost good faith” or any similar principle of disclosure in connection with the negotiation and execution of this Agreement and the Master Agreement; provided, however, that each Party reserves all of its rights and remedies in respect of any such duty of utmost good faith or similar duty of disclosure of the other Party arising after the Effective Time to the extent information relating to the liabilities reinsured hereunder has not been disclosed, or is not otherwise available to such Party.

 

15.          Construction .

 

(a)           Any reference herein to “days” (as opposed to “Business Days”) shall be deemed to mean calendar days.

 

(b)           Any reference herein to a “consent” shall be deemed to mean prior written consent.

 

(c)           Any reference herein to “notice” shall be deemed to mean prior written notice.

 

(d)           Any reference herein to “including” and words of similar import shall mean “including without limitation,” unless otherwise specified.

 

(remainder of page intentionally left blank)

 

37



 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed on the date(s) indicated below.

 

 

Genworth Life and Annuity Insurance Company

 

 

 

By:

 

 

 

 

 

 

 

Name:

 

 

 

 

 

 

 

Title:

 

 

 

 

 

 

 

Date Signed:

 

7

 

 

 

 

 

Protective Life Insurance Company

 

 

 

By:

 

 

 

 

 

 

 

Name:

 

 

 

 

 

 

 

Title:

 

 

 

 

 

 

 

Date Signed:

 

 

 


7  Both Parties will cause this Agreement to be signed and dated the Closing Date.

 


Exhibit 12

 

CONSOLIDATED EARNINGS RATIOS

 

The following table sets forth, for the years and periods ended, Protective Life Insurance Company’s (the “Company”) ratios of:

 

·                   Consolidated earnings to fixed charges.

·                   Consolidated earnings to fixed charges before interest credited on investment products.

 

 

 

Successor Company

 

 

Predecessor Company

 

 

 

February 1, 2015

 

 

January 1, 2015

 

For The Nine

 

 

 

 

 

 

 

 

 

 

 

 

 

to

 

 

to

 

Months ended

 

For The Year Ended December 31,

 

 

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

2014

 

2013

 

2012

 

2011

 

2010

 

Ratio of Consolidated Earnings to Fixed Charges (1)

 

1.2

 

 

2.5

 

1.7

 

1.8

 

1.4

 

1.4

 

1.4

 

1.3

 

Ratio of Consolidated Earnings to Fixed Charges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Before Interest Credited on Investment
Products
(2)

 

2.8

 

 

13.9

 

6.6

 

7.0

 

4.7

 

5.8

 

6.1

 

5.5

 

 


(1)              The Company calculates the ratio of “Consolidated Earnings to Fixed Charges” by dividing the sum of income (loss) from continuing operations before income tax (BT), interest expense (which includes an estimate of the interest component of operating lease expense) (I) and interest credited on investment products (IP) by the sum of interest expense (I) and interest credited on investment products (IP).   The formula for this ratio is: (BT+I+IP)(I+IP). The Company continues to sell investment products that credit interest to the contract holder.  Investment products include products such as guaranteed investment contracts, annuities, and variable universal life interest credited insurance policies.  The inclusion of interest credited on investment products results in a negative impact on the ratio of earnings to fixed charges because the effect of increases in interest credited to contract holders more than offsets the effect of the increase in earnings.

(2)              The Company calculates the ratio of “Consolidated Earnings to Fixed Charges Before Interest Credited on Investment Products” by dividing the sum of income (loss) from continuing operations before income tax (BT) and interest expense (I) by interest expense (I).  The formula for this calculation, therefore, would be: (BT+I)/I.

 



 

Computation of Consolidated Earnings Ratios

 

 

 

Successor

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Company

 

 

Predecessor Company

 

 

 

February 1, 2015

 

 

January 1, 2015

 

For The Nine

 

 

 

 

 

 

 

 

 

 

 

 

 

to

 

 

to

 

Months Ended

 

For The Year Ended December 31,

 

 

 

September 30, 2015

 

 

January 31, 2015

 

September 30, 2014

 

2014 

 

2013 

 

2012 

 

2011 

 

2010 

 

 

 

 

 

 

(Dollars In Thousands, Except Ratio Data)

 

Computation of Ratio of Consolidated Earnings to Fixed Charges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from Continuing Operations before Income Tax

 

$

145,090

 

 

$

132,847

 

$

508,346

 

$

738,789

 

$

422,499

 

$

459,579

 

$

475,275

 

$

333,176

 

Add Interest Expense (1)

 

79,413

 

 

10,265

 

90,811

 

122,152

 

115,113

 

95,759

 

93,797

 

73,841

 

Add Interest Credited on Investment Products

 

521,760

 

 

79,088

 

663,117

 

824,418

 

875,180

 

962,678

 

993,574

 

972,806

 

Earnings before Interest, Interest Credited on Investment Products and Taxes

 

$

746,263

 

 

$

222,200

 

$

1,262,274

 

$

1,685,359

 

$

1,412,792

 

$

1,518,016

 

$

1,562,646

 

$

1,379,823

 

Earnings before Interest, Interest Credited on Investment Products and Taxes Divided by Interest expense and Interest Credited on Investment Products

 

1.2

 

 

2.5

 

1.7

 

1.8

 

1.4

 

1.4

 

1.4

 

1.3

 

Computation of Ratio of Consolidated Earnings to Fixed Charges Before Interest Credited on Investment Products

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from Continuing Operations before Income Tax

 

$

145,090

 

 

$

132,847

 

$

508,346

 

$

738,789

 

$

422,499

 

$

459,579

 

$

475,275

 

$

333,176

 

Add Interest Expense (1)

 

79,413

 

 

10,265

 

90,811

 

122,152

 

115,113

 

95,759

 

93,797

 

73,841

 

Earnings before Interest and Taxes

 

$

224,503

 

 

$

143,112

 

$

599,157

 

$

860,941

 

$

537,612

 

$

555,338

 

$

569,072

 

$

407,017

 

Earnings before Interest and Taxes Divided by Interest Expense

 

2.8

 

 

13.9

 

6.6

 

7.0

 

4.7

 

5.8

 

6.1

 

5.5

 

 


(1) Interest expense primarily relates to interest on our non-recourse funding obligations.

 


Exhibit 31(a)

 

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, John D. Johns, certify that:

 

1.         I have reviewed the Quarterly Report on Form 10-Q for the period ended September 30, 2015, of Protective Life Insurance Company;

 

2.         Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.         Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.         The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)       Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)       Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)        Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)       Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.         The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a)       All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)       Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date:  November 10, 2015

 

 

/s/ John D. Johns

 

Chairman of the Board,

 

President and Chief Executive Officer

 


Exhibit 31(b)

 

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Richard J. Bielen, certify that:

 

1.         I have reviewed the Quarterly Report on Form 10-Q for the period ended September 30, 2015, of Protective Life Insurance Company;

 

2.         Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.         Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.         The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)       Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)       Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)        Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)       Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.         The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a)       All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)       Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date:  November 10, 2015

 

 

/s/ Richard J. Bielen

 

Vice Chairman and

 

Chief Financial Officer

 


Exhibit 32(a)

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Protective Life Insurance Company (the “Company”) on Form 10-Q for the period ended September 30, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John D. Johns, Chairman of the Board, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1)          The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)          The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ John D. Johns

 

Chairman of the Board,

 

President and Chief Executive Officer

 

 

 

November 10, 2015

 

 

This certification accompanies the Report pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.

 


Exhibit 32(b)

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Protective Life Insurance Company (the “Company”) on Form 10-Q for the period ended September 30, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Richard J. Bielen, Vice Chairman and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1)          The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)          The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Richard J. Bielen

 

Vice Chairman and

 

Chief Financial Officer

 

 

 

November 10, 2015

 

 

This certification accompanies the Report pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.